Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
ABHD12B	"BEM46L3, C14orf29"	ENSG00000131969	"Abhydrolase domain containing 12B"	Q7Z5M8	14	50872160-50904970	"Predicted intracellular proteins"		Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 10.0;retina: 10.0;skin 1: 21.6"	"Cell type enriched"	"Detected in some"	8	"Muller glia cells: 136.7"	"Cancer enriched"	"Detected in many"	5	"testis cancer: 7.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"eosinophil: 2.3;neutrophil: 5.4"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 5.4"	"Cell line enhanced"	"Detected in some"		"HEK 293: 1.3;Hep G2: 1.4;NB-4: 2.4;NTERA-2: 1.6;RH-30: 2.0;SH-SY5Y: 1.3;SuSa: 2.9;T-47d: 1.3;THP-1: 1.9"	"Region enriched"	"Detected in single"	5	"thalamus: 2.3"	"Low region specificity"	"Detected in many"			HPA002873	Uncertain		Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"HPA002873: AB_2220573"	"unprognostic (6.61e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.92e-3)"	"unprognostic (1.99e-3)"	"unprognostic (4.63e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.31e-2)"	"unprognostic (6.27e-2)"	"unprognostic (3.30e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.70e-3)"	"unprognostic (3.16e-2)"	"unprognostic (9.62e-2)"	"unprognostic (3.18e-3)"	"unprognostic (1.68e-1)"	1.1	0.2	2.4	0.4	10.0	2.4	2.8	0.3	5.2	0.2	1.5	5.4	0.3	0.2	0.8	0.4	0.7	2.0	0.4	0.5	1.4	1.2	0.6	0.2	0.8	0.4	2.2	2.7	0.3	1.1	1.3	0.3	0.4	2.2	0.3	2.4	10.0	0.2	0.2	0.2	21.6	0.3	0.2	0.7	0.2	0.2	1.2	3.9	0.0	0.4	0.0	0.3	0.2	0.2	0.0	0.1	5.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	1.4	0.5	0.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	1.6	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	2.9	1.3	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.9	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.4	0.0	0.1	0.0	0.0	0.0	2.4	10.0	0.3	5.2	1.4	1.2	2.2	2.7	2.2	3.9	0.0	0.0	0.0	0.0	0.3	3.3	1.4	0.0	14.7	0.0	1.8	2.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	2.8	1.1	0.0	0.0	0.0	0.9	136.7	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.2	0.2	1.3	0.2	0.0	1.6	0.1
AC092442.1		ENSG00000284684			4	6064977-6070162	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in single"	16	"blood: 1.5"	"Not detected"	"Not detected"											"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.5;naive CD8 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	16	"T-cells: 1.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	15	"hypothalamus: 0.7"											NA	NA																							0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.3	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACBD7	"bA455B2.2, FLJ38219"	ENSG00000176244	"Acyl-CoA binding domain containing 7"	Q8N6N7	10	15077523-15088776	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 35.3"	"Cell type enhanced"	"Detected in some"	12	"Ciliated cells: 2.7;Cone photoreceptor cells: 2.0;Early spermatids: 4.1;Intestinal endocrine cells: 1.7;Late spermatids: 1.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"JURKAT: 24.2;MOLT-4: 20.4;U-266/84: 15.3;U-698: 17.6"	"Region enriched"	"Detected in many"	5	"olfactory region: 21.6"	"Low region specificity"	"Detected in all"			"HPA043326, HPA062478"			Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA043326: AB_2678429, HPA062478: AB_2684777"	"unprognostic (2.15e-1)"	"unprognostic (8.94e-2)"	"unprognostic (7.79e-3)"	"unprognostic (6.53e-3)"	"unprognostic (7.30e-2)"	"unprognostic (6.89e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.34e-2)"	"unprognostic (3.59e-3)"	"unprognostic (3.06e-1)"	"unprognostic (2.18e-4)"	"unprognostic (9.72e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.14e-1)"	"unprognostic (6.90e-2)"	1.1	1.1	25.0	1.5	27.1	3.9	8.3	12.9	35.3	1.1	1.4	9.3	0.0	2.5	1.4	2.7	1.7	4.4	1.7	1.2	25.3	9.8	1.4	1.7	1.4	2.1	15.0	16.2	1.7	1.5	1.5	0.7	1.3	14.0	1.5	1.6	0.0	4.7	1.4	2.0	3.0	1.9	1.3	6.6	1.6	1.8	5.9	11.7	2.9	4.2	0.0	1.7	1.4	0.5	1.7	1.5	3.8	0.6	2.1	1.1	0.2	2.5	0.6	9.8	4.7	0.6	0.4	1.2	0.7	0.6	1.8	3.0	2.8	3.0	2.3	3.4	2.3	2.5	0.6	5.8	1.8	2.6	5.1	8.0	2.4	0.7	1.5	0.1	0.4	1.0	0.1	0.1	0.6	0.1	2.6	2.4	24.2	1.9	2.8	1.9	7.8	20.4	2.2	4.9	0.6	1.7	11.0	3.5	5.3	1.2	1.0	8.1	4.9	2.5	5.6	1.1	3.9	8.0	0.6	0.7	0.4	5.4	1.0	2.1	7.7	15.3	17.6	1.6	0.4	0.7	3.8	0.6	0.8	1.1	0.6	0.9	1.3	0.6	0.6	0.3	1.7	1.1	1.1	3.7	2.1	0.5	1.5	0.5	0.2	25.0	27.1	12.9	21.8	25.3	9.8	15.0	16.2	14.0	11.7	0.0	1.1	0.0	0.1	0.1	0.1	0.0	0.0	2.7	0.0	0.0	2.0	0.0	0.0	0.0	4.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.9	0.4	0.0	0.1	0.0	0.0	0.1
ADAMTS10	ADAM-TS10	ENSG00000142303	"ADAM metallopeptidase with thrombospondin type 1 motif 10"	Q9H324	19	8580242-8610735	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cholangiocytes: 7.6;Ductal cells: 6.3;Leydig cells: 6.9;Sertoli cells: 6.5;Smooth muscle cells: 6.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HeLa: 4.5;hTERT-RPE1: 5.9;NB-4: 28.4;REH: 7.6"	"Region enriched"	"Detected in single"	5	"cerebellum: 5.4"	"Low region specificity"	"Detected in all"			HPA040223	Uncertain				"Secreted to extracellular matrix"	NA	NA					"HPA040223: AB_10795376"	"unprognostic (2.60e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.91e-4)"	"unprognostic (4.98e-3)"	"unprognostic (4.06e-2)"	"unprognostic (2.24e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.54e-1)"	"prognostic unfavorable (4.55e-9)"	"unprognostic (6.86e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.12e-2)"	13.8	7.1	15.2	8.5	8.0	6.0	8.2	1.8	14.0	10.2	5.7	5.5	3.2	3.9	13.4	5.1	3.4	8.5	7.7	7.0	12.5	8.2	6.9	5.4	8.0	11.1	6.8	11.5	8.0	7.1	1.8	3.8	6.8	7.6	7.6	2.8	10.6	4.8	6.7	9.2	10.0	6.4	6.3	7.6	7.5	3.5	3.0	5.7	5.7	5.5	3.0	5.7	4.6	8.2	0.0	0.0	0.0	0.0	0.5	1.0	0.1	0.0	3.6	1.9	0.0	0.3	0.3	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	1.9	0.7	0.0	0.0	0.0	0.0	0.0	0.9	0.8	0.0	4.5	0.0	0.2	0.0	0.1	1.4	0.0	0.0	0.0	5.9	0.1	0.2	0.1	0.0	0.0	0.0	0.3	28.4	1.4	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	1.0	0.1	0.3	1.7	2.6	3.7	2.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.7	0.0	0.5	0.0	0.0	0.0	0.1	15.2	8.0	1.8	14.0	12.5	8.2	6.8	11.5	7.6	5.7	0.0	0.0	0.0	0.6	1.4	0.1	1.4	7.6	0.0	0.0	0.0	0.0	0.0	0.0	6.3	4.5	4.0	0.0	0.0	0.4	0.0	4.2	0.1	0.0	0.9	0.9	0.0	0.0	4.9	2.1	1.4	6.9	2.8	0.0	1.0	0.1	0.8	0.6	0.0	5.6	0.0	0.1	6.5	6.2	0.1	0.4	0.6	0.3	1.3	0.0	0.3
ADAMTS14		ENSG00000138316	"ADAM metallopeptidase with thrombospondin type 1 motif 14"	Q8WXS8	10	70672803-70762441	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.4;gallbladder: 12.3;placenta: 13.5"	"Group enriched"	"Detected in some"	6	"granulocytes: 4.6;Paneth cells: 11.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 1.1"	"Lineage enriched"	"Detected in single"	11	"monocytes: 1.1"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.8;CAPAN-2: 10.4;K-562: 11.6;RH-30: 6.3;U-138 MG: 10.5"	"Region enriched"	"Detected in single"	5	"hippocampal formation: 0.4"	"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"	NA	NA						"unprognostic (1.30e-1)"	"unprognostic (1.04e-2)"	"unprognostic (5.98e-3)"	"unprognostic (3.54e-3)"	"unprognostic (2.17e-3)"	"unprognostic (2.40e-1)"	"unprognostic (5.33e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.28e-2)"	"unprognostic (3.98e-2)"	"unprognostic (6.81e-2)"	"unprognostic (3.84e-13)"	"unprognostic (3.90e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.16e-2)"	1.7	0.5	4.6	5.4	10.7	1.1	0.6	1.0	4.7	1.3	3.3	13.4	1.0	4.1	1.4	1.0	1.8	1.1	12.3	2.8	7.2	3.0	0.7	0.5	2.7	2.0	8.1	5.7	0.7	0.5	0.2	0.4	13.5	4.0	1.1	3.6	2.6	1.6	0.4	0.4	2.5	5.7	3.9	4.6	0.8	2.6	0.9	5.9	0.5	0.4	2.3	2.3	6.7	0.8	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	4.8	0.0	1.2	3.7	0.3	2.0	0.0	10.4	0.0	0.8	1.9	0.5	0.8	0.0	0.0	0.1	4.0	0.0	0.4	0.0	0.3	0.0	0.0	2.7	0.4	0.1	0.9	0.2	1.2	0.0	0.0	11.6	0.0	1.5	0.0	0.0	1.0	0.4	0.1	0.0	0.0	6.3	0.2	0.0	0.0	4.0	0.7	0.0	0.1	0.3	0.2	0.0	0.0	0.0	10.5	0.1	0.9	0.5	1.0	0.0	0.0	0.5	1.1	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	4.6	10.7	1.0	4.7	7.2	3.0	8.1	5.7	4.0	5.9	0.0	0.0	0.0	0.0	0.8	0.0	0.8	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.1	1.0	0.0	4.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.2	11.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.3	0.0	0.1	0.0
ADAMTS18	ADAMTS21	ENSG00000140873	"ADAM metallopeptidase with thrombospondin type 1 motif 18"	Q8TE60	16	77247813-77435114	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	8	"adipose tissue: 16.1;brain: 31.9;placenta: 27.6"	"Group enriched"	"Detected in some"	6	"Muller glia cells: 16.4;Rod photoreceptor cells: 8.0"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in all"	5	"cerebellum: 31.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 13.2;HUVEC TERT2: 8.9;SuSa: 12.5;U-87 MG: 5.5"	"Region enriched"	"Detected in single"	5	"cerebellum: 3.7"	"Not detected"	"Not detected"			HPA044326	Uncertain		Approved	"Midbody,Mitotic spindle"	"Secreted to extracellular matrix"	Yes	NA			"Midbody, Mitotic spindle"		"HPA044326: AB_10961006"	"unprognostic (1.10e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.50e-1)"	"unprognostic (8.13e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.27e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.98e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.20e-2)"	"unprognostic (8.17e-4)"	"unprognostic (1.77e-5)"	"unprognostic (2.17e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.47e-4)"	16.1	0.6	1.1	0.8	5.1	0.4	3.2	31.9	3.3	2.2	0.4	8.2	0.0	0.5	1.6	0.4	0.5	0.7	1.1	0.4	2.0	1.3	0.5	0.3	0.5	0.5	1.8	1.4	0.5	0.8	0.4	1.4	27.6	6.4	1.0	0.4	0.2	2.1	0.5	1.0	0.4	0.4	1.2	3.7	0.3	0.3	0.7	2.4	0.0	0.4	0.0	0.3	0.8	0.4	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.2	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	12.5	0.0	0.5	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.2	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.1	5.1	31.9	3.3	2.0	1.3	1.8	1.4	6.4	2.4	0.0	0.0	0.0	0.1	0.1	0.4	0.5	0.0	0.0	0.0	1.8	2.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.4	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.2	0.2	0.1	0.2	0.0	0.0	0.0
ADAMTS19		ENSG00000145808	"ADAM metallopeptidase with thrombospondin type 1 motif 19"	Q8TE59	5	129460265-129738683	"Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 16.6;endometrium 1: 14.6;smooth muscle: 9.0"	"Group enriched"	"Detected in some"	6	"Cytotrophoblasts: 15.3;Syncytiotrophoblasts: 4.3"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"MCF7: 12.0;SH-SY5Y: 27.6"	"Region enriched"	"Detected in single"	5	"olfactory region: 4.8"	"Low region specificity"	"Detected in all"			"HPA056171, HPA058438"	Uncertain		Approved	Vesicles,Midbody	"Secreted to extracellular matrix"	Yes	NA			"Vesicles, Midbody"		"HPA056171: AB_2683054, HPA058438: AB_2683718"	"unprognostic (1.14e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.09e-1)"	"unprognostic (6.49e-2)"		"unprognostic (3.93e-2)"		"unprognostic (4.17e-2)"	"unprognostic (5.99e-3)"	"unprognostic (5.17e-1)"		"unprognostic (1.14e-1)"	"unprognostic (5.88e-2)"		"unprognostic (3.06e-2)"	0.2	1.2	0.7	0.6	3.6	0.1	0.2	0.0	4.9	16.6	0.5	1.2	0.0	0.4	14.6	0.3	1.5	2.6	0.8	0.5	1.0	0.8	0.7	0.1	0.2	0.2	0.5	4.3	2.8	0.2	0.2	0.1	5.3	1.8	0.4	0.6	0.9	1.1	0.2	0.8	0.2	0.3	9.0	1.0	0.2	0.2	0.4	0.8	0.0	0.1	1.8	0.1	0.9	1.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	12.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	27.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	3.6	0.0	4.9	1.0	0.8	0.5	4.3	1.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.8	0.0	15.3	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.3	0.4	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	4.3	0.0	0.0	0.0
ADCY5	AC5	ENSG00000173175	"Adenylate cyclase 5"	O95622	3	123282296-123449758	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"cAMP biosynthesis"	Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 69.9"	"Cell type enhanced"	"Detected in many"	10	"Cardiomyocytes: 56.0;Paneth cells: 59.6;Peritubular cells: 69.3;Sertoli cells: 64.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 18.0;RPMI-8226: 3.1;RPTEC TERT1: 6.5"	"Region enriched"	"Detected in many"	5	"basal ganglia: 347.3"	"Region enriched"	"Detected in all"	6	"basal ganglia: 205.1"	"HPA017730, HPA077682"	Uncertain		Enhanced	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA017730: AB_1844595, HPA077682: AB_2686851"	"unprognostic (3.55e-2)"	"unprognostic (1.01e-3)"	"unprognostic (7.61e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.61e-2)"	"unprognostic (2.49e-2)"	"unprognostic (2.34e-1)"	"unprognostic (7.27e-3)"	"unprognostic (2.64e-2)"	"prognostic favorable (7.46e-6)"	"unprognostic (1.81e-2)"	"unprognostic (5.65e-2)"	"unprognostic (3.19e-2)"	"unprognostic (5.97e-4)"	13.3	3.0	12.5	3.7	32.0	0.6	9.3	2.6	14.4	4.5	11.7	10.4	3.1	4.2	6.2	4.4	13.8	5.3	7.3	69.9	10.4	8.3	5.3	2.4	2.6	2.0	15.0	8.6	10.1	5.7	1.1	7.7	4.8	9.7	13.8	4.6	4.6	3.1	16.3	2.2	1.1	4.8	13.5	8.8	4.7	9.6	5.9	16.0	0.0	1.0	0.2	2.6	9.5	8.5	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.7	1.6	0.1	0.1	0.1	0.4	0.0	0.0	0.4	0.1	0.1	0.1	0.0	0.4	0.2	2.7	0.5	0.8	0.0	0.0	0.1	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	18.0	0.0	0.0	1.0	0.0	0.1	0.0	0.4	3.1	6.5	0.6	2.2	2.0	0.0	0.6	0.1	2.2	0.0	0.1	0.0	0.1	1.5	0.1	0.3	0.2	0.7	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	12.5	32.0	2.6	14.4	10.4	8.3	15.0	8.6	9.7	16.0	0.0	0.0	0.0	0.1	0.2	16.5	56.0	2.5	0.0	0.0	7.0	0.0	1.1	0.0	11.5	0.7	0.4	0.5	0.0	6.3	3.1	2.3	0.1	0.0	0.0	0.2	0.0	0.0	2.5	0.0	1.1	19.0	0.0	0.0	1.8	0.3	0.8	0.6	59.6	69.3	0.7	1.5	64.7	12.2	0.7	5.6	0.6	10.4	0.0	1.2	0.0
ADORA2A	"ADORA2, RDC8"	ENSG00000128271	"Adenosine A2a receptor"	P29274	22	24417879-24442360	"Cancer-related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	7	"blood: 22.8;bone marrow: 28.1;brain: 43.9;lymphoid tissue: 59.0"	"Cell type enriched"	"Detected in single"	25	"monocytes: 19.0"	"Not detected"	"Not detected"			"Region enriched"	"Detected in all"	8	"basal ganglia: 43.9"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 15.4;Karpas-707: 21.2;RPMI-8226: 15.0;SK-BR-3: 30.4;U-266/70: 21.2;U-266/84: 27.7;U-698: 21.7"	"Region enriched"	"Detected in some"	10	"basal ganglia: 357.5"	"Region enriched"	"Detected in single"	92	"basal ganglia: 166.0"	"CAB001943, HPA065566, HPA075997"	Enhanced	Supported				NA	NA					"CAB001943: , HPA065566: , HPA075997: AB_2732298"	"unprognostic (7.30e-2)"	"unprognostic (2.42e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.44e-2)"	"unprognostic (1.88e-3)"	"unprognostic (9.85e-2)"	"unprognostic (3.63e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.57e-3)"	"unprognostic (2.15e-3)"	"unprognostic (1.87e-3)"	"unprognostic (6.81e-4)"	"unprognostic (1.50e-1)"	"unprognostic (9.78e-3)"	"unprognostic (1.30e-1)"	"unprognostic (7.10e-3)"	1.0	2.4	1.9	10.4	43.9	28.1	1.5	3.4	3.8	0.8	2.0	1.7	0.3	5.4	1.4	1.4	1.0	0.9	2.4	3.5	2.4	1.8	3.5	4.3	5.1	14.8	2.6	1.6	1.2	0.8	0.0	2.1	1.4	2.3	1.6	0.8	3.3	2.7	1.5	1.2	0.9	2.6	0.7	1.3	7.5	2.8	2.0	5.7	59.0	1.3	0.9	8.6	3.8	1.3	17.7	1.1	13.7	9.0	2.2	22.8	11.2	0.2	0.3	0.4	0.1	0.2	0.1	0.4	0.2	9.5	0.5	1.0	1.7	0.1	15.4	1.0	0.3	1.0	0.3	0.9	0.0	0.0	1.8	2.7	0.2	0.0	2.2	0.2	0.3	7.7	0.1	0.0	2.9	0.0	0.2	3.4	2.2	0.1	21.2	0.0	0.2	5.3	1.6	0.6	2.0	0.0	0.2	0.7	15.0	0.0	0.1	1.5	8.9	0.4	30.4	0.1	0.4	0.4	1.5	0.2	0.9	1.5	0.2	0.1	21.2	27.7	21.7	4.8	5.2	0.1	3.0	0.8	4.8	8.6	2.6	20.1	9.6	16.1	16.9	1.1	17.7	22.8	18.3	13.7	2.2	9.0	1.1	21.4	11.2	1.9	43.9	3.4	3.8	2.4	1.8	2.6	1.6	2.3	5.7	0.0	0.3	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AGR3	"BCMP11, hAG-3, HAG3, PDIA18"	ENSG00000173467	"Anterior gradient 3, protein disulphide isomerase family member"	Q8TD06	7	16859405-16881987	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 40.5;intestine: 99.1"	"Cell type enhanced"	"Detected in many"	14	"Ciliated cells: 1287.5;Club cells: 422.0;Enterocytes: 526.8;Mucus-secreting cells: 499.0;Paneth cells: 524.0"	"Cancer enhanced"	"Detected in many"		"breast cancer: 104.5"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	27	"OE19: 27.2;T-47d: 86.4"	"Region enriched"	"Detected in single"	5	"olfactory region: 5.6"					HPA053942	Enhanced		Supported	"Endoplasmic reticulum,Vesicles"	"Intracellular and membrane"	NA	NA		31000	"Endoplasmic reticulum"	Vesicles	"HPA053942: AB_2682317"	"unprognostic (2.18e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.13e-1)"	"unprognostic (9.59e-2)"	"unprognostic (3.32e-3)"	"unprognostic (3.08e-2)"		"unprognostic (1.49e-1)"		"unprognostic (1.46e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.56e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.96e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.57e-1)"	0.6	0.0	0.6	7.5	0.7	0.0	13.1	0.7	0.6	4.4	45.8	0.6	0.6	29.2	1.2	5.4	0.9	40.5	11.8	0.6	0.6	0.3	1.5	0.6	26.3	0.6	0.6	0.6	5.1	1.9	0.0	12.9	2.8	1.9	1.1	38.9	0.6	9.4	0.6	0.6	0.3	99.1	1.2	0.8	0.6	17.1	1.0	0.6	0.6	1.4	1.9	3.9	4.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	27.2	0.0	0.0	0.0	0.5	2.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	86.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.7	0.6	0.6	0.3	0.6	0.6	1.9	0.6	309.7	310.7	0.0	9.4	2.4	0.0	0.0	35.7	1287.5	422.0	27.9	0.0	1.4	1.7	20.8	0.0	0.0	526.8	0.0	65.4	1.2	0.2	4.4	19.7	0.0	0.5	0.0	108.2	0.0	0.0	0.0	0.3	0.7	0.0	1.0	499.0	0.0	10.6	524.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	8.5	1.8	0.0	345.5	94.0
AGRP	"Agrt, ART, ASIP2"	ENSG00000159723	"Agouti related neuropeptide"	O00253	16	67482571-67483813	"Disease related genes, Plasma proteins, Predicted secreted proteins"			"Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 19.4;epididymis: 49.8"	"Group enriched"	"Detected in some"	6	"Distal tubular cells: 3.3;Hofbauer cells: 9.2;Leydig cells: 2.8;Peritubular cells: 2.5"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in some"	13	"hypothalamus: 19.4"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CACO-2: 2.6;CAPAN-2: 2.8;HeLa: 1.5;Hep G2: 2.2;HMC-1: 1.8"	"Region enriched"	"Detected in single"	16	"hypothalamus: 18.9"	"Region enhanced"	"Detected in many"		"hypothalamus: 3.9"	HPA041017	Enhanced	Supported			"Secreted in other tissues"	NA	NA	255000				"HPA041017: AB_10795498"	"unprognostic (1.32e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.16e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.61e-1)"	"unprognostic (3.34e-1)"	"unprognostic (4.68e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.74e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.72e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.18e-2)"	0.1	9.6	0.1	0.1	1.4	0.0	0.1	0.1	0.2	0.1	0.1	0.3	0.1	0.0	0.1	49.8	0.1	0.0	0.1	0.1	0.1	19.4	0.5	0.1	2.1	0.3	0.1	0.3	0.1	0.1	0.0	0.4	0.1	0.2	0.1	0.0	0.3	0.5	0.1	0.1	0.4	0.1	0.1	0.3	0.3	0.1	1.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	2.2	2.1	1.4	3.8	0.3	3.2	1.0	0.1	0.0	0.4	1.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.6	2.8	0.8	0.2	0.0	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.4	1.5	2.2	0.0	0.0	1.8	0.6	0.0	0.0	0.0	0.2	0.0	1.5	0.1	1.0	0.0	0.0	0.2	0.5	0.0	0.2	0.0	0.0	0.0	0.3	0.3	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.5	0.2	0.0	0.1	1.0	0.5	1.0	0.0	0.4	0.3	0.0	3.8	1.4	3.2	2.3	1.6	2.2	0.8	1.1	1.5	1.9	2.1	2.2	0.6	0.3	1.2	2.1	1.3	1.0	0.1	1.4	0.1	0.2	0.1	19.4	0.1	0.3	0.2	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0
ALOX12	12S-LOX	ENSG00000108839	"Arachidonate 12-lipoxygenase, 12S type"	P18054	17	6996065-7010736	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Dioxygenase, Hydrolase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 28.6;esophagus: 28.4;tongue: 22.7;vagina: 42.7"	"Group enriched"	"Detected in some"	6	"Cardiomyocytes: 1.8;Suprabasal keratinocytes: 1.0;Urothelial cells: 1.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.8"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"A-431: 17.5;HEL: 28.0"	"Region enriched"	"Detected in single"	5	"olfactory region: 5.4"					"HPA010691, CAB019287, HPA064819"	Enhanced		Supported	"Nuclear speckles,Vesicles,Cytosol"		NA	NA		5800000	Cytosol	"Nuclear speckles, Vesicles"	"CAB019287: , HPA010691: AB_1844756, HPA064819: "	"unprognostic (3.61e-3)"	"unprognostic (6.93e-2)"	"unprognostic (7.17e-5)"	"unprognostic (9.43e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.25e-3)"	"unprognostic (2.45e-1)"	"unprognostic (3.16e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.96e-5)"	"unprognostic (4.01e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.87e-1)"	"unprognostic (5.90e-2)"	"unprognostic (3.47e-2)"	0.3	0.6	0.3	1.5	0.4	2.0	0.3	0.3	1.0	28.6	0.4	0.3	0.3	0.7	3.4	0.5	28.4	0.4	1.6	0.8	0.3	0.1	0.3	0.3	0.5	1.9	0.5	0.3	0.4	0.8	0.0	0.3	0.7	0.4	0.3	0.0	0.4	8.1	0.3	0.5	12.8	0.8	0.3	0.3	1.5	0.3	0.6	0.3	0.3	0.8	22.7	9.5	1.2	42.7	1.1	1.3	4.8	0.9	0.7	0.8	14.3	17.5	2.9	1.3	1.0	0.0	0.0	1.2	1.1	0.0	0.0	0.0	2.6	0.6	0.9	0.6	0.0	1.0	2.2	0.0	0.1	0.0	1.9	2.3	28.0	3.9	1.9	0.1	0.2	4.6	0.0	0.0	0.0	0.0	1.7	0.0	1.9	1.8	1.0	0.0	0.2	0.3	0.6	0.9	0.1	0.6	1.0	0.6	0.4	0.0	2.2	0.1	0.6	0.5	0.6	0.2	1.8	1.0	0.7	3.2	1.5	0.9	1.5	0.7	0.5	0.2	0.5	0.9	2.1	0.7	1.8	0.9	1.7	0.7	0.5	0.5	1.1	0.5	0.8	0.7	0.7	0.2	0.4	4.8	0.7	0.4	1.3	0.3	14.3	0.3	0.4	0.3	0.6	0.3	0.1	0.5	0.3	0.4	0.3	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	1.7
ALX3	FND	ENSG00000156150	"ALX homeobox 3"	O95076	1	110059994-110070700	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"retina: 19.3"	"Group enriched"	"Detected in some"	9	"Bipolar cells: 2.4;Cone photoreceptor cells: 3.9;Rod photoreceptor cells: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 2.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Region enriched"	"Detected in single"	7	"olfactory region: 14.8"	"Low region specificity"	"Detected in single"			HPA074290			Approved	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA074290: "	"unprognostic (4.28e-1)"				"unprognostic (4.41e-2)"			"unprognostic (2.91e-1)"		"unprognostic (2.48e-2)"					"unprognostic (1.31e-1)"			0.5	1.8	1.2	1.0	2.7	0.8	2.6	0.9	4.1	0.7	0.4	1.2	0.3	1.6	2.7	0.9	2.6	2.6	1.7	0.7	1.3	1.5	0.8	0.4	1.0	2.3	0.5	1.9	3.1	1.0	0.2	5.3	0.7	0.5	0.8	0.0	19.3	2.0	0.3	2.8	8.0	2.7	0.3	0.4	2.4	0.8	1.8	0.6	0.3	2.1	1.8	0.3	1.4	2.4	0.4	0.0	1.4	0.1	0.0	2.0	0.2	3.3	1.7	4.3	6.3	0.0	0.0	8.1	8.5	11.2	0.0	0.0	3.4	1.5	1.8	3.5	0.1	1.3	5.1	0.0	0.0	0.0	4.5	6.2	1.1	3.9	2.0	0.0	2.0	0.9	0.0	0.0	0.0	0.0	4.4	0.0	3.5	2.9	0.5	0.0	3.9	1.4	1.6	4.5	2.4	4.8	3.1	5.4	1.5	0.0	4.5	5.3	7.4	3.9	6.0	5.7	4.8	2.7	3.2	3.3	5.1	4.4	6.4	2.1	3.3	1.2	2.0	5.4	4.8	3.5	0.8	0.1	1.4	0.1	0.0	0.3	0.2	1.1	0.4	0.0	0.4	0.1	2.0	0.0	0.0	0.1	0.0	0.1	0.2	1.2	2.7	0.9	4.1	1.3	1.5	0.5	1.9	0.5	0.6	0.0	0.0	0.0	0.0	0.0	2.4	0.2	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0
ALX4	"FPP, KIAA1788, PFM, PFM2"	ENSG00000052850	"ALX homeobox 4"	Q9H161	11	44260444-44310166	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Craniosynostosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 10.5;retina: 14.4"	"Group enriched"	"Detected in some"	15	"Cardiomyocytes: 17.1;Leydig cells: 4.4"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 5.4;BJ: 4.5;HAP1: 6.3;HEK 293: 6.5;HEL: 8.8;K-562: 4.1;SiHa: 9.4"	"Region enriched"	"Detected in single"	8	"olfactory region: 11.1"	"Region enriched"	"Detected in single"	34	"olfactory region: 27.7"	HPA001903			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA001903: AB_2666495"	"unprognostic (7.56e-5)"	"unprognostic (1.69e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.74e-1)"	"unprognostic (7.24e-3)"	"unprognostic (2.63e-4)"	"unprognostic (1.95e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.33e-4)"	"unprognostic (5.13e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.34e-6)"	"unprognostic (3.62e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.02e-3)"	"unprognostic (2.03e-1)"	1.6	0.1	0.6	0.0	1.6	0.0	10.5	0.7	1.6	2.0	0.1	1.4	0.0	0.0	2.4	2.4	0.5	0.8	0.3	0.9	1.3	0.7	0.3	0.0	0.5	0.0	0.4	2.2	0.2	0.1	0.2	0.3	0.0	0.3	2.0	0.0	14.4	5.6	0.1	3.1	2.8	0.0	1.1	0.2	0.1	0.1	2.5	0.5	0.0	0.4	4.2	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	5.4	0.0	0.0	0.0	4.5	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	6.3	0.0	0.0	1.3	6.5	8.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.6	0.7	1.6	1.3	0.7	0.4	2.2	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	17.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0
ANO2	"C12orf3, TMEM16B"	ENSG00000047617	"Anoctamin 2"	Q9NQ90	12	5531869-5946232	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"placenta: 46.9;retina: 30.6;testis: 13.4"	"Group enriched"	"Detected in many"	12	"Cone photoreceptor cells: 76.6;Early spermatids: 58.6;Late spermatids: 219.4;Rod photoreceptor cells: 168.7"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.4"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	4	"basophil: 5.1"	"Lineage enriched"	"Detected in single"	51	"granulocytes: 5.1"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 8.6;HUVEC TERT2: 8.5;U-2 OS: 22.5"	"Region enriched"	"Detected in some"	4	"basal ganglia: 20.0"					"HPA036276, HPA057499"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA036276: AB_10670713, HPA057499: AB_2732613"	"unprognostic (6.32e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.05e-3)"	"unprognostic (2.86e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.84e-3)"	"unprognostic (3.78e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.10e-2)"	"unprognostic (9.93e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.17e-1)"	5.8	0.1	1.0	1.3	2.3	0.0	4.3	1.2	1.3	3.3	1.0	1.6	0.9	0.8	1.8	2.1	0.9	1.9	1.5	3.9	1.9	0.9	1.2	0.9	4.7	0.9	1.6	2.0	0.9	0.9	1.4	0.9	46.9	1.2	1.4	0.7	30.6	0.9	1.6	2.3	0.6	0.9	2.1	1.1	1.9	1.0	13.4	0.9	0.9	1.6	1.3	0.9	1.3	2.3	0.0	0.0	5.1	0.0	0.0	0.0	0.2	2.2	0.0	4.0	0.0	0.0	0.2	1.9	0.0	8.6	0.4	0.9	0.0	0.1	0.1	0.2	0.0	0.1	0.3	0.0	0.1	0.6	0.2	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.5	0.0	0.0	1.7	0.0	0.8	0.0	0.0	4.1	2.0	0.0	1.7	0.0	0.9	0.1	0.1	0.0	0.0	2.1	1.4	0.0	3.7	1.2	0.0	0.2	0.0	22.5	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	1.0	2.3	1.2	1.3	1.9	0.9	1.6	2.0	1.2	0.9	0.0	0.0	0.0	0.0	0.0	7.4	1.1	0.0	0.0	0.0	0.0	76.6	1.1	0.0	0.0	58.6	3.6	0.0	0.0	0.0	1.8	0.3	0.0	0.0	0.0	0.2	9.5	0.0	1.8	0.0	219.4	0.3	0.0	0.0	0.0	0.0	10.6	0.0	0.0	1.4	0.0	168.7	0.0	0.4	1.5	1.3	0.1	2.1	0.0	0.0	0.0
AQP6	AQP2L	ENSG00000086159	"Aquaporin 6"	Q13520	12	49967194-49977139	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	25	"kidney: 40.1"	"Group enriched"	"Detected in some"	5	"Cardiomyocytes: 4.5;Collecting duct cells: 5.2"	"Cancer enriched"	"Detected in many"	9	"renal cancer: 9.1"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A549: 2.0;OE19: 5.1;SH-SY5Y: 2.1"	"Region enriched"	"Detected in some"	7	"cerebellum: 23.5"	"Low region specificity"	"Detected in many"			HPA015278	Enhanced					NA	NA					"HPA015278: AB_10600982"	"unprognostic (1.23e-1)"	"unprognostic (1.32e-2)"	"unprognostic (9.53e-2)"	"unprognostic (2.02e-2)"	"unprognostic (6.46e-2)"	"unprognostic (4.60e-3)"	"unprognostic (3.45e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.36e-1)"	"unprognostic (8.68e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.74e-1)"	"unprognostic (6.85e-2)"	"unprognostic (9.22e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.77e-1)"	0.1	0.2	0.6	0.1	1.1	0.0	0.1	0.3	1.6	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.0	0.1	0.1	0.7	0.5	40.1	0.2	0.1	0.1	1.2	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.2	0.0	0.1	1.0	0.3	0.1	0.0	0.1	0.1	0.4	0.1	0.2	0.7	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.8	0.5	1.2	0.2	0.2	0.4	0.2	0.3	2.0	0.1	0.3	0.1	0.0	0.0	0.4	0.2	0.0	0.0	1.1	1.2	0.0	0.9	0.0	0.0	0.2	0.3	0.0	0.0	0.2	1.4	0.0	0.1	0.7	0.3	0.0	0.1	0.1	0.0	0.0	0.1	1.1	0.0	0.2	0.4	0.6	0.0	0.9	0.0	0.6	0.4	5.1	1.0	1.0	0.1	0.5	0.9	0.0	0.5	2.1	0.7	0.0	0.7	0.3	0.0	0.1	0.0	0.6	0.9	0.0	0.5	0.2	0.2	0.0	0.2	0.2	0.4	1.2	0.2	0.1	0.4	0.1	0.1	0.3	0.1	0.2	0.5	0.8	0.2	0.3	1.1	0.2	0.2	0.2	0.3	0.2	0.6	1.1	0.3	0.3	0.7	0.5	1.2	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.7	0.2	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0
AREG	"AREGB, SDGF"	ENSG00000109321	Amphiregulin	P15514	4	74445134-74455009	"Cancer-related genes, Predicted membrane proteins"		"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 83.5"	"Cell type enhanced"	"Detected in many"	9	"Basal glandular cells: 759.9;Basal keratinocytes: 994.1;Enterocytes: 632.3;granulocytes: 633.9;Urothelial cells: 1407.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	9	"basophil: 8.2;eosinophil: 11.6;NK-cell: 3.3"	"Group enriched"	"Detected in many"	9	"granulocytes: 11.6;NK-cells: 3.3"	"Cell line enhanced"	"Detected in some"		"CACO-2: 42.8;HBEC3-KT: 74.1;hTCEpi: 75.5;hTERT-HME1: 161.4;MCF7: 46.5"	"Region enriched"	"Detected in single"	4	"olfactory region: 1.5"	"Low region specificity"	"Detected in all"			"HPA008720, CAB023519"	Approved		Approved	Mitochondria		NA	NA	1520000		Mitochondria		"CAB023519: AB_2060673, HPA008720: AB_1844978"	"unprognostic (1.44e-2)"	"unprognostic (1.84e-3)"	"unprognostic (3.36e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.54e-3)"	"prognostic unfavorable (2.61e-5)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (2.90e-1)"	"unprognostic (8.06e-2)"	"prognostic unfavorable (8.32e-5)"	"unprognostic (2.56e-2)"	"unprognostic (2.49e-3)"	"unprognostic (2.40e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.83e-3)"	19.5	1.1	0.4	9.2	2.1	28.9	20.3	0.3	0.4	5.7	6.7	0.2	0.2	0.7	1.7	1.6	22.3	6.0	34.8	13.6	0.5	0.4	2.5	1.7	14.4	13.3	0.4	0.0	5.8	1.0	0.0	7.8	83.5	1.3	1.9	5.0	1.4	3.9	0.9	9.9	3.4	10.0	1.5	1.0	11.3	5.3	4.6	0.0	1.6	1.2	13.4	13.6	8.7	4.6	0.4	0.8	11.6	0.0	3.3	0.4	0.1	1.7	12.2	0.0	0.0	0.1	0.1	0.0	0.3	0.5	0.0	0.3	42.8	6.8	0.0	0.9	0.0	0.0	1.9	0.0	74.1	0.7	0.0	0.0	0.0	0.3	2.0	23.0	0.2	0.0	0.7	75.5	4.4	161.4	0.1	0.0	0.0	0.1	0.0	1.6	46.5	0.0	0.0	0.0	8.8	4.9	0.0	0.0	0.0	4.2	0.3	0.0	0.0	2.5	0.1	0.0	0.0	1.3	0.0	0.1	0.0	1.7	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.2	8.2	0.0	11.6	0.0	0.0	0.0	0.3	0.4	0.0	0.8	0.4	0.2	0.0	0.1	3.3	0.0	0.1	0.0	0.1	0.4	2.1	0.3	0.4	0.5	0.4	0.4	0.0	1.3	0.0	184.6	339.4	82.8	759.9	994.1	0.0	30.5	71.4	92.3	310.5	48.8	0.0	1.3	0.0	52.7	45.1	3.9	632.3	0.0	8.6	1.2	28.2	73.6	633.9	2.9	31.8	0.0	39.8	10.4	189.5	5.9	0.3	134.1	32.1	1.8	188.0	0.0	301.5	221.0	1.1	0.5	0.0	19.4	4.4	52.0	45.0	299.4	0.9	149.6	119.9	1407.8
ARHGEF16	"GEF16, NBR"	ENSG00000130762	"Rho guanine nucleotide exchange factor 16"	Q5VV41	1	3454426-3481113	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 28.6;intestine: 45.9"	"Cell type enhanced"	"Detected in many"	8	"Enterocytes: 71.7;Extravillous trophoblasts: 39.4;Mucus-secreting cells: 36.4;Paneth cells: 35.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 28.8;MCF7: 16.2;OE19: 19.3;SK-BR-3: 17.8"	"Region enriched"	"Detected in single"	4	"olfactory region: 5.8"	"Not detected"	"Not detected"			HPA010609	Approved					NA	NA					"HPA010609: AB_1845004"	"unprognostic (1.28e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.31e-1)"	"unprognostic (2.09e-2)"	"prognostic unfavorable (1.82e-4)"	"unprognostic (2.65e-1)"	"unprognostic (5.59e-2)"	"unprognostic (1.79e-2)"	"unprognostic (5.39e-2)"	"unprognostic (9.16e-2)"	"prognostic favorable (1.24e-10)"	"unprognostic (6.46e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.71e-2)"	"unprognostic (3.29e-2)"	1.8	0.1	0.5	7.5	1.0	0.0	2.9	1.1	0.8	2.5	30.4	1.2	11.5	24.8	1.0	4.6	11.4	1.3	28.6	0.5	1.1	0.9	11.7	4.3	3.1	0.5	1.3	0.5	0.9	7.0	4.8	7.7	9.0	2.2	5.7	6.8	1.5	10.1	13.7	0.7	3.4	45.9	1.0	1.9	0.5	15.8	2.3	0.7	0.9	9.0	5.9	5.3	5.1	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	3.5	0.9	0.1	0.0	0.0	6.2	0.1	0.2	0.2	0.7	10.5	28.8	0.0	6.9	0.0	1.8	9.1	1.5	6.1	0.0	0.0	3.1	0.0	4.3	8.1	0.3	0.0	0.0	0.1	5.9	0.6	0.3	0.6	0.0	0.1	1.1	0.0	0.0	16.2	0.0	0.2	7.0	19.3	0.2	0.0	0.0	1.2	7.3	4.6	4.7	0.9	1.7	17.8	0.4	3.9	7.9	0.3	0.0	0.1	2.1	0.1	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.0	1.1	0.8	1.1	0.9	1.3	0.5	2.2	0.7	8.9	4.8	0.0	11.6	2.9	1.0	1.3	12.7	6.7	9.1	15.7	5.9	2.3	13.3	15.0	0.0	0.4	71.7	0.0	11.1	39.4	0.3	4.3	0.0	3.4	1.0	3.2	9.8	0.6	0.0	0.0	0.0	0.7	0.0	1.0	36.4	34.7	20.3	35.7	0.0	8.4	8.1	0.0	0.8	0.4	3.4	0.9	5.6	0.0	24.3	14.8
ARHGEF33		ENSG00000214694	"Rho guanine nucleotide exchange factor 33"	A8MVX0	2	38889841-38975449	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	4	"brain: 42.5"	"Group enriched"	"Detected in some"	5	"Early spermatids: 25.0;Late spermatids: 21.2;Spermatocytes: 30.7;Spermatogonia: 34.3"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in all"	5	"cerebellum: 42.5"	"Cell type enriched"	"Detected in single"	8	"eosinophil: 6.7"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 6.7"	"Group enriched"	"Detected in some"	4	"BEWO: 9.0;HeLa: 4.0;SiHa: 11.2"	"Region enriched"	"Detected in single"	32	"cerebellum: 314.4"	"Region enriched"	"Detected in all"	11	"cerebellum: 47.0"	"HPA034661, HPA041051"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			Vesicles	"Nucleoplasm, Cytosol"	"HPA034661: AB_10669679, HPA041051: AB_2677274"	"unprognostic (8.38e-2)"	"unprognostic (7.05e-4)"	"unprognostic (1.95e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.49e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.66e-1)"	"unprognostic (3.37e-1)"	"unprognostic (5.82e-2)"	"unprognostic (2.05e-3)"	"unprognostic (4.99e-1)"	"unprognostic (4.12e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.99e-1)"	0.3	4.0	3.7	1.0	8.6	0.0	1.7	42.5	3.4	2.3	0.7	0.6	0.7	0.1	2.8	5.1	0.7	2.2	1.4	0.8	3.3	3.6	1.4	0.2	1.2	0.5	2.0	2.9	6.8	0.2	2.2	3.5	0.8	3.2	1.7	0.6	0.8	0.4	1.2	0.4	1.3	0.6	1.0	1.5	0.5	0.9	10.1	2.4	0.2	1.4	0.2	0.4	1.2	0.6	0.2	0.1	6.7	0.8	0.0	0.2	0.1	0.3	0.0	0.4	0.2	0.2	0.2	9.0	0.8	0.0	0.0	0.0	0.1	0.2	0.5	0.1	0.8	0.0	0.0	0.0	0.0	0.0	1.9	1.0	0.3	4.0	0.3	0.7	0.4	0.3	0.8	1.0	0.5	0.0	0.5	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.9	0.4	0.5	0.3	11.2	0.4	0.0	1.1	0.0	0.3	0.6	0.2	1.5	0.0	0.1	0.5	0.2	0.0	0.2	0.2	0.1	0.0	0.6	6.7	0.0	0.8	0.1	0.1	0.0	0.2	0.1	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	3.7	8.6	42.5	3.4	3.3	3.6	2.0	2.9	3.2	2.4	0.0	1.0	0.0	0.1	0.0	2.5	0.4	0.0	5.3	1.2	0.0	0.0	0.8	0.0	0.1	25.0	0.3	0.0	0.0	0.0	1.3	1.1	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	21.2	1.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	3.2	0.2	3.1	0.0	0.7	30.7	34.3	0.1	0.5	0.0	0.0	0.2
ARHGEF39	"C9orf100, FLJ14642"	ENSG00000137135	"Rho guanine nucleotide exchange factor 39"	Q8N4T4	9	35658875-35675866	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 18.0"	"Cell type enhanced"	"Detected in many"	18	"Early spermatids: 86.7;Erythroid cells: 46.7;Late spermatids: 30.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Region enriched"	"Detected in single"	4	"basal ganglia: 2.4"	"Low region specificity"	"Detected in all"			HPA061299	Uncertain					NA	Yes					"HPA061299: AB_2684473"	"unprognostic (2.93e-1)"	"unprognostic (3.90e-1)"	"unprognostic (3.31e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.25e-4)"	"unprognostic (3.60e-2)"	"unprognostic (8.55e-2)"	"prognostic favorable (4.48e-4)"	"unprognostic (1.14e-1)"	"unprognostic (9.75e-2)"	"unprognostic (6.04e-9)"	"unprognostic (3.31e-3)"	"unprognostic (3.38e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.46e-1)"	1.6	1.4	0.6	10.0	0.6	3.3	1.3	1.7	0.6	1.4	3.7	0.3	0.7	4.1	2.1	1.6	5.6	0.5	3.6	0.9	1.0	0.6	0.9	1.0	1.4	3.7	0.6	0.0	0.8	1.6	0.0	0.6	2.8	0.6	0.8	2.1	0.4	1.4	0.7	0.6	2.0	5.5	1.4	0.6	2.0	2.7	2.9	0.1	18.0	0.5	1.7	7.1	0.9	1.7	1.8	0.9	1.4	1.2	1.7	3.6	0.7	5.3	8.3	7.9	3.9	0.1	0.3	5.3	4.0	1.5	3.5	3.1	9.2	4.3	3.3	2.4	0.6	4.8	4.2	3.9	2.3	1.4	9.8	6.2	5.4	10.7	3.3	0.0	4.5	8.1	0.3	0.2	1.7	1.0	1.2	1.3	4.9	3.7	3.1	1.5	2.7	1.1	2.5	5.0	3.8	2.7	4.5	6.1	2.0	1.3	2.3	5.6	2.2	2.0	4.4	1.2	3.3	6.5	2.6	0.8	2.6	8.3	2.9	2.8	3.1	3.7	1.5	1.5	2.4	5.5	1.2	1.0	0.8	2.4	0.7	3.6	0.9	1.7	2.4	0.9	1.8	0.6	1.6	1.4	1.7	1.2	0.8	1.9	0.7	0.6	0.6	1.7	0.6	1.0	0.6	0.6	0.0	0.6	0.1	0.0	0.0	2.7	1.4	2.4	1.7	1.0	2.5	1.4	1.2	1.8	0.0	1.4	0.0	0.8	86.7	1.1	1.0	46.7	0.7	16.7	1.9	0.9	0.0	0.6	4.4	0.0	3.4	1.8	3.1	30.7	0.9	2.5	5.0	0.0	2.4	1.9	0.6	0.0	0.4	0.3	1.8	0.0	1.7	2.6	3.3	1.8	1.6	1.9	3.6	0.7
ART5		ENSG00000167311	"ADP-ribosyltransferase 5"	Q96L15	11	3638503-3642316	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 12.1;testis: 33.3"	"Group enriched"	"Detected in some"	4	"Early spermatids: 12.7;Late spermatids: 14.5;Spermatocytes: 15.9"	"Cancer enhanced"	"Detected in some"		"testis cancer: 4.5"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	11	"memory CD4 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.0"	"Cell line enriched"	"Detected in some"	5	"SuSa: 17.9"	"Region enriched"	"Detected in single"	5	"olfactory region: 0.5"	"Not detected"	"Not detected"			"HPA041637, HPA044099"	Uncertain				"Secreted in other tissues"	NA	NA					"HPA041637: AB_2677589, HPA044099: AB_2678808"	"unprognostic (6.32e-2)"	"unprognostic (3.26e-5)"	"unprognostic (4.09e-3)"	"unprognostic (2.06e-4)"	"unprognostic (1.53e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.21e-2)"	"unprognostic (5.65e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.67e-1)"	"prognostic favorable (1.85e-4)"	"unprognostic (3.10e-3)"	"unprognostic (3.46e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.18e-1)"	0.8	0.1	0.3	0.3	0.5	0.0	0.8	0.3	0.6	3.3	0.3	0.3	1.0	0.0	3.3	0.9	0.4	1.5	1.2	2.9	0.3	0.2	0.7	0.6	0.9	0.3	0.3	0.3	9.3	0.3	1.7	0.6	1.7	0.5	1.1	0.0	5.3	1.2	0.8	12.1	0.3	0.4	1.0	0.3	0.5	0.3	33.3	0.5	0.3	3.5	5.2	0.5	0.5	1.9	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	2.0	2.2	0.0	0.0	3.7	0.2	1.8	0.9	2.1	0.1	0.0	0.0	0.9	0.2	0.0	0.0	1.8	0.0	0.5	0.0	2.6	0.0	0.4	0.2	0.0	0.0	1.7	0.6	0.0	0.0	0.0	0.3	0.0	0.1	0.6	0.0	0.2	0.4	0.0	0.0	1.8	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	1.8	0.1	17.9	0.6	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.3	0.6	0.3	0.2	0.3	0.3	0.5	0.5	0.0	2.6	0.0	1.8	0.2	0.4	1.6	0.0	0.0	1.2	0.0	0.0	0.4	0.0	0.4	12.7	0.3	0.0	0.0	0.2	0.4	0.7	0.6	0.0	1.7	0.1	0.0	0.0	0.0	0.3	14.5	3.1	0.0	0.0	0.0	0.0	3.3	0.2	0.0	1.1	0.3	0.7	0.0	0.2	15.9	1.7	0.3	2.4	0.0	0.0	0.1
ARTN	"ENOVIN, EVN, NBN"	ENSG00000117407	Artemin	Q5T4W7	1	43933320-43937241	"Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"parathyroid gland: 18.3"	"Cell type enriched"	"Detected in some"	10	"Urothelial cells: 56.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"A-431: 29.8;HaCaT: 31.5;HBEC3-KT: 28.0;hTCEpi: 11.8;hTERT-HME1: 9.0"	"Region enriched"	"Detected in single"	9	"olfactory region: 4.0"	"Region enhanced"	"Detected in single"		"olfactory region: 1.0"						"Secreted in other tissues"	NA	NA						"unprognostic (1.98e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.07e-3)"	"unprognostic (1.18e-1)"	"unprognostic (3.08e-1)"	"prognostic favorable (8.18e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.59e-6)"	"unprognostic (2.35e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.48e-3)"	"unprognostic (1.53e-1)"	2.4	1.1	0.7	2.2	2.5	1.2	2.1	4.3	1.7	3.9	3.7	0.5	7.6	0.6	3.6	5.6	4.1	2.0	5.1	2.0	0.6	1.6	6.2	0.4	2.1	0.5	1.0	0.1	2.4	14.4	18.3	8.0	10.4	4.8	10.0	2.5	0.7	5.3	12.4	1.0	1.2	1.1	2.0	2.0	0.6	1.7	2.2	0.7	0.6	1.8	4.4	1.5	4.7	4.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	29.8	0.7	0.5	0.4	0.1	0.1	0.1	1.2	0.2	1.2	1.2	0.1	0.7	0.3	0.1	0.4	0.3	31.5	0.0	28.0	0.2	0.1	0.9	0.4	3.0	0.0	0.0	0.1	0.6	0.0	11.8	0.5	9.0	5.4	0.0	0.4	0.3	0.9	0.1	2.1	0.1	1.7	2.6	0.0	1.1	0.5	0.0	0.4	0.1	0.5	0.6	0.2	0.1	0.0	0.6	0.5	5.0	4.5	0.3	0.5	0.2	0.2	1.2	3.0	2.2	0.3	4.0	1.4	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	2.5	4.3	1.7	0.6	1.6	1.0	0.1	4.8	0.7	0.0	0.0	0.0	2.6	0.0	1.7	0.6	0.0	0.0	0.0	0.0	0.0	0.1	3.3	0.1	5.6	0.0	0.8	0.0	0.2	0.0	0.2	3.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.4	0.8	4.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	56.7
ASGR1	CLEC4H1	ENSG00000141505	"Asialoglycoprotein receptor 1"	P07306	17	7173431-7179564	"Predicted intracellular proteins"	"Endocytosis, Host-virus interaction"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"liver: 171.0"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 1020.7"	"Cancer enriched"	"Detected in many"	90	"liver cancer: 131.6"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"classical monocyte: 39.1;intermediate monocyte: 17.9;myeloid DC: 13.7"	"Group enriched"	"Detected in many"	13	"dendritic cells: 13.7;monocytes: 39.1"	"Cell line enriched"	"Detected in some"	30	"Hep G2: 104.5"	"Region enriched"	"Detected in many"	9	"cerebellum: 49.4"	"Not detected"	"Not detected"			"HPA011954, HPA012852"	Enhanced		Supported	"Vesicles,Cell Junctions"	"Intracellular and membrane"	NA	NA			Vesicles	"Cell Junctions"	"HPA011954: AB_1845079, HPA012852: AB_1845080"	"unprognostic (3.56e-3)"	"unprognostic (3.57e-1)"	"unprognostic (8.76e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.86e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.39e-1)"	"unprognostic (8.55e-5)"	"unprognostic (1.55e-1)"	"unprognostic (8.33e-11)"	"unprognostic (1.45e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.73e-3)"	"unprognostic (4.46e-3)"	0.2	0.1	0.8	0.9	0.6	0.6	0.2	2.8	1.8	0.1	0.2	0.2	0.2	0.5	0.2	0.1	0.1	0.1	0.7	0.1	0.8	0.8	0.1	171.0	0.7	0.3	0.4	1.2	0.1	0.3	0.9	0.2	0.1	0.7	0.1	0.1	0.1	0.1	0.1	0.3	0.7	0.3	0.3	0.3	0.5	0.2	2.9	0.2	0.1	1.4	0.1	0.1	0.3	0.1	0.2	13.7	2.1	39.1	0.1	0.3	10.1	0.0	0.1	2.0	0.9	0.0	0.0	0.1	0.1	0.2	0.2	0.3	3.5	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.3	104.5	0.0	0.1	0.4	0.2	0.0	0.1	0.0	0.1	1.8	1.6	0.2	0.1	0.1	0.0	0.1	0.2	0.3	0.0	0.1	0.1	0.8	0.0	0.0	0.1	0.1	0.8	0.1	0.0	0.1	0.3	0.1	0.0	0.2	0.2	0.7	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	2.1	39.1	0.1	0.1	17.9	0.3	0.1	0.0	0.0	13.7	0.2	0.1	0.1	1.1	0.1	4.5	0.6	0.1	10.1	0.8	0.6	2.8	1.8	0.8	0.8	0.4	1.2	0.7	0.2	0.0	6.6	13.0	1.0	2.9	31.7	1.2	73.9	1.4	2.3	3.5	151.2	3.2	3.3	0.8	212.5	12.7	0.3	23.3	0.2	3.6	2.0	0.8	0.0	1020.7	41.3	14.3	15.0	23.9	110.6	80.2	2.3	18.3	0.0	0.0	0.7	2.6	0.4	0.6	1.1	1.6	39.8	0.0	0.4	4.5	7.8	4.3	10.4	0.7	1.0	2.4
ATOH7	"bHLHa13, Math5"	ENSG00000179774	"Atonal bHLH transcription factor 7"	Q8N100	10	68230624-68232103	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"brain: 10.4;liver: 3.9"	"Cell type enhanced"	"Detected in single"	18	"Cone photoreceptor cells: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"SCLC-21H: 13.4"	"Region enriched"	"Detected in some"	9	"cerebellum: 32.2"	"Low region specificity"	"Detected in many"			HPA027008	Uncertain					NA	NA					"HPA027008: AB_10600783"	"unprognostic (7.17e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.66e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.20e-3)"	"unprognostic (7.40e-2)"	"unprognostic (7.76e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.46e-1)"	"unprognostic (9.28e-4)"	"unprognostic (4.96e-3)"	"unprognostic (1.17e-1)"	"unprognostic (5.06e-4)"	"unprognostic (1.72e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.36e-1)"	"unprognostic (7.18e-2)"	0.4	0.4	5.5	0.2	5.7	0.3	0.4	4.9	10.4	0.5	0.7	0.2	0.0	1.4	1.1	0.9	0.3	0.4	0.4	0.4	3.9	0.9	1.6	3.9	0.2	0.2	0.5	5.0	0.3	1.5	0.2	0.2	0.2	0.2	0.3	0.5	0.0	0.4	0.4	0.5	0.3	1.6	0.5	0.2	0.3	0.7	0.8	0.5	0.0	0.3	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.3	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.4	0.0	0.0	0.3	0.0	0.4	0.0	0.1	0.0	13.4	0.5	0.5	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	5.7	4.9	10.4	3.9	0.9	0.5	5.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0
ATP2A1	"ATP2A, SERCA1"	ENSG00000196296	"ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1"	O14983	16	28878405-28904509	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	Translocase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	26	"skeletal muscle: 456.3;tongue: 209.0"	"Cell type enhanced"	"Detected in some"	20	"Cone photoreceptor cells: 13.7;Late spermatids: 2.9;Rod photoreceptor cells: 4.6;Spermatogonia: 3.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 4.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"NK-cell: 4.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 19.8"	"Region enriched"	"Detected in single"	8	"thalamus: 14.3"	"Not detected"	"Not detected"			"CAB002310, CAB032706"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB002310: AB_564139, CAB032706: AB_2061286"	"unprognostic (2.37e-1)"	"unprognostic (6.81e-2)"	"unprognostic (2.23e-5)"	"unprognostic (5.35e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.22e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.72e-4)"	"unprognostic (1.70e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.51e-2)"	7.6	0.1	0.1	0.2	0.1	0.2	0.2	0.2	0.1	0.1	0.1	0.0	0.0	0.2	0.1	1.1	5.2	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.6	0.1	12.6	7.0	0.3	456.3	0.2	0.2	0.1	0.1	0.1	0.1	0.9	0.0	0.0	4.2	209.0	6.5	0.2	0.1	1.6	3.1	0.7	0.2	4.7	1.5	0.6	4.8	5.2	9.6	5.8	0.4	1.6	8.9	2.3	1.3	0.4	0.4	2.9	4.4	7.6	2.7	0.4	3.2	5.1	2.4	0.1	0.7	3.8	19.8	2.7	11.8	9.0	0.2	1.1	2.6	4.1	1.1	0.6	0.5	4.9	0.2	14.3	5.2	6.5	0.3	9.7	10.9	6.1	9.7	1.8	7.4	16.9	6.8	5.7	0.0	0.6	6.2	4.9	3.3	4.5	3.4	3.7	3.4	2.7	2.0	3.0	6.3	5.6	2.8	9.5	5.8	7.4	5.9	15.0	2.9	0.0	0.1	0.7	1.0	0.0	1.3	1.6	1.1	1.0	0.0	0.8	1.4	1.3	0.0	4.7	0.2	3.1	1.5	0.6	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.3	0.3	0.0	0.0	0.0	0.0	13.7	0.3	0.0	0.1	1.0	0.0	0.5	0.0	0.2	0.1	0.2	0.1	0.0	0.8	0.1	0.0	0.0	0.0	0.3	2.9	0.3	0.0	0.0	0.0	0.1	0.5	0.2	0.3	0.0	0.0	4.6	0.0	0.0	1.8	3.0	0.1	0.6	0.0	0.6	0.0
ATP2A3	SERCA3	ENSG00000074370	"ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3"	Q93084	17	3923870-3964464	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 82.4;salivary gland: 88.1"	"Cell type enhanced"	"Detected in many"	10	"Enterocytes: 61.6;Intestinal endocrine cells: 94.0;Mucus-secreting cells: 112.7;Paneth cells: 46.0"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"cerebellum: 10.9;midbrain: 4.1"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 39.3;HMC-1: 58.2;JURKAT: 32.7;MOLT-4: 52.0;SK-BR-3: 42.3"	"Region enriched"	"Detected in some"	15	"cerebellum: 75.4"	"Low region specificity"	"Detected in many"			"HPA007180, CAB010882"	Approved					NA	NA		100000000			"CAB010882: AB_258368, HPA007180: AB_1845177"	"unprognostic (4.14e-2)"	"prognostic favorable (4.69e-5)"	"unprognostic (1.21e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.02e-2)"	"prognostic favorable (2.51e-4)"	"unprognostic (8.83e-3)"	"unprognostic (2.30e-1)"	"unprognostic (8.29e-2)"	"unprognostic (3.67e-3)"	"unprognostic (3.95e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.45e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.97e-3)"	2.1	4.9	0.9	36.9	1.6	24.3	2.7	10.9	1.7	2.3	15.4	1.8	48.8	8.1	3.4	2.8	4.5	2.2	16.0	2.6	0.9	0.7	3.4	1.6	7.8	25.6	4.1	1.4	2.1	20.2	0.0	0.8	1.7	1.4	7.4	9.0	8.7	88.1	47.3	0.9	9.4	26.1	3.0	1.0	36.4	25.5	1.6	1.2	82.4	4.2	6.0	47.5	5.4	2.6	8.3	10.8	21.1	1.0	2.5	7.8	3.9	0.0	1.6	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.3	39.3	2.4	0.1	0.0	0.1	0.6	0.0	0.0	4.8	0.4	20.5	1.2	0.0	0.3	22.3	58.2	0.0	0.0	0.1	0.0	0.0	0.0	32.7	4.1	25.4	0.0	24.4	52.0	24.0	0.2	11.1	0.3	5.7	0.0	9.0	0.0	0.7	2.5	0.7	0.3	42.3	0.0	0.2	2.6	5.5	0.1	0.0	0.4	0.1	0.0	9.4	2.8	13.8	0.5	15.9	0.0	9.1	1.0	21.1	7.8	0.6	6.1	6.9	4.8	7.2	1.0	8.3	3.6	4.4	9.0	2.5	0.3	10.8	4.2	3.9	0.9	1.6	10.9	1.7	0.9	0.7	4.1	1.4	1.4	1.2	0.0	3.4	44.0	0.4	0.8	0.0	2.2	5.1	1.4	2.3	22.7	0.0	0.2	0.0	1.7	0.1	3.6	61.6	0.0	10.8	0.2	2.0	6.5	33.4	0.8	2.8	0.0	94.0	7.4	3.5	0.0	0.0	2.6	11.8	0.0	112.7	0.2	17.0	46.0	0.7	0.2	0.1	0.0	3.1	0.0	0.7	0.3	0.0	20.8	41.2	2.5
AVP	"ADH, ARVP"	ENSG00000101200	"Arginine vasopressin"	P01185	20	3082556-3084724	"Disease related genes, Predicted secreted proteins"		"Hormone, Vasoactive, Vasoconstrictor"	"Diabetes insipidus, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	44	"brain: 270.1"	"Group enriched"	"Detected in some"	5	"Late spermatids: 18.7;Proximal tubular cells: 32.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	18	"hypothalamus: 270.1"	"Cell type enriched"	"Detected in some"	6	"eosinophil: 6.1"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 6.1"	"Cell line enriched"	"Detected in single"	13	"NB-4: 7.1"	"Region enriched"	"Detected in some"	10	"hypothalamus: 273.6"	"Group enriched"	"Detected in some"	633	"basal ganglia: 1065.4;hypothalamus: 1058.2"	"CAB025318, HPA071892"	Enhanced	Supported			"Secreted to blood"	NA	NA	19300				"CAB025318: , HPA071892: AB_2732190"										"unprognostic (1.15e-1)"					"unprognostic (2.61e-1)"			0.7	0.9	11.7	0.4	15.0	4.2	0.0	0.0	0.9	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	270.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	1.0	0.1	11.7	15.0	0.0	0.9	3.4	270.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	4.8	0.0	0.0	0.0	18.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.3	0.0	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0
AZGP1	"ZA2G, ZAG"	ENSG00000160862	"Alpha-2-glycoprotein 1, zinc-binding"	P25311	7	99966720-99976157	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 158.8;salivary gland: 270.5"	"Group enriched"	"Detected in many"	6	"Glandular cells: 2272.6;Hepatocytes: 3981.0"	"Group enriched"	"Detected in many"	12	"breast cancer: 412.6;liver cancer: 273.6;prostate cancer: 469.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 16.8;Karpas-707: 9.6;OE19: 49.6;RPMI-8226: 38.9;T-47d: 13.0"	"Region enriched"	"Detected in single"	4	"olfactory region: 0.9"					"HPA012582, HPA012876, CAB016087, CAB032276"	Enhanced		Approved	Nucleoplasm,Vesicles	"Secreted to blood"	NA	NA	55200000000	160000000000	Vesicles	Nucleoplasm	"CAB016087: AB_667849, CAB032276: AB_2062580, HPA012582: AB_1845226, HPA012876: "	"unprognostic (8.14e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.41e-1)"	"unprognostic (5.42e-3)"	"unprognostic (4.98e-2)"	"unprognostic (5.74e-3)"	"prognostic favorable (2.90e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.79e-1)"	"prognostic favorable (1.53e-4)"	"unprognostic (2.18e-1)"	"unprognostic (2.08e-2)"	"unprognostic (9.80e-2)"	"unprognostic (3.51e-3)"	6.4	0.0	1.1	1.3	1.7	0.0	64.1	1.1	1.4	1.1	1.4	1.5	0.9	1.4	0.9	1.2	1.3	0.0	2.2	9.0	1.2	0.4	18.0	158.8	3.0	0.9	2.7	1.2	1.0	55.3	0.0	0.9	1.0	1.3	62.4	0.0	1.6	270.5	2.5	1.0	11.5	1.5	0.9	1.1	0.9	14.4	1.2	1.7	0.9	1.0	3.0	3.2	1.0	1.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	1.7	0.0	0.0	0.0	0.0	0.0	1.2	4.3	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.8	1.6	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	1.4	0.0	49.6	0.0	0.0	0.5	38.9	0.0	0.0	0.0	0.6	0.2	7.9	3.8	0.0	13.0	0.0	0.0	0.1	0.0	0.6	0.3	0.6	0.2	0.1	0.0	0.1	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	1.7	1.1	1.4	1.2	0.4	2.7	1.2	1.3	1.7	20.8	187.7	32.0	321.8	3.8	0.0	94.8	420.4	5.3	50.0	5.2	2.0	0.0	39.7	11.0	1.3	0.4	8.5	46.7	221.1	0.0	0.2	2272.6	3.5	3981.0	0.0	0.0	11.9	58.3	79.1	3.1	0.9	0.3	59.1	3.6	5.4	22.6	173.5	5.8	0.0	512.3	0.2	0.0	1.1	4.3	0.4	8.4	0.0	15.2	6.3	497.4
B3GNT5	"B3GN-T5, beta3Gn-T5"	ENSG00000176597	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5"	Q9BYG0	3	183253244-183298504	"Enzymes, Predicted intracellular proteins"		"Developmental protein, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 80.2"	"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 101.7;Syncytiotrophoblasts: 132.0;Urothelial cells: 125.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	6	"neutrophil: 9.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 9.0"	"Cell line enhanced"	"Detected in many"		"GAMG: 30.4;HBEC3-KT: 25.2;hTCEpi: 30.7"	"Region enriched"	"Detected in single"	12	"cerebellum: 16.5"	"Low region specificity"	"Detected in all"			HPA017292	Uncertain		Approved	Nucleoli		NA	NA			Nucleoli		"HPA017292: AB_1845237"	"unprognostic (2.17e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.07e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (5.09e-4)"	"unprognostic (7.10e-3)"	"unprognostic (7.78e-2)"	"unprognostic (8.48e-2)"	"prognostic unfavorable (7.23e-6)"	"unprognostic (4.20e-1)"	"prognostic unfavorable (1.30e-7)"	"unprognostic (1.18e-2)"	"unprognostic (2.71e-1)"	"unprognostic (3.53e-2)"	"unprognostic (8.10e-3)"	8.6	1.4	2.2	6.1	2.3	31.6	4.3	1.2	2.5	6.4	29.8	5.4	2.1	17.5	3.2	5.4	23.5	5.4	10.1	3.3	3.0	2.9	3.5	3.0	11.2	5.1	4.0	0.7	4.2	3.5	1.8	5.1	19.8	4.5	3.9	9.2	3.2	8.7	2.5	6.6	8.0	80.2	2.9	6.3	2.3	5.1	2.9	2.3	1.0	4.6	18.9	8.9	5.0	10.6	0.1	1.1	9.0	1.5	0.0	0.3	0.4	16.1	1.5	8.7	5.3	7.3	21.6	7.9	0.2	0.4	1.7	1.4	3.2	8.5	0.0	1.0	0.0	30.4	7.4	8.9	25.2	1.4	0.0	5.5	0.8	0.7	0.0	9.3	8.1	4.0	10.1	30.7	1.3	23.0	2.3	15.7	0.0	9.2	0.0	13.8	0.0	0.0	2.6	3.6	9.5	14.0	2.5	4.4	0.0	5.3	4.5	0.4	8.3	4.5	0.0	1.9	4.1	0.0	9.9	23.1	0.4	3.4	0.5	3.9	0.0	0.0	0.0	3.3	19.2	8.6	0.0	1.5	1.5	0.0	0.3	0.0	0.1	0.1	0.0	1.1	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.3	0.4	2.2	2.3	1.2	2.5	3.0	2.9	4.0	0.7	4.5	2.3	6.0	17.4	0.0	55.5	57.9	7.1	2.0	12.7	101.7	27.3	5.2	21.6	24.4	1.7	15.7	9.9	10.0	77.7	0.0	10.5	9.4	7.4	42.6	13.9	0.4	25.3	3.2	36.7	3.1	9.7	19.2	1.4	50.1	11.8	11.8	73.1	3.2	25.3	42.1	0.4	4.3	12.7	0.0	3.4	0.9	0.4	74.2	132.0	0.7	26.9	125.2
BARHL2		ENSG00000143032	"BarH like homeobox 2"	Q9NY43	1	90711539-90717237	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	4	"brain: 29.3"	"Cell type enriched"	"Detected in some"	5	"Horizontal cells: 22.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	42	"cerebellum: 29.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 2.5;HEK 293: 8.9;HEL: 1.3;HMC-1: 2.5;JURKAT: 1.5"	"Region enriched"	"Detected in some"	5	"cerebellum: 14.5"	"Region enriched"	"Detected in many"	20	"cerebellum: 48.3"							NA	NA										"unprognostic (1.83e-1)"				"unprognostic (1.73e-1)"	"unprognostic (6.80e-2)"				"unprognostic (3.10e-1)"	"unprognostic (1.60e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	8.9	1.3	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	4.1	3.6	0.0	0.0	0.0	0.0	0.0
BCL2L15	"Bfk, C1orf178, FLJ22588"	ENSG00000188761	"BCL2 like 15"	Q5TBC7	1	113878168-113887547	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"intestine: 84.0"	"Cell type enhanced"	"Detected in many"	11	"Enterocytes: 93.5;Exocrine glandular cells: 101.2;Pancreatic endocrine cells: 70.7;Undifferentiated cells: 44.4"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 10.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 1.6;neutrophil: 1.9"	"Group enriched"	"Detected in many"	6	"granulocytes: 1.9;T-cells: 1.6"	"Group enriched"	"Detected in some"	5	"CAPAN-2: 19.5;EFO-21: 6.7;OE19: 21.8;RPTEC TERT1: 5.8"	"Region enriched"	"Detected in single"	32	"cerebellum: 36.9"	"Low region specificity"	"Detected in many"			"HPA029732, HPA029733"	Enhanced					NA	NA					"HPA029732: AB_10599615, HPA029733: AB_10600422"	"unprognostic (5.96e-2)"	"unprognostic (6.41e-3)"	"unprognostic (5.82e-2)"	"prognostic favorable (5.63e-4)"	"unprognostic (2.16e-1)"	"unprognostic (6.23e-3)"	"unprognostic (4.97e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.42e-7)"	"unprognostic (5.20e-2)"	"unprognostic (2.24e-2)"	"unprognostic (9.04e-3)"	"unprognostic (4.27e-2)"	0.4	0.2	0.4	3.8	0.4	5.7	0.4	0.9	0.4	2.6	30.5	0.4	0.7	25.4	0.6	2.4	2.3	0.5	4.9	0.4	0.4	0.2	1.3	0.4	0.7	0.4	0.4	0.4	0.6	9.4	0.0	0.4	0.4	0.4	0.5	18.8	0.4	0.4	0.4	0.4	0.2	84.0	0.4	0.4	0.5	9.4	0.6	0.4	0.4	0.4	0.9	0.6	0.8	0.6	0.0	0.0	1.9	0.3	0.0	1.6	0.4	0.0	2.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.1	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.1	0.0	0.3	0.0	1.8	0.3	0.2	0.0	21.8	0.0	0.0	0.3	0.4	5.8	0.0	0.1	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.2	0.3	0.1	0.7	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.6	0.0	1.2	0.5	0.0	0.0	0.2	0.0	1.9	0.0	0.3	0.0	0.0	0.4	0.4	0.4	0.9	0.4	0.4	0.2	0.4	0.4	0.4	0.4	0.0	2.2	0.8	4.4	0.3	1.7	0.3	7.6	4.0	9.1	22.7	5.9	0.1	0.0	2.7	1.2	0.0	93.5	0.0	101.2	0.0	0.8	2.1	0.0	0.0	0.6	1.6	2.4	0.0	0.6	0.0	0.0	2.1	0.0	2.8	33.4	0.5	70.7	17.3	0.0	0.2	2.4	0.0	1.0	0.5	0.7	1.0	0.1	1.3	44.4	13.9
BPIFB1	"bA49G10.6, C20orf114, dJ1187J4.1, LPLUNC1, MGC14597, VEMSGP"	ENSG00000125999	"BPI fold containing family B member 1"	Q8TDL5	20	33273480-33309878	"Plasma proteins, Predicted secreted proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 100.1;lung: 101.0;lymphoid tissue: 115.1;stomach 1: 76.9"	"Group enriched"	"Detected in some"	16	"Ciliated cells: 887.4;Club cells: 1261.4"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 75.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 5.0;OE19: 6.6;RT4: 3.9;SK-BR-3: 7.9"	"Region enriched"	"Detected in single"	7	"olfactory region: 6.2"	"Not detected"	"Not detected"			HPA024256	Enhanced				"Secreted in other tissues"	NA	NA		7500000			"HPA024256: AB_1845664"	"unprognostic (2.42e-1)"	"unprognostic (5.41e-2)"		"unprognostic (3.67e-2)"	"unprognostic (3.09e-1)"	"unprognostic (6.72e-2)"	"unprognostic (3.43e-2)"	"unprognostic (9.37e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.82e-1)"	"unprognostic (4.00e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.36e-7)"	"unprognostic (3.30e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.55e-2)"	0.1	0.0	0.2	0.2	0.2	0.0	0.2	0.1	0.2	100.1	0.1	0.3	0.1	3.7	0.5	0.2	23.3	0.0	0.3	0.3	0.2	0.0	0.1	0.1	101.0	0.1	0.1	0.1	0.1	0.1	0.0	4.7	0.1	0.1	0.9	0.0	0.1	38.8	0.8	1.0	0.0	0.1	0.1	0.1	0.1	76.9	1.1	0.1	0.2	0.2	29.6	115.1	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.1	6.6	0.0	0.7	0.0	0.3	0.0	3.9	0.0	0.0	0.0	7.9	0.0	0.1	0.6	0.0	0.6	0.0	0.9	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.2	0.2	0.0	0.1	0.1	0.1	0.1	8.9	17.7	0.0	0.4	1.1	0.0	0.4	5.1	887.4	1261.4	0.0	0.0	0.2	0.0	0.1	66.1	0.2	0.0	0.0	0.2	0.1	0.9	1.9	3.5	0.0	0.2	0.0	0.0	0.0	0.0	66.3	0.3	0.3	1.7	0.0	0.0	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.1	0.9	0.4	0.4	0.1	0.0	0.0	0.7
BSX	BSX1	ENSG00000188909	"Brain specific homeobox"	Q3C1V8	11	122977570-122981720	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"brain: 4.9;pituitary gland: 1.7;testis: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	21	"HDLM-2: 1.5;SCLC-21H: 2.7;SH-SY5Y: 2.0"	"Region enriched"	"Detected in single"	5	"hypothalamus: 5.3"	"Region enriched"	"Detected in single"	8	"hypothalamus: 4.5"	HPA015654	Uncertain					NA	NA					"HPA015654: AB_1845470"																		0.0	0.0	0.9	0.0	0.8	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.2	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	1.7	0.0	4.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.8	0.0	0.8	0.0	4.9	0.0	1.2	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C15orf62	LOC643338	ENSG00000188277	"Chromosome 15 open reading frame 62"	A8K5M9	15	40770080-40772449	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 22.8;lymphoid tissue: 21.9;tongue: 18.8"	"Group enriched"	"Detected in some"	5	"Basal glandular cells: 2.8;Glandular cells: 4.5;Horizontal cells: 3.2;Urothelial cells: 8.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 20.0;SK-BR-3: 6.4"	"Region enriched"	"Detected in single"	5	"olfactory region: 1.5"	"Low region specificity"	"Detected in all"			HPA044636	Approved					NA	NA					"HPA044636: AB_10794052"	"unprognostic (9.95e-3)"	"unprognostic (3.73e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.83e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.24e-2)"	"unprognostic (5.37e-3)"	"unprognostic (7.68e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.40e-1)"	1.5	0.9	0.8	1.5	1.1	1.5	1.1	4.0	1.7	1.7	1.0	0.8	0.8	2.0	1.1	0.8	22.8	0.9	1.4	0.8	0.8	0.6	0.9	1.9	1.6	2.1	1.1	0.8	1.3	0.9	0.0	1.3	0.8	0.9	1.1	0.0	0.8	5.4	1.8	1.9	11.9	1.8	0.8	0.8	1.5	1.2	0.9	0.8	1.8	1.0	18.8	21.9	0.9	3.8	0.4	0.7	0.0	0.1	0.4	1.0	0.1	0.6	0.5	1.8	2.3	0.7	0.2	0.4	0.8	0.2	0.1	0.2	2.0	2.5	1.1	2.0	0.0	1.6	4.5	0.8	0.0	0.0	1.6	1.9	1.1	4.1	0.6	0.0	0.9	1.4	0.2	1.0	0.0	0.1	2.0	0.6	0.8	0.9	1.4	0.0	0.5	1.4	1.8	0.7	3.0	0.8	1.6	0.3	0.6	20.0	1.7	4.0	1.0	0.6	6.4	0.2	0.7	2.2	1.5	0.9	2.2	1.0	2.0	0.7	1.6	1.0	1.0	0.7	3.3	0.8	0.0	0.0	0.0	0.7	0.1	0.2	0.0	0.9	0.6	0.0	0.4	1.0	1.0	0.0	0.4	0.0	0.7	0.8	0.1	0.8	1.1	4.0	0.9	0.8	0.6	1.1	0.8	0.9	0.8	0.0	0.0	0.0	2.8	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.5	0.0	0.5	0.2	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.3	8.8
C17orf67		ENSG00000214226	"Chromosome 17 open reading frame 67"	Q0P5P2	17	56791913-56838773	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"vagina: 24.4"	"Cell type enhanced"	"Detected in many"	4	"Rod photoreceptor cells: 18.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 10.0;MOLT-4: 15.3;PC-3: 10.6"	"Region enriched"	"Detected in single"	5	"olfactory region: 3.8"	"Low region specificity"	"Detected in many"			HPA043479	Approved				"Secreted - unknown location"	NA	NA					"HPA043479: AB_10964083"	"unprognostic (2.78e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.54e-3)"	"unprognostic (1.69e-3)"	"unprognostic (1.59e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.47e-1)"	"unprognostic (4.63e-2)"	"unprognostic (2.82e-3)"	"unprognostic (9.64e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.68e-5)"	"unprognostic (2.49e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.43e-3)"	3.2	1.9	5.5	3.4	7.3	1.0	7.4	9.9	6.2	5.1	2.2	2.0	3.5	1.9	5.2	4.0	2.4	3.3	4.8	2.2	5.2	2.9	2.1	3.3	3.1	3.9	6.4	1.6	4.4	3.3	2.1	3.2	2.2	5.8	4.9	1.4	1.3	2.8	3.5	1.7	2.0	2.7	4.8	3.6	6.9	2.8	3.8	8.5	9.1	2.4	0.5	2.7	5.2	24.4	3.8	1.1	0.9	0.8	0.6	3.9	1.0	3.3	2.2	1.4	1.5	0.7	1.0	0.6	2.0	2.5	1.7	2.0	2.7	1.1	1.8	3.5	0.8	1.8	1.7	1.0	0.5	1.7	10.0	3.7	1.7	2.3	1.7	0.9	1.3	3.4	0.4	2.7	1.2	1.1	1.3	1.7	3.6	1.6	8.6	1.1	2.6	15.3	2.3	1.3	1.0	10.6	3.3	2.7	1.9	1.2	0.9	0.7	1.8	2.0	0.4	1.0	0.5	2.2	0.9	2.3	1.8	4.5	1.2	1.4	3.6	8.9	1.0	1.3	1.5	0.6	0.0	0.5	0.9	0.6	0.7	1.2	3.8	1.9	2.6	0.4	2.3	2.0	2.5	0.8	0.6	0.8	1.1	3.9	1.0	5.5	7.3	9.9	6.2	5.2	2.9	6.4	1.6	5.8	8.5	3.0	0.0	7.8	11.9	2.1	10.8	0.8	10.2	1.4	0.0	7.0	13.7	0.1	0.0	2.8	7.5	10.1	5.4	0.0	1.2	0.7	2.8	10.1	1.1	4.4	2.3	4.8	8.5	4.3	6.1	5.3	7.2	3.2	1.7	4.6	2.0	2.4	1.9	2.5	1.1	0.0	18.8	0.0	3.1	11.5	6.8	1.5	0.2	6.4	1.7	5.5
C1orf232		ENSG00000282872	"Chromosome 1 open reading frame 230"	A0A0U1RR37	1	26164161-26168581	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"fallopian tube: 1.4;testis: 2.2;thyroid gland: 1.6"	"Not detected"	"Not detected"											"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"SCLC-21H: 8.9"	"Region enriched"	"Detected in single"	4	"cerebellum: 1.8"											NA	NA																							0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	1.4	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.8	0.0	0.0	0.0		0.0	0.0	2.2			1.6		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
C20orf85	"bA196N14.1, LLC1"	ENSG00000124237	"Chromosome 20 open reading frame 85"	Q9H1P6	20	58150904-58161150	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 113.6;testis: 62.8"	"Group enriched"	"Detected in some"	6	"Ciliated cells: 1056.0;Early spermatids: 339.0;Late spermatids: 299.2"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 57.9"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	9	"SCLC-21H: 3.5"	"Region enriched"	"Detected in single"	5	"basal ganglia: 1.5"	"Low region specificity"	"Detected in many"			"HPA058271, HPA065540"	Enhanced					NA	NA					"HPA058271: AB_2683661, HPA065540: AB_2685510"				"unprognostic (4.50e-3)"				"unprognostic (1.87e-1)"		"unprognostic (1.03e-2)"	"unprognostic (3.00e-1)"	"unprognostic (6.46e-2)"		"unprognostic (3.62e-1)"	"unprognostic (2.79e-2)"			0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.1	7.4	0.0	0.5	0.2	0.0	1.4	26.9	0.0	113.6	0.0	0.0	0.1	0.8	0.0	0.0	29.4	0.3	0.0	0.0	29.0	0.0	0.0	0.9	0.0	1.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	62.8	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.1	0.1	0.8	0.0	0.0	1.5	0.1	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	1056.0	97.8	0.0	0.0	0.0	0.0	0.0	339.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	299.2	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	78.9	1.9	0.0	0.0	0.0	0.0	0.0
C6orf163		ENSG00000203872	"Chromosome 6 open reading frame 163"	Q5TEZ5	6	87344849-87365463	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 20.2"	"Group enriched"	"Detected in some"	26	"Early spermatids: 164.9;Late spermatids: 171.0"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Region enriched"	"Detected in single"	4	"basal ganglia: 1.4"	"Low region specificity"	"Detected in all"			"HPA044797, HPA052927"	Uncertain		Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"HPA044797: AB_10962365, HPA052927: AB_2681990"	"unprognostic (4.98e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.33e-2)"	"unprognostic (4.18e-2)"	"unprognostic (3.49e-2)"	"unprognostic (7.55e-3)"	"unprognostic (3.96e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.95e-2)"	"unprognostic (5.60e-4)"	"unprognostic (6.66e-2)"	"unprognostic (3.77e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.93e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.42e-2)"	0.7	0.8	0.5	0.5	4.3	3.2	1.3	0.7	1.0	0.8	0.8	1.5	0.5	0.0	1.4	3.0	0.5	2.3	0.5	1.0	0.9	0.4	0.6	0.9	1.7	0.9	0.5	0.5	3.3	1.1	1.7	1.8	0.5	4.6	1.2	1.2	0.5	1.2	0.5	1.5	2.4	1.1	0.5	0.5	1.7	0.8	20.2	1.2	0.5	1.1	0.5	0.8	0.6	0.6	1.4	0.7	3.4	0.9	1.2	1.8	0.4	0.2	0.6	3.0	4.5	0.5	3.3	3.6	0.0	0.0	0.6	1.0	1.3	0.9	1.8	0.5	0.4	1.9	0.8	1.2	2.6	0.0	1.6	1.8	2.3	1.0	1.0	0.0	1.1	0.6	1.6	1.5	0.8	0.8	1.3	0.5	1.9	3.5	1.6	0.4	0.7	0.3	1.5	0.7	0.1	0.2	4.0	1.0	0.1	1.9	2.9	2.3	1.2	0.3	0.5	1.2	3.2	0.6	1.3	1.0	1.8	1.4	0.9	1.4	0.5	0.8	0.3	0.2	2.1	1.1	0.5	0.7	0.3	1.8	0.4	0.9	1.3	1.8	1.2	0.7	1.4	1.7	1.8	3.4	1.2	0.9	0.4	1.0	0.4	0.5	4.3	0.7	1.0	0.9	0.4	0.5	0.5	4.6	1.2	0.0	0.3	0.0	0.3	0.3	0.6	1.7	2.5	1.4	0.0	0.0	0.0	0.4	0.0	0.1	164.9	0.0	0.2	0.0	0.0	0.3	0.4	0.4	0.0	0.2	0.2	0.0	0.0	0.0	1.2	171.0	2.3	0.0	1.7	0.0	0.3	0.0	0.1	0.0	1.8	0.4	0.5	6.5	0.4	2.1	1.6	0.1	0.7	0.0	0.2	0.3
CA4	"CAIV, Car4, RP17"	ENSG00000167434	"Carbonic anhydrase 4"	P22748	17	60149936-60170899	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Lyase	"Disease mutation, FDA approved drug targets, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 81.7"	"Cell type enriched"	"Detected in many"	43	"Paneth cells: 2128.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"cerebellum: 50.1"	"Cell type enriched"	"Detected in some"	7	"neutrophil: 37.0"	"Lineage enriched"	"Detected in single"	370	"granulocytes: 37.0"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 1.5;NTERA-2: 3.4;OE19: 3.9;RPTEC TERT1: 1.9;SuSa: 2.6"	"Region enriched"	"Detected in all"	5	"cerebellum: 336.9"	"Low region specificity"	"Detected in many"			"HPA011089, HPA017258"	Enhanced					NA	NA		190000			"HPA011089: AB_1845996, HPA017258: AB_1845997"	"unprognostic (2.07e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.55e-2)"	"unprognostic (7.78e-3)"	"unprognostic (8.42e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.19e-2)"	"unprognostic (5.84e-2)"	"unprognostic (7.76e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.68e-3)"	"unprognostic (8.59e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.45e-1)"	"unprognostic (4.57e-2)"	32.2	0.9	3.4	9.8	4.4	5.7	46.4	50.1	11.8	2.3	81.7	2.0	31.5	1.4	2.3	17.4	0.9	1.7	12.2	8.8	4.7	2.6	12.0	0.3	33.3	2.4	3.5	5.2	1.9	9.5	3.3	5.1	3.2	3.0	2.4	54.9	20.3	4.8	24.0	10.0	1.0	3.2	1.1	2.1	4.9	2.5	1.2	0.3	0.2	23.1	5.0	0.2	1.7	7.9	0.0	0.0	37.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.1	0.3	0.0	0.0	0.0	0.5	0.8	0.1	0.0	0.3	0.0	0.0	0.3	1.3	0.0	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.4	3.9	0.0	0.0	0.2	1.3	1.9	0.0	0.7	0.3	0.2	0.0	0.0	2.6	0.0	0.6	0.0	0.2	0.7	0.4	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.0	0.0	0.0	0.0	0.0	0.0	3.4	4.4	50.1	11.8	4.7	2.6	3.5	5.2	3.0	0.3	0.0	3.7	0.0	0.2	1.3	0.0	9.2	0.0	1.4	1.2	14.0	0.0	0.0	28.2	3.1	0.2	15.8	49.7	0.0	0.2	0.0	1.5	0.1	11.5	0.0	0.5	0.0	18.6	1.8	0.0	0.0	0.6	0.8	0.0	0.0	27.9	0.0	0.1	2128.8	0.0	18.6	0.0	6.5	17.9	0.0	0.0	1.0	0.0	0.0	32.8	0.3
CA8	"CALS, CARP"	ENSG00000178538	"Carbonic anhydrase 8"	P35219	8	60187347-60281412	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 41.0;brain: 26.8;parathyroid gland: 56.8"	"Cell type enhanced"	"Detected in many"	11	"Intestinal endocrine cells: 33.7;Mucus-secreting cells: 16.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	20	"basophil: 41.0"	"Lineage enriched"	"Detected in many"	20	"granulocytes: 41.0"	"Cell line enhanced"	"Detected in some"		"HEK 293: 11.6;JURKAT: 11.4;K-562: 21.0;NB-4: 12.1;OE19: 18.4"	"Region enriched"	"Detected in some"	37	"cerebellum: 1413.4"	"Region enriched"	"Detected in all"	9	"cerebellum: 163.0"	"HPA024748, CAB025545, CAB047309"	Enhanced					NA	NA					"CAB025545: , CAB047309: , HPA024748: AB_1846003"	"unprognostic (1.55e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.43e-2)"	"unprognostic (3.46e-3)"	"unprognostic (6.67e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.19e-1)"	"prognostic favorable (5.79e-5)"	"unprognostic (3.23e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.41e-1)"	2.3	1.5	9.2	1.1	11.6	1.1	6.5	26.8	6.9	6.3	2.2	3.6	0.6	1.8	2.8	12.8	0.9	2.5	1.0	3.8	7.8	6.0	7.4	0.6	1.6	1.0	4.2	5.3	0.7	3.0	56.8	9.8	8.1	3.4	3.3	3.1	1.5	6.6	0.9	2.0	0.9	1.7	1.3	1.9	1.3	5.9	9.3	6.2	1.7	0.7	1.3	1.0	1.3	2.1	0.1	2.0	41.0	0.0	0.0	0.0	0.0	0.0	2.7	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	1.2	0.0	0.1	0.0	11.6	4.9	0.0	0.0	3.9	1.9	1.3	0.0	0.0	0.0	0.0	0.0	0.0	11.4	21.0	0.2	0.0	0.0	3.3	12.1	0.2	18.4	0.0	0.0	0.0	0.2	0.4	0.9	5.3	0.0	0.0	1.1	0.0	2.4	4.9	0.7	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.1	41.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	9.2	11.6	26.8	6.9	7.8	6.0	4.2	5.3	3.4	6.2	0.0	3.7	0.0	0.2	0.9	0.9	3.3	0.0	1.4	6.8	3.5	0.0	7.7	3.3	4.0	7.7	5.3	0.4	0.0	5.4	0.3	3.4	1.8	0.0	0.0	7.4	0.0	33.7	0.0	2.7	3.6	1.4	0.2	6.8	0.0	16.7	2.3	1.5	2.9	1.4	0.0	0.8	0.0	0.4	3.6	4.5	0.4	1.1	0.0	2.3	0.1
CA9	"CAIX, MN"	ENSG00000107159	"Carbonic anhydrase 9"	Q16790	9	35673856-35681159	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"gallbladder: 70.4;pancreas: 47.4;stomach 1: 70.8"	"Cell type enhanced"	"Detected in some"	25	"Cholangiocytes: 53.5;Early spermatids: 178.0;Exocrine glandular cells: 46.4;Pancreatic endocrine cells: 33.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	10	"cerebellum: 7.3"	"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 40.0;HDLM-2: 20.8;hTERT-RPE1: 25.5;U-87 MG: 83.9"	"Region enriched"	"Detected in some"	4	"cerebellum: 13.8"	"Low region specificity"	"Detected in some"			"CAB005100, CAB017107, HPA055207"	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Plasma membrane"		"CAB005100: AB_2066539, CAB017107: , HPA055207: AB_2682738"	"unprognostic (8.01e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.71e-5)"	"unprognostic (1.47e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.24e-3)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (2.22e-7)"	"unprognostic (7.29e-2)"	"prognostic favorable (9.50e-4)"	"unprognostic (2.97e-3)"	"unprognostic (8.67e-2)"	1.0	0.1	0.0	0.1	0.3	0.0	0.0	7.3	0.7	0.5	7.2	0.1	0.2	6.7	0.1	1.5	0.3	0.1	70.4	0.7	0.0	0.0	0.1	0.7	0.1	0.0	0.0	0.0	0.7	47.4	0.0	0.2	0.7	0.4	0.2	0.0	0.1	0.0	0.0	0.0	2.6	8.0	0.0	0.4	0.0	70.8	1.4	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	1.1	0.0	0.0	0.4	0.1	0.0	40.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.2	0.3	20.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	25.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.2	0.0	0.0	1.0	0.0	0.0	0.0	83.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.1	0.0	0.0	0.0	0.3	7.3	0.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	3.9	0.0	0.3	53.5	0.0	0.0	0.0	0.0	0.0	0.0	27.8	178.0	0.0	0.0	0.0	46.4	0.1	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.6	0.0	12.2	1.4	0.0	0.0	1.0	0.1	1.5	33.9	0.0	0.7	0.0	0.0	0.0	0.4	0.9	2.7	2.8	0.2	0.0	0.2	0.3
CABP2	DFNB93	ENSG00000167791	"Calcium binding protein 2"	Q9NPB3	11	67518912-67524517	"Disease related genes, Predicted intracellular proteins"	"Hearing, Sensory transduction, Vision"		"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	8	"retina: 10.7"	"Cell type enriched"	"Detected in some"	8	"Bipolar cells: 54.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"AF22: 1.9"	"Region enriched"	"Detected in single"	22	"cerebellum: 5.2"	"Not detected"	"Not detected"									NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.5	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
CACNG1	CACNLG	ENSG00000108878	"Calcium voltage-gated channel auxiliary subunit gamma 1"	Q06432	17	67044590-67056797	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"skeletal muscle: 126.7"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HSkMC: 8.3;SH-SY5Y: 2.6"	"Region enriched"	"Detected in single"	6	"basal ganglia: 3.0"	"Not detected"	"Not detected"									NA	NA						"unprognostic (1.76e-1)"	"unprognostic (9.83e-3)"		"unprognostic (1.75e-5)"	"unprognostic (2.60e-1)"	"unprognostic (6.72e-3)"	"unprognostic (2.85e-1)"	"unprognostic (1.44e-2)"		"unprognostic (4.84e-3)"	"unprognostic (1.07e-1)"	"unprognostic (4.20e-2)"		"unprognostic (1.60e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.94e-1)"	5.7	0.4	0.3	0.0	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.3	1.6	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.9	0.0	126.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.7	25.0	1.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	8.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	2.6	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CALCA	CALC1	ENSG00000110680	"Calcitonin related polypeptide alpha"	"P01258, P06881"	11	14966668-14972354	"Cancer-related genes, Plasma proteins, Predicted secreted proteins, Transporters"		Hormone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"parathyroid gland: 122.2;thyroid gland: 55.3"	"Cell type enriched"	"Detected in some"	5	"Collecting duct cells: 34.9"	"Cancer enriched"	"Detected in many"	7	"lung cancer: 64.7"	"Region enriched"	"Detected in single"	48	"pons and medulla: 19.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 2.9;hTERT-HME1: 1.8;Karpas-707: 1.8;SCLC-21H: 3.5"	"Region enriched"	"Detected in many"	5	"pons and medulla: 60.6"					"HPA059886, HPA064453"	Enhanced	Supported			"Secreted to blood"	NA	NA	51500				"HPA059886: , HPA064453: "			"unprognostic (1.97e-1)"	"prognostic unfavorable (4.49e-5)"	"unprognostic (5.99e-2)"		"unprognostic (2.42e-1)"	"unprognostic (1.17e-1)"		"unprognostic (6.45e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.66e-2)"	"unprognostic (3.33e-2)"	"unprognostic (7.49e-2)"	"unprognostic (6.74e-2)"	"unprognostic (2.53e-3)"	"unprognostic (1.02e-2)"	0.2	0.0	0.1	0.3	0.4	0.0	0.8	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	6.2	16.8	0.6	0.0	0.1	0.0	0.0	0.1	122.2	0.2	0.0	19.8	1.2	0.0	0.3	0.4	0.0	0.3	0.0	0.0	0.3	1.5	4.6	0.0	0.0	0.0	0.6	55.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.7	0.0	0.0	2.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.5	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.4	0.1	0.2	0.0	0.2	0.1	0.0	19.8	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.3	0.0	0.0	0.0	34.9	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	6.5	0.0	3.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.1	0.0	0.5	0.0	0.0	0.0	1.3
CALCB	"CALC2, CGRP-II, FLJ30166"	ENSG00000175868	"Calcitonin related polypeptide beta"	P10092	11	14904997-15082342	"Plasma proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 14.3;pancreas: 7.9;thyroid gland: 26.0"	"Cell type enhanced"	"Detected in some"	23	"Basal keratinocytes: 1.1;Melanocytes: 5.0;Spermatogonia: 2.1"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.4"	"Group enriched"	"Detected in many"	8	"hypothalamus: 13.5;pons and medulla: 14.3"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEK 293: 6.3;Karpas-707: 11.3;SH-SY5Y: 3.9;U-266/70: 16.9"	"Region enriched"	"Detected in single"	7	"pons and medulla: 10.1"					HPA059886		Supported			"Secreted to blood"	NA	NA					"HPA059886: "	"unprognostic (7.84e-2)"	"unprognostic (4.07e-1)"	"unprognostic (3.92e-1)"	"prognostic unfavorable (3.42e-5)"	"unprognostic (2.02e-1)"	"unprognostic (8.40e-2)"	"unprognostic (1.75e-1)"	"unprognostic (7.21e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.32e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.33e-1)"	0.5	0.2	0.0	1.6	1.6	0.3	1.5	1.5	0.8	0.3	1.5	0.0	0.0	0.9	0.4	0.3	0.3	0.2	0.3	0.9	0.0	13.5	0.4	1.1	1.3	1.0	0.7	0.2	0.2	7.9	0.3	2.7	0.4	14.3	0.4	0.5	1.8	0.7	0.2	1.2	0.3	0.8	0.4	3.9	0.9	0.3	1.4	0.3	0.6	26.0	0.0	0.3	0.3	0.0	0.2	0.3	1.1	0.2	1.8	1.2	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.3	6.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	2.0	0.1	0.4	0.1	0.0	11.3	0.0	0.0	0.0	0.7	3.0	0.1	0.1	0.5	0.0	0.2	0.0	0.0	1.2	3.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.2	0.0	16.9	0.6	0.4	2.3	0.0	0.0	0.0	0.2	1.1	0.8	0.1	1.2	0.0	0.5	0.7	0.3	0.2	1.2	1.1	0.6	1.8	0.0	0.0	0.1	0.4	0.0	1.6	1.5	0.8	0.0	13.5	0.7	0.2	14.3	0.3	0.0	0.0	0.0	0.0	1.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.4	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	2.1	0.0	0.1	0.0	0.0	0.0
CASQ2	PDIB2	ENSG00000118729	"Calsequestrin 2"	O14958	1	115700007-115768781	"Disease related genes, Predicted intracellular proteins"		"Muscle protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 172.4;skeletal muscle: 46.5;smooth muscle: 45.9"	"Cell type enriched"	"Detected in some"	8	"Cardiomyocytes: 697.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.7"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 1.7"	"Cell line enriched"	"Detected in single"	19	"HSkMC: 17.7"	"Region enriched"	"Detected in many"	5	"cerebellum: 48.4"	"Low region specificity"	"Detected in single"			"HPA027285, HPA055298"	Enhanced				"Intracellular and membrane"	NA	NA					"HPA027285: AB_1845933, HPA055298: AB_2682777"	"unprognostic (1.13e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.41e-2)"	"prognostic unfavorable (2.30e-4)"	"unprognostic (1.03e-4)"	"unprognostic (1.78e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.34e-1)"	"unprognostic (8.92e-2)"	"unprognostic (7.20e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (2.25e-5)"	4.9	0.6	0.4	1.8	0.7	0.1	1.6	0.7	0.5	4.3	11.1	0.6	1.1	0.6	6.2	6.3	13.6	3.0	1.9	172.4	0.4	0.5	0.7	0.2	1.1	0.2	0.6	0.5	5.0	0.3	0.5	0.2	0.3	1.0	12.1	3.1	4.6	1.8	3.6	46.5	1.0	3.2	45.9	0.5	0.2	3.5	1.9	0.0	0.0	1.4	17.2	1.8	36.4	1.8	0.0	0.1	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	0.3	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.9	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.4	0.7	0.7	0.5	0.4	0.5	0.6	0.5	1.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	697.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	15.5	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	90.5	23.9	0.1	0.2	0.3	0.0	0.0	0.0	0.0
CBLN1		ENSG00000102924	"Cerebellin 1 precursor"	P23435	16	49277917-49281831	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 106.6"	"Group enriched"	"Detected in some"	6	"Early spermatids: 80.9;Late spermatids: 214.3"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 8.5"	"Region enriched"	"Detected in many"	12	"cerebellum: 106.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	28	"NTERA-2: 16.7;SCLC-21H: 53.2"	"Region enriched"	"Detected in many"	9	"cerebellum: 688.3"	"Region enriched"	"Detected in all"	15	"cerebellum: 300.1"						"Secreted in brain"	NA	NA		2900000				"unprognostic (1.39e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.07e-2)"	"unprognostic (9.65e-3)"	"unprognostic (1.18e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.04e-2)"	"unprognostic (7.68e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.06e-2)"	"prognostic favorable (7.10e-4)"	"unprognostic (1.60e-2)"	9.9	0.8	0.9	0.1	1.0	0.0	1.2	106.6	4.9	2.0	0.4	0.4	0.4	0.6	5.9	1.4	0.8	0.9	9.0	4.2	0.7	9.2	0.2	0.7	0.1	0.9	4.5	1.0	0.5	2.4	0.0	0.9	0.4	4.6	0.3	0.4	1.1	0.7	3.0	0.5	0.3	0.5	1.5	2.3	0.1	0.5	16.0	0.4	0.2	0.6	0.6	2.4	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	1.1	1.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	53.2	1.2	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.0	106.6	1.4	0.7	9.2	4.5	1.0	4.6	0.4	0.0	0.0	0.0	0.0	0.0	3.3	1.7	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	80.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	1.6	12.7	0.0	0.0	214.3	2.0	0.0	0.0	0.0	0.1	0.3	0.3	0.0	0.4	0.0	1.5	25.8	4.4	17.6	4.5	0.1	0.0	0.0	0.0	0.0
CBLN3		ENSG00000139899	"Cerebellin 3 precursor"	Q6UW01	14	24426532-24430954	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"brain: 105.2"	"Cell type enhanced"	"Detected in some"	8	"Fibroblasts: 2.3;Leydig cells: 2.3;monocytes: 3.6"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	23	"cerebellum: 105.2"	"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.5;naive B-cell: 2.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 10.9;HDLM-2: 12.7;HSkMC: 18.9;Karpas-707: 14.2;U-266/70: 9.9"	"Region enriched"	"Detected in some"	25	"cerebellum: 481.8"	"Region enriched"	"Detected in some"	47	"cerebellum: 583.0"	HPA041266	Enhanced	Supported	Approved	Nucleoplasm	"Secreted in brain"	NA	NA			Nucleoplasm		"HPA041266: AB_10674430"	"unprognostic (5.02e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.43e-3)"	"prognostic unfavorable (4.22e-4)"	"unprognostic (4.39e-4)"	"unprognostic (5.39e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.16e-2)"	"unprognostic (9.76e-2)"	"unprognostic (6.20e-2)"	"unprognostic (2.71e-2)"	"prognostic unfavorable (6.20e-6)"	"unprognostic (2.75e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.72e-1)"	"unprognostic (9.02e-2)"	2.1	7.7	1.2	4.5	1.3	0.0	1.2	105.2	1.7	1.8	1.1	1.9	1.0	0.6	1.3	4.8	1.0	1.2	3.1	1.6	1.0	1.1	1.2	1.4	1.3	7.9	1.3	1.4	3.3	1.0	1.0	1.3	1.7	4.6	1.2	0.7	1.7	1.6	1.6	1.4	1.6	1.3	1.3	2.0	7.4	1.4	1.6	1.1	1.1	1.2	1.5	5.3	1.9	1.3	2.3	0.3	0.1	0.8	0.0	0.3	0.0	1.1	1.0	0.5	1.9	5.0	10.9	0.3	4.2	8.6	1.7	2.2	0.5	2.0	1.8	0.9	2.6	1.9	0.3	0.6	2.3	1.1	12.7	0.4	0.0	3.5	0.8	2.8	0.3	0.7	18.9	1.0	2.1	1.7	7.0	1.5	0.8	0.5	14.2	2.1	0.6	0.0	0.5	0.1	1.1	1.1	0.0	0.0	1.3	1.0	0.4	0.7	0.4	0.3	0.1	0.6	0.3	0.6	0.4	6.6	6.1	1.2	2.5	0.2	9.9	2.3	2.0	0.3	0.8	1.0	0.0	0.0	0.1	0.0	0.8	0.3	1.5	0.1	0.1	0.0	2.3	0.2	0.0	0.1	0.0	0.1	0.3	0.0	0.0	1.2	1.3	105.2	1.7	1.0	1.1	1.3	1.4	4.6	1.1	0.0	0.0	0.0	0.5	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.5	0.0	1.0	0.5	2.3	0.5	0.0	0.0	0.8	0.0	0.0	0.0	0.8	0.0	2.3	0.0	0.0	3.6	0.2	0.8	0.8	0.0	1.4	0.5	0.3	0.0	1.2	0.0	0.1	0.5	0.7	0.0	0.4	0.5
CCDC179		ENSG00000255359	"Coiled-coil domain containing 179"	H3BU77	11	22846931-22860426	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	42	"testis: 41.8"	"Group enriched"	"Detected in some"	128	"Early spermatids: 1036.4;Late spermatids: 1370.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 1.8;U-266/70: 1.0"	"Region enriched"	"Detected in single"	6	"cerebellum: 3.6"											NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.8	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1036.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1370.7	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	9.4	2.8	0.0	0.0	0.0	0.0	0.0
CCDC28B	"MGC1203, RP4-622L5.5"	ENSG00000160050	"Coiled-coil domain containing 28B"	Q9BUN5	1	32200386-32205387	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Bardet-Biedl syndrome, Ciliopathy, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skeletal muscle: 66.7"	"Cell type enhanced"	"Detected in many"	8	"Intestinal endocrine cells: 86.5;monocytes: 107.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Region enriched"	"Detected in all"	4	"cerebellum: 140.1"	"Low region specificity"	"Detected in all"			HPA028589	Uncertain					NA	NA					"HPA028589: AB_10602175"	"prognostic favorable (2.92e-4)"	"unprognostic (6.01e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.61e-2)"	"unprognostic (2.59e-3)"	"unprognostic (5.18e-2)"	"unprognostic (7.50e-3)"	"unprognostic (7.87e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.79e-2)"	"prognostic favorable (1.10e-5)"	"unprognostic (2.61e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.07e-2)"	2.0	6.5	7.0	4.1	7.2	3.4	1.6	12.4	6.5	2.2	3.1	2.0	1.4	2.4	3.1	3.2	3.2	2.7	3.9	8.6	6.3	4.6	2.9	1.1	2.0	6.8	5.0	6.0	3.4	3.5	4.4	10.1	3.0	4.3	2.7	1.7	4.7	4.0	2.6	66.7	2.6	1.9	3.8	3.6	3.4	2.8	11.7	5.2	4.5	3.2	11.7	4.7	3.2	1.9	9.3	14.2	3.1	4.3	15.8	15.6	8.4	4.6	1.5	10.3	9.9	3.0	3.8	0.8	3.3	4.8	5.8	3.9	3.0	5.3	10.2	5.4	3.9	0.9	1.3	8.3	3.9	1.1	11.6	11.7	13.2	7.1	1.8	4.2	0.3	4.5	4.7	1.8	6.6	0.1	5.5	7.9	17.0	8.5	1.3	3.8	0.6	17.2	2.6	10.4	1.3	2.5	18.3	5.0	8.2	5.3	0.7	19.9	8.8	4.8	1.0	5.8	6.2	3.2	3.9	4.7	3.3	4.4	4.5	2.1	2.8	0.7	0.6	5.6	17.8	3.1	3.1	4.3	0.9	15.6	2.0	7.8	7.8	7.4	13.2	9.8	9.3	12.4	12.3	0.4	15.8	0.5	14.2	9.6	8.4	7.0	7.2	12.4	6.5	6.3	4.6	5.0	6.0	4.3	5.2	0.0	6.7	6.7	5.3	8.0	29.4	12.8	10.2	2.7	1.2	12.2	21.6	1.7	29.9	17.1	11.4	9.0	0.5	23.3	6.6	3.2	31.7	3.0	3.5	0.8	9.8	22.3	86.5	8.6	3.4	22.6	18.7	4.8	16.9	107.4	5.3	16.1	9.1	1.7	15.9	3.3	43.3	0.0	21.7	2.7	11.9	6.8	1.8	22.9	3.3	1.3
CCDC63	"FLJ35843, ODA5"	ENSG00000173093	"Coiled-coil domain containing 63"	Q8NA47	12	110846769-110907535	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"testis: 26.2"	"Group enriched"	"Detected in some"	54	"Early spermatids: 233.1;Late spermatids: 164.1"	"Cancer enriched"	"Detected in single"	12	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	18	"MCF7: 9.9"	"Region enriched"	"Detected in single"	9	"cerebellum: 10.3"	"Not detected"	"Not detected"			HPA061568			Approved	"Nucleoplasm,Nuclear bodies,Vesicles"		No	NA			"Nucleoplasm, Nuclear bodies"	Vesicles	"HPA061568: AB_2684561"					"unprognostic (1.98e-2)"	"unprognostic (1.05e-1)"		"unprognostic (1.17e-1)"	"unprognostic (2.65e-1)"					"unprognostic (5.59e-2)"	"unprognostic (1.09e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.9	0.1	0.0	0.0	0.0	0.0	0.0	26.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.1	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	233.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	164.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	3.7	3.4	0.0	0.1	0.0	0.0	0.0
CCR6	"BN-1, CD196, CKR-L3, CMKBR6, DCR2, DRY-6, GPR-CY4, GPR29, STRL22"	ENSG00000112486	"C-C motif chemokine receptor 6"	P51684	6	167111807-167139696	"CD markers, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 30.7;intestine: 9.9;lymphoid tissue: 33.7"	"Cell type enhanced"	"Detected in many"	11	"B-cells: 21.0;Late spermatids: 20.6;T-cells: 11.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"MAIT T-cell: 30.7;memory B-cell: 23.8;memory CD4 T-cell: 11.9;naive B-cell: 28.2;T-reg: 20.9"	"Group enriched"	"Detected in many"	5	"B-cells: 28.2;T-cells: 30.7"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.6;Hep G2: 14.1;OE19: 4.9"	"Region enriched"	"Detected in single"	8	"basal ganglia: 0.9"	"Not detected"	"Not detected"			"CAB006820, HPA014488"	Approved					NA	NA					"CAB006820: , HPA014488: AB_1846639"	"unprognostic (1.12e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.07e-3)"	"unprognostic (2.08e-1)"	"unprognostic (8.43e-2)"	"unprognostic (2.05e-4)"	"unprognostic (2.39e-1)"	"unprognostic (4.98e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.19e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.68e-4)"	"unprognostic (3.74e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.77e-1)"	0.5	0.3	1.0	24.4	1.5	1.3	1.1	0.3	1.1	0.6	3.0	0.1	0.0	1.4	0.3	0.8	2.1	0.5	3.1	0.3	0.9	0.9	1.0	0.5	3.3	27.3	0.6	0.0	0.3	0.3	0.0	0.4	0.5	0.2	0.5	1.2	0.3	5.0	0.8	0.3	1.1	9.9	0.0	0.4	23.4	2.2	2.7	0.1	3.7	0.6	2.1	33.7	4.8	0.4	28.2	5.4	0.2	0.0	0.4	30.7	2.5	0.1	0.2	0.2	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.5	0.2	1.3	0.3	0.0	0.0	0.0	0.3	0.2	0.1	2.6	0.7	0.1	0.3	14.1	0.0	0.7	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.0	0.1	0.2	0.1	4.9	0.0	0.2	0.2	0.2	0.4	0.0	0.8	0.4	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.8	0.1	0.3	0.5	0.3	0.4	0.0	0.2	0.6	0.0	0.0	0.1	1.6	0.0	30.7	23.8	11.9	4.7	5.4	28.2	0.1	0.0	0.2	0.4	0.0	0.6	20.9	2.5	1.0	1.5	0.3	1.1	0.9	0.9	0.6	0.0	0.2	0.1	0.0	6.2	21.0	0.3	0.9	0.9	0.0	0.0	1.4	3.4	0.0	2.0	0.0	1.7	0.1	5.7	0.0	0.0	0.0	0.2	0.0	0.7	0.1	2.3	0.8	0.1	0.0	0.0	1.3	0.0	20.6	0.0	5.1	1.7	4.6	0.3	0.4	0.1	0.0	0.4	0.3	3.8	0.0	0.1	2.3	0.4	0.4	0.1	11.4	0.0	0.1
CD4		ENSG00000010610	"CD4 molecule"	P01730	12	6786858-6820808	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Host-virus interaction, Immunity"	"Host cell receptor for virus entry, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 111.5;parathyroid gland: 78.4"	"Cell type enhanced"	"Detected in many"	19	"Hofbauer cells: 121.3;Ito cells: 382.4;Kupffer cells: 192.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	17	"classical monocyte: 42.2;intermediate monocyte: 42.5;memory CD4 T-cell: 29.1;myeloid DC: 29.3;naive CD4 T-cell: 24.8;non-classical monocyte: 33.3;plasmacytoid DC: 46.7;T-reg: 26.4"	"Group enriched"	"Detected in many"	20	"dendritic cells: 46.7;monocytes: 42.5;T-cells: 29.1"	"Group enriched"	"Detected in some"	6	"HEL: 34.3;HL-60: 13.8;NB-4: 19.7;THP-1: 39.0;U-937: 36.7"	"Region enriched"	"Detected in single"	15	"basal ganglia: 41.4"	"Not detected"	"Not detected"			"CAB000011, HPA004252, HPA004472, CAB068180"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB000011: AB_442062, CAB068180: AB_2665653, HPA004252: AB_1078466, HPA004472: AB_1078465"	"unprognostic (1.39e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.75e-2)"	"prognostic favorable (2.16e-4)"	"unprognostic (7.76e-2)"	"unprognostic (4.82e-3)"	"unprognostic (3.70e-2)"	"unprognostic (2.74e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (7.45e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.65e-3)"	"unprognostic (9.08e-3)"	"unprognostic (2.95e-1)"	13.8	5.4	6.1	16.0	5.8	4.4	5.6	1.2	4.3	4.5	5.1	8.6	1.8	3.6	3.5	8.3	3.0	5.5	7.3	5.4	4.9	4.4	6.1	32.2	24.0	30.8	6.3	3.1	3.0	3.1	78.4	3.4	10.9	6.2	4.1	6.5	5.7	5.4	3.9	1.9	3.5	9.5	5.2	10.2	49.1	3.9	2.8	5.7	111.5	3.9	4.1	18.6	8.6	3.2	0.1	46.7	1.9	42.5	0.3	29.1	33.6	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	34.3	0.0	0.2	3.8	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	19.7	0.3	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	39.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.7	0.0	0.1	42.2	0.3	0.3	42.5	1.1	0.0	29.1	0.1	29.3	0.1	24.8	0.1	1.9	0.3	33.3	46.7	26.4	33.6	6.1	5.8	1.2	4.3	4.9	4.4	6.3	3.1	6.2	5.7	0.0	6.9	8.2	0.2	3.1	1.5	1.6	15.3	26.8	3.4	3.5	0.0	0.8	5.0	0.0	0.0	2.8	0.0	0.0	0.3	0.9	5.4	0.1	7.0	7.8	121.3	4.8	0.0	382.4	192.9	0.0	15.5	72.7	5.0	39.7	0.0	14.3	0.0	0.0	14.2	1.1	0.1	12.9	4.2	0.0	0.1	1.9	1.0	28.4	0.0	0.3
CD72	"CD72b, LYB2"	ENSG00000137101	"CD72 molecule"	P21854	9	35609533-35646810	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	13	"blood: 75.5;lymphoid tissue: 59.7"	"Cell type enriched"	"Detected in some"	4	"B-cells: 82.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	16	"memory B-cell: 34.3;naive B-cell: 75.5"	"Lineage enriched"	"Detected in many"	22	"B-cells: 75.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 12.7;Karpas-707: 8.2;REH: 5.3;U-698: 28.3"	"Region enriched"	"Detected in single"	7	"basal ganglia: 3.6"	"Low region specificity"	"Detected in single"			"CAB002505, HPA044658"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"CAB002505: AB_563629, HPA044658: AB_2679039"	"unprognostic (1.13e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.21e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.87e-2)"	"unprognostic (7.81e-2)"	"unprognostic (7.11e-2)"	"unprognostic (2.95e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.89e-1)"	"prognostic unfavorable (2.49e-8)"	"unprognostic (1.42e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.59e-2)"	1.9	1.2	0.8	16.6	1.1	2.6	1.3	0.6	0.6	0.7	0.9	0.2	0.5	0.3	0.8	2.1	0.8	0.7	1.6	0.6	0.8	0.7	1.5	2.3	2.2	26.8	0.8	0.1	0.5	1.4	0.5	1.6	1.5	1.1	0.9	0.3	1.1	3.4	0.1	0.5	0.8	5.2	0.6	1.8	59.7	0.8	0.8	0.2	1.5	1.4	0.3	22.2	4.9	0.6	75.5	3.4	0.2	0.6	1.7	0.7	2.5	0.1	0.0	0.4	0.2	0.7	3.9	0.1	0.2	0.1	0.3	0.5	0.0	0.1	12.7	0.0	0.2	0.1	0.0	0.0	0.1	0.4	1.2	0.3	0.4	0.0	0.0	0.4	0.2	2.8	1.1	0.0	0.2	0.3	0.6	0.0	2.8	0.0	8.2	0.7	0.0	0.2	1.7	0.1	0.0	0.1	5.3	0.0	3.8	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.5	0.1	0.2	0.0	0.1	0.2	28.3	0.5	0.4	0.0	0.0	0.3	0.0	0.5	0.6	0.7	34.3	0.2	0.3	3.4	75.5	0.1	0.4	0.2	1.7	0.0	1.8	0.3	2.5	0.8	1.1	0.6	0.6	0.8	0.7	0.8	0.1	1.1	0.2	0.0	1.1	82.7	0.3	0.9	0.0	0.6	2.5	1.4	0.0	3.5	0.0	0.1	0.0	0.6	0.1	0.5	0.5	0.0	0.6	0.2	0.6	0.4	0.0	0.0	19.7	0.0	1.7	0.6	16.7	0.0	0.9	8.0	0.0	1.8	0.0	0.5	1.2	0.0	0.4	0.3	0.7	0.0	0.8	0.2	1.2	1.0	0.2	4.9	0.3	0.1
CDC20B	FLJ37927	ENSG00000164287	"Cell division cycle 20B"	Q86Y33	5	55112995-55173175	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"endometrium 1: 1.8;fallopian tube: 5.5;kidney: 2.9;lung: 4.9;testis: 6.3"	"Cell type enriched"	"Detected in some"	12	"Ciliated cells: 33.5"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 4.5;T-47d: 3.3;U-87 MG: 1.3"	"Region enriched"	"Detected in single"	4	"hypothalamus: 0.4"					HPA053900	Uncertain					NA	NA					"HPA053900: AB_2682299"	"unprognostic (7.39e-3)"	"unprognostic (1.02e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.78e-3)"	"unprognostic (9.94e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.59e-2)"	"unprognostic (5.60e-2)"	"unprognostic (7.84e-3)"	"unprognostic (2.83e-2)"	"unprognostic (3.06e-1)"	"unprognostic (5.15e-4)"	"unprognostic (1.99e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.29e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	1.8	0.1	0.1	5.5	0.1	0.1	0.1	0.1	2.9	0.1	4.9	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	6.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.7	0.2	0.0	0.0	0.1	0.0	0.4	0.5	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.3	0.0	3.3	0.0	0.4	0.0	0.2	0.8	0.1	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.8	0.1	0.0	0.0	0.4	0.0	33.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.2	1.7	0.0	0.0	0.0	0.0	2.9	0.0	0.5	0.0	0.0	0.0	0.7	0.5	0.1	0.1	0.0	0.2	0.1
CDC42BPG	"DMPK2, HSMDPKIN, kappa-200, MRCKgamma"	ENSG00000171219	"CDC42 binding protein kinase gamma"	Q6DT37	11	64823387-64844569	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Club cells: 12.5;Enterocytes: 10.6;Paneth cells: 14.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	9	"cerebellum: 19.4"	"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 19.5;HaCaT: 14.6;MCF7: 19.7;RT4: 12.0;SK-BR-3: 12.1;T-47d: 11.9"	"Region enriched"	"Detected in single"	4	"cerebellum: 5.9"	"Low region specificity"	"Detected in single"			"HPA027382, HPA061836"	Enhanced		Supported	Cytosol		NA	NA			Cytosol		"HPA027382: AB_1846378, HPA061836: AB_2684622"	"unprognostic (3.26e-2)"	"unprognostic (1.58e-1)"	"unprognostic (6.00e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.68e-1)"	"unprognostic (5.27e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.81e-1)"	"prognostic favorable (5.99e-13)"	"unprognostic (2.60e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.14e-2)"	"unprognostic (3.99e-3)"	0.5	2.7	0.8	2.1	0.5	1.1	3.5	19.4	0.8	2.9	9.1	0.8	6.3	8.2	1.0	8.0	14.3	2.9	10.5	0.5	0.7	0.0	3.5	0.5	4.2	0.7	0.5	0.5	1.5	7.9	7.0	6.5	13.0	2.0	4.4	3.4	1.0	14.3	7.6	0.5	22.4	19.7	1.6	0.8	0.8	8.5	2.5	0.7	1.8	3.9	8.1	7.7	5.4	6.3	0.4	0.0	0.0	0.0	0.2	1.0	0.1	5.6	0.8	0.5	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	7.6	4.8	0.1	2.8	0.0	0.2	14.6	0.9	5.7	0.0	0.2	2.2	0.4	3.1	2.4	0.0	0.1	1.4	0.0	7.2	0.1	0.1	0.0	0.0	2.3	3.8	0.0	0.0	19.7	0.1	1.0	1.8	5.3	0.8	0.8	0.3	2.7	3.4	12.0	10.4	0.5	1.8	12.1	0.3	2.9	11.9	0.2	0.0	0.0	2.1	0.0	0.0	1.4	1.3	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.2	0.3	0.1	0.0	0.4	0.2	0.0	0.0	0.2	0.0	0.0	0.4	0.1	0.8	0.5	19.4	0.8	0.7	0.0	0.5	0.5	2.0	0.7	8.9	6.4	0.0	2.3	5.8	0.0	1.6	2.5	6.7	12.5	1.8	0.0	4.8	0.0	1.7	0.5	0.0	10.6	0.0	5.3	4.1	0.6	2.1	1.1	0.0	0.9	0.0	3.5	0.0	0.0	0.4	0.0	0.2	0.0	1.8	3.3	0.9	2.8	14.0	0.0	0.3	0.0	0.0	0.5	1.7	1.1	7.0	5.6	0.0	3.8	2.0
CDH15	"CDH14, CDH3"	ENSG00000129910	"Cadherin 15"	P55291	16	89171767-89195492	"Disease related genes, Predicted membrane proteins"	"Cell adhesion"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 44.2;skeletal muscle: 60.3"	"Cell type enhanced"	"Detected in some"	14	"Alveolar cells type 2: 1.3;Ito cells: 1.3;Melanocytes: 1.7;Muller glia cells: 1.5;Spermatocytes: 1.6;Spermatogonia: 4.3"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in some"	24	"cerebellum: 44.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RH-30: 57.9"	"Region enriched"	"Detected in some"	7	"cerebellum: 17.6"	"Region enriched"	"Detected in all"	6	"cerebellum: 17.9"	"HPA009139, HPA070961"	Enhanced	Supported	Enhanced	"Golgi apparatus,Plasma membrane"		NA	NA		390000	"Golgi apparatus, Plasma membrane"		"HPA009139: AB_1078372, HPA070961: AB_2686328"	"unprognostic (1.26e-1)"	"unprognostic (7.70e-3)"	"unprognostic (6.64e-3)"	"unprognostic (2.81e-1)"	"unprognostic (7.79e-3)"	"unprognostic (2.70e-3)"	"unprognostic (2.84e-3)"	"unprognostic (4.37e-2)"	"unprognostic (2.30e-3)"	"unprognostic (7.66e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.14e-7)"	"unprognostic (3.09e-2)"	"unprognostic (3.13e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.64e-2)"	0.8	0.2	0.0	0.1	0.0	0.1	0.1	44.2	0.2	0.7	0.1	0.0	0.0	0.2	0.1	2.8	0.6	0.1	0.1	0.1	0.0	0.0	0.2	0.8	0.2	0.1	0.0	0.0	0.1	0.9	0.1	0.0	0.8	1.8	0.5	0.1	0.0	0.3	0.2	60.3	0.1	0.1	0.1	0.3	0.6	0.1	0.3	0.0	0.0	0.1	6.5	0.3	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	12.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	57.9	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	44.2	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.2	0.2	0.0	0.6	0.3	0.0	0.0	1.3	0.0	0.4	0.0	0.0	1.7	0.0	0.0	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.3	1.6	4.3	0.0	0.1	0.0	0.0	0.0
CDHR1	"CORD15, KIAA1775, PCDH21, RP65"	ENSG00000148600	"Cadherin related family member 1"	Q96JP9	10	84194635-84219621	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	Receptor	"Cone-rod dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 31.2;intestine: 22.6;retina: 42.5;skin 1: 86.8"	"Group enriched"	"Detected in many"	5	"Cone photoreceptor cells: 357.4;Rod photoreceptor cells: 231.3"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 13.8"	"Region enhanced"	"Detected in many"		"basal ganglia: 31.2"	"Cell type enriched"	"Detected in single"	11	"NK-cell: 10.5"	"Lineage enriched"	"Detected in single"	11	"NK-cells: 10.5"	"Cell line enhanced"	"Detected in some"		"HAP1: 10.5;HEK 293: 5.4;HEL: 6.3;K-562: 4.5;NTERA-2: 4.6;RPTEC TERT1: 17.2"	"Region enriched"	"Detected in some"	21	"olfactory region: 408.8"	"Low region specificity"	"Detected in all"			HPA036819	Enhanced				"Intracellular and membrane"	NA	NA					"HPA036819: AB_10671750"	"unprognostic (8.91e-4)"	"unprognostic (5.60e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.71e-2)"	"unprognostic (2.63e-2)"	"unprognostic (3.03e-2)"	"unprognostic (6.40e-2)"	"unprognostic (7.77e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.67e-1)"	"unprognostic (6.69e-4)"	"unprognostic (1.90e-1)"	"unprognostic (5.51e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.56e-3)"	"unprognostic (5.07e-2)"	0.3	1.2	1.9	0.7	31.2	0.5	2.3	0.9	7.7	2.8	12.3	2.2	0.0	0.3	0.6	2.2	4.8	0.6	0.5	0.9	3.4	2.1	0.5	0.5	0.4	0.7	1.5	3.1	0.8	0.4	0.3	1.5	0.4	9.3	0.9	22.6	42.5	1.0	2.2	0.7	86.8	5.3	0.9	1.2	3.0	0.4	0.4	3.0	2.4	0.4	3.3	0.9	0.4	1.5	0.0	0.0	0.0	0.0	10.5	0.9	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	10.5	2.0	0.0	0.0	5.4	6.3	0.0	0.0	0.2	0.0	0.2	0.0	2.3	0.0	0.8	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	1.5	4.6	0.0	0.0	0.0	0.0	1.4	17.2	0.0	3.6	0.8	0.0	0.0	0.0	2.7	0.0	0.2	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.1	1.9	31.2	0.9	7.7	3.4	2.1	1.5	3.1	9.3	3.0	0.0	0.3	0.0	0.3	45.4	19.5	1.0	0.0	0.0	1.2	0.0	357.4	0.0	0.0	0.0	0.0	0.0	26.2	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	4.8	12.2	0.0	0.3	0.0	0.0	0.0	3.3	0.0	35.5	25.1	0.0	24.6	0.0	0.1	231.3	0.0	0.2	0.0	0.0	59.0	0.0	2.9	47.2	0.1
CDHR2	"FLJ20124, FLJ20383, PC-LKC, PCDH24, PCLKC"	ENSG00000074276	"Cadherin related family member 2"	Q9BYE9	5	176542511-176595974	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Differentiation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"intestine: 179.8"	"Group enriched"	"Detected in many"	9	"Early spermatids: 170.9;Enterocytes: 298.9;Late spermatids: 532.5;Paneth cells: 175.4"	"Group enriched"	"Detected in many"	14	"colorectal cancer: 9.1;liver cancer: 5.7;pancreatic cancer: 11.7;renal cancer: 8.6;stomach cancer: 9.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	14	"Hep G2: 22.2"	"Region enriched"	"Detected in single"	6	"hypothalamus: 2.5"	"Not detected"	"Not detected"			"HPA012569, HPA017053"	Enhanced					NA	NA		3600000			"HPA012569: AB_1845298, HPA017053: AB_1845297"	"unprognostic (1.34e-2)"	"unprognostic (8.90e-4)"	"unprognostic (3.82e-2)"	"unprognostic (8.51e-2)"	"unprognostic (5.10e-4)"	"unprognostic (4.24e-3)"	"unprognostic (6.66e-2)"	"unprognostic (2.06e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.66e-3)"	"unprognostic (1.75e-1)"	"prognostic favorable (9.29e-4)"	"unprognostic (6.58e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.42e-1)"	0.1	0.0	0.1	2.5	0.3	0.0	0.1	0.1	0.3	0.1	80.0	0.1	0.1	67.2	0.1	0.8	0.1	0.2	7.1	0.1	0.1	0.4	3.0	26.6	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	2.9	0.5	0.1	0.1	0.1	0.1	179.8	0.1	0.1	0.1	2.8	1.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.8	0.3	0.0	0.1	0.1	0.0	0.3	0.3	0.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.0	0.2	0.2	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	22.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.2	0.6	0.0	0.2	0.0	0.1	0.0	1.5	0.0	0.0	0.3	1.2	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.3	0.0	0.0	0.1	0.1	0.3	0.1	0.3	0.1	0.4	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.6	12.7	0.0	0.0	1.8	0.0	0.0	0.0	2.9	170.9	0.0	298.9	0.0	0.9	0.0	0.0	0.0	0.0	5.6	0.0	0.0	32.2	0.0	0.3	532.5	1.4	0.0	0.0	0.0	34.1	1.5	9.3	175.4	2.1	11.8	0.2	0.0	0.0	4.1	1.9	0.0	0.1	0.0	6.6	0.0
CEP72	"FLJ10565, KIAA1519"	ENSG00000112877	"Centrosomal protein 72"	Q9P209	5	612272-667168	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Melanocytes: 128.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 3.2;NK-cells: 7.7;T-cells: 3.2"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 27.0;HeLa: 21.8"	"Region enriched"	"Detected in single"	8	"cerebellum: 15.8"	"Not detected"	"Not detected"			"HPA058235, HPA074879"	Approved		Supported	Centrosome		NA	NA			Centrosome		"HPA058235: AB_2683649, HPA074879: AB_2686720"	"unprognostic (2.06e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (8.50e-2)"	"unprognostic (9.74e-2)"	"unprognostic (2.94e-3)"	"unprognostic (3.20e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.38e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.81e-3)"	"unprognostic (3.60e-2)"	"unprognostic (2.93e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.24e-2)"	2.5	2.3	4.7	6.5	6.5	7.1	4.0	7.3	5.9	5.4	3.0	6.6	2.0	3.8	4.8	3.1	4.6	4.5	9.1	2.2	4.5	2.7	2.8	4.2	4.8	6.4	3.8	3.5	7.6	6.2	3.7	4.5	4.0	3.3	3.5	2.5	4.8	4.6	3.2	2.6	6.0	3.4	4.9	3.3	4.0	4.9	18.8	4.3	9.4	4.9	2.6	7.9	2.9	3.6	3.2	0.7	0.6	1.0	7.7	3.2	1.4	4.3	7.2	6.5	9.1	0.6	0.6	11.7	1.9	0.8	4.4	3.8	6.4	6.7	5.2	5.0	0.8	8.1	4.3	4.5	3.3	1.7	27.0	7.1	5.7	21.8	2.5	0.8	6.6	3.9	0.7	1.4	3.8	2.5	0.8	1.7	10.3	5.8	6.2	2.1	3.4	9.8	5.8	4.2	3.8	6.8	7.5	3.7	7.2	1.4	3.5	5.0	3.8	14.0	4.6	1.2	2.1	4.6	5.1	0.5	4.2	6.2	3.9	2.7	3.9	3.7	5.2	2.6	9.3	4.4	0.0	0.6	0.6	2.4	0.2	3.2	2.6	2.1	2.2	0.2	3.2	3.0	3.0	0.0	7.7	1.0	0.7	2.6	1.4	4.7	6.5	7.3	5.9	4.5	2.7	3.8	3.5	3.3	4.3	3.0	1.0	1.3	0.9	5.0	2.0	2.0	2.5	4.0	0.0	0.0	0.0	0.9	0.0	2.5	2.1	1.1	0.5	0.0	0.7	4.6	0.8	0.4	0.0	0.8	1.2	3.2	0.0	0.6	1.2	1.5	1.1	0.8	128.2	1.8	0.7	0.8	1.6	0.0	2.5	0.3	2.0	0.0	1.0	25.7	8.5	3.1	1.4	0.0	1.1	2.4
CEP76	"C18orf9, FLJ12542, HsT1705"	ENSG00000101624	"Centrosomal protein 76"	Q8TAP6	18	12661833-12702777	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Early spermatids: 203.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 36.9"	"Region enriched"	"Detected in many"	11	"cerebellum: 70.6"					HPA039395	Approved					NA	NA					"HPA039395: AB_10673357"	"unprognostic (3.39e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.26e-1)"	"unprognostic (9.31e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.57e-4)"	"unprognostic (2.99e-1)"	"unprognostic (4.00e-4)"	"unprognostic (7.88e-3)"	"unprognostic (2.45e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.67e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.37e-1)"	"unprognostic (5.70e-2)"	"unprognostic (8.21e-2)"	6.1	7.5	6.2	6.8	9.9	10.4	7.9	18.6	10.2	7.8	5.9	4.4	5.2	5.3	7.0	11.0	12.0	5.9	5.4	5.4	5.4	6.3	6.5	9.6	5.6	7.1	5.3	9.1	7.9	6.7	6.5	9.9	6.9	8.8	6.0	8.3	5.0	8.2	7.9	11.4	10.3	6.4	7.1	5.3	6.1	6.8	18.4	5.9	15.7	7.6	6.0	9.3	7.0	7.4	4.4	3.6	3.5	7.1	6.0	6.6	3.7	4.3	4.5	7.7	3.6	4.5	2.4	7.4	5.1	5.9	10.2	7.8	10.1	5.3	5.9	4.6	3.3	5.9	3.5	7.3	3.3	8.7	3.6	6.1	5.3	5.5	8.7	3.4	11.8	6.1	1.9	3.3	6.0	3.9	2.8	5.3	8.3	8.6	9.0	6.5	3.3	10.4	8.5	5.6	36.9	3.0	7.3	6.6	6.3	5.3	4.4	5.7	5.1	6.5	4.1	4.1	5.3	3.0	6.7	4.9	6.9	13.9	6.6	6.1	5.0	8.7	6.9	3.5	5.9	4.5	0.8	3.9	3.5	4.9	7.1	6.6	3.4	5.3	5.8	3.6	4.4	5.3	6.0	1.4	6.0	2.9	2.0	5.8	3.7	6.2	9.9	18.6	10.2	5.4	6.3	5.3	9.1	8.8	5.9	6.0	5.1	3.7	3.3	8.7	5.7	1.6	2.5	4.0	6.8	0.0	11.8	4.5	1.7	2.6	203.5	2.4	5.1	0.0	2.2	6.3	3.5	3.8	5.7	3.9	3.5	3.2	5.8	3.1	2.5	39.5	3.4	3.5	6.8	2.8	5.5	2.3	3.2	0.0	4.2	2.1	7.0	6.5	2.2	21.9	21.5	7.2	5.1	3.2	3.3	3.3
CHRNA10		ENSG00000129749	"Cholinergic receptor nicotinic alpha 10 subunit"	Q9GZZ6	11	3665587-3671384	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	15	"skeletal muscle: 33.6"	"Cell type enhanced"	"Detected in some"	5	"Ciliated cells: 2.7"	"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in some"		"neutrophil: 2.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Region enriched"	"Detected in single"	6	"olfactory region: 8.9"	"Not detected"	"Not detected"									NA	NA						"unprognostic (3.04e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.11e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.71e-2)"	"unprognostic (8.22e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.79e-2)"	"unprognostic (2.74e-1)"	"unprognostic (6.90e-5)"	"unprognostic (4.35e-2)"	"unprognostic (1.06e-5)"	"unprognostic (5.60e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.32e-1)"	"unprognostic (4.39e-3)"	0.2	0.2	0.2	0.4	0.3	0.2	0.1	1.1	0.1	0.2	0.2			0.4	0.2	0.2	0.4	0.3	0.1	0.2	0.2	0.2	0.3	0.6	0.4	0.3	0.1		0.3	0.1	0.0	0.7	0.1		0.7	0.1		0.3	0.1	33.6	0.4	0.2	0.1	0.0	1.0	0.2	0.3			0.5		0.1	0.1	0.0	0.3	0.3	2.2	0.6	0.2	1.0	0.2	1.4	1.5	2.1	2.8	0.9	0.3	1.4	1.7	0.4	1.3	1.3	1.1	2.5	2.5	1.0	0.8	1.1	3.1	1.6	0.9	1.1	1.6	5.2	0.7	3.9	0.5	1.2	0.6	2.7	0.9	1.0	0.9	0.3	0.5	0.8	3.1	2.0	0.6	1.0	0.4	1.5	4.1	2.9	2.6	2.0	2.8	0.9	0.4	1.0	2.0	1.9	0.8	0.9	0.9	1.5	1.8	0.6	3.2	0.7	1.8	2.3	1.3	2.1	0.7	1.7	1.3	0.9	1.3	1.2	0.0	0.4	0.4	1.0	0.0	0.3	0.0	0.8	0.2	0.1	0.3	0.4	0.5	2.2	0.2	0.6	0.3	0.6	0.2											0.0	0.3	0.0	0.6	1.5	1.6	0.8	0.0	2.7	0.0	0.0	0.0	0.3	0.0	0.2	1.2	0.6	0.7	0.0	0.4	0.2	0.3	0.6	0.0	0.8	0.5	1.6	0.0	1.3	0.8	0.4	0.3	0.0	1.7	1.0	0.7	1.3	0.2	0.0	0.4	0.0	0.7	0.0	0.9	0.2	0.4	1.0	0.2	0.0	0.8	0.6
CHRNA9	NACHRA9	ENSG00000174343	"Cholinergic receptor nicotinic alpha 9 subunit"	Q9UGM1	4	40335329-40355217	"Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.3;fallopian tube: 3.9;pituitary gland: 4.6;salivary gland: 2.7;skin 1: 2.7"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"glioma: 3.5"	"Region enhanced"	"Detected in some"		"pons and medulla: 2.6"	"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 1.5;naive CD8 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.5"	"Cell line enriched"	"Detected in some"	7	"U-87 MG: 19.2"	"Region enriched"	"Detected in single"	6	"basal ganglia: 1.0"	"Low region specificity"	"Detected in single"									NA	NA						"unprognostic (6.20e-3)"	"unprognostic (9.18e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.54e-1)"	"unprognostic (3.48e-1)"		"unprognostic (1.58e-1)"	"unprognostic (1.89e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.94e-1)"		"unprognostic (8.96e-6)"	"unprognostic (9.00e-2)"	"unprognostic (1.76e-1)"	"unprognostic (5.01e-2)"	"unprognostic (9.18e-3)"	0.0	0.0	0.9	0.0	0.2	0.0	0.1	0.0	1.5	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	3.9	0.0	0.0	0.2	0.6	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.2	4.6	0.7	2.6	0.0	0.0	0.0	2.7	0.0	0.0	2.7	0.0	0.0	3.3	0.1	0.0	0.4	0.0	0.0	0.4	0.0	0.4	0.7	0.2	0.3	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	2.8	0.0	0.0	0.3	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.9	0.0	0.1	0.1	0.1	0.1	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.4	0.5	0.0	0.3	1.5	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.2	0.0	1.4	0.2	0.6	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CLSPN		ENSG00000092853	Claspin	Q9HAW4	1	35720218-35769967	"Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 12.6;lymphoid tissue: 30.4;testis: 10.0"	"Group enriched"	"Detected in many"	5	"Extravillous trophoblasts: 33.9;Rod photoreceptor cells: 96.1;Spermatocytes: 71.5;Spermatogonia: 133.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Region enriched"	"Detected in single"	12	"basal ganglia: 7.0"	"Low region specificity"	"Detected in all"			"HPA026305, HPA026312"			Enhanced	"Nucleoplasm,Golgi apparatus"		Yes	Yes			"Nucleoplasm, Golgi apparatus"		"HPA026305: AB_2671833, HPA026312: AB_2671837"	"unprognostic (4.75e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.64e-3)"	"unprognostic (3.54e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.18e-6)"	"unprognostic (3.99e-3)"	"unprognostic (2.08e-3)"	"unprognostic (1.63e-2)"	"unprognostic (8.71e-6)"	"unprognostic (3.23e-2)"	"unprognostic (7.61e-6)"	"prognostic favorable (4.92e-4)"	"unprognostic (5.12e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.29e-1)"	1.5	0.8	0.9	11.5	1.0	12.6	1.7	0.3	3.6	0.9	2.1	0.1	0.0	1.0	0.5	0.9	2.9	0.5	2.8	0.6	1.1	0.6	1.0	0.7	1.9	6.0	0.6	0.1	0.5	0.5	0.3	0.4	4.3	0.7	0.5	2.7	1.9	1.0	0.0	0.4	1.2	3.4	1.0	0.8	4.4	1.1	10.0	0.5	30.4	0.5	4.2	6.6	0.9	1.2	0.9	0.9	3.4	1.1	1.3	1.6	1.1	8.7	7.3	15.9	8.4	1.1	2.1	5.9	18.0	5.0	13.2	17.7	11.5	8.2	18.7	5.8	4.8	9.6	8.8	15.5	6.2	20.7	12.8	7.0	26.3	15.9	5.1	0.0	21.5	15.5	0.4	0.2	22.7	1.6	1.5	7.1	11.2	17.7	13.0	12.6	5.7	22.6	4.9	15.0	6.0	5.2	14.4	24.1	5.6	2.7	14.5	5.9	6.9	15.6	4.8	3.1	11.2	4.1	8.5	5.1	19.0	14.4	11.6	20.0	4.7	11.4	19.7	6.0	15.4	15.3	1.6	1.1	1.1	1.6	0.5	0.5	0.4	1.0	0.8	0.9	0.9	0.4	0.8	3.4	1.3	0.7	0.8	1.3	1.1	0.9	1.0	0.3	3.6	1.1	0.6	0.6	0.1	0.7	0.5	0.0	0.3	1.5	4.6	4.9	7.9	1.1	2.5	0.0	3.4	0.0	11.8	5.5	0.0	1.3	6.2	1.9	0.4	0.0	0.6	33.9	3.9	1.4	1.1	0.0	14.0	1.6	1.2	3.7	3.2	4.9	2.3	6.5	3.3	15.4	1.6	6.6	0.9	1.9	0.4	0.0	96.1	6.5	2.5	71.5	133.3	1.8	8.7	5.1	4.1	2.6
CNGA2	"CNCA, CNCA1, CNG2, FLJ46312, OCNC1, OCNCa, OCNCALPHA"	ENSG00000183862	"Cyclic nucleotide gated channel alpha 2"	Q16280	X	151738451-151745304	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Olfaction, Sensory transduction, Transport"	"Calmodulin-binding, Ion channel, Ligand-gated ion channel"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	26	"testis: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SK-BR-3: 1.8"	"Region enriched"	"Detected in single"	4	"olfactory region: 0.6"	"Not detected"	"Not detected"			HPA015065	Uncertain					NA	NA					"HPA015065: AB_1847034"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CNPY1		ENSG00000146910	"Canopy FGF signaling regulator 1"	Q3B7I2	7	155474206-155555450	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	7	"brain: 21.1;pancreas: 8.5"	"Cell type enriched"	"Detected in single"	17	"Spermatogonia: 4.9"	"Cancer enriched"	"Detected in single"	10	"glioma: 1.6"	"Region enriched"	"Detected in some"	17	"cerebellum: 21.1"	"Cell type enhanced"	"Detected in single"		"basophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	8	"AF22: 26.6"	"Region enriched"	"Detected in single"	29	"cerebellum: 215.6"					HPA047400	Uncertain					NA	NA					"HPA047400: AB_10960413"					"unprognostic (4.28e-3)"	"unprognostic (2.12e-1)"					"unprognostic (4.18e-2)"		"unprognostic (8.27e-12)"	"unprognostic (1.44e-1)"	"unprognostic (2.16e-1)"			0.1	0.0	0.2	0.1	0.3	0.7	0.1	21.1	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.8	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.3	0.9	0.1	0.2	8.5	0.0	0.2	0.1	1.2	0.1	0.1	0.5	0.2	0.1	0.1	1.2	0.5	0.1	0.5	0.1	0.2	2.1	0.4	0.1	0.3	0.1	0.1	0.1	0.1	0.3	0.0	1.5	0.0	0.0	0.5	0.0	0.0	0.0	26.6	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.4	0.0	2.3	0.0	0.0	0.0	2.5	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	3.2	0.0	0.0	0.2	0.0	0.0	0.1	0.6	0.1	0.1	0.5	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	1.5	0.0	0.3	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.3	21.1	0.5	0.2	0.2	0.9	0.1	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	4.9	0.0	0.0	0.0	0.0	0.0
COL17A1	"BP180, BPAG2"	ENSG00000065618	"Collagen type XVII alpha 1 chain"	Q9UMD9	10	104031286-104086002	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"			"Cancer-related genes, Disease mutation, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 85.8;skin 1: 123.2;tongue: 64.0"	"Cell type enriched"	"Detected in many"	4	"Basal keratinocytes: 520.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 227.4"	"Region enriched"	"Detected in single"	4	"basal ganglia: 1.2"	"Cell type enriched"	"Detected in single"	15	"neutrophil: 3.7"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 3.7"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 24.8;HaCaT: 56.6;HBEC3-KT: 90.6;hTCEpi: 117.8;hTERT-HME1: 100.3"	"Region enriched"	"Detected in single"	4	"cerebellum: 1.1"	"Not detected"	"Not detected"			"HPA043673, HPA052963"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"	"Secreted to extracellular matrix"	NA	NA			"Plasma membrane"	"Golgi apparatus"	"HPA043673: AB_10960893, HPA052963: AB_2681999"	"prognostic favorable (1.38e-4)"	"unprognostic (1.33e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.65e-2)"	"unprognostic (3.75e-1)"	"unprognostic (2.13e-1)"	"unprognostic (6.82e-3)"	"unprognostic (1.63e-1)"	"unprognostic (7.85e-3)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (2.12e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.75e-2)"	"unprognostic (8.35e-2)"	0.2	0.0	0.2	4.4	1.2	7.5	8.1	0.2	0.2	15.2	9.3	0.2	0.9	2.0	0.6	2.6	31.5	0.1	1.2	0.2	0.2	0.1	0.4	0.2	0.7	0.2	0.2	0.2	0.2	0.2	0.0	0.6	85.8	0.2	5.0	5.4	0.2	15.5	7.3	0.5	123.2	23.2	0.8	0.2	0.3	3.9	4.0	0.2	18.1	2.0	64.0	24.7	3.0	17.3	0.0	0.0	3.7	0.2	0.0	0.0	0.8	3.1	0.0	0.1	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	0.0	24.8	0.0	0.7	0.0	0.5	56.6	0.1	90.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	117.8	0.0	100.3	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.6	0.3	0.0	0.0	0.0	5.1	3.1	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.2	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.2	0.0	0.0	0.8	0.2	1.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.6	0.0	12.4	520.3	0.6	0.8	0.0	2.7	20.5	0.0	0.0	3.5	0.0	0.7	8.5	1.0	105.8	0.0	0.8	8.3	2.1	0.6	0.0	0.0	1.2	0.0	2.4	0.0	0.0	2.6	0.3	1.0	32.1	0.0	5.9	0.4	45.8	16.1	0.7	0.0	0.4	0.0	1.7	8.3	1.1	121.8	4.7	0.0	14.5	8.0
COL18A1	"KNO, KNO1, KS"	ENSG00000182871	"Collagen type XVIII alpha 1 chain"	P39060	21	45405137-45513720	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 273.2"	"Cell type enhanced"	"Detected in many"	10	"Hepatocytes: 362.6;Sertoli cells: 219.9;Smooth muscle cells: 163.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 7.3"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 7.3"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 31.8;EFO-21: 71.6;NTERA-2: 39.8;TIME: 42.1"	"Region enriched"	"Detected in many"	6	"cerebellum: 24.8"	"Low region specificity"	"Detected in all"			"HPA030933, HPA036104"	Supported		Approved	"Golgi apparatus"	"Secreted to extracellular matrix"	NA	NA		250000000	"Golgi apparatus"		"HPA030933: , HPA036104: AB_2674943"	"unprognostic (4.32e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.25e-2)"	"unprognostic (5.55e-2)"	"prognostic favorable (6.16e-4)"	"unprognostic (4.23e-3)"	"unprognostic (9.93e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.77e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.83e-2)"	"unprognostic (9.44e-2)"	"unprognostic (9.10e-3)"	"unprognostic (2.25e-3)"	25.5	14.4	2.2	12.7	13.0	5.6	17.7	3.4	8.5	40.4	12.7	26.0	19.6	12.6	22.2	72.5	12.0	18.8	25.3	18.5	3.5	5.3	36.2	273.2	11.9	7.6	35.5	3.5	43.3	21.8	2.6	17.8	16.5	20.8	13.9	2.3	17.3	8.8	20.2	8.1	23.1	10.6	33.4	31.9	14.5	7.1	11.0	23.6	2.3	16.0	12.0	6.7	28.7	18.2	0.4	0.4	7.3	0.4	0.0	1.2	0.2	2.5	19.5	4.8	4.4	9.1	7.6	1.0	18.7	31.8	9.0	2.4	12.1	6.9	0.5	71.6	18.5	5.2	8.8	1.0	1.1	1.7	0.2	5.4	11.2	0.3	16.5	8.8	0.4	1.1	8.8	0.7	0.8	1.0	2.1	27.6	0.2	11.3	0.1	3.2	4.5	0.4	1.1	39.8	0.8	7.2	0.5	3.1	1.1	30.2	0.4	5.5	4.2	1.8	2.0	5.9	17.9	1.8	3.0	42.1	0.2	2.8	0.1	4.4	0.1	0.2	0.3	0.1	0.9	7.7	1.0	0.4	1.5	0.1	0.4	0.2	0.4	0.4	0.0	0.1	0.1	1.2	0.6	7.3	0.0	0.3	0.4	0.0	0.2	2.2	13.0	3.4	8.5	3.5	5.3	35.5	3.5	20.8	23.6	0.0	5.5	7.0	15.2	60.1	7.9	13.7	53.5	0.0	4.5	106.4	3.9	1.4	8.3	111.6	1.1	54.0	0.0	0.0	4.9	1.1	50.8	5.3	58.6	362.6	2.2	0.0	0.0	84.7	7.3	4.5	73.9	8.3	47.2	2.8	0.0	116.0	10.0	0.0	118.5	54.9	3.8	219.9	163.2	2.6	4.5	25.0	2.1	7.5	0.0	2.2
COL28A1		ENSG00000215018	"Collagen type XXVIII alpha 1 chain"	Q2UY09	7	7356203-7535853	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	12	"Ciliated cells: 16.0;Cone photoreceptor cells: 17.7"	"Cancer enhanced"	"Detected in many"		"glioma: 4.2"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 3.3;U-266/70: 14.2;U-266/84: 3.8;WM-115: 6.9"	"Region enriched"	"Detected in single"	8	"olfactory region: 4.5"	"Not detected"	"Not detected"			"HPA043844, HPA060468"	Uncertain		Approved	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"	NA	NA			"Nucleoplasm, Cytosol"		"HPA043844: AB_2732508, HPA060468: AB_2684288"	"unprognostic (6.28e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.28e-1)"	"unprognostic (8.71e-3)"	"unprognostic (1.89e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.61e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.69e-2)"	"unprognostic (3.90e-3)"	"unprognostic (2.33e-2)"	"unprognostic (3.45e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.48e-3)"	"unprognostic (3.09e-2)"	2.7	3.7	1.0	7.0	1.1	0.3	3.1	2.4	1.6	10.2	11.8	0.6	11.5	1.3	2.9	16.2	14.7	5.5	5.7	7.0	1.3	2.2	2.8	1.9	1.3	1.0	9.8	0.2	2.9	5.8	0.1	12.2	0.5	6.1	5.8	4.7	12.8	19.3	6.2	5.6	2.1	6.6	16.0	7.9	0.3	5.7	3.2	0.2	0.2	1.4	10.2	0.9	8.4	14.2	0.6	0.3	1.6	0.2	2.1	1.0	0.0	2.0	0.0	0.0	0.0	0.2	1.1	0.3	0.1	0.6	0.0	0.0	1.6	0.6	0.3	0.1	0.1	1.4	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.6	0.0	0.0	0.4	0.3	0.1	0.2	0.0	0.3	2.0	0.2	0.3	0.0	0.9	1.2	0.5	0.0	0.1	0.0	3.3	0.1	0.2	0.0	0.1	1.0	0.0	0.5	0.1	0.9	1.0	0.0	0.7	1.8	0.0	14.2	3.8	0.0	0.2	0.8	6.9	0.5	0.1	0.3	0.1	0.2	0.2	0.1	0.1	0.2	0.0	0.6	0.4	1.0	1.6	2.1	0.1	0.3	0.0	0.0	1.0	1.1	2.4	1.3	1.3	2.2	9.8	0.2	6.1	0.2	0.0	2.6	0.0	0.1	0.2	4.6	0.8	0.0	16.0	5.7	3.5	17.7	0.3	0.0	0.1	0.8	0.0	0.0	0.0	0.2	0.0	0.5	0.1	1.1	0.0	0.1	4.8	0.0	3.1	0.0	0.8	0.9	0.0	0.0	0.0	0.3	2.4	0.5	2.8	0.7	0.3	4.5	0.0	0.0	0.7	0.0	0.1	0.2	0.0	0.3	0.1
CPA6	CPAH	ENSG00000165078	"Carboxypeptidase A6"	Q8N4T0	8	67422038-67746385	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 16.2;prostate: 10.6;retina: 13.0"	"Cell type enhanced"	"Detected in some"	11	"Basal glandular cells: 26.9;Early spermatids: 15.2;Muller glia cells: 22.3;Pancreatic endocrine cells: 12.5;Urothelial cells: 26.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 2.0;CACO-2: 6.2;EFO-21: 3.5;Hep G2: 9.5;OE19: 4.2"	"Region enriched"	"Detected in single"	10	"olfactory region: 15.5"	"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"	NA	NA						"unprognostic (2.85e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.88e-1)"	"unprognostic (9.35e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.23e-2)"	"unprognostic (6.99e-2)"	"unprognostic (3.57e-4)"	"unprognostic (9.61e-5)"	"unprognostic (1.75e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.41e-2)"	0.2	0.1	0.1	9.8	0.1	0.2	0.2	0.1	0.1	9.4	16.2	0.7	0.8	0.2	8.3	1.7	3.7	0.2	0.3	0.1	0.2	0.1	0.3	0.1	0.7	0.1	0.2	0.0	0.1	0.1	0.1	0.2	0.3	0.3	10.6	7.2	13.0	0.1	0.7	0.1	0.2	1.3	3.4	0.7	0.3	0.5	1.3	0.0	0.0	0.2	1.5	0.6	4.1	5.5	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.2	0.0	0.0	6.2	0.0	0.0	3.5	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.8	0.0	4.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.0	26.9	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.0	0.0	0.0	0.3	0.0	0.0	5.6	0.0	0.0	0.1	1.6	2.4	0.0	0.0	0.5	1.7	0.0	0.0	0.0	0.7	22.3	12.5	2.9	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	26.0
CRLF1	"CISS, CISS1, CLF, CLF-1"	ENSG00000006016	"Cytokine receptor like factor 1"	O75462	19	18572220-18607741	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		Receptor	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	9	"Basal keratinocytes: 8.7;Ciliated cells: 6.7;Distal tubular cells: 5.0;Early spermatids: 6.3;Smooth muscle cells: 6.4"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 36.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"ASC diff: 151.1;Hep G2: 62.7"	"Region enriched"	"Detected in some"	7	"hippocampal formation: 23.3"	"Low region specificity"	"Detected in single"			"HPA041493, HPA041793"	Approved				"Secreted in other tissues"	NA	NA					"HPA041493: AB_10795637, HPA041793: AB_10804117"	"unprognostic (1.97e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.34e-3)"	"unprognostic (9.31e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.34e-3)"	"unprognostic (4.95e-2)"	"unprognostic (7.92e-2)"	"prognostic unfavorable (3.96e-4)"	"unprognostic (1.33e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.86e-2)"	"unprognostic (5.27e-3)"	15.8	10.4	6.6	2.7	21.2	1.2	19.8	0.8	19.8	14.3	3.6	14.8	6.8	2.2	4.3	18.8	10.4	4.6	7.8	35.0	5.0	3.3	3.6	1.6	5.1	6.0	0.5	8.5	2.4	6.9	1.7	3.2	26.6	4.3	2.0	1.9	0.3	5.8	12.8	30.5	15.1	1.5	3.8	0.8	1.5	2.4	5.6	3.4	0.0	31.9	10.0	1.6	4.3	4.9	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	1.5	151.1	2.2	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	9.5	4.5	0.2	0.0	1.5	0.0	0.0	0.0	0.1	0.0	2.6	62.7	1.0	0.0	0.0	1.7	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.3	1.8	0.0	0.1	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	6.6	21.2	0.8	13.6	5.0	3.3	0.5	8.5	4.3	3.4	0.0	0.0	0.0	0.5	8.7	0.1	2.7	0.0	6.7	3.4	0.0	0.0	0.0	5.0	0.3	6.3	0.0	0.0	0.0	0.2	0.7	2.4	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.7	0.0	6.4	0.1	1.5	4.0	0.2	0.0	0.0	0.0
CRTAM	CD355	ENSG00000109943	"Cytotoxic and regulatory T cell molecule"	O95727	11	122838500-122872639	"CD markers, Predicted membrane proteins"	"Adaptive immunity, Cell adhesion, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 140.8"	"Cell type enhanced"	"Detected in some"	25	"Hofbauer cells: 6.2;Kupffer cells: 9.1;Macrophages: 7.2;T-cells: 34.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	24	"cerebellum: 140.8"	"Cell type enhanced"	"Detected in many"		"NK-cell: 25.7"	"Group enriched"	"Detected in many"	5	"NK-cells: 25.7;T-cells: 16.7"	"Cell line enriched"	"Detected in single"	34	"SCLC-21H: 17.4"	"Region enriched"	"Detected in single"	44	"cerebellum: 115.2"	"Low region specificity"	"Detected in all"									NA	NA		3200000				"unprognostic (3.51e-3)"	"unprognostic (6.73e-4)"	"unprognostic (1.33e-2)"	"unprognostic (3.73e-3)"	"unprognostic (2.40e-2)"	"unprognostic (5.25e-4)"	"unprognostic (1.25e-1)"	"unprognostic (3.66e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.49e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.83e-4)"	"unprognostic (6.01e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.87e-2)"	"unprognostic (6.59e-2)"	0.4	0.3	0.3	2.7	0.4	1.9	0.4	140.8	0.4	0.3	0.4	0.2	0.1	0.4	0.8	0.4	0.3	0.3	1.8	0.3	0.3	0.3	0.3	1.0	2.2	10.6	0.4	0.1	0.3	0.3	0.0	0.3	0.2	5.8	0.3	0.5	0.3	0.7	0.1	0.3	0.3	1.3	0.2	1.2	4.4	0.7	0.3	0.1	3.3	0.3	0.2	4.3	1.1	0.3	0.1	1.7	0.6	4.4	25.7	16.7	2.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.5	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.4	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	2.2	0.2	6.7	2.7	6.5	0.0	0.7	13.5	1.7	0.1	2.2	16.7	0.6	25.7	4.4	0.1	0.0	2.8	0.3	0.4	140.8	0.4	0.3	0.3	0.4	0.1	5.8	0.1	0.0	1.4	0.0	0.4	1.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.1	0.3	1.1	0.0	6.2	0.0	0.0	0.6	9.1	0.6	0.0	7.2	3.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.6	0.1	34.1	0.0	0.3
CRYBG1	"AIM1, ST4"	ENSG00000112297	"Crystallin beta-gamma domain containing 1"	Q9Y4K1	6	106360808-106571978	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 61.7;placenta: 96.6"	"Group enriched"	"Detected in many"	11	"Cytotrophoblasts: 184.0;Syncytiotrophoblasts: 501.8"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in some"	9	"pons and medulla: 10.3"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 32.1;HBEC3-KT: 40.2;hTERT-HME1: 31.1"	"Region enriched"	"Detected in single"	5	"olfactory region: 5.1"	"Low region specificity"	"Detected in single"			"CAB026378, HPA030948, HPA030949"	Approved		Approved	Nucleoplasm,Microtubules,Cytosol		NA	NA			"Nucleoplasm, Microtubules, Cytosol"		"CAB026378: , HPA030948: AB_2673670, HPA030949: AB_2673671"	"unprognostic (1.66e-1)"	"unprognostic (3.44e-2)"	"unprognostic (9.02e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.69e-3)"	"unprognostic (5.61e-2)"	"unprognostic (8.97e-2)"	"unprognostic (3.53e-2)"	"unprognostic (8.89e-2)"	"unprognostic (8.60e-2)"	"unprognostic (3.25e-2)"	4.6	0.8	0.6	6.8	0.7	6.5	11.3	0.6	0.9	7.4	7.4	1.6	2.5	7.6	1.5	10.8	61.7	2.0	2.0	0.9	1.1	0.6	9.8	3.6	4.0	5.6	0.7	0.7	2.0	5.5	5.0	0.9	96.6	10.3	12.6	5.9	16.0	10.2	4.3	0.8	16.6	7.6	4.4	0.8	6.5	2.5	1.8	0.5	2.3	1.8	24.6	35.8	11.5	13.1	6.8	8.7	3.1	4.4	5.7	10.9	3.9	10.6	0.0	0.0	0.0	9.0	32.1	3.3	1.5	11.8	3.4	3.2	0.7	3.8	16.7	0.7	7.3	4.8	17.2	0.1	40.2	1.7	22.7	0.7	0.0	0.5	5.2	4.2	10.1	0.0	16.0	23.5	6.5	31.1	0.0	14.7	13.2	0.5	2.4	9.2	1.2	2.9	4.0	0.1	0.0	7.1	5.0	0.1	0.1	5.4	25.3	0.7	0.0	6.5	11.1	0.1	1.0	5.5	7.7	4.2	3.9	0.5	0.0	10.6	1.8	1.4	18.2	18.4	12.8	8.3	0.3	3.8	0.4	8.1	4.4	10.9	6.8	10.5	8.9	8.7	3.8	6.7	6.3	3.1	5.7	4.4	1.0	9.9	3.9	0.6	0.7	0.6	0.9	1.1	0.6	0.7	0.7	10.3	0.5	11.9	11.0	0.0	0.0	0.0	0.0	0.0	0.0	16.0	23.9	31.4	0.0	184.0	3.3	8.8	0.0	0.0	0.0	0.0	10.8	7.2	0.0	0.0	1.1	0.0	31.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	16.4	0.0	0.0	13.9	0.0	0.0	0.0	0.0	0.0	0.0	501.8	0.0	0.0	0.0
CRYGN		ENSG00000127377	"Crystallin gamma N"	Q8WXF5	7	151428835-151440813	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"seminal vesicle: 4.3;thyroid gland: 16.3"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	25	"thyroid cancer: 15.7"					"Group enriched"	"Detected in some"	31	"memory CD4 T-cell: 3.4;naive CD4 T-cell: 3.4;naive CD8 T-cell: 2.2"	"Lineage enriched"	"Detected in single"	35	"T-cells: 3.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.7;CAPAN-2: 2.7;MOLT-4: 2.0;SCLC-21H: 3.6"	"Region enriched"	"Detected in single"	4	"basal ganglia: 9.3"	"Not detected"	"Not detected"			HPA050788	Uncertain					NA	NA					"HPA050788: AB_2681239"	"unprognostic (1.69e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.55e-3)"	"unprognostic (5.50e-2)"	"unprognostic (2.94e-5)"	"unprognostic (2.49e-3)"	"unprognostic (1.55e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.97e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.48e-2)"	"unprognostic (8.93e-10)"	"unprognostic (2.55e-4)"	"unprognostic (2.71e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.36e-1)"	0.3	0.0	0.3	0.0	0.5	0.0	0.2	0.0	0.4	1.1	0.3			0.0	0.9	0.0	0.0	0.5	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0		0.4	0.0	2.6	0.8	0.3		0.3	0.0		0.1	4.3	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0			16.3		0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.4	0.0	0.0	0.0	0.6	0.0	0.0	1.7	0.0	0.3	0.0	0.8	1.0	2.7	0.3	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.7	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.3	0.4	0.0	2.0	0.5	1.1	0.0	0.6	0.3	0.0	0.0	0.0	0.0	3.6	0.2	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.4	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	3.4	2.2	0.0	0.0	0.0	0.0	0.0	0.4											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0
CST7		ENSG00000077984	"Cystatin F"	O76096	20	24949230-24959928	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Thiol protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 120.9;bone marrow: 160.2;lymphoid tissue: 51.3"	"Group enriched"	"Detected in many"	14	"monocytes: 1133.5;T-cells: 425.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 120.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HL-60: 16.1;HMC-1: 45.1;NB-4: 44.2;U-937: 79.4"	"Region enriched"	"Detected in single"	5	"olfactory region: 2.3"	"Low region specificity"	"Detected in all"			HPA040442	Enhanced				"Secreted to blood"	NA	NA		12000			"HPA040442: AB_2676988"	"prognostic favorable (6.55e-4)"	"prognostic favorable (7.90e-4)"	"unprognostic (9.37e-2)"	"prognostic favorable (9.17e-6)"	"unprognostic (2.38e-2)"	"prognostic favorable (5.85e-5)"	"unprognostic (1.00e-2)"	"unprognostic (8.66e-2)"	"unprognostic (2.84e-3)"	"unprognostic (7.93e-2)"	"unprognostic (5.05e-2)"	"unprognostic (7.42e-2)"	"prognostic unfavorable (4.37e-6)"	"unprognostic (7.64e-2)"	"unprognostic (3.38e-1)"	"unprognostic (4.45e-1)"	"unprognostic (7.62e-2)"	4.9	0.9	0.8	9.7	0.9	160.2	1.4	0.9	1.0	2.5	1.9	0.1	0.5	1.1	2.2	1.8	2.4	4.6	10.7	6.2	0.9	0.8	1.6	3.5	23.0	30.4	4.0	0.0	2.2	1.1	0.2	0.9	1.6	0.7	3.5	1.0	3.2	1.3	0.7	1.9	1.2	3.7	1.0	1.2	51.3	1.6	1.7	0.2	6.6	1.6	2.5	15.4	6.0	11.8	0.3	2.5	29.8	0.2	53.9	120.9	42.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	16.1	45.1	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.6	0.0	0.0	0.4	44.2	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.8	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	79.4	0.0	5.0	0.2	0.8	120.9	0.2	67.5	0.3	18.3	84.3	2.5	0.3	4.0	52.3	29.8	53.9	0.2	0.6	10.5	42.2	0.8	0.9	0.9	1.0	0.9	0.8	4.0	0.0	0.7	0.2	8.9	22.7	14.7	0.3	20.3	0.0	0.8	2.5	4.0	1.2	0.0	0.0	0.1	0.0	0.4	0.0	0.3	0.0	0.0	3.0	0.0	6.1	0.1	55.7	2.1	1.4	0.0	0.0	8.6	13.8	0.0	0.0	51.5	23.6	1133.5	0.0	0.0	0.3	0.0	0.0	1.4	0.0	0.0	2.3	0.0	0.1	20.8	0.9	425.3	0.0	0.3
CTXND1	LINC01314	ENSG00000259417	"Cortexin domain containing 1"		15	80195484-80252213	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"			"Tissue enhanced"	"Detected in some"		"brain: 20.8;epididymis: 9.1;liver: 14.7"	"Cell type enhanced"	"Detected in some"	17	"Alveolar cells type 2: 4.6;Ciliated cells: 1.4;Collecting duct cells: 1.8;Distal tubular cells: 1.7;Proximal tubular cells: 5.6"	"Group enriched"	"Detected in many"	7	"glioma: 3.4;liver cancer: 2.7;melanoma: 9.1;thyroid cancer: 5.6"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"OE19: 1.7;SK-MEL-30: 3.4;WM-115: 10.2"	"Region enriched"	"Detected in many"	4	"hippocampal formation: 38.5"											NA	NA						"unprognostic (4.15e-5)"	"unprognostic (8.42e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.86e-3)"	"unprognostic (5.59e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.41e-1)"	"unprognostic (7.04e-2)"	"unprognostic (3.90e-4)"	"unprognostic (2.43e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.92e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.14e-3)"	"unprognostic (1.34e-1)"	0.3	4.2	12.8	0.3	5.7	0.1	0.2	4.4	8.2	0.2	0.5	2.2	0.0	0.7	0.2	9.1	0.2	0.4	0.2	6.6	20.8		3.5	14.7	2.6	0.4	1.9	1.9	0.4	0.7	0.0	0.0	0.1	4.5	0.2	0.5	1.1	0.2	0.3	0.6	1.3	0.8	0.2	3.3	2.0	3.3	0.3	7.1	0.0	0.8	0.0	0.5	0.2	0.0	0.4	0.1	0.5	0.1	0.3	0.6	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	1.2	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	1.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	3.4	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.2	0.3	0.1	0.2	0.2	10.2	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.4	0.6	0.1	0.5	0.3	0.0	0.1	0.1	0.0											0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	1.8	0.0	0.0	1.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DACH1	DACH	ENSG00000276644	"Dachshund family transcription factor 1"	Q9UI36	13	71437966-71867192	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	14	"Early spermatids: 70.5;Horizontal cells: 82.6;Late spermatids: 80.3;Muller glia cells: 155.3"	"Low cancer specificity"	"Detected in many"							"Group enriched"	"Detected in some"	15	"basophil: 4.7;eosinophil: 9.2;NK-cell: 4.9;plasmacytoid DC: 7.5"	"Group enriched"	"Detected in many"	30	"dendritic cells: 7.5;granulocytes: 9.2;NK-cells: 4.9"	"Cell line enhanced"	"Detected in some"		"AF22: 8.2;HAP1: 12.8;HEK 293: 9.6;HL-60: 20.7;NB-4: 9.2;SCLC-21H: 21.3;SH-SY5Y: 17.1;THP-1: 15.0"	"Region enriched"	"Detected in many"	5	"basal ganglia: 34.7"	"Region enriched"	"Detected in all"	5	"basal ganglia: 34.0"	"HPA012672, HPA012938"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA012672: AB_1847466, HPA012938: "	"unprognostic (3.16e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.21e-2)"	"unprognostic (5.63e-2)"	"unprognostic (2.22e-2)"	"unprognostic (8.08e-3)"	"unprognostic (2.12e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.04e-3)"	"unprognostic (4.37e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.17e-2)"	4.9	12.2	0.6	3.8	15.5	5.7	9.2	1.8	2.9	11.4	5.4	0.0	3.5	5.4	6.3	4.1	0.9	2.9	15.8	3.0	0.2		10.2	1.9	10.2	0.3	0.0	1.5	0.9	1.8	7.3	24.4	7.3	4.9	7.9	3.5	19.6	1.9	6.9	3.6	0.6	9.6	2.1	2.9	7.8	1.8	6.1	6.6	6.1	0.0	1.2	0.2	2.1	10.2	0.0	7.5	9.2	0.2	4.9	0.0	0.1	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	12.8	0.0	0.0	0.0	9.6	0.1	0.0	0.0	0.2	20.7	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.5	9.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	21.3	17.1	0.0	0.0	0.0	0.0	0.5	15.0	0.0	0.2	0.2	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.1	4.7	0.2	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	4.9	0.0	7.5	0.0	0.1											0.0	1.1	0.0	2.9	1.4	10.4	1.6	0.0	1.4	0.0	7.0	3.9	0.0	5.0	0.5	70.5	17.3	1.1	0.0	0.0	0.0	0.8	9.2	4.7	0.0	0.2	82.6	32.7	1.8	1.6	80.3	3.1	1.1	0.0	0.0	13.3	155.3	0.5	0.0	1.8	3.5	4.8	12.9	1.4	21.1	7.0	1.1	0.0	0.0	3.7	1.8
DBH	DBM	ENSG00000123454	"Dopamine beta-hydroxylase"	P09172	9	133636360-133659344	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Catecholamine biosynthesis"	"Monooxygenase, Oxidoreductase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"adrenal gland: 86.6;brain: 36.2;liver: 35.6"	"Cell type enriched"	"Detected in single"	43	"Ito cells: 17.2"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	45	"pons and medulla: 36.2"	"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 2.0"	"Lineage enriched"	"Detected in single"	21	"T-cells: 2.0"	"Cell line enriched"	"Detected in single"	340	"SH-SY5Y: 206.1"	"Region enriched"	"Detected in some"	6	"pons and medulla: 23.2"	"Region enriched"	"Detected in single"	38	"pons and medulla: 25.1"	"HPA002130, HPA005960, HPA070789"	Enhanced		Supported	"Endoplasmic reticulum,Vesicles"	"Intracellular and membrane"	NA	NA		2000000000	Vesicles	"Endoplasmic reticulum"	"HPA002130: AB_2666554, HPA005960: AB_1078628, HPA070789: AB_2686312"	"unprognostic (1.93e-3)"	"unprognostic (7.52e-3)"	"unprognostic (8.53e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.18e-3)"	"unprognostic (3.38e-3)"	"unprognostic (3.39e-3)"	"unprognostic (3.97e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.99e-2)"	"unprognostic (5.80e-2)"	"unprognostic (7.69e-2)"	"unprognostic (2.81e-7)"	"unprognostic (9.31e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.49e-2)"	"unprognostic (5.06e-3)"	0.7	86.6	0.1	0.3	0.1	0.0	0.0	0.1	0.8	0.3	0.0	1.9	0.7	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.5	35.6	0.3	0.6	0.0	0.0	0.1	1.3	0.0	0.6	0.4	36.2	0.8	0.0	1.0	0.2	5.9	0.0	0.0	0.2	0.0	1.4	0.4	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.8	0.5	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.2	206.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.8	0.0	0.1	0.0	0.0	36.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DCX	"DBCN, DC, LISX, SCLH, XLIS"	ENSG00000077279	Doublecortin	O43602	X	111293779-111412429	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Disease mutation, Epilepsy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 17.1;testis: 6.4"	"Cell type enriched"	"Detected in some"	12	"Rod photoreceptor cells: 22.7"	"Cancer enriched"	"Detected in some"	5	"glioma: 5.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"SCLC-21H: 34.6;SH-SY5Y: 14.2"	"Region enriched"	"Detected in many"	9	"olfactory region: 90.9"	"Region enriched"	"Detected in all"	5	"olfactory region: 130.1"	HPA036121	Enhanced	Supported	Approved	Cytosol		NA	NA			Cytosol		"HPA036121: AB_2674950"	"unprognostic (1.36e-2)"	"unprognostic (1.99e-1)"	"unprognostic (7.36e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.00e-2)"	"unprognostic (7.18e-2)"	"unprognostic (3.24e-2)"		"unprognostic (2.33e-3)"	"unprognostic (3.67e-1)"	"unprognostic (4.90e-4)"	"unprognostic (5.02e-3)"	"unprognostic (1.27e-1)"		"unprognostic (1.85e-1)"	0.8	1.1	7.0	0.7	9.2	0.7	3.2	0.7	17.1	0.7	0.6	0.9	0.0	0.7	4.1	3.6	0.6	0.6	0.8	0.7	4.2	5.4	0.5	0.5	0.6	0.7	2.5	6.7	0.6	0.8	0.5	1.0	0.6	3.7	0.5	0.8	0.0	2.2	0.6	0.5	0.7	0.7	0.6	3.0	0.6	1.2	6.4	2.3	0.0	0.6	0.0	0.5	0.6	0.3	0.3	0.4	0.6	0.2	0.7	0.4	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	34.6	14.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.2	0.2	0.1	0.4	0.3	0.3	0.2	0.1	0.3	0.3	0.3	0.6	0.7	0.0	0.4	0.1	0.0	7.0	9.2	0.7	10.8	4.2	5.4	2.5	6.7	3.7	2.3	0.0	0.0	0.0	0.0	0.0	1.8	0.6	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	1.3	0.2	0.0	1.4	0.0	22.7	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0
DHRS2	"HEP27, SDR25C1"	ENSG00000100867	"Dehydrogenase/reductase 2"	Q13268	14	23630115-23645639	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 79.9;prostate: 40.2;urinary bladder: 120.7;vagina: 47.1"	"Cell type enhanced"	"Detected in some"	11	"Extravillous trophoblasts: 10.3;Spermatogonia: 8.5;Syncytiotrophoblasts: 20.7;Urothelial cells: 11.9"	"Cancer enriched"	"Detected in many"	6	"urothelial cancer: 141.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 49.9;RT4: 59.8;SK-BR-3: 292.6;U-2 OS: 95.8"	"Region enriched"	"Detected in single"	4	"cerebellum: 2.7"					"HPA053915, HPA069551"	Enhanced		Supported	Nucleoplasm,Mitochondria		No	NA			Mitochondria	Nucleoplasm	"HPA053915: AB_2682307, HPA069551: AB_2686150"	"unprognostic (3.07e-1)"	"unprognostic (4.91e-2)"	"unprognostic (3.44e-2)"	"prognostic unfavorable (3.23e-4)"	"unprognostic (9.97e-2)"	"unprognostic (5.03e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.08e-1)"	"unprognostic (6.91e-2)"	"unprognostic (6.66e-2)"	"unprognostic (4.59e-2)"	"prognostic unfavorable (3.75e-5)"	"unprognostic (1.83e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.76e-1)"	"prognostic favorable (6.45e-4)"	0.1	0.3	0.3	0.0	0.2	0.0	79.9	0.1	0.2	0.5	0.1	0.1	0.3	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.3	0.8	1.8	5.0	0.2	0.0	0.2	0.0	9.0	5.9	0.3	0.5	5.0	0.1	40.2	0.0	0.1	20.1	0.6	0.1	0.7	0.1	23.1	0.3	3.7	0.8	0.9	0.0	0.0	0.1	0.0	0.0	120.7	47.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	14.4	0.0	0.0	0.2	0.0	0.0	0.4	0.0	1.0	0.0	0.0	0.1	0.0	0.7	0.1	0.0	0.0	0.1	20.1	1.5	0.1	0.0	49.9	0.0	0.2	1.8	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.1	0.0	0.0	0.4	2.2	0.1	0.4	0.1	0.0	59.8	0.2	0.3	0.4	292.6	0.3	0.0	0.2	0.0	0.0	0.1	95.8	0.5	0.3	0.1	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.2	0.3	0.8	0.2	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	5.9	6.6	0.0	3.4	0.0	0.0	0.0	0.2	10.3	0.3	0.2	0.0	0.8	1.6	0.0	3.4	0.0	0.8	3.0	0.0	0.0	0.0	1.0	0.0	0.0	6.7	0.0	1.1	0.1	1.0	6.5	0.0	0.0	8.5	0.1	20.7	0.0	0.5	11.9
DRD1		ENSG00000184845	"Dopamine receptor D1"	P21728	5	175440039-175444208	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	12	"brain: 34.5"	"Group enriched"	"Detected in some"	13	"Bipolar cells: 40.8;Horizontal cells: 31.8"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	5	"basal ganglia: 34.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RT4: 24.2"	"Region enriched"	"Detected in many"	9	"basal ganglia: 147.4"	"Region enriched"	"Detected in many"	13	"basal ganglia: 95.6"	"HPA013393, HPA017304"		Supported	Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA013393: AB_1847833, HPA017304: "	"unprognostic (2.74e-2)"	"unprognostic (6.36e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.63e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.15e-6)"	"unprognostic (6.69e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.74e-2)"	"unprognostic (8.60e-4)"	"unprognostic (5.86e-2)"	"unprognostic (5.43e-1)"	"unprognostic (6.00e-3)"	"unprognostic (1.10e-2)"	0.7	1.5	1.9	0.2	34.5	0.0	0.1	0.1	12.0	0.7	0.7	0.4	0.0	0.5	0.4	0.7	0.7	0.6	1.1	0.3	1.0	0.6	0.7	2.6	1.8	0.1	0.5	1.6	0.3	0.0	0.0	0.1	2.5	0.3	2.7	0.9	2.1	0.1	1.2	0.1	0.1	0.3	0.4	0.1	0.4	0.4	0.1	6.8	0.1	0.1	0.0	0.4	1.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	24.2	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	34.5	0.1	5.3	1.0	0.6	0.5	1.6	0.3	6.8	0.0	0.0	0.0	0.0	0.1	40.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	31.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	2.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DRD2		ENSG00000149295	"Dopamine receptor D2"	P14416	11	113409615-113475691	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	8	"adrenal gland: 17.3;brain: 52.0;pituitary gland: 51.6"	"Cell type enriched"	"Detected in some"	12	"Horizontal cells: 57.2"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	5	"basal ganglia: 52.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"SCLC-21H: 45.2"	"Region enriched"	"Detected in many"	10	"basal ganglia: 183.8"	"Group enriched"	"Detected in many"	8	"basal ganglia: 126.7;midbrain: 41.7"	"HPA015139, HPA015691"	Supported	Supported				NA	NA					"HPA015139: , HPA015691: AB_1847834"	"unprognostic (8.49e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.29e-4)"	"unprognostic (2.32e-2)"	"unprognostic (1.15e-1)"		"unprognostic (1.97e-2)"	"unprognostic (5.89e-2)"	"unprognostic (4.40e-2)"	"unprognostic (8.33e-4)"	"unprognostic (1.10e-1)"	"unprognostic (6.65e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.82e-2)"	"unprognostic (8.49e-3)"	0.6	17.3	0.9	0.5	52.0	0.2	2.1	0.2	3.3	1.3	0.6	1.5	0.0	0.3	2.3	0.4	0.9	2.1	0.6	0.5	0.3	4.1	0.3	0.2	0.6	0.2	9.9	0.2	0.3	0.4	0.3	51.6	0.2	2.4	1.5	0.9	3.9	5.1	1.7	1.7	0.3	0.5	3.2	0.2	0.2	0.5	1.6	9.5	0.0	0.2	0.0	0.3	0.3	0.3	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.1	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.5	0.2	0.0	0.0	0.5	0.0	0.0	0.0	4.8	0.0	0.0	0.0	45.2	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.9	52.0	0.2	3.3	0.3	4.1	9.9	0.2	2.4	9.5	0.0	0.0	0.0	0.0	0.0	4.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DRD3		ENSG00000151577	"Dopamine receptor D3"	P35462	3	114128652-114199407	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets, Schizophrenia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 2.0;brain: 8.3;testis: 4.2"	"Group enriched"	"Detected in some"	39	"Early spermatids: 5.5;Late spermatids: 12.5"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 2.0;T-reg: 1.4"	"Lineage enriched"	"Detected in single"	6	"T-cells: 2.0"	"Cell line enhanced"	"Detected in single"		"HAP1: 1.0"	"Region enriched"	"Detected in some"	5	"basal ganglia: 7.5"	"Region enriched"	"Detected in many"	12	"basal ganglia: 25.2"							NA	NA										"unprognostic (2.32e-1)"													0.0	0.0	0.0	0.1	8.3	0.0	0.0	0.0	0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.2			0.0		0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	2.0	0.6	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.0	1.4	0.2											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
DRGX	"DRG11, PRRXL1"	ENSG00000165606	"Dorsal root ganglia homeobox"	A6NNA5	10	49364181-49396016	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	8	"adrenal gland: 13.9;brain: 8.0"	"Cell type enriched"	"Detected in single"	4	"Melanocytes: 1.7"	"Low cancer specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"cerebral cortex: 3.3;midbrain: 2.0;pons and medulla: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RH-30: 8.2;SH-SY5Y: 37.4;U-2197: 13.5"	"Region enriched"	"Detected in single"	6	"pons and medulla: 4.1"	"Low region specificity"	"Detected in all"			HPA043978	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoplasm, Nucleoli"	Cytosol	"HPA043978: AB_10961154"		"unprognostic (1.42e-2)"	"unprognostic (5.68e-2)"		"unprognostic (3.92e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.58e-1)"		"unprognostic (4.54e-2)"	"unprognostic (3.74e-2)"			"unprognostic (8.91e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.09e-2)"		0.2	13.9	0.0	0.4	0.2	0.3	0.1	0.4	3.3	0.0	0.4	0.8	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.2	0.3	0.0	0.0	0.5	0.1	2.0	0.6	0.0	0.0	0.0	0.9	0.0	4.8	0.0	0.9	0.0	0.0	0.0	0.0	1.3	0.3	0.0	8.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	37.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	13.5	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	3.3	0.2	0.3	2.0	0.6	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DSP	"DPI, DPII, KPPS2, PPKS2"	ENSG00000096696	Desmoplakin	P15924	6	7541575-7586717	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cardiomyopathy, Disease mutation, Epidermolysis bullosa, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 138.3;skin 1: 136.5;tongue: 189.6"	"Cell type enhanced"	"Detected in many"	13	"Basal keratinocytes: 801.2;Cardiomyocytes: 699.5;Suprabasal keratinocytes: 1763.9"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 314.1"	"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	19	"naive B-cell: 5.8"	"Lineage enriched"	"Detected in single"	59	"B-cells: 5.8"	"Cell line enhanced"	"Detected in many"		"BEWO: 46.0;HaCaT: 49.6;HBEC3-KT: 35.7;hTCEpi: 112.8;SuSa: 35.9"	"Region enriched"	"Detected in single"	23	"hippocampal formation: 12.8"	"Low region specificity"	"Detected in all"			"CAB037324, HPA045840, HPA054950"	Enhanced		Supported	"Cell Junctions"		NA	NA		110000000	"Cell Junctions"		"CAB037324: , HPA045840: AB_2679468, HPA054950: AB_2682645"	"unprognostic (1.65e-1)"	"unprognostic (3.09e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.82e-2)"	"unprognostic (7.03e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.94e-2)"	"prognostic favorable (1.53e-9)"	"unprognostic (2.45e-1)"	"unprognostic (2.88e-1)"	"unprognostic (8.38e-2)"	"prognostic unfavorable (1.82e-4)"	1.3	2.7	0.9	9.6	0.7	0.0	12.5	0.6	0.8	27.5	19.4	0.2	9.1	8.1	2.8	11.2	138.3	2.5	8.7	71.8	0.7	0.6	8.7	21.9	8.0	1.4	0.6	0.9	1.4	23.0	8.1	2.7	25.7	2.5	9.0	7.0	3.4	25.6	8.5	0.6	136.5	28.2	1.1	1.4	1.0	7.4	0.8	0.1	15.0	17.1	189.6	48.7	3.1	46.9	5.8	0.0	0.0	0.0	0.0	0.0	0.0	20.8	6.3	0.0	0.0	0.9	1.4	46.0	4.1	3.6	2.0	2.0	18.0	5.5	0.0	5.9	6.6	1.6	49.6	7.6	35.7	0.3	0.0	8.8	0.0	3.6	24.1	0.0	0.1	0.1	0.3	112.8	1.8	20.6	5.0	0.0	0.1	0.0	0.0	3.6	9.8	0.0	0.1	0.9	10.1	3.1	0.0	0.0	5.3	7.6	5.6	2.1	0.0	4.6	9.9	0.0	35.9	11.7	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.7	0.6	0.8	0.7	0.6	0.6	0.9	2.5	0.1	47.6	14.2	5.1	114.0	801.2	2.1	699.5	132.5	179.3	220.6	57.6	13.7	231.6	1.7	136.3	1.3	28.8	238.5	0.0	97.9	229.6	43.4	178.6	3.5	162.5	23.9	0.0	167.6	3.1	1.6	0.5	0.9	5.6	96.2	4.6	145.6	14.8	137.3	200.0	0.0	11.0	27.9	0.0	22.7	1.4	2.5	1763.9	322.6	2.9	145.6	184.4
DWORF		ENSG00000240045	"DWARF open reading frame"		3	155290229-155293775	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	7	"skeletal muscle: 173.0"	"Cell type enriched"	"Detected in some"	4	"Proximal tubular cells: 7.9"	"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in single"		"basophil: 2.9"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.9"	"Low cell line specificity"	"Detected in some"			"Region enriched"	"Detected in some"	8	"basal ganglia: 19.5"											NA	NA									"unprognostic (6.77e-4)"		"unprognostic (1.60e-2)"					"unprognostic (6.62e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.82e-3)"	"unprognostic (1.33e-2)"				0.4	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	5.2	2.9	0.0	0.0	0.6	0.0		0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	1.6	0.0	173.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.7	23.7	0.9	0.0	0.0	0.5	0.4	2.9	0.2	0.4	0.2	0.0	0.2	0.0	0.6	0.0	0.0	2.3	0.7	0.3	0.0	0.0	0.6	0.0	1.3	0.0	0.4	0.0	0.4	0.5	0.3	0.5	0.0	0.3	0.6	0.4	0.5	0.5	0.0	1.8	0.4	2.1	0.0	0.0	0.5	0.4	0.8	0.0	0.6	1.3	1.2	0.4	0.2	1.7	1.2	0.7	0.6	0.3	0.2	0.3	0.0	0.0	1.0	0.9	0.0	0.7	0.1	1.0	0.9	1.1	1.9	1.8	1.3	0.8	0.2	0.2	0.3	0.8	0.8	0.3	0.0	2.9	0.2	0.2	0.1	0.1	0.1	0.2	0.1	0.2	0.2	0.5	0.2	0.2	0.8	0.4	0.1	0.4	0.1	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ELL3	FLJ22637	ENSG00000128886	"Elongation factor for RNA polymerase II 3"	Q9HB65	15	43772600-43777543	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 13.3;lymphoid tissue: 24.2"	"Cell type enhanced"	"Detected in some"	15	"Ciliated cells: 5.3;Early spermatids: 1.5;Enterocytes: 1.7;Late spermatids: 1.8;Mucus-secreting cells: 2.0;Undifferentiated cells: 2.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"memory B-cell: 5.3;naive B-cell: 8.5"	"Lineage enriched"	"Detected in many"	7	"B-cells: 8.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 7.9;U-698: 19.2"	"Region enriched"	"Detected in single"	11	"olfactory region: 2.4"	"Not detected"	"Not detected"			"HPA028938, HPA073494"	Approved		Supported	"Nucleoplasm,Nucleoli,Mitotic chromosome"		NA	NA			"Nucleoplasm, Nucleoli"	"Mitotic chromosome"	"HPA028938: AB_10795352, HPA073494: "	"unprognostic (2.59e-2)"	"unprognostic (4.41e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.59e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.42e-3)"	"unprognostic (1.52e-2)"	"unprognostic (3.89e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.67e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.24e-2)"	0.7	1.1	1.0	24.2	0.6	0.4	2.5	4.7	0.6	2.3	10.6	0.5	1.6	4.8	1.0	1.0	5.5	1.3	0.9	0.6	1.0	0.6	1.8	0.5	0.9	7.5	1.3	0.0	1.3	0.7	0.6	1.2	0.8	2.6	2.1	1.8	0.8	2.0	0.7	1.0	7.0	13.3	0.9	0.6	1.5	1.1	12.3	0.5	0.8	1.1	2.8	16.7	1.3	1.7	8.5	1.0	0.1	0.1	0.1	1.2	0.6	0.6	0.1	0.6	0.2	1.6	0.1	0.1	0.2	0.5	0.8	1.3	0.1	0.5	7.9	0.1	0.7	0.1	2.9	0.3	0.0	0.5	0.7	3.4	0.3	2.6	0.8	0.5	0.0	0.0	0.0	0.5	0.2	0.1	0.1	0.3	0.2	0.3	0.0	0.1	1.2	0.3	0.9	0.0	1.1	0.8	0.8	0.1	0.1	0.2	0.0	3.6	0.2	0.3	1.5	0.3	0.1	3.6	0.2	0.1	0.2	0.0	0.3	0.2	0.0	0.0	19.2	0.2	0.7	0.1	0.0	0.1	0.0	0.0	0.0	0.2	5.3	0.5	0.2	0.0	8.5	1.2	0.3	0.1	0.1	0.0	1.0	0.3	0.6	1.0	0.6	4.7	0.6	1.0	0.6	1.3	0.0	2.6	0.5	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	1.7	0.0	0.6	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	2.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.2	0.0	2.0	0.1
EMILIN3	"C20orf130, dJ620E11.4, EMILIN5"	ENSG00000183798	"Elastin microfibril interfacer 3"	Q9NT22	20	41359966-41366827	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"epididymis: 49.9"	"Cell type enhanced"	"Detected in some"	25	"Leydig cells: 1.7;Peritubular cells: 4.6"	"Cancer enhanced"	"Detected in many"		"glioma: 10.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 6.9;HAP1: 12.1;NTERA-2: 7.7;SCLC-21H: 14.4"	"Region enriched"	"Detected in single"	29	"cerebellum: 3.7"	"Low region specificity"	"Detected in single"			"HPA044034, HPA059912, HPA078559"	Enhanced		Approved	"Golgi apparatus,Microtubules,Cytokinetic bridge"	"Secreted to extracellular matrix"	NA	NA		650000	"Golgi apparatus"	"Microtubules, Cytokinetic bridge"	"HPA044034: AB_2678783, HPA059912: AB_2684158, HPA078559: "	"unprognostic (1.66e-4)"	"unprognostic (1.85e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.65e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.71e-1)"	"unprognostic (7.66e-2)"	"unprognostic (2.18e-3)"	"unprognostic (2.57e-1)"	"unprognostic (6.54e-2)"	"unprognostic (7.66e-2)"	"unprognostic (3.13e-7)"	"unprognostic (2.64e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.97e-1)"	"unprognostic (9.62e-2)"	0.9	1.9	2.9	1.6	2.0	0.5	3.5	0.7	8.2	7.1	4.1	1.9	8.5	1.1	2.7	49.9	1.1	3.2	0.9	6.0	3.0	2.9	0.8	0.6	0.7	0.6	3.8	0.7	9.2	0.6	0.5	1.6	0.6	2.7	8.1	0.8	5.8	1.5	10.0	1.3	3.4	1.4	1.6	2.2	0.6	1.9	4.3	2.3	0.3	0.7	2.9	0.8	2.4	5.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	6.9	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.4	0.0	0.0	0.1	0.0	0.4	0.0	12.1	0.0	0.3	0.0	1.4	0.0	0.0	0.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	14.4	1.4	0.0	0.0	0.0	2.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	2.9	2.0	0.7	8.2	3.0	2.9	3.8	0.7	2.7	2.3	0.0	0.0	0.0	0.0	0.8	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0
EN1		ENSG00000163064	"Engrailed homeobox 1"	Q05925	2	118842171-118847678	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adipose tissue: 5.6;brain: 11.4;skeletal muscle: 20.1;skin 1: 10.0"	"Cell type enriched"	"Detected in some"	5	"Melanocytes: 11.8"	"Cancer enhanced"	"Detected in many"		"breast cancer: 5.6"	"Group enriched"	"Detected in some"	10	"midbrain: 11.4;pons and medulla: 8.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 14.4;ASC TERT1: 6.5;fHDF/TERT166: 11.3;HSkMC: 12.1;PC-3: 6.8;U-138 MG: 8.8;U-2197: 9.8"	"Region enriched"	"Detected in single"	5	"midbrain: 5.9"	"Region enriched"	"Detected in some"	5	"midbrain: 23.9"	"CAB014884, HPA073141"	Enhanced		Approved	"Nucleoplasm,Nucleoli rim"		NA	NA			"Nucleoli rim"	Nucleoplasm	"CAB014884: , HPA073141: AB_2686573"	"unprognostic (5.20e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.78e-2)"	"unprognostic (4.84e-7)"	"unprognostic (1.87e-3)"	"unprognostic (1.90e-1)"		"unprognostic (1.95e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.46e-1)"	"unprognostic (3.38e-9)"	"unprognostic (2.15e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.30e-3)"	5.6	0.1	0.0	0.1	0.4	0.0	2.7	0.9	0.4	0.0	0.1	0.1	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.0	2.4	11.4	0.0	0.1	0.0	0.1	0.0	0.0	8.8	0.1	0.1	0.2	0.7	0.1	20.1	10.0	0.1	0.1	2.7	0.1	0.1	0.4	0.1	0.2	0.3	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.2	0.5	0.2	14.4	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	4.2	0.4	0.5	0.0	0.0	0.0	1.1	0.0	0.6	0.0	0.1	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.1	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	2.1	0.0	0.0	0.0	8.8	0.9	9.8	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.4	0.2	0.1	11.4	0.0	8.8	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	2.3	0.0	0.0	0.0	0.0
EN2		ENSG00000164778	"Engrailed homeobox 2"	P19622	7	155458129-155464831	"Disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	"Autism, Autism spectrum disorder"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 26.5"	"Cell type enhanced"	"Detected in single"	16	"Spermatocytes: 1.2"	"Cancer enhanced"	"Detected in many"		"melanoma: 6.3"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 27.5;AN3-CA: 10.1;HAP1: 5.9;HEK 293: 16.7;SK-MEL-30: 8.1"	"Region enriched"	"Detected in some"	8	"cerebellum: 31.1"	"Region enriched"	"Detected in some"	6	"cerebellum: 71.6"	"HPA045646, HPA069809"			Supported	"Nucleoplasm,Nucleoli fibrillar center"		No	No			Nucleoplasm	"Nucleoli fibrillar center"	"HPA045646: AB_2679404, HPA069809: AB_2686205"	"unprognostic (2.44e-3)"	"unprognostic (1.71e-2)"	"unprognostic (4.89e-2)"	"unprognostic (7.99e-3)"	"prognostic unfavorable (1.74e-6)"	"unprognostic (2.54e-1)"	"unprognostic (8.02e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.87e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.03e-13)"	"unprognostic (4.91e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.24e-1)"	"unprognostic (5.64e-3)"	0.3	0.2	0.1	0.0	0.1	0.0	0.1	26.5	0.1	0.0	0.0			0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.3		1.3	1.2	5.0	0.0	0.0		0.0	0.0		0.0	0.0	0.8	1.1	0.0	0.0	0.4	0.0	0.0	2.1			0.0		0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.5	27.5	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.1	0.0	0.9	0.0	5.9	0.0	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.2	3.5	0.0	0.0	0.0	0.0	1.3	0.0	2.1	0.0	0.1	0.2	0.0	0.0	2.0	0.0	8.1	0.0	0.0	1.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.5	0.1	0.0	0.0	0.0	0.0
EOMES	TBR2	ENSG00000163508	Eomesodermin	O95936	3	27715949-27722711	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Adaptive immunity, Differentiation, Gastrulation, Immunity, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 17.9;brain: 22.6;lymphoid tissue: 21.4"	"Group enriched"	"Detected in some"	8	"Erythroid cells: 23.3;T-cells: 32.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.8"	"Region enriched"	"Detected in some"	20	"cerebellum: 22.6"	"Group enriched"	"Detected in many"	7	"gdT-cell: 10.0;MAIT T-cell: 16.5;memory CD8 T-cell: 12.0;naive CD8 T-cell: 7.5;NK-cell: 17.9"	"Group enriched"	"Detected in many"	102	"NK-cells: 17.9;T-cells: 16.5"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 10.2;JURKAT: 12.3;SCLC-21H: 5.7"	"Region enriched"	"Detected in some"	8	"olfactory region: 95.2"	"Group enriched"	"Detected in many"	13	"cerebellum: 44.2;olfactory region: 21.9"	HPA028896	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA028896: AB_10601370"	"unprognostic (1.53e-4)"	"unprognostic (5.95e-3)"	"unprognostic (3.01e-2)"	"unprognostic (1.60e-4)"	"unprognostic (4.13e-2)"	"unprognostic (9.63e-4)"	"unprognostic (4.29e-4)"	"unprognostic (3.14e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.82e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (9.45e-6)"	"unprognostic (1.61e-1)"	"unprognostic (5.09e-1)"	"unprognostic (6.32e-3)"	"unprognostic (1.49e-2)"	1.4	0.7	0.5	6.8	0.4	1.6	1.6	22.6	0.4	1.8	0.8	0.0	0.0	0.3	3.2	0.9	1.4	0.6	5.0	0.7	0.4	0.7	1.0	4.9	10.1	15.6	0.5	0.3	1.3	0.9	0.0	0.6	1.6	1.1	2.1	0.9	3.3	2.2	0.1	0.4	0.4	1.8	0.7	0.9	21.4	1.4	0.5	0.0	1.8	1.1	0.9	11.2	3.3	0.8	0.0	0.0	0.1	0.0	17.9	16.5	1.4	0.0	1.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	2.6	2.0	0.0	10.2	1.5	0.0	0.1	0.8	0.0	1.2	0.0	0.1	1.2	0.0	1.4	0.5	0.0	12.3	0.3	0.0	0.0	3.0	2.7	0.0	0.3	0.2	1.2	1.9	0.0	0.0	1.0	0.0	5.7	0.0	0.0	0.0	1.2	0.5	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	10.0	0.0	16.5	0.0	1.9	12.0	0.0	0.0	0.1	7.5	0.1	17.9	0.0	0.0	0.0	1.4	0.5	0.4	22.6	0.4	0.4	0.7	0.5	0.3	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	3.7	3.0	0.0	0.3	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	1.6	0.1	0.0	32.6	0.0	0.0
EXOC1L		ENSG00000250821	"Exocyst complex component 1 like"		4	55819819-55837487	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"adipose tissue: 1.7;blood: 5.2;testis: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	52	"NK-cell: 5.2"	"Lineage enriched"	"Detected in single"	52	"NK-cells: 5.2"	"Group enriched"	"Detected in some"	6	"HEK 293: 5.8;HSkMC: 2.3"	"Region enriched"	"Detected in single"	4	"pons and medulla: 3.0"	"Not detected"	"Not detected"									NA	NA																							1.7	0.0		0.0		0.0	0.0		0.5	0.0	0.0			0.0	0.0	0.0	0.0	0.1	0.0	0.3			0.0	0.4	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.2		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.7	1.3			0.0		0.1	0.0		0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.5	0.0	0.0	0.0	5.8	0.7	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
FABP7	"B-FABP, BLBP"	ENSG00000164434	"Fatty acid binding protein 7"	O15540	6	122779475-122784074	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 62.7;breast: 26.8"	"Cell type enriched"	"Detected in some"	5	"Muller glia cells: 827.1"	"Group enriched"	"Detected in many"	6	"glioma: 139.3;renal cancer: 51.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 3.1"	"Group enriched"	"Detected in many"	5	"granulocytes: 3.1;NK-cells: 1.1"	"Group enriched"	"Detected in some"	8	"AF22: 38.7;U-251 MG: 10.5;WM-115: 23.3"	"Region enriched"	"Detected in all"	6	"olfactory region: 1471.1"	"Low region specificity"	"Detected in all"			"CAB025488, HPA028825, CAB058697"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			Nucleoplasm	"Golgi apparatus, Cytosol"	"CAB025488: , CAB058697: AB_2665600, HPA028825: AB_10602130"	"prognostic favorable (2.49e-4)"	"unprognostic (1.56e-2)"		"unprognostic (2.53e-3)"	"unprognostic (5.80e-2)"	"unprognostic (2.29e-1)"		"unprognostic (1.14e-1)"	"unprognostic (7.11e-2)"		"unprognostic (2.09e-2)"	"unprognostic (3.42e-2)"	"prognostic unfavorable (1.65e-6)"	"unprognostic (9.83e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.50e-1)"	"unprognostic (8.66e-2)"	2.1	1.3	34.8	1.1	15.5	1.3	26.8	51.6	62.7	1.1	1.5	13.0	0.0	1.2	1.2	1.3	1.6	1.2	1.2	1.2	32.0	16.4	1.6	1.4	1.1	1.1	11.4	30.3	1.1	1.1	1.0	2.1	1.3	11.2	1.3	1.2	5.7	7.0	3.7	6.7	10.5	1.1	1.1	8.1	1.1	1.3	1.2	6.9	0.0	1.1	0.0	1.1	1.4	0.0	0.4	0.2	3.1	0.3	1.1	0.4	0.0	0.0	0.0	38.7	0.0	0.0	0.0	1.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	10.5	0.0	0.0	0.0	0.4	0.0	23.3	3.1	0.3	0.1	0.3	0.1	0.3	0.2	0.3	0.4	0.1	0.4	0.3	0.3	0.5	1.1	0.2	0.2	0.1	0.0	34.8	15.5	51.6	27.3	32.0	16.4	11.4	30.3	11.2	6.9	0.0	0.0	0.0	0.1	10.9	6.8	0.4	0.0	0.0	0.0	0.0	11.8	4.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	162.7	1.1	0.0	0.0	0.0	2.5	4.8	0.0	0.0	0.0	0.0	0.0	0.0	28.7	0.0	0.0	827.1	0.0	0.0	0.0	0.2	37.4	0.0	0.8	0.0	0.0	16.6	5.9	0.0	0.0	0.0
FAM19A4	TAFA-4	ENSG00000163377	"Family with sequence similarity 19 member A4, C-C motif chemokine like"	Q96LR4	3	68731766-68953297	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 26.0;brain: 10.9"	"Cell type enriched"	"Detected in some"	7	"Cone photoreceptor cells: 31.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 2.7;NTERA-2: 13.9;SuSa: 4.1"	"Region enriched"	"Detected in some"	5	"thalamus: 14.7"	"Low region specificity"	"Detected in all"								"Secreted in brain"	NA	NA						"unprognostic (1.92e-1)"			"unprognostic (9.97e-3)"	"unprognostic (2.28e-1)"			"unprognostic (8.19e-3)"		"unprognostic (8.78e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.66e-2)"	"unprognostic (8.06e-2)"	"unprognostic (2.50e-1)"		0.5	26.0	2.3	0.9	7.3	0.5	0.6	0.4	7.5	0.5	0.7	10.8	0.0	0.6	0.5	0.5	1.1	0.6	2.7	0.5	2.9	4.2	0.7	0.5	0.6	0.6	10.9	1.8	1.0	0.5	0.5	1.8	1.8	8.7	2.2	0.6	5.0	0.7	1.1	0.5	0.5	0.5	1.0	10.4	0.6	8.3	2.1	8.2	0.0	0.6	0.0	0.6	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	13.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.6	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	7.3	0.4	7.5	2.9	4.2	10.9	1.8	8.7	8.2	0.0	0.0	0.0	0.0	0.0	4.3	0.3	0.0	0.0	0.0	0.0	31.4	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.6	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0
FAM240B		ENSG00000283329	"Family with sequence similarity 240 member B"	A0A1B0GVZ2	9	38694263-38720428	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 6.9;tongue: 6.0"	"Not detected"	"Not detected"											"Cell type enhanced"	"Detected in many"		"basophil: 6.9"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 6.9"	"Low cell line specificity"	"Detected in some"			"Region enriched"	"Detected in single"	9	"cerebellum: 0.8"											NA	NA																							0.1	0.0	0.1	0.1	0.1	1.9	0.1	0.1	0.6	0.1	0.1	0.1	0.1	0.0	0.1	0.9	0.1	0.0	0.4	0.1	0.1		0.1	0.1	0.1	0.6	0.1	0.1	0.1	2.6	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	1.0	1.5	0.3	0.1	0.1	0.8	0.0	1.6	0.1	0.1	0.2	6.0	0.1	0.1	0.1	1.5	1.6	6.9	0.8	1.2	0.7	0.5	1.0	0.7	0.6	0.8	0.0	1.0	0.5	0.0	0.2	0.2	0.0	2.0	0.7	0.2	0.3	0.0	0.4	1.7	0.0	0.4	0.3	1.0	0.5	0.8	1.8	0.4	0.4	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.2	0.9	0.0	0.4	0.2	0.9	0.4	0.2	0.9	0.0	1.2	0.0	0.0	0.3	1.1	0.3	0.4	0.2	1.7	0.0	1.2	0.2	0.0	0.4	0.1	1.3	0.8	0.9	1.6	0.4	0.0	0.6	0.0	6.9	0.8	1.5	0.6	0.7	0.5	1.1	0.6	0.6	0.3	1.5	0.6	0.7	3.9	1.2	0.6	1.6	0.4	0.5											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAT2	"CDHF8, CDHR9, HFAT2, MEGF1"	ENSG00000086570	"FAT atypical cadherin 2"	Q9NYQ8	5	151504093-151568944	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 61.0;skin 1: 35.1"	"Group enriched"	"Detected in some"	7	"Basal glandular cells: 5.4;Basal keratinocytes: 16.0;Early spermatids: 12.8;Extravillous trophoblasts: 18.5;Late spermatids: 5.5;Melanocytes: 6.8;Suprabasal keratinocytes: 17.1;Urothelial cells: 13.7"	"Group enriched"	"Detected in many"	6	"cervical cancer: 13.9;head and neck cancer: 21.4;lung cancer: 6.1;urothelial cancer: 5.6"	"Region enriched"	"Detected in some"	34	"cerebellum: 61.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"BEWO: 17.3;EFO-21: 10.4;HaCaT: 25.0;HBEC3-KT: 11.4;hTCEpi: 34.7"	"Region enriched"	"Detected in single"	18	"cerebellum: 35.9"	"Region enriched"	"Detected in some"	66	"cerebellum: 442.8"	CAB033680	Enhanced					NA	NA					"CAB033680: AB_2100956"	"unprognostic (8.06e-3)"	"unprognostic (6.01e-2)"	"unprognostic (3.47e-1)"	"unprognostic (4.80e-3)"	"unprognostic (1.33e-1)"	"unprognostic (4.43e-1)"	"unprognostic (9.78e-3)"	"unprognostic (2.28e-1)"	"unprognostic (8.25e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.84e-7)"	"unprognostic (2.38e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.77e-2)"	"unprognostic (3.64e-3)"	0.4	0.0	0.4	0.4	1.7	0.0	2.2	61.0	0.4	2.4	0.4	0.4	0.4	0.0	0.4	1.0	11.8	0.5	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4	0.4	0.4	1.3	0.4	0.0	0.4	0.4	0.9	0.9	0.0	0.4	3.8	3.2	0.4	35.1	0.4	0.4	0.4	0.4	0.0	2.7	0.4	0.4	0.4	0.4	1.9	1.0	4.9	0.2	0.6	0.1	0.4	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	17.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.1	25.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.7	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.3	0.0	0.0	0.0	0.5	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.1	0.6	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.4	1.7	61.0	0.4	0.4	0.0	0.4	0.4	0.9	0.4	0.0	0.0	0.0	5.4	16.0	0.0	1.6	0.0	0.0	0.0	1.8	0.0	0.2	0.0	0.0	12.8	0.0	0.0	0.0	0.0	18.5	0.4	0.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	5.5	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	17.1	0.8	0.0	0.0	13.7
FBLN2		ENSG00000163520	"Fibulin 2"	P98095	3	13549131-13638422	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 80.5"	"Group enriched"	"Detected in many"	6	"Fibroblasts: 266.2;Leydig cells: 158.2;Peritubular cells: 213.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 9.2;naive CD8 T-cell: 5.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 75.4;fHDF/TERT166: 49.5;HMC-1: 60.2;HSkMC: 43.7;U-2197: 26.7"	"Region enriched"	"Detected in some"	7	"olfactory region: 15.4"	"Low region specificity"	"Detected in all"			"HPA001934, CAB018622"	Enhanced		Supported	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		28000000	"Plasma membrane"		"CAB018622: AB_2294196, HPA001934: AB_1078827"	"unprognostic (1.19e-1)"	"unprognostic (7.76e-2)"	"unprognostic (3.21e-1)"	"prognostic unfavorable (9.48e-4)"	"unprognostic (2.82e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (3.17e-4)"	"unprognostic (8.02e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.57e-1)"	"unprognostic (4.66e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.41e-1)"	58.5	2.7	1.8	8.0	2.2	0.1	34.3	0.8	3.2	21.4	11.5	1.3	9.5	2.1	11.6	23.6	32.7	7.2	21.9	80.5	1.6	1.7	2.1	1.2	7.8	5.1	2.4	1.4	6.3	3.2	1.1	0.9	31.8	2.3	22.1	4.2	7.9	10.8	3.3	20.1	20.8	6.1	42.9	1.5	2.3	6.9	41.8	0.5	4.8	20.7	23.8	8.5	34.2	36.3	2.2	9.2	0.0	0.0	0.4	5.4	1.1	0.0	0.2	9.8	0.0	75.4	10.2	4.5	23.5	18.8	23.6	15.6	1.5	0.0	0.0	1.1	49.5	0.0	0.0	0.0	0.1	4.4	0.0	0.0	18.6	0.4	0.0	5.1	0.0	60.2	43.7	0.3	3.7	0.0	0.0	0.0	1.6	0.1	0.1	0.1	0.0	0.9	0.1	2.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.5	0.4	0.0	17.3	0.0	2.7	0.0	0.0	0.0	0.0	0.0	26.7	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	1.7	0.0	0.3	9.2	2.2	0.0	5.4	0.0	0.4	0.0	0.7	0.0	1.1	1.8	2.2	0.8	3.2	1.6	1.7	2.4	1.4	2.3	0.5	0.0	1.0	0.0	0.7	27.4	0.0	7.3	0.0	0.0	3.4	7.0	2.0	6.6	0.0	0.0	3.4	29.2	0.0	0.0	0.2	4.5	266.2	1.0	24.1	0.2	3.2	0.0	0.0	25.8	0.3	6.5	158.2	2.1	37.1	0.0	0.0	1.3	0.2	0.0	213.6	0.0	0.2	12.9	19.6	2.6	8.8	25.2	5.1	0.0	0.0	0.9
FERMT1	"C20orf42, FLJ20116, KIND1, UNC112A, URP1"	ENSG00000101311	"Fermitin family member 1"	Q9BQL6	20	6074845-6123544	"Disease related genes, Predicted intracellular proteins"	"Cell adhesion"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	15	"Pancreatic endocrine cells: 223.7;Undifferentiated cells: 66.9"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 59.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.2"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"A-431: 17.1;CAPAN-2: 25.8;HaCaT: 30.0;HBEC3-KT: 30.4;OE19: 22.4;RT4: 17.3"	"Region enriched"	"Detected in single"	5	"hippocampal formation: 2.1"	"Not detected"	"Not detected"			"HPA039778, HPA041966"	Approved					NA	NA					"HPA039778: AB_10805593, HPA041966: AB_10795387"	"unprognostic (1.08e-3)"	"unprognostic (4.63e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.64e-3)"	"unprognostic (1.75e-3)"	"unprognostic (2.82e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.53e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.83e-1)"	"prognostic unfavorable (6.60e-4)"	"unprognostic (4.38e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.11e-2)"	"unprognostic (2.04e-1)"	"unprognostic (4.60e-2)"	"unprognostic (5.33e-2)"	1.2	18.2	4.6	8.9	5.1	0.2	2.7	1.6	8.0	5.2	16.3	7.5	1.5	9.5	2.1	4.9	17.0	2.5	9.7	1.7	3.6	2.7	2.5	1.0	1.3	0.0	3.5	2.2	4.3	2.8	13.1	1.1	6.9	6.0	8.1	23.5	0.7	4.2	7.1	0.9	10.6	12.9	3.7	2.4	0.9	9.3	1.1	3.4	2.4	2.5	17.6	11.3	7.5	6.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	17.1	5.1	0.0	0.0	0.1	1.5	5.9	0.9	0.0	0.6	0.2	7.3	25.8	0.0	5.1	1.0	1.9	30.0	10.6	30.4	0.6	0.0	0.9	2.9	3.5	8.2	0.3	0.0	0.8	1.5	13.1	3.5	7.4	0.1	0.4	0.1	0.0	0.0	0.7	0.3	0.0	0.7	3.5	22.4	13.9	0.0	3.9	9.0	3.1	17.3	2.4	0.3	2.9	0.1	0.0	0.2	2.6	0.7	0.1	1.6	1.1	0.2	12.0	0.1	0.0	0.0	1.3	2.8	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.6	5.1	1.6	4.7	3.6	2.7	3.5	2.2	6.0	3.4	0.0	1.1	0.0	44.3	36.9	0.0	1.0	2.5	1.4	13.6	0.0	0.0	48.6	1.7	34.5	0.0	0.0	36.5	0.0	36.4	26.6	3.1	8.6	0.0	0.2	4.2	0.0	15.0	0.6	0.0	0.9	10.0	1.5	1.7	0.0	49.2	0.0	223.7	8.6	2.8	12.4	0.0	0.0	1.4	0.2	0.8	37.6	6.1	0.0	66.9	42.1
FEZF1	ZNF312B	ENSG00000128610	"FEZ family zinc finger 1"	A0PJY2	7	122301394-122310691	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 16.7;testis: 11.0"	"Cell type enriched"	"Detected in single"	5	"Spermatocytes: 2.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"hypothalamus: 16.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"NTERA-2: 58.8;SCLC-21H: 25.7"	"Region enriched"	"Detected in single"	11	"hypothalamus: 13.7"	"Region enriched"	"Detected in some"	9	"hypothalamus: 6.9"	"HPA064639, HPA073693"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA064639: AB_2685308, HPA073693: AB_2686626"		"unprognostic (8.48e-2)"	"unprognostic (3.41e-2)"	"unprognostic (3.64e-1)"	"unprognostic (3.43e-2)"	"unprognostic (4.17e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.64e-3)"			"unprognostic (2.54e-1)"	"unprognostic (1.34e-1)"		"unprognostic (2.96e-2)"	"unprognostic (2.55e-1)"		"unprognostic (1.48e-2)"	0.6	0.2	6.4	0.2	4.9	0.2	0.2	0.0	2.0	0.2	0.2	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.3	1.0	16.7	0.2	0.2	0.2	0.2	2.0	0.0	0.3	0.2	0.2	3.1	0.2	0.0	0.3	0.2	1.4	0.6	0.2	0.2	0.3	0.2	0.2	0.0	0.2	0.3	11.0	3.5	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	58.8	1.4	1.0	0.0	0.0	0.0	0.0	0.1	25.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.8	0.1	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	4.9	0.0	2.0	1.0	16.7	2.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.7	0.2	0.0	0.0	0.0	0.0	0.0
FGF17	FGF-13	ENSG00000158815	"Fibroblast growth factor 17"	O60258	8	22042398-22048809	"Cancer-related genes, Disease related genes, Predicted secreted proteins, RAS pathway related proteins"		"Developmental protein, Growth factor"	"Cancer-related genes, Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 31.3"	"Group enriched"	"Detected in some"	7	"Bipolar cells: 8.6;Cone photoreceptor cells: 13.7"	"Cancer enhanced"	"Detected in some"		"testis cancer: 3.9"	"Region enriched"	"Detected in many"	4	"cerebellum: 31.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 3.2;Hep G2: 2.4;MOLT-4: 2.3;RPMI-8226: 4.4"	"Region enriched"	"Detected in single"	4	"basal ganglia: 2.2"	"Low region specificity"	"Detected in some"			HPA052600	Uncertain				"Secreted in brain"	NA	NA					"HPA052600: AB_2681881"	"unprognostic (3.45e-2)"	"unprognostic (1.64e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.78e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.92e-5)"	"unprognostic (6.85e-2)"	"unprognostic (2.58e-4)"	"unprognostic (6.55e-3)"	"unprognostic (7.18e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.95e-3)"	0.4	4.9	2.5	0.4	3.2	0.2	0.4	31.3	7.7	0.5	0.4	0.4	0.4	0.2	2.2	0.6	0.4	0.7	0.6	0.4	2.2	4.7	0.4	0.4	0.5	0.4	1.3	2.9	0.5	2.6	3.6	2.1	0.4	3.3	1.2	0.2	0.4	2.4	0.5	0.4	0.9	0.4	1.0	0.9	3.0	0.8	0.6	0.4	1.6	2.3	0.4	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.2	0.6	0.6	1.0	0.3	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.6	0.0	0.2	3.2	0.0	0.0	0.0	0.0	0.9	0.7	0.0	2.4	0.1	0.0	1.5	0.0	0.3	0.0	0.1	1.4	0.0	1.2	0.1	0.1	0.0	0.7	2.3	0.8	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	1.0	1.6	0.0	0.0	0.2	0.3	0.0	1.2	0.0	0.0	0.1	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	3.2	31.3	7.7	2.2	4.7	1.3	2.9	3.3	0.4	0.0	0.0	0.0	0.2	0.0	8.6	0.8	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.3	0.0	1.7	0.0	0.0	0.1	0.1	0.0	1.1	0.0	1.1	0.0	0.3	0.2	0.2	0.0	0.2	0.0	0.0	0.1
FGF7	KGF	ENSG00000140285	"Fibroblast growth factor 7"	P21781	15	49423096-49488775	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Distal tubular cells: 101.2;Fibroblasts: 91.0;Leydig cells: 77.1;Smooth muscle cells: 82.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"basophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 24.2;ASC TERT1: 22.3;fHDF/TERT166: 10.0;HSkMC: 22.6;RH-30: 18.0;U-138 MG: 12.2"	"Region enriched"	"Detected in single"	9	"cerebellum: 9.7"					HPA043605	Uncertain		Approved	Nucleoplasm,Nucleoli	"Secreted in other tissues"	NA	NA			"Nucleoplasm, Nucleoli"		"HPA043605: AB_10960215"	"unprognostic (4.65e-1)"	"unprognostic (7.62e-2)"	"unprognostic (2.50e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.62e-2)"	"unprognostic (5.74e-3)"	"unprognostic (2.56e-2)"	"unprognostic (7.30e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.22e-3)"	"unprognostic (7.59e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.63e-3)"	39.7	2.7	0.6	9.9	0.6	0.0	16.5	0.6	2.4	73.3	22.2	0.0	10.1	1.1	13.1	16.1	25.2	14.1	25.4	19.1	0.6	0.6	5.9	1.2	44.8	5.5	2.1	0.0	43.7	2.5	2.9	2.8	9.1	0.8	42.5	4.5	2.7	6.4	8.1	25.6	3.6	4.2	38.3	1.4	1.0	6.6	12.7	0.0	0.0	23.2	24.7	2.9	72.2	32.4	0.2	0.1	1.6	0.2	0.3	0.5	0.0	0.1	0.0	0.1	0.1	24.2	22.3	0.0	7.3	4.5	0.0	0.0	0.0	0.1	0.0	0.1	10.0	0.2	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	2.1	0.1	0.0	22.6	0.4	1.9	0.0	0.1	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.1	0.1	0.0	0.1	0.0	18.0	0.0	0.0	0.0	0.9	0.3	0.2	0.0	0.0	0.1	0.1	0.1	0.1	12.2	0.2	0.4	0.0	0.2	0.1	0.0	3.3	0.0	0.2	1.6	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.3	0.0	0.2	0.5	0.2	0.0	0.3	0.2	0.1	0.4	0.0	0.6	0.6	0.6	0.6	0.6	0.6	2.1	0.0	0.8	0.0	11.9	13.4	0.9	13.5	12.8	7.9	40.0	5.1	0.0	0.0	8.7	2.0	4.7	101.2	1.1	2.8	5.3	0.0	0.0	0.6	3.8	91.0	9.0	1.1	2.5	1.8	3.2	0.0	0.0	1.0	3.1	77.1	3.1	6.8	0.0	0.0	7.3	0.6	0.0	4.6	24.5	6.0	6.5	82.4	0.3	0.1	11.0	2.4	1.0	0.0	7.1
FILIP1L	"DOC-1, GIP130"	ENSG00000168386	"Filamin A interacting protein 1 like"	Q4L180	3	99830141-100114513	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 302.8;Sertoli cells: 252.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 5.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 27.3;HDLM-2: 25.5;TIME: 47.6"	"Region enriched"	"Detected in some"	7	"olfactory region: 22.1"	"Low region specificity"	"Detected in all"			HPA043133	Approved		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA043133: AB_10793991"	"unprognostic (9.14e-2)"	"unprognostic (2.16e-1)"	"unprognostic (7.73e-2)"	"unprognostic (5.25e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.32e-1)"	"prognostic unfavorable (9.40e-4)"	"unprognostic (2.46e-2)"	"unprognostic (9.44e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.82e-3)"	29.0	7.5	11.7	22.1	2.4	0.0	15.2	1.3	7.4	36.2	28.3	0.9	27.2	6.9	52.5	50.0	25.3	17.8	24.3	23.8	4.0	2.1	12.5	6.7	15.9	10.9	2.9	6.5	65.6	10.3	7.7	3.1	14.6	9.4	36.7	7.7	5.5	6.1	36.8	44.8	9.5	19.2	86.3	2.2	27.1	25.1	19.9	1.3	2.5	11.7	53.4	5.8	49.8	16.2	1.5	4.4	0.5	5.9	1.0	0.4	0.5	18.7	0.0	7.4	0.0	12.2	10.4	0.6	9.6	19.3	16.8	19.1	5.7	0.0	0.0	1.7	27.3	4.4	2.3	0.0	4.7	20.0	25.5	0.2	1.5	0.0	7.5	6.1	0.4	0.0	8.2	1.7	1.9	0.0	10.8	7.5	0.0	1.2	0.1	2.5	0.1	1.6	0.3	0.4	1.0	0.0	0.0	8.7	0.2	11.3	0.3	0.6	1.2	0.1	0.1	0.0	4.1	0.0	3.4	47.6	2.9	0.0	0.6	5.0	1.4	0.0	0.1	2.2	0.1	0.0	0.3	1.0	0.2	0.3	2.2	0.1	1.4	0.4	0.3	4.4	1.5	0.2	0.2	0.5	1.0	5.9	0.8	0.3	0.5	11.7	2.4	1.3	7.4	4.0	2.1	2.9	6.5	9.4	1.3	14.9	17.2	0.0	37.5	24.6	4.0	115.5	33.1	2.7	2.3	5.2	7.9	0.6	1.7	158.4	302.8	69.7	2.9	0.0	97.5	0.6	90.1	2.5	33.5	0.5	3.0	100.1	2.9	44.2	29.2	157.4	76.8	76.0	16.9	28.9	3.0	1.0	44.0	0.0	97.9	0.3	5.9	252.2	159.4	7.1	1.9	19.8	2.6	0.5	0.3	3.7
FOXB2	bA159H20.4	ENSG00000204612	"Forkhead box B2"	Q5VYV0	9	77019655-77020953	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in single"		"brain: 2.6"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"prostate cancer: 0.6"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"NTERA-2: 5.5"	"Region enriched"	"Detected in single"	16	"hypothalamus: 1.4"	"Group enriched"	"Detected in many"	4	"basal ganglia: 3.1;hypothalamus: 6.4;midbrain: 2.0;pons and medulla: 2.0"	HPA067947	Uncertain					NA	NA					"HPA067947: AB_2685930"										"unprognostic (2.02e-1)"		"unprognostic (8.58e-2)"			"unprognostic (2.62e-1)"			0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.6	0.0	0.0			0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.1	0.0		0.2	0.0	0.0	0.0	0.0		0.0	0.0		0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2			0.0		0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FOXD3	"Genesis, HFH2"	ENSG00000187140	"Forkhead box D3"	Q9UJU5	1	63323041-63325126	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	7	"Melanocytes: 5.0"	"Group enriched"	"Detected in some"	6	"melanoma: 9.9;testis cancer: 3.5"	"Group enriched"	"Detected in some"	11	"midbrain: 1.9;pons and medulla: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"NTERA-2: 13.8;SK-MEL-30: 11.2;WM-115: 17.2"	"Region enriched"	"Detected in single"	13	"olfactory region: 2.1"	"Region enriched"	"Detected in single"	22	"olfactory region: 18.3"	CAB022455	Uncertain					NA	NA					"CAB022455: "	"unprognostic (1.39e-1)"	"unprognostic (3.23e-3)"	"unprognostic (2.33e-3)"		"unprognostic (4.63e-2)"	"unprognostic (7.79e-2)"		"unprognostic (8.22e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.92e-2)"	"unprognostic (3.28e-1)"		"unprognostic (3.00e-2)"	"unprognostic (8.56e-2)"		"unprognostic (5.83e-2)"	1.1	2.0	0.0	2.9	0.0	0.2	1.6	0.0	0.1	4.2	9.3	0.0	1.8	1.3	0.7	3.1	8.7	0.8	7.3	3.3	0.1	0.0	0.3	0.2	0.1	0.1	1.9	0.0	1.1	0.3	0.0	0.2	0.0	1.9	4.6	1.2	7.7	2.2	3.9	5.9	2.0	2.7	1.7	0.5	0.1	2.3	2.7	0.0	0.0	0.4	2.0	0.4	5.8	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	1.4	0.0	0.0	0.3	3.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.3	2.2	0.0	0.0	0.3	0.0	0.0	13.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.0	0.0	11.2	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.9	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0
FRMD7	"FLJ43346, NYS, NYS1"	ENSG00000165694	"FERM domain containing 7"	Q6ZUT3	X	132076993-132128020	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	Neurogenesis		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	6	"endometrium 1: 7.4;kidney: 6.6;smooth muscle: 5.5"	"Cell type enriched"	"Detected in single"	30	"Distal tubular cells: 8.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.1;HSkMC: 1.6;SuSa: 3.6;U-87 MG: 5.5"	"Region enriched"	"Detected in single"	29	"olfactory region: 80.8"	"Region enriched"	"Detected in single"	103	"olfactory region: 45.5"	HPA000886	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA000886: AB_1079269"	"unprognostic (3.08e-2)"	"unprognostic (1.27e-1)"			"unprognostic (1.36e-1)"	"unprognostic (3.07e-1)"	"unprognostic (4.02e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.84e-1)"	"unprognostic (3.54e-2)"			"unprognostic (3.00e-1)"			0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.0			0.0	7.4	1.1	0.0	1.1	0.0	0.1	0.0	0.1	6.6	1.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.5	0.0		0.0	1.1	0.0	0.5	0.0	5.5	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	3.6	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GABRA6		ENSG00000145863	"Gamma-aminobutyric acid type A receptor alpha6 subunit"	Q16445	5	161547063-161702593	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	23	"brain: 96.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	36	"cerebellum: 96.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"AF22: 1.0;PC-3: 1.5;TIME: 1.1;U-266/70: 2.5"	"Region enriched"	"Detected in some"	40	"cerebellum: 1204.9"	"Region enriched"	"Detected in some"	44	"cerebellum: 189.6"	CAB022462	Approved					NA	NA					"CAB022462: "																"unprognostic (3.79e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	96.4	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	96.4	0.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GABRQ	THETA	ENSG00000268089	"Gamma-aminobutyric acid type A receptor theta subunit"	Q9UN88	X	152638183-152657534	"FDA approved drug targets, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 28.9;cervix, uterine: 16.2"	"Cell type enhanced"	"Detected in some"	20	"Basal keratinocytes: 3.5;Spermatogonia: 1.1;Suprabasal keratinocytes: 1.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 6.6"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 9.0;SiHa: 8.7;SuSa: 4.1;U-87 MG: 28.8"	"Region enriched"	"Detected in many"	5	"hypothalamus: 61.6"	"Region enhanced"	"Detected in many"		"midbrain: 24.9"							NA	NA						"unprognostic (3.68e-3)"	"unprognostic (7.78e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.17e-4)"	"unprognostic (3.38e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.45e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.73e-1)"	"unprognostic (3.76e-2)"	"unprognostic (3.10e-5)"	"unprognostic (3.43e-3)"	"unprognostic (1.84e-1)"	"unprognostic (6.42e-2)"	"unprognostic (7.70e-2)"	0.2	4.4	10.5	0.2	5.7	0.1	0.1	0.0	7.5	16.2	0.2	1.5	1.0	0.2	2.6	0.5	1.1	0.3	0.1	0.2	23.4		0.2	0.1	0.1	0.2	0.0	13.6	0.1	0.1	0.1	0.0	0.3	28.9	0.9	0.2	0.0	0.1	1.7	0.1	0.7	0.5	1.6	7.2	0.2	0.1	4.7	1.0	0.0	0.3	1.5	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.2	0.2	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.7	0.0	2.2	0.0	0.0	0.0	0.0	1.2	8.7	1.6	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.1	3.5	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	1.1	1.6	0.7	0.0	0.0	0.3
GATA3	HDR	ENSG00000107485	"GATA binding protein 3"	P23771	10	8045378-8075203	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 97.8;skin 1: 61.7"	"Cell type enhanced"	"Detected in many"	19	"Cytotrophoblasts: 243.8;Extravillous trophoblasts: 651.3;Syncytiotrophoblasts: 949.1"	"Group enriched"	"Detected in many"	24	"breast cancer: 190.0;urothelial cancer: 87.0"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	42	"gdT-cell: 9.7;MAIT T-cell: 13.3;memory CD4 T-cell: 18.2;memory CD8 T-cell: 14.1;naive CD4 T-cell: 10.0;naive CD8 T-cell: 9.0;NK-cell: 16.6;T-reg: 18.9"	"Group enriched"	"Detected in many"	54	"NK-cells: 16.6;T-cells: 18.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 33.3;MCF7: 79.6;RT4: 32.6;SH-SY5Y: 28.0;T-47d: 103.7"	"Region enriched"	"Detected in single"	6	"midbrain: 7.3"	"Group enriched"	"Detected in some"	38	"midbrain: 25.5;pons and medulla: 17.5;thalamus: 20.0"	"CAB016217, HPA029730"	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB016217: AB_2108591, HPA029730: AB_10601907"	"unprognostic (1.70e-1)"	"unprognostic (7.23e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.03e-3)"	"unprognostic (4.68e-3)"	"unprognostic (4.23e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.83e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (1.48e-1)"	"unprognostic (5.16e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.82e-3)"	2.0	2.0	0.3	3.4	0.3	0.9	17.8	0.3	0.3	1.8	0.5	0.1	44.4	0.1	0.4	13.5	0.8	0.4	0.4	0.9	0.3	0.4	12.9	0.7	1.6	2.7	0.8	0.0	0.3	0.4	55.0	3.8	53.4	1.4	8.1	0.0	1.8	8.9	97.8	0.8	61.7	1.2	3.4	0.4	2.7	0.5	0.8	0.1	42.4	3.3	0.6	3.4	26.9	16.4	0.2	0.0	0.3	0.0	16.6	18.9	3.0	5.5	1.3	0.0	0.0	0.0	0.0	33.3	0.1	0.0	0.0	0.0	2.0	5.0	0.0	0.0	0.0	0.0	4.9	0.5	0.1	0.0	16.0	1.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.1	0.0	0.3	0.1	2.6	7.8	0.0	0.0	0.0	79.6	8.7	0.0	0.6	1.0	0.7	0.4	0.4	0.1	0.0	32.6	1.6	28.0	0.0	4.5	0.0	6.1	103.7	0.0	0.0	0.4	1.0	0.2	0.7	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	9.7	0.0	13.3	0.2	18.2	14.1	0.0	0.0	10.0	9.0	0.3	16.6	0.0	0.0	18.9	3.0	0.3	0.3	0.3	0.3	0.3	0.4	0.8	0.0	1.4	0.1	0.0	8.9	0.5	60.9	84.1	0.0	1.2	0.0	0.0	1.2	169.3	0.0	243.8	0.0	0.2	0.0	4.9	0.0	0.0	0.3	651.3	6.9	27.0	2.3	0.5	27.7	0.0	0.0	9.8	4.0	0.0	0.0	2.2	8.5	1.0	0.0	0.0	2.6	0.0	0.0	0.3	0.0	0.0	1.4	0.0	0.2	173.9	949.1	56.1	0.0	68.0
GCG	"GLP-1, GLP1, GLP2, GRPP"	ENSG00000115263	Glucagon	P01275	2	162142873-162152404	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"pancreas: 202.8"	"Cell type enriched"	"Detected in some"	14	"Intestinal endocrine cells: 5260.0"	"Cancer enriched"	"Detected in some"	209	"pancreatic cancer: 428.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"EFO-21: 38.0;U-2 OS: 54.1"	"Region enriched"	"Detected in single"	10	"pons and medulla: 3.7"	"Region enhanced"	"Detected in single"		"midbrain: 2.0"	"CAB000040, HPA036760, HPA036761"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to blood"	NA	NA	127000		"Endoplasmic reticulum"	Vesicles	"CAB000040: AB_10013726, HPA036760: AB_2675296, HPA036761: AB_2675297"			"unprognostic (3.13e-3)"								"unprognostic (9.99e-2)"	"unprognostic (1.16e-2)"		"unprognostic (1.26e-2)"				1.0	0.1	0.2	0.6	0.2	1.1	0.2	0.2	1.8	0.2	6.6	0.2	0.2	0.0	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.1	3.4	0.2	0.2	0.2	0.2	0.2	0.2	202.8	0.0	0.2	0.2	0.5	0.2	12.6	0.2	0.2	0.2	0.2	2.5	11.0	0.2	0.2	0.2	2.4	0.3	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.1	0.0	2.9	0.0	1.4	9.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.3	0.2	0.1	0.2	0.2	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5260.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	8.5	0.0	378.9	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0
GCGR	GGR	ENSG00000215644	"Glucagon receptor"	P47871	17	81804132-81814013	"FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Diabetes mellitus, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 68.8"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 60.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 10.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 3.9;MCF7: 6.1;SK-BR-3: 5.3;U-87 MG: 6.1"	"Region enriched"	"Detected in single"	5	"cerebellum: 0.9"	"Not detected"	"Not detected"			HPA071228			Uncertain	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA071228: AB_2686368"	"unprognostic (3.28e-4)"	"unprognostic (9.30e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.53e-4)"	"unprognostic (1.11e-1)"	"unprognostic (2.30e-3)"	"unprognostic (4.38e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.77e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.61e-1)"	"unprognostic (6.42e-2)"	"unprognostic (5.99e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.17e-3)"	"unprognostic (8.36e-3)"	0.2	3.9	0.1	0.6	0.3	0.0	0.1	0.1	0.3	0.2	0.2	0.1	0.1	0.2	0.1	0.2	0.2	0.0	0.1	0.1	0.1	0.0	11.4	68.8	0.1	0.1	0.1	0.1	0.1	0.5	3.9	0.1	0.1	0.5	0.2	0.0	1.4	0.3	0.1	0.1	0.9	0.2	0.1	0.1	0.1	0.0	0.2	0.1	0.2	0.2	0.6	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	3.9	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	1.6	0.0	5.3	0.0	0.0	0.0	0.6	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.3	0.1	0.0	0.1	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.8	0.2	0.6	0.0	0.0	0.0	3.5	2.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.2	0.1	0.0	0.0	1.3	3.7	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.4	0.0	0.0	0.0	0.0
GCNT2	"bA360O19.2, bA421M1.1, CCAT, GCNT5, IGNT, II, NACGT1, NAGCT1, ULG3"	ENSG00000111846	"Glucosaminyl (N-acetyl) transferase 2, I-branching enzyme (I blood group)"	Q8N0V5	6	10492223-10629368	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 25.1"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 71.5;Melanocytes: 47.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 26.4;Hep G2: 11.0;SuSa: 10.2"	"Region enriched"	"Detected in many"	4	"basal ganglia: 54.8"	"Low region specificity"	"Detected in all"			HPA026776	Approved		Approved	"Golgi apparatus"		No	No		560000	"Golgi apparatus"		"HPA026776: AB_1849573"	"unprognostic (2.47e-1)"	"unprognostic (6.87e-3)"	"unprognostic (3.12e-1)"	"unprognostic (1.42e-2)"	"unprognostic (9.31e-2)"	"unprognostic (2.51e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.11e-2)"	"unprognostic (6.28e-4)"	"unprognostic (3.96e-2)"	"unprognostic (1.58e-3)"	"unprognostic (6.54e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.53e-1)"	2.0	0.9	2.5	7.9	2.8	0.7	12.7	7.6	1.9	6.0	13.0	2.0	0.9	7.8	5.6	1.3	3.7	1.7	2.8	11.8	2.2	2.4	19.6	14.3	10.4	3.3	2.4	0.4	0.9	5.5	1.0	6.2	3.1	4.0	21.9	3.7	8.1	7.4	0.9	2.3	2.5	25.1	2.6	2.2	4.2	8.3	9.0	2.9	0.9	2.4	1.2	7.2	2.0	3.0	2.1	2.5	4.2	3.1	0.5	0.4	0.7	4.2	3.5	1.2	2.9	0.0	0.0	3.5	0.0	3.1	0.8	0.2	6.2	3.2	2.4	26.4	0.0	1.8	0.1	0.3	3.2	1.8	1.6	0.9	0.5	1.9	11.0	0.0	1.1	3.0	0.0	0.0	0.3	0.0	1.7	7.0	0.0	0.3	0.0	0.3	0.0	0.0	2.3	4.0	0.0	2.4	0.1	2.4	3.8	9.4	2.3	2.6	1.8	0.0	9.2	8.9	10.2	0.1	0.4	5.9	0.5	0.4	0.0	3.4	0.0	0.0	1.7	0.6	0.2	1.4	4.2	3.1	1.3	0.3	2.3	0.1	2.1	0.3	0.4	2.5	1.3	0.4	0.4	0.2	0.5	0.8	0.6	0.2	0.7	2.5	2.8	7.6	1.9	2.2	2.4	2.4	0.4	4.0	2.9	71.5	26.7	12.3	5.5	4.0	4.3	14.9	2.5	30.8	28.4	7.0	0.0	22.4	10.0	2.4	3.3	5.8	28.4	23.3	22.4	1.0	1.1	21.1	2.3	31.1	12.9	3.2	2.4	8.6	6.3	6.0	0.3	6.9	47.2	9.0	2.8	2.9	9.0	1.7	0.0	8.8	0.5	0.0	0.4	1.9	20.4	1.5	9.2	0.0	7.2	7.0
GDF10	BMP-3b	ENSG00000266524	"Growth differentiation factor 10"	P55107	10	47300386-47313547	"Plasma proteins, Predicted secreted proteins"	Osteogenesis	"Cytokine, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 15.8;tongue: 14.8"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 17.8;Cone photoreceptor cells: 15.7;Rod photoreceptor cells: 34.3"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.3;naive CD4 T-cell: 1.5"	"Lineage enriched"	"Detected in single"	16	"T-cells: 1.5"	"Cell line enhanced"	"Detected in some"		"AF22: 17.7;MOLT-4: 3.8;SH-SY5Y: 7.2"	"Region enriched"	"Detected in many"	8	"cerebellum: 47.7"	"Low region specificity"	"Detected in all"			HPA015498	Uncertain		Approved	Vesicles	"Secreted in other tissues"	NA	NA			Vesicles		"HPA015498: AB_1849584"	"unprognostic (4.34e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.41e-1)"	"unprognostic (5.09e-1)"	"unprognostic (3.17e-1)"	"unprognostic (9.84e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.72e-7)"	"unprognostic (3.49e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.59e-3)"	"unprognostic (2.63e-1)"	6.8	4.4	1.4	0.3	2.8	0.0	10.8	7.6	5.2	1.9	0.4	1.7	0.0	0.0	2.3	2.4	5.4	0.5	2.9	2.1	3.0		0.0	0.0	15.8	0.9	0.0	5.0	0.1	11.6	0.2	0.0	0.0	0.9	2.8	0.3	6.8	3.0	0.3	2.5	0.3	0.1	0.6	0.8	0.1	0.1	10.5	0.8	0.0	3.7	14.8	2.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	17.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.4	0.0	0.0	1.5	0.3	0.0	0.0	0.0	0.0	0.0	0.1											0.0	1.1	0.0	0.0	0.3	17.8	0.6	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	4.7	0.0	1.1	0.0	0.1	1.6	0.0	0.0	0.0	0.2	0.9	0.0	1.7	0.0	0.0	4.3	0.0	0.0	0.0	0.0	34.3	0.0	0.1	0.2	0.5	0.6	0.0	0.0	0.0	0.0
GDPD4	GDE6	ENSG00000178795	"Glycerophosphodiester phosphodiesterase domain containing 4"	Q6W3E5	11	77216558-77301687	"Predicted membrane proteins"		Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	6	"testis: 7.6"	"Group enriched"	"Detected in some"	14	"Early spermatids: 8.8;Late spermatids: 13.7;Spermatocytes: 12.7;Spermatogonia: 4.5"	"Cancer enriched"	"Detected in single"	10	"testis cancer: 1.6"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.6;HEL: 3.5;U-937: 1.1"	"Region enriched"	"Detected in single"	24	"olfactory region: 2.8"											NA	NA						"unprognostic (6.73e-6)"	"unprognostic (3.30e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.12e-1)"	"unprognostic (3.55e-4)"	"unprognostic (4.13e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.63e-2)"	"unprognostic (3.10e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.05e-4)"	"unprognostic (1.68e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.64e-2)"	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0		0.3	0.0	0.1	0.2	0.7		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	7.6			0.1		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	3.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.7	0.6	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	13.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	12.7	4.5	0.0	0.2	0.0	0.0	0.0
GFRAL	"bA360D14.1, C6orf144, GRAL, UNQ9356"	ENSG00000187871	"GDNF family receptor alpha like"	Q6UXV0	6	55327469-55402493	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adipose tissue: 1.9;blood: 2.2;liver: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"neutrophil: 2.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HeLa: 1.6;Karpas-707: 1.5"	"Region enriched"	"Detected in single"	10	"pons and medulla: 0.3"	"Low region specificity"	"Detected in many"			HPA047372	Uncertain					NA	NA					"HPA047372: AB_2680017"															"unprognostic (2.31e-1)"			1.9	0.0	0.1	0.3	0.1	0.4	0.6	0.2	0.2	0.0	0.0			0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.2	0.1		0.1	0.0	0.0	0.1	0.0		0.0	0.4		0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.9			0.0		0.1	0.0	0.0	1.2	0.7	2.2	0.6	0.6	0.3	0.0	0.0	0.4	0.1	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.6	1.6	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.3	0.0	0.0	0.1	0.1	0.8	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.5	0.3	0.1	0.8	0.6	0.2	0.2	0.1	0.1	0.8	0.2	0.1	0.0	1.2	0.3	0.3	2.2	0.6	0.2	0.7	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GFY	Goofy	ENSG00000261949	"Golgi associated olfactory signaling regulator"	I3L273	19	49423749-49428818	"Predicted membrane proteins"	"Olfaction, Sensory transduction"			"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	8	"brain: 2.1;testis: 4.0"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HEK 293: 3.9;SCLC-21H: 9.2;T-47d: 2.5;U-266/84: 5.6"	"Region enriched"	"Detected in single"	14	"olfactory region: 1.8"	"Region enriched"	"Detected in many"	7	"cerebellum: 14.5"							NA	NA						"unprognostic (8.04e-2)"	"unprognostic (8.21e-2)"		"unprognostic (1.16e-1)"	"unprognostic (2.43e-1)"	"unprognostic (4.50e-2)"		"unprognostic (8.99e-2)"		"unprognostic (8.85e-2)"				"unprognostic (1.42e-1)"	"unprognostic (1.82e-1)"		"unprognostic (9.62e-3)"	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.1	1.2	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.7	0.0	0.1	0.1	0.0	0.0	3.9	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.9	0.0	0.1	2.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	5.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0
GHRH	GHRF	ENSG00000118702	"Growth hormone releasing hormone"	P01286	20	37251082-37261835	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"brain: 37.3"	"Cell type enriched"	"Detected in single"	4	"Cardiomyocytes: 1.1"	"Cancer enriched"	"Detected in some"	7	"urothelial cancer: 8.5"	"Region enriched"	"Detected in some"	15	"hypothalamus: 37.3"	"Cell type enhanced"	"Detected in single"		"eosinophil: 2.7"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	7	"NTERA-2: 3.6;U-266/84: 12.7"	"Region enriched"	"Detected in some"	9	"hypothalamus: 38.7"	"Low region specificity"	"Detected in all"								"Secreted in other tissues"	NA	NA						"unprognostic (4.78e-2)"				"unprognostic (2.57e-2)"									"unprognostic (1.58e-1)"	"unprognostic (3.10e-1)"			0.1	2.7	0.3	0.1	2.4	0.0	0.6	0.1	1.0	0.1	4.0	0.1	0.1	8.1	0.1	0.1	0.7	0.0	0.1	6.5	0.1	37.3	0.1	0.1	0.1	0.1	0.1	0.8	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	7.7	0.1	0.1	0.1	1.9	0.1	0.1	7.5	0.4	0.1	0.1	0.1	0.1	0.0	0.7	2.7	0.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.6	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.4	0.1	1.0	0.1	37.3	0.1	0.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
GNG14		ENSG00000283980	"G protein subunit gamma 14"	A0A1W2PPG7	19	12687998-12688422	"Predicted intracellular proteins"		Transducer		"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"pancreas: 3.1;skin 1: 3.2;testis: 2.5"	"Not detected"	"Not detected"											"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 3.0;HEK 293: 5.4;MCF7: 5.1"	"Region enriched"	"Detected in single"	44	"thalamus: 132.6"	"Low region specificity"	"Detected in all"									NA	NA																							0.1	0.0		0.0		1.0	0.0		1.0	0.0	0.0			0.0	0.0	0.0	0.1	0.0	0.0	0.5			0.0	0.0	0.1	0.0			0.7	3.1	0.0		0.0		0.2	0.0		0.9	0.0	0.0	3.2	0.3	0.0		0.0	0.0	2.5			1.5		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.6	0.0	0.0	2.4	0.0	0.0	1.8	0.9	0.0	0.0	0.0	2.0	0.3	0.0	0.2	0.0	0.0	3.0	0.0	0.0	0.0	0.0	5.4	0.0	2.1	1.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.8	0.0	5.1	0.6	1.3	0.4	0.0	1.4	0.2	0.0	0.7	0.0	2.0	0.7	1.4	0.6	0.0	0.0	0.0	2.0	0.4	0.0	0.7	0.7	2.1	0.1	0.2	2.7	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GNG4		ENSG00000168243	"G protein subunit gamma 4"	P50150	1	235547687-235650754	"Predicted intracellular proteins, RAS pathway related proteins"		Transducer		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.1;ovary: 25.1;pituitary gland: 18.8"	"Cell type enhanced"	"Detected in many"	15	"Glandular cells: 31.6;Intestinal endocrine cells: 41.2;Mucus-secreting cells: 11.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 29.0;SCLC-21H: 30.7;SH-SY5Y: 43.2;U-2197: 12.9"	"Region enriched"	"Detected in many"	6	"olfactory region: 574.6"	"Region enhanced"	"Detected in all"		"olfactory region: 427.7"							NA	NA						"unprognostic (1.50e-3)"	"unprognostic (8.33e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.94e-2)"	"unprognostic (2.22e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.56e-9)"	"unprognostic (1.22e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.68e-3)"	"unprognostic (5.01e-3)"	1.9	9.4	16.8	2.0	21.5	0.9	1.1	8.6	24.1	1.8	3.4	6.5	0.5	2.5	8.3	1.1	8.4	1.6	1.2	0.9	10.2	20.8	1.3	0.8	0.9	4.7	6.3	7.7	25.1	4.5	0.8	18.8	4.2	11.2	17.1	3.0	1.7	1.4	1.4	0.8	1.1	4.8	5.8	7.1	0.9	3.6	2.1	2.8	3.1	0.9	0.0	3.9	1.2	1.1	1.3	0.8	3.8	0.6	1.0	0.8	0.3	6.8	0.4	5.1	0.0	0.0	0.2	0.4	0.0	0.0	0.6	0.8	0.0	0.3	0.0	0.0	2.1	1.7	0.8	5.4	0.2	1.3	3.5	2.0	0.0	0.1	2.6	0.1	0.0	2.3	0.4	0.0	0.1	0.2	0.0	0.0	0.4	0.0	0.0	0.4	0.0	1.3	0.2	29.0	0.0	0.0	0.0	2.7	0.1	0.0	0.2	30.7	43.2	0.2	0.1	0.6	0.3	0.0	1.0	0.0	0.3	0.9	12.9	0.9	1.0	0.0	0.0	0.9	0.0	8.5	3.8	0.6	0.6	0.5	0.5	0.4	1.0	0.8	0.5	0.2	1.3	0.6	0.6	2.3	1.0	0.5	0.8	0.6	0.3	16.8	21.5	8.6	21.7	10.2	20.8	6.3	7.7	11.2	2.8	0.0	0.0	0.0	1.6	0.5	2.3	0.4	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	1.0	0.4	3.1	0.0	7.4	5.8	0.5	31.6	0.0	0.0	0.8	1.6	41.2	0.0	0.0	0.6	0.3	0.6	0.0	1.8	11.8	0.5	2.6	0.6	0.4	2.6	1.0	0.0	0.5	1.2	2.1	0.0	5.3	0.0	1.5	0.9
GNG7	FLJ00058	ENSG00000176533	"G protein subunit gamma 7"	O60262	19	2511219-2702709	"Predicted intracellular proteins, RAS pathway related proteins"		Transducer		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 115.9"	"Group enriched"	"Detected in many"	5	"B-cells: 132.4;Cardiomyocytes: 52.7;Distal tubular cells: 104.5;Hofbauer cells: 49.0;Horizontal cells: 160.5;Melanocytes: 49.0;Muller glia cells: 53.2"	"Cancer enhanced"	"Detected in all"		"glioma: 21.9"	"Region enriched"	"Detected in all"	5	"basal ganglia: 115.9"	"Group enriched"	"Detected in many"	4	"memory B-cell: 23.9;naive B-cell: 20.5;plasmacytoid DC: 19.9"	"Group enriched"	"Detected in many"	4	"B-cells: 23.9;dendritic cells: 19.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 10.5;REH: 31.0;SK-MEL-30: 14.3;U-266/70: 29.8;U-266/84: 13.7"	"Region enriched"	"Detected in many"	6	"basal ganglia: 1142.7"	"Region enriched"	"Detected in all"	6	"basal ganglia: 484.6"	HPA057790	Supported	Supported				NA	NA					"HPA057790: AB_2683527"	"unprognostic (3.97e-3)"	"unprognostic (1.16e-4)"	"unprognostic (4.92e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.79e-1)"	"unprognostic (8.42e-4)"	"prognostic favorable (3.05e-4)"	"prognostic favorable (1.35e-5)"	"unprognostic (1.27e-2)"	"unprognostic (4.95e-2)"	"prognostic favorable (3.71e-4)"	"unprognostic (1.27e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (6.96e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.36e-2)"	"unprognostic (4.96e-2)"	3.1	4.8	19.8	4.5	115.9	5.4	4.1	9.7	28.2	2.6	3.8	23.4	0.8	4.7	4.8	4.9	11.1	6.5	3.3	22.5	20.3	11.4	6.0	2.2	3.0	8.0	20.0	10.0	10.0	7.2	5.4	4.6	1.4	20.9	7.1	3.0	12.2	22.8	5.7	2.9	1.7	4.9	3.4	28.5	11.0	5.8	5.5	22.0	0.1	3.7	0.4	8.2	3.4	1.4	23.9	19.9	5.0	0.6	0.0	0.5	1.3	0.1	0.0	1.5	3.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	10.5	0.5	0.1	0.1	0.1	1.7	0.0	0.0	0.0	1.4	0.2	0.0	1.2	0.8	0.0	6.3	0.2	0.2	0.0	0.1	0.1	0.0	1.2	0.1	6.8	0.0	1.0	0.2	0.6	1.2	0.2	0.6	31.0	0.0	2.8	0.1	0.0	0.0	4.5	0.0	0.0	14.3	1.1	0.2	2.6	0.0	0.0	1.5	0.1	0.1	29.8	13.7	2.2	0.1	3.3	7.9	1.1	0.6	3.2	0.1	0.2	0.4	23.9	0.2	0.1	2.5	20.5	0.5	0.3	5.0	0.0	0.0	19.9	0.0	1.3	19.8	115.9	9.7	20.0	20.3	11.4	20.0	10.0	20.9	22.0	6.0	3.4	132.4	10.1	2.3	5.4	52.7	10.2	5.3	5.7	8.7	7.9	0.5	104.5	10.7	4.3	12.1	0.5	0.0	4.2	0.9	1.7	8.1	12.7	11.6	49.0	160.5	5.8	14.7	7.2	7.4	2.3	6.6	49.0	12.6	2.6	53.2	3.9	1.5	2.5	15.8	10.2	6.5	8.0	1.7	2.9	1.8	2.9	2.2	1.7	6.7
GNMT		ENSG00000124713	"Glycine N-methyltransferase"	Q14749	6	42960758-42963880	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"liver: 83.9;pancreas: 100.1"	"Cell type enriched"	"Detected in many"	34	"Hepatocytes: 729.0"	"Group enriched"	"Detected in many"	20	"liver cancer: 69.6;prostate cancer: 49.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 3.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 10.5;SCLC-21H: 12.4;T-47d: 7.9"	"Region enriched"	"Detected in some"	4	"cerebellum: 17.7"	"Not detected"	"Not detected"			HPA027501	Enhanced		Approved	Cytosol		NA	NA		150000	Cytosol		"HPA027501: AB_1849879"	"unprognostic (1.53e-2)"	"unprognostic (8.02e-4)"	"unprognostic (3.11e-2)"	"unprognostic (4.24e-3)"	"unprognostic (3.91e-2)"	"unprognostic (6.40e-4)"	"prognostic favorable (1.86e-4)"	"unprognostic (4.08e-6)"	"unprognostic (1.01e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.63e-3)"	"unprognostic (2.52e-1)"	"unprognostic (3.50e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.49e-2)"	"unprognostic (4.92e-2)"	0.3	0.1	0.2	0.2	0.2	0.7	1.8	0.5	0.5	0.3	0.5	0.2	1.3	0.0	0.2	0.9	0.3	0.1	0.2	1.3	0.2	0.2	0.3	83.9	1.3	0.1	0.1	0.2	0.4	100.1	0.0	2.5	0.1	0.4	5.2	0.0	0.9	8.2	0.9	0.6	0.1	0.2	0.4	0.1	0.3	6.5	0.6	0.1	0.2	0.9	0.3	0.4	0.2	0.1	0.7	3.2	2.0	0.9	0.0	1.2	0.3	0.5	0.4	1.8	5.1	0.6	0.2	0.3	0.4	2.0	0.8	1.2	0.1	0.1	1.7	0.2	0.4	0.9	0.6	0.3	0.3	0.2	2.0	1.6	1.3	1.0	10.5	0.0	1.1	2.4	0.4	0.0	0.4	0.2	1.2	0.0	3.8	1.5	1.9	0.3	2.3	2.0	3.7	0.2	0.5	0.5	1.7	1.6	1.0	0.9	0.2	12.4	1.7	0.1	1.7	0.6	0.5	7.9	3.6	0.4	0.9	0.9	0.5	1.0	1.3	1.2	1.5	0.2	2.1	1.0	0.0	0.8	0.1	0.2	0.9	0.1	0.7	0.3	0.3	0.9	0.1	0.6	1.2	2.0	0.0	0.1	3.2	0.3	0.3	0.2	0.2	0.5	0.5	0.2	0.2	0.1	0.2	0.4	0.1	0.0	2.1	3.4	4.2	0.2	1.2	4.5	15.3	5.3	0.0	1.8	0.0	0.1	3.3	0.4	0.2	0.1	0.0	0.0	0.7	0.1	0.2	16.1	0.0	729.0	0.5	1.6	0.0	16.5	21.5	0.0	0.9	0.3	0.0	0.0	0.0	0.3	0.9	0.0	2.5	2.2	0.3	0.0	0.7	0.5	0.6	0.1	0.1	0.0	0.0	1.6
GPR151	"GALR4, PGR7"	ENSG00000173250	"G protein-coupled receptor 151"	Q8TDV0	5	146513103-146516190	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	7	"blood: 1.5;brain: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	19	"thalamus: 36.8"	"Region enriched"	"Detected in many"	7	"thalamus: 4.6"	HPA065728		Supported				NA	NA					"HPA065728: "					"unprognostic (2.09e-1)"					"unprognostic (2.30e-1)"				"unprognostic (1.14e-1)"	"unprognostic (1.32e-2)"			0.0	0.1	0.4	0.0	0.5	0.1	0.0	0.0	2.2	0.0	0.0			0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.8		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.1	0.0	0.0	2.8	0.0	0.0	0.3			0.0		0.0	0.0	0.0	1.5	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.1	0.1	0.4	0.4	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	1.5	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GPR50	"H9, Mel1c"	ENSG00000102195	"G protein-coupled receptor 50"	Q13585	X	151176653-151181465	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"pituitary gland: 64.9"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in single"		"hypothalamus: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HEK 293: 9.6;SuSa: 8.1"	"Region enriched"	"Detected in some"	6	"hypothalamus: 16.8"	"Region enriched"	"Detected in some"	9	"hypothalamus: 6.4"	"HPA049862, HPA054678"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA049862: AB_2680920, HPA054678: AB_2682570"						"unprognostic (8.84e-3)"		"unprognostic (5.59e-2)"							"unprognostic (1.15e-1)"			0.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.3	1.4	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	64.9	3.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GPR6		ENSG00000146360	"G protein-coupled receptor 6"	P46095	6	109978256-109980718	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	19	"brain: 42.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	9	"basal ganglia: 42.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	22	"SCLC-21H: 4.6"	"Region enriched"	"Detected in some"	11	"basal ganglia: 81.5"											NA	NA										"unprognostic (1.14e-2)"						"unprognostic (1.59e-2)"				"unprognostic (7.10e-3)"			0.4	0.5	3.5	0.4	42.5	0.5	0.4	0.0	6.5	0.4	0.4	0.0	0.0	0.4	0.4	0.4	0.4	0.4	0.4	0.4	1.3	1.8	0.4	0.4	0.4	0.4	0.1	0.8	0.4	0.4	0.4	2.2	0.4	0.0	0.4	0.4	0.0	0.5	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.8	0.5	4.6	0.0	0.4	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	42.5	0.0	4.0	1.3	1.8	0.1	0.8	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GPR88		ENSG00000181656	"G protein-coupled receptor 88"	Q9GZN0	1	100538137-100542018	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Mental retardation"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"brain: 62.7"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	9	"liver cancer: 12.0"	"Group enriched"	"Detected in many"	7	"basal ganglia: 62.7;thalamus: 32.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"HSkMC: 4.9;SCLC-21H: 6.1"	"Region enriched"	"Detected in many"	11	"basal ganglia: 643.5"	"Region enriched"	"Detected in some"	34	"basal ganglia: 223.4"	HPA007488		Approved				NA	NA					"HPA007488: AB_2667844"	"unprognostic (1.65e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.30e-2)"	"unprognostic (8.37e-3)"	"unprognostic (5.41e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.03e-2)"	"unprognostic (7.76e-2)"	"unprognostic (8.23e-3)"	"unprognostic (2.45e-1)"	"unprognostic (3.93e-4)"	"unprognostic (1.85e-2)"	"unprognostic (5.56e-2)"	"unprognostic (4.41e-1)"	"unprognostic (1.35e-2)"	0.7	0.6	1.2	0.5	62.7	0.2	10.9	0.0	6.8	0.1	0.3	0.8	0.0	0.6	0.2	0.2	0.2	0.1	0.2	0.4	0.9	0.8	0.3	13.1	0.2	0.3	0.7	1.1	3.8	0.1	4.6	0.5	0.2	7.0	0.6	0.5	0.3	0.7	0.1	0.3	0.1	0.5	0.3	0.5	13.7	0.4	0.2	32.8	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.4	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	4.9	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	62.7	0.0	6.8	0.9	0.8	0.7	1.1	7.0	32.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GPRC5C	RAIG-3	ENSG00000170412	"G protein-coupled receptor class C group 5 member C"	Q9NQ84	17	74424851-74451653	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 76.2"	"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 193.6;Hepatocytes: 148.3;Paneth cells: 149.7;Sertoli cells: 142.3"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 31.1"	"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 10.2"	"Group enriched"	"Detected in many"	9	"dendritic cells: 10.2;monocytes: 4.7"	"Cell line enhanced"	"Detected in many"		"Hep G2: 24.0;HMC-1: 42.2;RPTEC TERT1: 56.9;RT4: 26.3;T-47d: 32.0"	"Region enriched"	"Detected in many"	9	"cerebellum: 47.7"	"Low region specificity"	"Detected in all"			HPA029776	Enhanced		Uncertain	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Centriolar satellite"	"Nucleoplasm, Cytosol"	"HPA029776: AB_10602324"	"unprognostic (1.48e-1)"	"unprognostic (3.35e-1)"	"unprognostic (6.01e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.80e-2)"	"unprognostic (1.09e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.69e-2)"	"unprognostic (9.61e-3)"	"unprognostic (1.05e-1)"	"prognostic favorable (1.58e-5)"	"unprognostic (7.58e-2)"	"unprognostic (3.70e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.54e-3)"	4.3	4.1	5.2	2.2	5.3	0.0	7.7	31.1	5.7	19.7	15.4	4.4	17.0	10.0	5.8	9.9	5.3	12.5	17.6	7.7	5.3	2.6	43.8	46.1	11.5	2.8	4.8	4.9	12.3	76.2	12.0	3.4	4.5	6.1	15.1	6.2	18.0	16.8	11.7	25.4	9.2	15.2	3.9	4.6	5.1	44.7	4.4	4.1	1.9	42.2	10.2	3.5	12.6	8.0	0.7	10.2	0.1	4.7	0.0	0.1	0.3	4.6	16.7	1.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.3	21.4	0.0	13.3	0.1	5.4	14.7	2.2	0.3	0.0	0.0	2.7	0.0	1.2	24.0	4.9	0.0	42.2	0.4	7.6	0.0	0.0	22.7	0.0	0.0	1.2	0.3	0.0	5.2	0.1	4.5	2.7	23.1	19.4	0.0	0.0	1.1	56.9	26.3	8.1	0.7	0.8	1.8	0.0	10.9	32.0	1.2	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	2.1	0.6	0.1	0.0	1.7	0.1	0.0	3.4	0.0	0.7	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	4.7	10.2	0.0	0.3	5.2	5.3	31.1	5.7	5.3	2.6	4.8	4.9	6.1	4.1	3.0	48.9	1.5	39.6	12.0	0.8	193.6	68.8	22.7	18.2	129.1	0.0	0.7	24.9	53.1	0.1	8.7	61.7	0.0	58.9	7.1	19.9	46.9	10.3	148.3	9.6	4.8	43.7	25.8	8.5	0.5	16.7	4.2	3.3	5.4	47.3	18.8	37.9	149.7	20.8	51.6	0.8	142.3	56.7	0.4	3.0	9.8	21.2	1.5	44.1	40.9
GPX6	GPXP3	ENSG00000198704	"Glutathione peroxidase 6"	P59796	6	28503296-28528215	"Enzymes, Predicted secreted proteins"		"Oxidoreductase, Peroxidase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"epididymis: 9.3"	"Cell type enhanced"	"Detected in some"	22	"Early spermatids: 2.5;Late spermatids: 2.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.0;HEL: 1.6"	"Region enriched"	"Detected in single"	16	"basal ganglia: 21.3"	"Not detected"	"Not detected"								"Secreted in male reproductive system"	NA	NA																				"unprognostic (2.99e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.1	0.0	0.0	0.4	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9			0.0		0.0	0.0	0.0	0.1	0.1	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0
GRXCR2	DFNB101	ENSG00000204928	"Glutaredoxin and cysteine rich domain containing 2"	A6NFK2	5	145858521-145937126	"Disease related genes, Predicted intracellular proteins"			"Deafness, Non-syndromic deafness"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"heart muscle: 2.9;skin 1: 2.0;testis: 3.5"	"Group enriched"	"Detected in some"	15	"Early spermatids: 14.9;Late spermatids: 8.9"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	5	"T-reg: 1.1"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.1"	"Cell line enhanced"	"Detected in some"		"CACO-2: 1.5;GAMG: 1.1;RPMI-8226: 1.5;T-47d: 1.1;U-87 MG: 1.0"	"Region enriched"	"Detected in single"	4	"amygdala: 1.3"	"Low region specificity"	"Detected in all"			HPA059421	Uncertain					NA	NA					"HPA059421: AB_2684010"						"unprognostic (4.71e-2)"						"unprognostic (2.91e-1)"						0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0			0.0	0.0	1.6	0.2	0.1	0.0	2.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.7	0.0		1.3	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	3.5			0.2		0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	1.5	0.4	0.1	0.2	0.0	1.1	0.1	0.0	0.8	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.5	0.1	0.0	0.0	0.0	0.8	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HCRT	"OX, PPOX"	ENSG00000161610	"Hypocretin neuropeptide precursor"	O43612	17	42184060-42185452	"Disease related genes, Predicted secreted proteins"		Neuropeptide	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	31	"brain: 84.3"	"Cell type enhanced"	"Detected in some"	12	"Collecting duct cells: 1.8;Intestinal endocrine cells: 2.9;Kupffer cells: 1.8"	"Cancer enhanced"	"Detected in single"		"glioma: 0.5"					"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 2.7;granulocytes: 2.3;T-cells: 2.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.0;Karpas-707: 1.0;RPMI-8226: 3.7"	"Region enriched"	"Detected in some"	5	"hypothalamus: 110.5"	"Region enriched"	"Detected in some"	57	"hypothalamus: 152.0"	"HPA064801, CAB079778"	Enhanced	Supported			"Secreted to blood"	NA	NA					"CAB079778: , HPA064801: "			"unprognostic (3.34e-2)"		"unprognostic (7.76e-5)"					"unprognostic (3.21e-2)"	"unprognostic (3.01e-2)"		"unprognostic (2.20e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.23e-1)"			0.9	0.0	0.0	1.1	0.2	0.9	0.0	0.0	0.7	0.0	0.5			1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	84.3	0.4	0.0	0.0	0.4	0.1		0.3	0.0	0.0	0.0	0.3		0.0	0.1		0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.1	0.3			0.0		0.0	0.0	0.0	2.7	0.4	2.3	0.5	0.4	2.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.9	0.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	1.0	0.0	0.0	0.8	0.8	0.4	0.9	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.2	0.7	0.8	0.2	0.0	0.1	0.0	2.3	0.5	0.0	1.2	0.4	2.2	1.5	0.9	1.6	0.4	2.7	1.4	1.3	0.1	0.4	0.2	0.3	0.5	0.1											0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	2.9	0.6	1.8	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.6	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.5	0.7	0.1
HDC		ENSG00000140287	"Histidine decarboxylase"	P19113	15	50241947-50266026	"Enzymes, Predicted intracellular proteins"	"Catecholamine biosynthesis"	"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	8	"blood: 83.5;brain: 36.0;epididymis: 36.9"	"Cell type enriched"	"Detected in some"	7	"granulocytes: 556.0"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	52	"hypothalamus: 36.0"	"Cell type enriched"	"Detected in single"	835	"basophil: 83.5"	"Lineage enriched"	"Detected in single"	835	"granulocytes: 83.5"	"Group enriched"	"Detected in some"	4	"HEL: 61.2;HMC-1: 147.3"	"Region enriched"	"Detected in many"	5	"hypothalamus: 51.5"	"Low region specificity"	"Detected in all"			HPA038891	Enhanced		Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA038891: AB_10673231"	"unprognostic (4.97e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.43e-4)"	"unprognostic (1.08e-1)"	"unprognostic (6.16e-2)"	"unprognostic (3.93e-7)"	"unprognostic (4.18e-5)"	"unprognostic (8.79e-3)"	"unprognostic (1.48e-1)"	"unprognostic (8.46e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.53e-1)"	"unprognostic (7.20e-2)"	"unprognostic (9.78e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.50e-1)"	1.7	0.2	0.2	5.1	0.4	2.4	1.1	0.2	0.3	2.7	1.9	0.2	1.2	2.1	3.1	36.9	2.7	0.6	6.6	2.1	0.2	36.0	0.6	0.8	4.9	2.3	0.6	0.1	0.4	0.5	0.3	0.7	0.2	0.3	2.2	1.9	3.0	0.9	1.3	1.8	1.8	2.4	5.4	0.2	0.4	6.9	2.4	0.2	0.4	0.3	0.4	1.7	1.8	2.7	0.0	0.0	83.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	61.2	0.0	0.0	0.0	0.1	147.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	83.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.4	0.2	0.3	0.2	36.0	0.6	0.1	0.3	0.2	11.9	81.4	0.0	0.0	0.7	0.5	0.3	0.0	8.1	13.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	556.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0
HEPHL1	DKFZp686F22190	ENSG00000181333	"Hephaestin like 1"	Q6MZM0	11	94021361-94113751	"Predicted membrane proteins"	"Copper transport, Ion transport, Transport"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"tongue: 68.0"	"Cell type enriched"	"Detected in some"	5	"Basal keratinocytes: 9.3"	"Cancer enriched"	"Detected in some"	5	"head and neck cancer: 20.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.4;HaCaT: 4.2;HBEC3-KT: 7.5"	"Region enriched"	"Detected in single"	21	"olfactory region: 1.4"	"Not detected"	"Not detected"			HPA031517	Uncertain					NA	NA		51000000			"HPA031517: AB_10603769"	"unprognostic (9.16e-2)"	"prognostic unfavorable (4.94e-4)"	"unprognostic (2.40e-1)"	"unprognostic (3.26e-6)"	"unprognostic (3.17e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.72e-2)"	"unprognostic (6.71e-2)"	"unprognostic (5.34e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.66e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.25e-1)"	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.1	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.1	6.5	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	68.0	16.2	0.0	4.8	1.1	0.3	0.1	0.0	0.9	0.1	0.0	0.9	0.1	0.0	0.0	0.0	0.0	1.4	0.2	0.1	0.0	0.0	0.1	0.5	0.0	0.3	0.0	0.1	4.2	0.0	7.5	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.9	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.1	0.3	1.1	0.0	0.1	0.1	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0
HES3	bHLHb43	ENSG00000173673	"Hes family bHLH transcription factor 3"	Q5TGS1	1	6244192-6245578	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in some"	4	"lymphoid tissue: 6.8"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	28	"testis cancer: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"NTERA-2: 16.1"	"Region enriched"	"Detected in single"	30	"cerebellum: 39.0"	"Low region specificity"	"Detected in many"			"HPA047927, HPA072697"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA047927: AB_2680213, HPA072697: "															"unprognostic (7.42e-2)"			0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HEY2	"bHLHb32, HERP1, HESR2"	ENSG00000135547	"Hes related family bHLH transcription factor with YRPW motif 2"	Q9UBP5	6	125747664-125761269	"Predicted intracellular proteins, Transcription factors"	"Notch signaling pathway, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"heart muscle: 28.5"	"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 37.9;Late spermatids: 59.0;Muller glia cells: 32.0;Sertoli cells: 51.8;Smooth muscle cells: 35.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.6;naive CD8 T-cell: 1.4"	"Lineage enriched"	"Detected in single"	20	"T-cells: 2.6"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 5.2;HEK 293: 6.7;SK-MEL-30: 6.1;TIME: 13.9;U-266/70: 16.9"	"Region enriched"	"Detected in all"	4	"olfactory region: 34.5"	"Low region specificity"	"Detected in all"			"HPA030205, HPA074851"	Approved		Approved	"Nuclear bodies,Aggresome"		NA	NA			"Nuclear bodies"	Aggresome	"HPA030205: AB_10600712, HPA074851: AB_2686718"	"unprognostic (5.10e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.41e-3)"	"unprognostic (2.43e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.52e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.10e-3)"	"unprognostic (7.34e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.28e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.19e-1)"	6.0	1.8	7.4	1.8	9.2	0.7	5.5	5.7	11.8	10.4	2.9	13.1	0.7	2.2	11.3	24.0	2.8	19.3	7.6	28.5	8.2	6.2	3.6	7.8	3.7	1.2	8.2	11.4	10.7	4.1	7.1	5.4	5.4	12.8	2.3	2.4	10.4	3.0	4.5	19.1	2.1	2.2	2.9	11.3	2.9	2.0	6.5	7.2	0.0	3.6	4.9	1.4	3.5	4.9	0.0	0.0	0.0	0.1	0.0	2.6	0.4	0.0	0.0	0.0	5.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	3.7	0.0	0.0	0.8	0.2	0.2	0.1	0.0	0.4	6.7	1.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.5	0.0	0.5	0.0	0.4	0.0	0.0	3.0	0.0	0.3	0.5	0.6	0.8	0.0	0.1	2.2	0.0	0.0	0.0	6.1	3.2	1.8	0.0	13.9	0.3	0.0	0.1	0.7	16.9	0.3	0.1	0.6	0.0	1.9	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.5	1.4	0.0	0.0	0.1	0.0	0.0	0.4	7.4	9.2	5.7	5.9	8.2	6.2	8.2	11.4	12.8	7.2	3.0	0.6	0.5	0.3	3.4	0.4	17.9	0.0	6.7	1.2	0.0	7.9	0.0	8.3	0.0	37.9	3.7	0.0	23.3	1.6	0.1	3.0	0.3	0.0	7.3	0.1	1.6	0.0	1.3	0.3	59.0	6.1	0.6	3.3	0.0	0.0	32.0	1.8	0.0	21.9	4.2	5.0	51.8	35.0	10.8	7.0	1.8	0.0	0.5	0.0	0.4
HOMER3	HOMER-3	ENSG00000051128	"Homer scaffolding protein 3"	Q9NSC5	19	18929201-18941261	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 64.8"	"Cell type enhanced"	"Detected in many"	7	"Hofbauer cells: 64.5;Muller glia cells: 59.6;Proximal tubular cells: 70.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 14.7"	"Group enriched"	"Detected in many"	4	"granulocytes: 5.1;monocytes: 14.7"	"Cell line enhanced"	"Detected in many"		"NB-4: 62.2;THP-1: 74.8;U-266/84: 64.3"	"Region enriched"	"Detected in many"	6	"cerebellum: 212.2"	"Low region specificity"	"Detected in all"			"CAB032656, HPA040999, CAB079015"	Enhanced	Supported	Supported	"Plasma membrane,Cytosol,Cytoplasmic bodies"		NA	NA			Cytosol	"Plasma membrane, Cytoplasmic bodies"	"CAB032656: AB_2120801, CAB079015: , HPA040999: AB_2677242"	"unprognostic (3.41e-2)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (4.24e-5)"	"unprognostic (1.19e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (4.93e-5)"	"unprognostic (1.07e-1)"	"unprognostic (8.88e-2)"	"unprognostic (5.78e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.10e-2)"	"unprognostic (5.99e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.11e-2)"	11.4	8.3	11.1	6.5	16.0	12.4	31.0	42.3	12.2	8.7	6.7	17.6	2.1	4.9	8.2	5.2	7.6	4.8	10.9	11.9	15.8	9.0	21.2	4.1	7.0	5.5	19.4	7.2	8.2	5.3	13.6	2.4	9.7	15.5	8.1	4.5	15.4	8.4	7.0	49.2	10.9	5.5	7.6	24.2	64.8	6.5	3.4	14.6	2.2	19.6	7.8	3.3	12.3	16.8	2.4	1.2	5.1	14.7	0.0	0.7	3.6	19.6	5.1	9.7	8.1	9.1	9.2	4.8	19.5	17.3	19.6	9.9	2.6	7.6	0.1	9.2	21.9	14.1	12.3	3.3	25.3	11.0	0.7	2.0	0.0	1.6	4.8	8.5	3.7	0.3	7.4	16.4	10.9	14.7	21.0	23.8	1.4	0.5	5.2	14.2	5.3	0.3	62.2	5.0	1.0	21.1	9.7	2.9	9.2	7.1	5.0	0.0	8.3	4.8	5.7	13.8	1.9	2.5	74.8	18.9	17.5	7.8	21.0	23.4	50.7	64.3	16.3	27.6	48.1	12.7	0.1	14.7	2.6	0.1	5.1	0.0	2.4	0.7	0.3	1.2	1.7	0.1	0.0	5.1	0.0	1.4	0.2	0.7	3.6	11.1	16.0	42.3	12.2	15.8	9.0	19.4	7.2	15.5	14.6	3.0	0.0	2.4	17.6	10.5	1.9	3.4	2.5	0.0	2.3	12.2	0.0	0.6	10.0	17.4	1.3	13.1	0.0	0.0	11.6	1.4	13.0	10.5	10.3	0.8	64.5	1.6	1.7	20.9	18.2	1.7	12.7	16.1	11.8	1.0	0.9	59.6	32.9	0.0	10.3	70.5	4.1	0.0	6.1	1.0	5.1	12.7	0.9	0.5	0.1	19.7
HOXA1	"HOX1, HOX1F"	ENSG00000105991	"Homeobox A1"	P49639	7	27092993-27095996	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Autism spectrum disorder"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"urinary bladder: 12.9"	"Cell type enhanced"	"Detected in some"	7	"Basal keratinocytes: 2.1;granulocytes: 2.3;Intestinal endocrine cells: 2.9;Ito cells: 3.1;Kupffer cells: 1.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	10	"pons and medulla: 5.0"	"Group enriched"	"Detected in many"	5	"intermediate monocyte: 6.0;NK-cell: 6.8;non-classical monocyte: 8.7"	"Group enriched"	"Detected in many"	6	"monocytes: 8.7;NK-cells: 6.8"	"Cell line enhanced"	"Detected in many"		"HMC-1: 12.8"	"Region enriched"	"Detected in single"	7	"pons and medulla: 1.0"	"Group enriched"	"Detected in some"	5	"midbrain: 1.3;pons and medulla: 1.9"							NA	NA						"unprognostic (7.39e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.17e-4)"	"unprognostic (2.79e-2)"	"prognostic unfavorable (6.73e-5)"	"unprognostic (4.70e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.65e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.06e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.77e-3)"	"unprognostic (1.17e-1)"	1.5	1.2	0.2	3.7	0.4	0.4	2.9	0.2	0.3	1.1	1.9	0.4	0.0	0.4	1.2	3.6	8.2	2.2	2.9	0.9	0.2	0.2	2.9	0.5	0.8	2.1	0.4	0.0	3.8	0.4	3.2	0.3	0.9	5.0	3.7	1.9	0.3	0.3	5.3	0.7	4.1	3.0	2.6	4.9	8.0	1.2	0.8	0.0	3.1	0.4	1.3	5.2	12.9	10.6	0.4	1.2	1.0	8.7	6.8	1.3	0.6	5.4	2.4	0.2	3.1	0.0	0.0	5.0	0.7	3.2	2.1	2.5	12.2	3.5	3.8	7.3	1.9	7.8	11.9	4.3	3.5	1.5	0.3	12.6	4.9	0.2	0.1	0.6	4.1	12.8	2.3	3.5	2.5	5.1	0.0	3.1	3.9	5.3	0.0	4.2	0.1	0.0	6.7	0.0	2.2	0.5	4.7	1.4	0.0	7.0	5.3	0.4	0.0	2.7	0.0	3.3	4.3	0.0	1.9	2.3	0.5	5.0	3.7	0.9	0.0	0.0	1.7	1.9	7.3	5.2	1.0	0.3	0.6	1.2	6.0	1.2	0.4	1.3	1.2	1.2	0.0	0.6	1.2	0.3	6.8	8.7	0.0	1.2	0.6	0.2	0.4	0.2	0.3	0.2	0.2	0.4	0.0	5.0	0.0	0.0	0.0	0.0	1.2	2.1	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.2	0.2	2.3	0.0	0.1	0.0	2.9	3.1	1.9	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.9	0.0	0.1	1.0	0.0	1.0	0.9	1.1
HOXA2	HOX1K	ENSG00000105996	"Homeobox A2"	O43364	7	27100354-27102811	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 18.1"	"Cell type enhanced"	"Detected in some"	17	"Intestinal endocrine cells: 4.6;Ito cells: 6.2;Melanocytes: 1.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	44	"pons and medulla: 15.7"	"Cell type enriched"	"Detected in single"	5	"neutrophil: 1.8"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.8"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 16.8;HaCaT: 6.9;RPTEC TERT1: 5.5"	"Region enriched"	"Detected in single"	35	"pons and medulla: 6.1"	"Region enriched"	"Detected in single"	27	"pons and medulla: 7.7"	HPA078220			Approved	Nucleoplasm,Vesicles		Yes	NA			"Nucleoplasm, Vesicles"		"HPA078220: AB_2686880"	"unprognostic (7.30e-2)"	"unprognostic (4.90e-4)"	"unprognostic (2.81e-1)"	"unprognostic (7.43e-4)"	"unprognostic (1.44e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.85e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.58e-2)"	"unprognostic (4.98e-9)"	"unprognostic (1.34e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.28e-2)"	2.7	1.6	0.3	1.9	0.1	0.0	2.6	0.1	0.2	1.4	4.5	0.2	8.7	1.5	3.4	9.7	8.3	6.3	4.9	1.8	0.1	0.0	4.2	0.7	4.7	1.9	0.3	0.1	3.8	0.4	9.6	0.1	0.1	15.7	2.8	3.5	0.1	0.1	4.1	1.2	2.7	4.3	2.4	18.1	2.9	3.7	0.8	0.1	3.8	2.2	2.9	3.3	3.2	3.5	0.0	0.0	1.8	0.3	0.0	0.1	0.0	1.2	0.8	4.2	16.8	0.0	0.0	0.0	0.2	0.1	0.0	0.1	2.2	4.1	0.2	1.9	0.2	2.3	6.9	0.2	0.0	0.0	0.0	2.4	0.0	0.1	0.4	1.9	0.1	0.3	1.0	0.0	3.6	3.4	0.0	2.8	0.4	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.1	1.1	1.0	0.7	0.0	5.5	0.7	1.2	0.0	0.2	0.0	1.1	0.3	0.0	0.0	2.8	0.0	0.2	1.2	0.6	0.0	0.0	0.1	0.1	0.7	3.0	0.0	0.1	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.2	0.0	0.1	0.0	0.3	0.1	0.1	0.2	0.1	0.0	0.3	0.1	15.7	0.1	0.0	0.0	0.0	0.3	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	4.6	6.2	0.0	0.0	0.0	0.0	1.7	0.0	1.3	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	1.4	0.3
HOXA3	"HOX1, HOX1E"	ENSG00000105997	"Homeobox A3"	O43365	7	27106184-27152581	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Ito cells: 9.2;Mucus-secreting cells: 14.6;Proximal tubular cells: 11.0;Undifferentiated cells: 13.6"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	5	"pons and medulla: 6.6"	"Cell type enhanced"	"Detected in some"		"neutrophil: 3.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 19.1;CACO-2: 12.3;CAPAN-2: 32.9;HEK 293: 14.7;WM-115: 17.6"	"Region enriched"	"Detected in single"	31	"pons and medulla: 2.9"	"Region enriched"	"Detected in single"	34	"pons and medulla: 5.0"	HPA029157	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA029157: AB_10601020"	"unprognostic (1.32e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.85e-3)"	"unprognostic (2.94e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.05e-2)"	"unprognostic (8.61e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.09e-2)"	"prognostic unfavorable (2.52e-6)"	"unprognostic (1.03e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.65e-2)"	"unprognostic (5.82e-2)"	5.3	2.6	0.5	11.0	0.5	0.0	8.9	0.5	0.5	3.9	13.7	0.7	9.8	3.9	7.5	7.2	6.9	16.0	4.7	4.7	0.5	0.0	9.9	1.5	5.2	3.5	1.3	0.5	5.5	0.6	5.4	0.5	0.5	6.6	5.6	4.9	0.5	0.5	4.2	7.2	3.8	7.8	3.6	4.7	2.5	6.3	2.7	0.5	6.7	2.5	9.8	2.7	9.4	6.0	0.5	1.3	3.8	1.1	1.3	0.5	0.3	5.7	6.8	0.0	19.1	0.0	0.0	0.0	0.2	0.1	0.0	0.1	12.3	32.9	0.9	9.5	0.5	2.6	7.7	0.3	0.8	0.0	0.2	14.7	0.2	0.1	9.9	0.6	0.3	0.3	1.2	0.0	1.5	1.8	0.0	1.8	0.8	0.6	0.1	0.7	0.3	0.0	0.5	0.0	1.6	4.2	6.8	2.2	0.0	5.6	2.6	2.8	0.0	1.0	0.0	2.7	0.3	0.5	0.4	8.1	0.0	1.0	2.0	1.5	0.0	0.0	0.3	0.6	1.2	17.6	1.7	0.2	0.7	0.5	0.2	0.0	0.5	0.3	0.5	1.3	0.1	0.0	0.3	3.8	1.3	1.1	0.1	0.5	0.3	0.5	0.5	0.5	0.5	0.5	0.0	1.3	0.5	6.6	0.5	0.0	0.0	0.0	3.0	1.0	0.0	0.6	0.0	0.0	0.0	3.5	0.0	0.0	5.0	0.0	6.5	1.4	5.0	0.0	0.0	0.0	1.1	2.2	1.1	0.0	0.1	0.0	4.1	9.2	0.3	7.3	0.6	0.0	3.3	0.0	14.6	0.0	0.0	7.0	0.0	11.0	0.0	0.0	4.2	1.2	0.4	1.1	0.0	0.0	13.6	2.6
HOXA4	"HOX1, HOX1D"	ENSG00000197576	"Homeobox A4"	Q00056	7	27128507-27130799	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Distal tubular cells: 13.3;Ito cells: 12.3;Proximal tubular cells: 10.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	18	"pons and medulla: 26.7"	"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 19.1;HEK 293: 14.5;REH: 13.4;WM-115: 19.0"	"Region enriched"	"Detected in single"	47	"pons and medulla: 11.9"	"Region enriched"	"Detected in single"	60	"pons and medulla: 24.6"	HPA060088	Approved		Supported	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA060088: AB_2684200"	"unprognostic (3.37e-2)"	"unprognostic (6.27e-3)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (6.37e-4)"	"unprognostic (3.12e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.22e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.39e-2)"	"unprognostic (4.23e-1)"	"unprognostic (5.63e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.38e-1)"	"unprognostic (3.59e-4)"	"unprognostic (3.93e-2)"	8.9	6.2	0.4	2.2	0.3	0.2	11.6	0.3	1.2	2.7	7.5	0.4	8.2	3.5	3.9	10.3	27.5	18.1	5.7	4.8	0.3	0.0	9.6	2.0	10.5	3.0	1.4	0.3	8.8	1.1	17.6	0.3	0.5	26.7	4.1	1.7	0.3	0.7	5.6	29.8	3.5	5.2	4.9	25.8	5.5	9.3	1.6	0.4	0.3	2.3	3.4	1.2	5.5	10.9	0.9	1.4	0.1	0.5	0.1	0.3	0.2	6.0	2.0	0.0	19.1	0.0	0.0	1.2	0.5	0.6	2.0	2.0	3.8	1.2	1.6	0.1	1.8	1.8	2.6	0.7	0.3	1.6	0.0	14.5	0.0	0.6	8.7	2.2	2.0	3.6	2.1	1.6	6.8	0.5	0.0	6.7	0.5	0.0	0.0	6.5	1.6	0.0	7.1	0.0	2.1	4.7	13.4	2.9	0.1	9.6	1.4	0.9	0.0	1.9	0.0	7.0	0.7	0.4	1.0	8.8	0.0	3.1	5.0	0.1	0.0	0.0	0.7	4.1	3.3	19.0	0.0	0.0	0.1	0.0	0.0	0.1	0.9	0.2	0.2	0.2	0.0	0.3	0.0	0.0	0.1	0.5	1.4	0.0	0.2	0.4	0.3	0.3	1.2	0.3	0.0	1.4	0.3	26.7	0.4	0.0	0.0	0.0	2.9	0.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.4	1.9	0.7	0.0	0.0	0.5	0.3	0.6	0.0	0.0	0.2	0.0	2.9	12.3	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	10.1	0.0	0.0	2.1	0.2	2.7	1.1	0.1	0.0	2.0	2.4
HOXA5	"HOX1, HOX1C"	ENSG00000106004	"Homeobox A5"	P20719	7	27141052-27143668	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 42.0"	"Cell type enhanced"	"Detected in many"	7	"Ito cells: 16.0;Paneth cells: 15.9;Proximal tubular cells: 21.3;Undifferentiated cells: 18.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	46	"pons and medulla: 16.3"	"Group enriched"	"Detected in some"	4	"basophil: 3.0;neutrophil: 1.6;NK-cell: 2.5"	"Group enriched"	"Detected in many"	5	"granulocytes: 3.0;NK-cells: 2.5"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 33.1;HEK 293: 56.5;RPTEC TERT1: 12.8"	"Region enriched"	"Detected in single"	88	"pons and medulla: 23.0"	"Region enriched"	"Detected in single"	22	"pons and medulla: 5.5"							NA	NA						"unprognostic (2.43e-1)"	"unprognostic (3.98e-3)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (1.87e-1)"	"unprognostic (7.80e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.02e-2)"	"unprognostic (5.54e-2)"	"unprognostic (2.31e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.00e-2)"	"unprognostic (4.37e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.47e-3)"	"unprognostic (2.00e-1)"	6.8	42.0	0.2	2.1	0.2	1.2	10.9	0.2	0.3	1.9	6.6	1.0	16.0	1.1	6.0	25.0	12.3	22.1	2.5	1.4	0.2	0.0	16.8	1.8	23.9	1.5	0.2	0.2	9.3	1.3	2.0	0.5	0.3	16.3	3.9	3.3	0.2	0.2	7.1	5.6	3.4	6.8	3.0	19.4	4.4	5.6	2.6	0.2	0.2	1.3	0.2	0.2	6.6	3.3	0.2	0.4	3.0	0.5	2.5	0.2	0.1	1.9	1.0	0.0	33.1	0.0	0.0	0.1	0.5	0.4	0.6	0.5	0.6	3.4	1.0	4.9	1.0	0.7	2.6	1.8	0.1	0.6	0.4	56.5	0.7	0.4	1.9	0.3	1.2	0.8	3.7	0.2	1.1	1.9	0.0	7.3	1.9	0.1	0.0	1.1	0.6	0.0	0.3	0.0	0.7	1.0	4.5	0.1	0.0	12.8	2.6	3.9	0.0	2.5	0.0	1.1	0.1	0.4	0.4	2.9	0.1	0.4	2.0	1.3	0.0	0.0	1.1	0.2	3.6	3.6	3.0	0.4	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.4	0.2	0.2	0.1	1.6	2.5	0.5	0.4	0.1	0.1	0.2	0.2	0.2	0.3	0.2	0.0	0.2	0.2	16.3	0.2	0.0	0.6	0.0	3.8	3.1	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	5.1	9.3	0.0	0.0	0.0	1.3	2.2	0.0	0.0	0.6	0.0	8.6	16.0	4.1	0.0	0.3	0.9	1.7	1.0	8.4	0.0	0.0	15.9	0.0	21.3	0.0	0.0	3.3	0.2	0.7	2.5	0.1	0.0	18.1	5.0
HOXA6	"HOX1, HOX1B"	ENSG00000106006	"Homeobox A6"	P31267	7	27145396-27150603	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"fallopian tube: 10.4"	"Cell type enhanced"	"Detected in some"	12	"Distal tubular cells: 5.0;Enterocytes: 3.5;Intestinal endocrine cells: 8.6;Paneth cells: 4.8;Undifferentiated cells: 4.4"	"Low cancer specificity"	"Detected in many"							"Group enriched"	"Detected in some"	8	"basophil: 5.9;NK-cell: 2.0"	"Group enriched"	"Detected in many"	8	"granulocytes: 5.9;NK-cells: 2.0"	"Group enriched"	"Detected in some"	9	"AN3-CA: 29.3;HEK 293: 39.9"	"Region enriched"	"Detected in single"	34	"pons and medulla: 3.5"					"HPA004203, HPA077900"	Approved		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			Nucleoplasm	"Nuclear speckles"	"HPA004203: AB_1079079, HPA077900: "	"unprognostic (1.70e-1)"	"unprognostic (6.76e-3)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (1.06e-1)"	"unprognostic (6.06e-2)"		"unprognostic (9.73e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.94e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.17e-1)"	"prognostic favorable (2.03e-4)"	"unprognostic (1.45e-1)"	"unprognostic (2.81e-2)"		"unprognostic (3.93e-1)"	3.2	2.9	0.0	1.2	0.0	0.0	2.3	0.0	0.0	1.6	5.4			0.0	6.7	4.6	0.1	10.4	0.0	0.0	0.0	0.0	5.9	0.0	2.3	0.8	0.0		0.0	0.0	0.5	0.0	0.0		2.5	1.5		0.0	2.2	1.0	3.2	4.2	1.4	1.0	0.0	1.2	0.0			0.0		0.0	4.3	1.3	0.1	0.5	5.9	0.1	2.0	0.2	0.0	0.5	0.9	0.0	29.3	0.0	0.0	0.1	0.2	0.3	0.2	0.3	0.7	3.4	0.7	1.1	0.2	0.1	1.3	0.7	0.0	0.0	0.8	39.9	0.4	0.5	0.4	0.0	0.6	1.0	2.4	0.0	0.0	0.3	0.0	1.3	0.9	0.2	0.0	0.3	0.3	0.0	0.1	0.0	0.1	1.0	3.8	0.0	0.0	2.8	1.8	3.1	0.0	1.3	0.1	0.6	0.0	0.3	0.3	0.0	0.0	0.4	1.6	1.0	0.0	0.0	0.6	0.0	2.8	2.9	5.9	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	2.0	0.0	0.5	0.2	0.0											0.0	0.0	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	5.0	0.0	0.0	0.1	3.5	0.0	0.0	0.0	0.2	1.2	0.0	0.0	0.1	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	4.8	0.0	1.0	0.0	0.0	1.0	0.0	0.0	0.4	0.0	0.0	4.4	1.0
HOXA7	"HOX1, HOX1A"	ENSG00000122592	"Homeobox A7"	P31268	7	27153716-27157936	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 27.8"	"Group enriched"	"Detected in many"	5	"Distal tubular cells: 111.0;Proximal tubular cells: 39.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	14	"pons and medulla: 9.2"	"Cell type enriched"	"Detected in some"	5	"NK-cell: 7.7"	"Lineage enriched"	"Detected in many"	5	"NK-cells: 7.7"	"Cell line enhanced"	"Detected in many"		"HAP1: 19.7;RPTEC TERT1: 24.4;SCLC-21H: 19.7"	"Region enriched"	"Detected in single"	12	"pons and medulla: 1.4"	"Region enriched"	"Detected in single"	10	"pons and medulla: 2.9"	HPA074048			Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			Nucleoplasm	"Nuclear membrane"	"HPA074048: AB_2686655"	"unprognostic (5.40e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (7.87e-5)"	"unprognostic (3.30e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (1.15e-5)"	"unprognostic (9.08e-2)"	"unprognostic (8.90e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.25e-1)"	6.5	14.5	0.2	4.8	0.2	0.0	11.2	0.3	0.6	7.3	10.0	0.2	7.9	0.0	5.0	15.4	3.0	12.2	0.5	0.2	0.2	0.0	25.4	0.4	2.6	3.5	0.2	0.2	6.2	0.2	0.3	0.2	1.3	9.2	8.2	7.2	0.2	0.2	8.9	27.8	8.2	6.1	8.1	14.3	3.7	3.2	2.7	0.2	1.6	0.9	0.2	1.1	11.4	6.7	0.2	0.9	0.0	0.0	7.7	1.6	0.2	6.9	2.4	0.0	7.5	0.0	0.0	0.4	2.5	4.3	5.2	6.0	3.6	2.7	4.8	7.0	1.9	0.2	4.8	19.7	0.0	3.1	0.0	12.4	0.3	2.8	0.1	0.5	0.4	0.2	4.1	0.2	0.6	7.0	0.0	9.8	8.4	0.0	0.0	1.9	1.2	0.0	1.1	0.3	5.0	0.7	2.5	4.6	0.0	24.4	4.8	19.7	0.0	13.6	0.0	0.0	1.4	0.2	1.9	0.8	0.0	4.7	14.0	2.4	0.0	0.1	0.1	0.0	9.4	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.2	0.9	0.0	0.0	0.1	0.0	7.7	0.0	0.6	0.4	0.2	0.2	0.2	0.3	0.6	0.2	0.0	0.2	0.2	9.2	0.2	0.0	0.0	0.0	7.5	8.0	0.0	0.3	0.0	0.0	0.0	12.2	0.0	0.4	111.0	0.0	15.9	2.2	3.0	0.0	0.0	4.6	2.7	4.0	0.0	0.0	0.2	0.0	15.5	0.0	0.0	2.1	0.6	0.5	3.3	0.0	11.2	0.0	0.1	10.4	0.0	39.0	0.0	0.0	7.3	0.4	0.2	10.8	0.2	0.9	15.7	2.6
HOXB2	"HOX2, HOX2H"	ENSG00000173917	"Homeobox B2"	P14652	17	48540894-48544989	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 53.1"	"Cell type enhanced"	"Detected in many"	13	"Collecting duct cells: 50.6;Distal tubular cells: 132.6"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in some"	6	"pons and medulla: 12.9"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 21.0;EFO-21: 20.3;HEK 293: 23.0;HMC-1: 45.9;WM-115: 20.1"	"Region enriched"	"Detected in single"	34	"pons and medulla: 4.7"	"Region enriched"	"Detected in single"	29	"pons and medulla: 5.4"	HPA047857			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA047857: AB_2680184"	"unprognostic (8.58e-3)"	"unprognostic (4.39e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (1.99e-4)"	"unprognostic (3.16e-1)"	"unprognostic (2.12e-2)"	"unprognostic (7.72e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.24e-1)"	"unprognostic (3.04e-3)"	"unprognostic (4.12e-1)"	"unprognostic (5.75e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.89e-1)"	9.2	11.0	0.2	6.3	0.3	1.9	24.2	0.3	0.2	14.5	15.4	0.4	53.1	2.4	6.9	32.5	19.3	12.2	12.8	4.5	0.5	0.1	25.6	2.8	6.4	4.4	2.0	0.3	6.4	1.6	8.9	0.9	1.7	12.9	8.2	1.7	0.8	0.6	33.2	6.1	3.7	6.4	7.5	19.4	6.8	6.7	2.7	0.2	2.4	3.0	3.9	2.6	7.9	16.3	0.8	6.0	5.0	0.4	2.2	9.5	1.3	0.0	0.7	21.0	0.0	4.8	5.6	0.0	1.9	0.0	0.0	0.0	0.3	0.1	0.0	20.3	5.8	0.0	0.0	3.1	0.0	0.0	0.1	23.0	7.9	0.8	0.0	8.5	0.0	45.9	3.5	0.0	9.1	3.6	0.2	3.3	0.0	15.5	0.0	12.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	10.4	0.0	15.0	1.8	0.0	0.0	1.5	0.0	12.0	1.5	11.0	0.0	0.1	0.0	1.3	0.2	0.0	0.0	0.0	0.0	8.2	0.0	20.1	5.0	0.4	0.0	4.2	0.4	1.3	0.2	6.2	4.7	1.9	0.8	9.5	3.9	0.0	2.2	0.3	6.0	7.3	1.3	0.2	0.3	0.3	0.2	0.5	0.1	2.0	0.3	12.9	0.2	3.0	1.4	5.2	6.2	6.3	0.0	0.8	0.0	1.4	2.3	50.6	0.0	14.4	132.6	0.8	0.6	5.6	0.0	0.0	0.2	23.9	18.1	7.9	20.7	0.0	6.8	0.0	2.4	21.5	12.6	0.9	0.0	11.9	11.8	6.4	1.3	0.0	0.1	1.1	0.0	17.2	0.0	0.0	30.9	1.7	6.8	5.0	20.8	27.4	0.7	21.3
HOXB3	"HOX2, HOX2G"	ENSG00000120093	"Homeobox B3"	P14651	17	48548870-48604912	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 56.7;epididymis: 44.9;seminal vesicle: 68.4"	"Group enriched"	"Detected in many"	5	"Collecting duct cells: 94.2;Early spermatids: 27.9;Ito cells: 27.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 20.7;EFO-21: 18.1;HEK 293: 21.9;RPTEC TERT1: 17.0;U-251 MG: 19.5"	"Region enriched"	"Detected in single"	40	"pons and medulla: 9.3"	"Region enriched"	"Detected in single"	29	"pons and medulla: 12.9"	"CAB009860, HPA064990"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB009860: AB_2119262, HPA064990: AB_2685398"	"unprognostic (5.88e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.61e-2)"	"unprognostic (7.04e-2)"	"unprognostic (8.39e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.88e-2)"	"unprognostic (3.09e-2)"	"unprognostic (4.32e-3)"	"unprognostic (8.14e-2)"	"unprognostic (8.27e-2)"	"unprognostic (3.17e-1)"	"unprognostic (7.60e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.32e-1)"	"prognostic favorable (8.45e-6)"	8.3	4.5	1.0	7.3	1.1	0.2	8.0	1.0	1.0	11.3	16.4	1.0	56.7	2.3	10.1	44.9	5.5	17.7	3.6	1.7	1.0	0.0	16.3	1.6	4.8	1.6	1.0	1.0	2.8	1.7	6.7	1.0	3.8	2.6	4.1	4.9	1.0	1.0	68.4	4.0	2.9	11.3	3.5	4.8	6.5	7.8	3.7	1.0	1.0	1.8	1.0	1.1	6.4	5.2	0.1	2.8	1.7	0.9	1.4	1.1	0.4	3.3	7.0	4.7	2.2	3.9	5.5	1.2	0.1	0.0	0.1	0.1	3.2	20.7	1.7	18.1	14.8	2.3	0.1	1.0	0.3	0.0	5.3	21.9	5.1	3.1	0.0	6.4	0.0	13.6	6.4	0.0	6.1	0.4	2.8	6.4	6.7	6.9	0.1	3.8	0.1	0.3	0.1	0.1	6.7	0.7	0.0	3.4	0.7	17.0	3.1	0.0	0.0	0.7	0.0	3.3	3.8	6.6	1.4	7.2	2.2	7.1	1.2	19.5	1.8	2.1	0.1	4.6	0.0	3.8	1.7	0.1	0.0	0.9	0.1	0.4	0.0	0.5	1.1	0.3	0.1	0.8	1.0	0.0	1.4	0.9	2.8	1.1	0.4	1.0	1.1	1.0	1.0	1.0	0.0	1.0	1.0	2.6	1.0	0.0	3.4	0.0	2.3	2.3	0.0	0.8	0.0	0.0	1.2	94.2	0.0	2.5	6.6	0.2	27.9	7.7	7.4	0.0	0.0	0.7	5.1	3.6	8.1	0.2	0.6	0.0	2.4	27.6	2.1	7.9	0.3	1.0	5.0	0.0	6.3	0.0	0.4	3.5	0.4	0.6	0.0	0.0	3.3	4.5	9.2	1.3	0.3	1.3	9.7	4.7
HOXB4	"HOX2, HOX2F"	ENSG00000182742	"Homeobox B4"	P17483	17	48575513-48580111	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 13.3"	"Cell type enhanced"	"Detected in many"	15	"Collecting duct cells: 61.1;Cytotrophoblasts: 18.4;Spermatogonia: 21.8"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 2.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"EFO-21: 23.4;HEK 293: 11.3;HMC-1: 14.4;K-562: 11.4"	"Region enriched"	"Detected in single"	36	"pons and medulla: 3.7"	"Region enriched"	"Detected in single"	23	"pons and medulla: 7.5"	HPA057432	Uncertain		Supported	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA057432: AB_2683437"	"unprognostic (2.71e-2)"	"unprognostic (3.87e-2)"	"unprognostic (8.97e-3)"	"unprognostic (5.39e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavorable (2.23e-4)"	"unprognostic (3.22e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.10e-1)"	"unprognostic (4.85e-2)"	"unprognostic (9.25e-3)"	"unprognostic (3.41e-3)"	4.4	2.4	0.0	1.5	0.0	0.0	2.9	0.0	0.0	4.2	8.1			1.2	2.3	13.3	2.7	8.5	1.5	0.4	0.0	0.0	5.7	0.7	3.6	0.6	0.0		0.0	0.7	1.8	0.0	1.0		0.6	1.1		0.0	4.8	0.8	0.9	4.3	2.0	2.4	3.0	3.9	0.5			0.6		0.2	1.3	1.7	0.3	2.4	0.0	0.1	0.6	0.7	0.1	0.1	0.3	0.0	0.1	4.9	3.9	1.9	0.0	0.0	0.2	0.1	2.2	2.0	3.1	23.4	1.5	0.4	0.1	4.1	0.0	0.0	8.0	11.3	7.6	0.7	0.0	5.0	0.0	14.4	3.8	0.0	5.7	0.0	0.8	6.6	5.2	11.4	0.2	5.6	0.0	1.8	0.0	0.0	2.1	0.0	0.0	4.4	1.6	4.6	1.9	0.0	0.0	0.6	0.0	2.9	1.6	0.4	1.5	2.5	0.3	0.2	0.8	0.2	1.9	4.0	0.7	1.6	0.0	2.2	0.0	0.1	0.0	0.7	0.0	0.1	0.3	0.2	0.5	0.0	0.1	0.2	0.1	0.0	0.6	0.0	2.4	0.0	0.1											0.0	0.0	1.7	0.9	3.4	0.0	0.8	0.0	1.4	0.0	61.1	0.0	18.4	10.0	0.1	0.0	7.1	0.8	0.0	0.0	11.0	9.7	0.4	3.5	0.0	3.2	0.0	0.0	15.4	1.8	0.0	0.3	1.9	5.0	0.0	2.0	0.0	0.0	1.9	0.0	1.4	0.0	0.0	5.2	0.2	21.8	1.6	5.0	10.5	1.5	2.6
HOXB5	"HOX2, HOX2A"	ENSG00000120075	"Homeobox B5"	P09067	17	48591257-48593961	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.4;ductus deferens: 25.9;seminal vesicle: 27.6"	"Cell type enhanced"	"Detected in some"	16	"Collecting duct cells: 50.6;Distal tubular cells: 21.6;Mucus-secreting cells: 13.9"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 28.1"	"Region enriched"	"Detected in single"	33	"pons and medulla: 25.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 21.5;RPTEC TERT1: 16.1"	"Region enriched"	"Detected in single"	90	"pons and medulla: 24.0"	"Region enriched"	"Detected in single"	128	"pons and medulla: 14.7"	"HPA043851, HPA074454"			Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center, Cytosol"	"HPA043851: AB_2732509, HPA074454: AB_2686690"	"unprognostic (6.50e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.22e-2)"	"prognostic favorable (6.28e-4)"	"unprognostic (6.48e-3)"	"unprognostic (7.12e-2)"	"unprognostic (8.14e-2)"	"prognostic unfavorable (4.61e-4)"	"unprognostic (2.47e-1)"	"unprognostic (1.47e-3)"	"unprognostic (5.10e-2)"	"unprognostic (9.64e-2)"	"unprognostic (7.61e-3)"	"unprognostic (8.08e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.86e-2)"	"prognostic favorable (8.59e-5)"	3.4	3.1	0.2	2.1	0.2	0.0	5.0	0.2	0.7	5.4	10.5	0.2	25.9	1.5	2.2	18.5	0.6	7.2	0.2	0.7	0.2	0.0	16.0	0.4	5.2	0.8	0.2	0.2	1.9	0.5	0.9	0.2	1.2	25.4	1.3	4.7	0.2	0.6	27.6	0.2	0.5	9.5	1.6	22.5	2.0	4.3	0.7	0.2	0.2	0.7	0.2	0.2	3.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	4.8	0.0	2.5	2.4	2.7	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	5.2	2.7	0.6	0.0	0.2	0.0	0.0	0.0	21.5	0.9	5.6	0.0	4.2	0.0	1.2	1.4	0.0	2.9	0.0	0.8	1.4	0.1	1.6	0.0	3.3	0.0	0.0	0.0	0.0	2.7	1.7	0.0	1.0	0.0	16.1	1.6	0.0	0.0	0.1	0.0	2.3	0.1	0.4	0.0	5.3	0.7	2.1	0.5	0.3	0.0	0.0	0.0	0.1	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.7	0.2	0.0	0.2	0.2	25.4	0.2	0.0	0.6	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	50.6	0.0	0.0	21.6	0.0	0.6	2.4	8.9	0.0	0.0	0.0	3.7	0.1	0.0	0.0	0.5	0.0	4.1	9.2	5.0	0.0	0.0	0.0	1.7	0.0	13.9	0.0	0.0	3.5	0.4	0.4	0.0	0.0	1.0	7.2	10.8	0.3	0.0	0.0	11.5	0.0
HOXB6	"HOX2, HOX2B"	ENSG00000108511	"Homeobox B6"	P17509	17	48595751-48604992	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 73.7;seminal vesicle: 56.7"	"Group enriched"	"Detected in many"	8	"Collecting duct cells: 129.1;Distal tubular cells: 96.2"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 32.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 1.5"	"Group enriched"	"Detected in many"	6	"B-cells: 1.5;T-cells: 1.0"	"Cell line enhanced"	"Detected in many"		"EFO-21: 13.4;HEK 293: 36.8;RPTEC TERT1: 25.0;TIME: 13.9"	"Region enriched"	"Detected in single"	60	"pons and medulla: 10.6"	"Region enriched"	"Detected in single"	25	"pons and medulla: 14.6"	HPA042063			Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA042063: AB_10796470"	"unprognostic (5.01e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.99e-1)"	"prognostic favorable (2.46e-4)"	"unprognostic (1.30e-1)"	"unprognostic (8.80e-3)"	"unprognostic (5.64e-2)"	"unprognostic (2.06e-3)"	"unprognostic (3.97e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.97e-2)"	"unprognostic (6.64e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.53e-3)"	"unprognostic (5.76e-2)"	"unprognostic (7.11e-2)"	"unprognostic (4.19e-3)"	5.2	4.3	0.3	18.1	0.3	0.0	3.8	0.3	0.3	12.0	8.5	0.3	73.7	0.5	7.2	30.5	0.4	8.7	0.3	0.3	0.3	0.0	26.6	0.4	3.4	0.3	0.3	0.3	0.6	0.6	1.9	0.3	1.5	0.9	4.3	3.8	0.3	0.3	56.7	1.0	0.6	8.2	1.8	10.0	1.7	5.9	1.8	0.3	0.3	0.3	0.3	0.3	4.2	10.0	1.5	0.2	0.0	0.0	0.0	1.0	0.3	2.3	5.5	0.0	2.9	2.5	2.7	0.0	0.0	0.0	0.0	0.0	2.9	3.6	0.0	13.4	6.5	0.9	0.0	0.6	0.2	0.0	0.1	36.8	3.2	9.1	0.0	3.8	0.2	8.6	3.3	0.1	5.3	0.1	2.0	2.5	0.2	2.1	0.0	7.3	0.1	0.0	0.1	0.0	9.1	2.2	0.0	6.2	0.3	25.0	1.2	0.0	0.0	2.0	0.0	3.6	0.0	0.9	1.2	13.9	0.5	2.9	2.3	10.1	0.0	0.0	0.0	0.4	0.0	4.5	0.0	0.0	0.0	0.7	0.0	0.2	1.4	0.4	1.0	0.2	1.5	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.9	0.3	0.0	0.0	0.0	0.4	0.7	0.0	0.2	0.0	0.0	0.0	129.1	0.0	0.2	96.2	0.1	0.6	2.2	14.0	0.0	1.6	1.6	2.6	0.3	0.0	0.0	1.4	0.0	7.5	4.9	14.7	0.0	0.9	1.7	0.0	0.0	7.5	0.0	0.9	14.1	0.0	2.1	0.0	0.0	2.1	4.2	6.8	1.0	0.2	1.0	10.3	0.6
HOXB7	"HOX2, HOX2C"	ENSG00000260027	"Homeobox B7"	P09629	17	48607227-48633572	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 62.3"	"Cell type enhanced"	"Detected in many"	9	"Collecting duct cells: 82.0;Distal tubular cells: 126.0;Enterocytes: 102.1;Mucus-secreting cells: 73.3;Paneth cells: 56.1;Undifferentiated cells: 65.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	6	"pons and medulla: 4.1"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 30.4;OE19: 26.5;RPTEC TERT1: 24.2;SK-MEL-30: 28.8"	"Region enriched"	"Detected in single"	45	"pons and medulla: 6.0"	"Region enriched"	"Detected in single"	14	"pons and medulla: 1.5"	HPA049940	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA049940: AB_2616461"	"unprognostic (6.76e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.39e-3)"	"unprognostic (1.42e-2)"	"unprognostic (1.69e-2)"	"unprognostic (8.05e-3)"	"unprognostic (9.16e-2)"	"unprognostic (9.91e-2)"	"unprognostic (7.01e-3)"	"unprognostic (7.81e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.41e-1)"	"prognostic favorable (2.39e-4)"	8.3	8.3	0.0	7.3	0.3	0.1	17.2	0.1	0.6	10.0	8.1	0.1	24.1	0.5	4.1	62.3	0.8	4.2	0.3	1.1	0.0	0.0	23.7	0.8	1.7	2.4	0.1	0.3	2.3	0.6	0.4	0.5	4.1	4.1	5.2	7.0	0.1	0.1	22.1	2.4	2.2	12.4	3.5	20.1	2.2	4.6	3.0	0.2	0.1	0.5	0.1	0.6	5.8	15.1	2.2	1.8	0.0	0.0	2.0	4.7	0.5	16.9	7.4	0.0	0.1	5.3	8.0	0.0	0.0	0.0	0.1	0.3	11.3	0.3	0.3	30.4	7.1	8.8	2.5	0.0	0.0	0.0	7.8	5.5	2.6	5.8	0.0	4.4	0.0	5.5	5.2	2.3	5.2	0.0	1.3	16.0	5.3	2.8	0.1	16.8	4.4	0.3	0.1	0.0	26.5	0.0	0.0	14.4	1.9	24.2	5.7	0.0	0.0	5.7	0.0	28.8	0.4	1.4	1.6	13.7	0.0	9.3	7.5	13.1	0.9	2.2	0.0	0.1	0.0	21.3	0.0	0.0	0.0	3.8	0.0	1.9	1.9	0.7	2.1	0.0	2.2	0.0	1.4	0.0	2.0	0.0	1.8	4.7	0.5	0.0	0.3	0.1	0.6	0.0	0.0	0.1	0.3	4.1	0.2	0.0	0.0	3.7	0.8	4.8	0.0	0.3	0.0	0.0	0.0	82.0	0.0	6.2	126.0	0.0	0.1	2.2	102.1	0.0	1.1	14.9	8.2	0.7	4.7	0.0	8.8	0.0	35.1	1.3	7.8	0.0	0.6	2.8	23.6	2.8	73.3	0.0	0.5	56.1	0.0	27.8	0.0	0.0	8.0	1.4	23.4	1.8	1.5	1.0	65.0	3.1
HOXB8	"HOX2, HOX2D"	ENSG00000120068	"Homeobox B8"	P17481	17	48611377-48614939	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 49.3;ductus deferens: 45.4;epididymis: 39.2;kidney: 16.1;seminal vesicle: 34.6"	"Group enriched"	"Detected in some"	7	"Collecting duct cells: 83.7;Distal tubular cells: 61.3;Intestinal endocrine cells: 42.3"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 33.3"	"Region enriched"	"Detected in single"	82	"pons and medulla: 8.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 20.9;HDLM-2: 9.4;HEK 293: 21.6;LHCN-M2: 11.0;RPTEC TERT1: 23.0"	"Region enriched"	"Detected in single"	48	"pons and medulla: 6.8"	"Low region specificity"	"Detected in many"			HPA075905			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA075905: AB_2686767"	"unprognostic (4.44e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.94e-2)"	"unprognostic (9.07e-5)"	"unprognostic (6.63e-3)"	"unprognostic (1.40e-3)"	"unprognostic (6.00e-2)"	"unprognostic (5.66e-3)"	"unprognostic (2.93e-2)"	"unprognostic (1.14e-2)"	"prognostic favorable (1.30e-7)"	"unprognostic (1.77e-2)"	"unprognostic (6.64e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.88e-3)"	3.5	4.3	0.0	1.6	0.0	0.0	2.5	0.0	0.0	7.7	2.1	0.0	45.4	0.0	2.1	39.2	0.0	0.9	0.0	0.0	0.0	0.0	16.1	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.4	0.2	0.2	8.2	1.9	0.8	0.0	0.1	34.6	0.2	0.4	4.0	1.1	49.3	0.0	4.3	2.8	0.0	0.1	0.1	0.0	0.0	5.0	6.7	0.0	0.0	0.0	0.1	0.0	0.6	0.0	1.1	3.3	0.0	0.4	0.4	0.6	0.4	0.0	0.0	0.0	0.0	0.1	0.4	0.0	20.9	3.3	0.4	0.0	0.0	0.0	0.0	9.4	21.6	0.5	0.0	0.0	0.2	0.0	3.1	0.6	0.0	0.0	0.0	0.4	1.4	0.1	6.2	0.0	11.0	0.0	0.0	0.2	0.0	7.0	0.0	0.0	2.1	0.0	23.0	0.6	0.0	0.0	0.3	0.0	3.1	0.0	0.2	0.0	5.2	0.0	0.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.3	0.0	0.0	0.0	83.7	0.0	0.0	61.3	0.0	0.1	0.5	1.3	0.0	0.0	0.7	0.4	0.2	0.0	0.0	0.2	0.0	42.3	0.0	0.0	0.2	0.3	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.4	4.3	0.0	0.0	0.3	0.5	9.6	0.0	0.0	0.0	4.1	0.0
HOXC4	"HOX3, HOX3E"	ENSG00000198353	"Homeobox C4"	P09017	12	54016931-54056030	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.7;ovary: 31.6"	"Cell type enhanced"	"Detected in some"	12	"Early spermatids: 3.5;Leydig cells: 2.8;Proximal tubular cells: 2.4;Sertoli cells: 6.5;Spermatocytes: 2.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	27	"pons and medulla: 29.7"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 14.1;HDLM-2: 18.1;HEK 293: 19.9;SH-SY5Y: 16.9"	"Region enriched"	"Detected in single"	24	"pons and medulla: 9.9"	"Region enriched"	"Detected in single"	13	"pons and medulla: 3.7"	HPA053910			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA053910: AB_2682305"	"unprognostic (2.78e-2)"	"unprognostic (8.51e-2)"	"unprognostic (2.96e-6)"	"unprognostic (3.30e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.63e-3)"	"unprognostic (6.42e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.83e-3)"	"unprognostic (4.37e-2)"	"unprognostic (7.81e-2)"	"unprognostic (8.43e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.11e-4)"	"unprognostic (9.82e-2)"	16.2	4.4	0.7	3.2	0.7	0.0	17.9	0.7	0.7	1.3	2.3	0.6	1.4	0.9	11.5	17.8	6.0	20.9	1.0	1.0	0.7	0.7	15.4	0.8	0.9	3.2	1.1	0.0	31.6	0.7	0.0	0.7	5.8	29.7	2.4	0.0	0.3	0.7	1.3	8.1	4.2	9.2	4.4	10.5	1.2	2.6	8.3	0.9	0.0	1.0	0.0	1.8	2.1	3.4	1.1	0.5	0.0	0.0	0.0	1.1	0.0	3.0	3.1	0.0	14.1	5.9	3.0	0.0	1.4	1.5	1.4	1.0	0.1	2.6	12.2	0.1	10.7	0.0	2.7	0.2	0.3	0.9	18.1	19.9	0.1	1.4	0.0	0.7	1.4	0.4	7.8	1.4	8.5	1.4	0.0	0.2	4.0	0.6	0.0	5.4	0.1	1.7	0.3	0.1	0.5	0.0	3.9	4.5	0.0	6.1	0.0	0.0	16.9	2.2	0.7	7.9	0.7	10.6	0.7	0.0	7.4	4.2	0.6	7.5	3.2	3.5	6.3	0.4	1.3	7.7	0.0	0.0	0.0	0.8	0.0	0.8	1.1	0.0	0.8	0.0	0.7	0.0	1.1	0.0	0.0	0.0	0.5	0.6	0.0	0.7	0.7	0.7	0.7	0.7	0.7	1.1	0.0	29.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	3.5	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.2	1.8	2.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	2.4	0.0	6.5	0.0	2.8	0.4	0.0	0.2	0.7	0.0	0.0
HOXC5	"HOX3, HOX3D"	ENSG00000172789	"Homeobox C5"	Q00444	12	54032853-54035358	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 8.8;ovary: 13.4"	"Cell type enhanced"	"Detected in some"	8	"Collecting duct cells: 1.8;Distal tubular cells: 1.7;Fibroblasts: 2.4;Leydig cells: 2.3;Peritubular cells: 2.5;Smooth muscle cells: 2.1;Spermatocytes: 3.2"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.7"	"Region enriched"	"Detected in single"	14	"pons and medulla: 8.8"	"Group enriched"	"Detected in some"	5	"gdT-cell: 5.9;naive CD8 T-cell: 1.9"	"Lineage enriched"	"Detected in single"	59	"T-cells: 5.9"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 8.5;ASC diff: 5.1;ASC TERT1: 6.2;HSkMC: 5.8;SH-SY5Y: 9.3"	"Region enriched"	"Detected in single"	40	"pons and medulla: 4.8"	"Region enriched"	"Detected in single"	7	"pons and medulla: 1.0"	HPA026794	Uncertain		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"HPA026794: AB_10612118"	"unprognostic (1.57e-1)"	"unprognostic (7.73e-3)"		"unprognostic (1.70e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.16e-3)"		"unprognostic (2.87e-3)"	"unprognostic (6.89e-2)"	"unprognostic (9.53e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.69e-2)"	"unprognostic (2.01e-3)"	"unprognostic (1.17e-2)"	"unprognostic (7.53e-3)"	"unprognostic (2.19e-3)"	"unprognostic (1.08e-2)"	1.8	1.6	0.2	1.0	0.2	0.0	1.8	0.2	0.6	0.2	1.6	0.2	0.2	0.3	0.5	5.3	1.7	8.0	1.5	0.2	0.2	0.0	1.5	0.2	0.2	0.3	0.4	0.2	13.4	0.2	0.0	0.2	1.4	8.8	0.2	0.0	0.8	0.2	0.2	4.2	2.1	4.6	2.5	2.6	0.2	3.9	2.4	0.2	0.2	0.4	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	5.9	0.3	0.9	2.2	0.0	8.5	5.1	6.2	0.0	0.5	0.4	1.0	0.7	3.6	0.5	0.0	0.6	2.5	0.0	1.4	0.2	0.0	0.3	2.7	3.0	0.0	1.0	0.1	0.2	0.0	0.1	5.8	0.6	4.1	0.4	0.0	0.0	0.0	0.0	0.0	1.8	1.3	0.0	0.1	0.0	1.5	0.3	0.0	0.0	0.0	1.2	0.0	0.0	9.3	0.6	0.2	4.4	1.2	1.7	0.1	0.0	1.5	0.9	3.2	0.3	0.0	0.0	0.0	0.2	0.2	3.2	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.2	0.6	0.2	0.0	0.4	0.2	8.8	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	1.7	0.0	0.2	0.0	0.0	0.0	0.2	0.1	2.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.9	0.0	0.0	2.1	3.2	0.6	0.6	0.2	0.0	0.0	0.0
HOXC6	"HOX3, HOX3C"	ENSG00000197757	"Homeobox C6"	P09630	12	53990624-54030823	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 31.2"	"Cell type enhanced"	"Detected in many"	12	"Distal tubular cells: 14.9;Fibroblasts: 27.4;Leydig cells: 20.8;Peritubular cells: 14.2;Spermatocytes: 39.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	17	"pons and medulla: 7.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 38.1;fHDF/TERT166: 19.0;HDLM-2: 31.8"	"Region enriched"	"Detected in single"	23	"pons and medulla: 1.5"	"Not detected"	"Not detected"			HPA054981			Supported	Nucleoplasm,Cytosol		No	No			Nucleoplasm	Cytosol	"HPA054981: AB_2682662"	"unprognostic (3.54e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.68e-6)"	"unprognostic (3.92e-2)"	"unprognostic (1.10e-3)"	"unprognostic (5.01e-4)"	"unprognostic (5.52e-3)"	"unprognostic (3.32e-3)"	"unprognostic (2.81e-1)"	"unprognostic (6.26e-2)"	"unprognostic (8.82e-2)"	"unprognostic (3.70e-3)"	"prognostic unfavorable (3.55e-6)"	"unprognostic (8.63e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.71e-2)"	10.9	11.2	0.4	1.2	0.4	0.0	16.3	0.4	0.4	0.7	1.9	0.6	0.4	0.0	3.9	14.8	3.1	13.5	0.4	2.0	0.4	0.0	11.3	0.4	0.9	3.0	0.4	0.4	31.2	0.4	0.0	0.4	4.0	7.0	0.8	0.0	0.4	0.4	0.4	11.0	7.6	8.8	6.1	8.1	1.0	0.3	3.3	0.4	0.4	0.6	0.8	0.4	0.7	2.5	0.0	0.0	0.1	0.0	0.0	0.5	0.0	2.5	1.8	0.0	38.1	13.9	13.3	0.4	1.9	1.9	3.1	2.9	1.6	2.9	1.1	2.5	19.0	0.9	4.3	1.5	0.2	2.8	31.8	11.0	2.0	4.9	0.0	1.5	0.2	4.8	12.6	2.0	6.2	2.2	0.0	0.1	0.1	1.3	0.0	11.0	0.6	0.0	1.2	0.0	0.3	1.6	0.0	1.4	0.0	9.6	0.1	0.0	4.7	2.9	2.8	7.8	3.4	6.7	0.5	0.0	4.0	8.6	4.3	2.7	0.3	0.3	0.0	1.4	0.3	8.1	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	7.0	0.4	0.0	0.0	0.0	0.0	5.6	0.0	0.3	0.0	0.0	0.0	3.5	0.0	0.3	14.9	0.0	1.1	0.2	0.0	0.0	0.0	2.5	27.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	20.8	0.4	11.8	0.0	0.0	0.2	0.0	0.0	14.2	7.8	1.9	6.5	5.0	39.3	1.1	3.4	0.2	0.0	0.0	0.0
HOXD1	"HOX4, HOX4G"	ENSG00000128645	"Homeobox D1"	Q9GZZ0	2	176188579-176190907	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.9;epididymis: 14.1;seminal vesicle: 20.4"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 2: 21.0;Distal tubular cells: 21.6;Enterocytes: 18.8;Mucus-secreting cells: 16.6;Undifferentiated cells: 20.6"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 6.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 5.9;Hep G2: 6.0;RPTEC TERT1: 18.8;RT4: 14.4;SCLC-21H: 5.0"	"Region enriched"	"Detected in single"	5	"pons and medulla: 1.2"	"Low region specificity"	"Detected in many"			"HPA040062, HPA056900"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA040062: AB_2676826, HPA056900: AB_2683270"	"unprognostic (8.78e-2)"	"unprognostic (9.97e-2)"	"unprognostic (7.11e-3)"	"unprognostic (1.06e-3)"	"unprognostic (2.70e-1)"	"unprognostic (3.19e-2)"	"unprognostic (7.33e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.44e-1)"	"unprognostic (9.64e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.54e-5)"	"unprognostic (4.33e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.32e-1)"	2.4	0.6	1.5	1.1	3.5	0.3	2.0	0.6	3.9	0.5	5.2	18.8	11.8	0.7	0.8	14.1	0.9	8.8	1.4	0.3	4.1	2.2	6.8	0.2	5.7	0.9	9.8	1.3	1.2	0.5	0.2	0.2	0.3	15.5	1.7	3.7	0.3	1.0	20.4	0.3	1.2	4.4	0.9	18.9	1.5	0.7	2.2	6.3	0.0	0.4	0.0	0.5	4.6	1.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	5.9	0.3	0.5	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.0	6.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	18.8	14.4	5.0	0.9	0.0	0.0	0.9	0.8	0.0	0.0	3.3	0.0	0.2	0.7	0.3	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	3.5	0.6	3.2	4.1	2.2	9.8	1.3	15.5	6.3	3.0	21.0	0.0	0.2	3.8	0.0	0.0	0.0	0.0	4.5	7.0	0.0	0.0	21.6	0.0	0.0	2.9	18.8	0.0	0.0	0.0	0.1	0.5	2.3	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	3.3	0.0	16.6	0.0	0.1	11.5	0.4	2.9	0.0	0.0	0.1	2.6	6.4	2.3	0.0	0.0	20.6	1.8
HOXD3	"HOX1D, HOX4, HOX4A"	ENSG00000128652	"Homeobox D3"	P31249	2	176136612-176173102	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 25.9;epididymis: 36.4;seminal vesicle: 22.6"	"Group enriched"	"Detected in some"	5	"Collecting duct cells: 8.7;Distal tubular cells: 13.3;Early spermatids: 12.5;Leydig cells: 3.7;Peritubular cells: 4.2"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 1.2"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 8.0;HSkMC: 9.5;RPTEC TERT1: 9.9;SCLC-21H: 14.2;SH-SY5Y: 9.5;SK-MEL-30: 3.9"	"Region enriched"	"Detected in single"	36	"pons and medulla: 3.8"	"Region enriched"	"Detected in single"	32	"pons and medulla: 6.7"	"HPA051831, HPA063671"			Supported	"Nucleoplasm,Nuclear bodies"		No	NA			Nucleoplasm	"Nuclear bodies"	"HPA051831: , HPA063671: AB_2685083"	"unprognostic (1.13e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.52e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.54e-2)"	"unprognostic (9.56e-2)"	"unprognostic (5.57e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.57e-4)"	"unprognostic (1.47e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.44e-1)"	"unprognostic (7.44e-2)"	6.2	1.1	0.4	3.2	0.4	0.2	19.6	0.2	0.2	8.7	3.6	0.0	22.5	0.3	25.9	36.4	1.1	4.8	2.0	0.4	0.8	0.5	8.5	0.2	0.3	0.8	1.5	0.0	7.0	0.3	0.2	0.2	0.2	0.5	2.1	0.4	0.0	0.6	22.6	0.7	0.7	0.4	4.0	7.2	1.9	0.3	3.6	0.0	0.0	0.4	0.2	0.3	1.7	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.9	0.1	0.0	0.1	0.0	0.0	0.1	1.5	0.0	0.0	0.1	0.0	0.0	0.0	9.5	0.8	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	9.9	0.5	14.2	9.5	0.1	0.1	3.9	0.2	0.0	0.0	0.6	0.0	0.2	0.7	0.4	0.0	0.1	0.0	0.3	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.2	0.2	0.8	0.5	1.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	13.3	0.0	12.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.1	3.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.2	1.6	0.0	0.0	0.3	0.7	0.5	1.1	0.0	0.0	0.5	0.0
HOXD8	"HOX4, HOX4E"	ENSG00000175879	"Homeobox D8"	P13378	2	176129694-176132695	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 37.6;epididymis: 42.6"	"Cell type enhanced"	"Detected in many"	15	"Collecting duct cells: 57.6;Distal tubular cells: 180.8;Early spermatids: 75.5;Peritubular cells: 50.5;Spermatocytes: 62.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 21.6;RPTEC TERT1: 35.3;TIME: 15.4"	"Region enriched"	"Detected in single"	15	"pons and medulla: 0.6"	"Not detected"	"Not detected"									NA	NA						"unprognostic (1.22e-1)"	"unprognostic (6.31e-2)"	"unprognostic (2.19e-3)"	"unprognostic (2.68e-2)"	"unprognostic (3.35e-1)"	"unprognostic (3.49e-1)"	"unprognostic (2.56e-3)"	"prognostic unfavorable (3.78e-4)"	"unprognostic (2.79e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.93e-1)"	"unprognostic (3.05e-1)"	"unprognostic (3.63e-2)"	"unprognostic (4.80e-2)"	"unprognostic (5.21e-2)"	"unprognostic (8.31e-2)"	"unprognostic (2.80e-2)"	11.1	9.1	0.3	2.4	0.3	0.0	9.8	0.2	0.4	10.3	5.9	0.4	37.6	0.3	12.6	42.6	2.0	7.7	2.5	2.6	0.3	0.0	32.8	0.2	0.7	1.9	0.2	0.2	16.9	1.7	0.2	0.2	1.4	1.2	5.6	1.8	0.3	0.8	27.5	6.9	2.4	4.2	5.3	11.5	9.1	0.8	21.0	0.2	0.3	2.9	2.3	0.9	5.3	10.8	0.2	0.0	0.0	0.0	0.0	0.2	0.0	6.4	1.0	0.0	0.0	4.3	6.8	0.1	0.8	3.4	1.0	0.1	0.0	0.0	0.0	8.3	4.9	0.8	0.0	2.2	0.2	2.6	0.0	3.2	1.0	0.3	0.0	1.4	0.6	0.4	11.9	21.6	0.1	3.3	0.0	10.7	2.0	0.1	0.0	1.7	0.0	0.0	0.1	0.1	0.0	1.2	0.0	2.3	0.0	35.3	4.4	6.9	13.0	2.0	0.0	12.8	0.6	0.0	0.0	15.4	0.6	4.4	7.3	4.3	0.0	0.0	0.0	10.3	0.0	12.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.4	0.3	0.0	0.2	0.2	1.2	0.2	0.0	0.6	0.0	2.2	2.4	0.0	2.0	0.0	1.4	0.0	57.6	0.0	0.0	180.8	0.0	75.5	29.8	0.9	0.0	0.0	0.0	9.7	1.5	0.0	0.0	0.1	0.0	4.6	0.6	0.0	19.6	47.5	0.0	10.1	0.0	1.3	0.0	0.0	0.0	50.5	16.1	0.0	32.3	3.3	62.8	9.6	2.5	0.1	0.0	4.1	0.5
HPD	"4-HPPD, 4HPPD, GLOD3, PPD"	ENSG00000158104	"4-hydroxyphenylpyruvate dioxygenase"	P32754	12	121839527-121863596	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	"Dioxygenase, Oxidoreductase"	"Disease mutation, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 267.5"	"Group enriched"	"Detected in some"	9	"Hepatocytes: 1077.2;Proximal tubular cells: 1892.6"	"Cancer enriched"	"Detected in many"	100	"liver cancer: 540.9"	"Region enriched"	"Detected in single"	29	"pons and medulla: 13.7"	"Group enriched"	"Detected in many"	4	"eosinophil: 9.8;neutrophil: 4.8;plasmacytoid DC: 5.0"	"Group enriched"	"Detected in many"	5	"dendritic cells: 5.0;granulocytes: 9.8"	"Cell line enriched"	"Detected in some"	30	"Hep G2: 107.2"	"Region enriched"	"Detected in single"	8	"amygdala: 0.4"	"Not detected"	"Not detected"			"HPA038321, HPA038322"	Enhanced		Uncertain	"Nuclear speckles"		NA	NA		23000000	"Nuclear speckles"		"HPA038321: AB_2675957, HPA038322: AB_10670778"	"unprognostic (3.01e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.81e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.10e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.13e-2)"	"unprognostic (8.84e-2)"	"unprognostic (5.58e-2)"	"unprognostic (6.14e-3)"	"unprognostic (9.72e-3)"	"unprognostic (8.61e-3)"	"unprognostic (7.16e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.12e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.34e-1)"	0.1	0.5	0.0	0.1	0.1	0.0	0.4	0.1	0.3	0.2	0.1	2.1	0.3	0.0	0.3	0.4	0.1	0.7	0.2	0.3	0.4	0.0	51.3	267.5	0.2	0.4	0.1	0.0	0.7	0.7	0.0	0.1	0.0	13.7	0.5	0.0	3.8	0.0	0.8	0.2	0.0	0.1	0.4	0.2	0.2	0.1	0.8	0.1	0.0	0.1	0.1	0.1	0.6	0.2	0.1	5.0	9.8	1.4	0.0	0.3	0.3	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.1	107.2	2.5	0.3	3.5	0.8	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.2	0.2	0.0	0.1	2.1	0.0	0.0	0.0	0.3	0.1	0.0	0.3	0.0	0.0	0.3	0.0	0.0	1.5	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.8	9.8	0.0	1.0	0.1	0.1	0.1	0.1	1.3	0.1	0.3	0.2	4.8	0.0	1.4	5.0	0.0	0.3	0.0	0.1	0.1	0.3	0.4	0.0	0.1	0.0	13.7	0.1	0.0	0.0	18.3	0.0	0.0	0.0	0.3	48.4	0.0	0.0	87.2	0.0	0.6	164.2	0.3	33.1	0.0	0.0	0.0	14.8	0.2	0.0	0.0	0.0	1077.2	0.3	0.0	0.0	33.2	23.4	97.3	2.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.9	1892.6	0.0	0.0	0.0	1.7	1.1	0.0	0.9	0.0	0.0	0.0
HTR1B	"5-HT1B, 5-HT1DB, HTR1D2, S12"	ENSG00000135312	"5-hydroxytryptamine receptor 1B"	P28222	6	77461753-77463773	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	Behavior	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 11.8;placenta: 14.2;stomach 1: 10.2"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"basal ganglia: 11.8"	"Cell type enriched"	"Detected in single"	17	"basophil: 1.6"	"Lineage enriched"	"Detected in single"	17	"granulocytes: 1.6"	"Group enriched"	"Detected in some"	15	"HUVEC TERT2: 41.8;TIME: 18.4"	"Region enriched"	"Detected in many"	4	"basal ganglia: 34.5"					HPA028808	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA028808: AB_2672782"	"unprognostic (3.86e-2)"	"unprognostic (3.56e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.11e-1)"	"unprognostic (8.96e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.10e-3)"	"unprognostic (3.08e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.02e-1)"	2.2	1.5	1.3	1.1	11.8	0.3	2.4	0.4	3.7	2.9	0.6	0.1	0.0	0.6	1.1	1.0	1.4	0.8	2.8	0.4	1.0	2.1	0.9	0.3	1.1	0.3	1.2	0.9	1.1	0.5	0.3	0.5	14.2	3.0	1.6	0.4	0.3	1.3	1.2	0.9	0.5	0.4	4.1	0.6	0.4	10.2	1.5	0.6	0.0	0.5	0.0	0.3	2.6	1.4	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.9	1.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.1	0.4	1.1	0.8	41.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	11.8	0.4	3.7	1.0	2.1	1.2	0.9	3.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ICMT	"HSTE14, PCCMT, PPMT"	ENSG00000116237	"Isoprenylcysteine carboxyl methyltransferase"	O60725	1	6221193-6235972	"Enzymes, Plasma proteins, Predicted membrane proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 126.5"	"Low region specificity"	"Detected in all"			"HPA032024, HPA032025"	Uncertain					NA	NA					"HPA032024: AB_2674115, HPA032025: AB_10601819"	"unprognostic (1.95e-3)"	"unprognostic (3.83e-2)"	"unprognostic (7.34e-2)"	"unprognostic (4.40e-2)"	"unprognostic (5.53e-2)"	"unprognostic (9.30e-2)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (2.30e-2)"	"unprognostic (7.05e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.87e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.11e-1)"	"unprognostic (5.27e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.99e-3)"	19.0	20.9	11.2	11.4	22.6	3.2	37.4	20.1	19.8	19.8	16.6	12.9	13.3	17.3	18.0	19.7	19.0	15.1	17.7	28.5	11.5	10.3	23.5	14.5	17.2	13.9	13.9	8.4	8.7	20.2	26.2	24.0	20.3	12.7	16.2	16.0	21.5	15.4	18.2	41.3	16.9	22.8	19.8	11.1	11.3	13.5	9.1	7.8	13.0	18.1	30.3	17.2	15.4	13.6	4.1	6.2	4.1	5.1	4.6	7.4	3.9	12.7	11.9	16.4	16.0	50.4	20.1	7.0	30.8	20.8	18.4	14.0	12.7	10.4	14.0	11.9	24.4	15.8	17.4	18.7	13.1	19.6	27.9	18.1	9.6	17.5	9.7	9.8	15.1	13.7	12.8	8.8	19.2	7.3	12.3	14.2	11.7	9.3	11.1	20.7	8.0	15.1	10.5	11.0	23.2	16.6	12.7	23.1	8.1	22.1	9.4	22.3	10.9	15.1	36.0	13.2	19.1	9.4	12.8	17.6	21.0	8.2	24.5	22.1	10.3	20.1	11.3	10.3	35.0	10.8	4.1	4.2	3.6	7.4	5.1	6.5	2.7	6.0	7.3	3.9	4.1	5.4	4.5	1.8	4.6	4.0	6.2	3.4	3.9	11.2	22.6	20.1	19.8	11.5	10.3	13.9	8.4	12.7	7.8	20.8	8.9	6.0	9.0	5.6	15.7	32.2	20.4	24.1	19.4	27.9	29.5	48.9	11.6	19.2	3.3	13.5	31.1	0.0	19.1	66.8	18.8	11.7	4.7	21.7	25.0	46.1	21.9	21.5	8.6	2.9	19.2	7.9	6.8	10.8	18.3	15.1	21.2	7.0	24.8	31.9	55.6	12.9	15.5	13.4	29.6	9.2	26.8	10.0	19.9	12.3
IDO1	"IDO, INDO"	ENSG00000131203	"Indoleamine 2,3-dioxygenase 1"	P14902	8	39902275-39928444	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Immunity, Tryptophan catabolism"	"Dioxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 77.7;placenta: 33.2"	"Cell type enriched"	"Detected in some"	552	"monocytes: 4555.6"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	17	"eosinophil: 77.7"	"Lineage enriched"	"Detected in many"	17	"granulocytes: 77.7"	"Cell line enriched"	"Detected in some"	7	"EFO-21: 36.6"	"Region enriched"	"Detected in single"	13	"basal ganglia: 30.5"	"Low region specificity"	"Detected in all"			"HPA023072, HPA023149, HPA027772, CAB072820"	Enhanced		Supported	Nucleoplasm,Vesicles,Mitochondria,Cytosol		NA	NA			Cytosol	"Nucleoplasm, Vesicles, Mitochondria"	"CAB072820: , HPA023072: AB_1846220, HPA023149: AB_1846221, HPA027772: AB_1846222"	"unprognostic (1.68e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.08e-3)"	"unprognostic (7.21e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.06e-2)"	"prognostic favorable (5.27e-4)"	"prognostic favorable (3.32e-4)"	"unprognostic (3.59e-2)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (1.12e-7)"	"unprognostic (4.18e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.97e-2)"	8.7	0.2	0.9	11.2	0.9	0.0	1.4	0.9	0.9	4.0	1.5	0.9	0.9	2.6	2.6	0.9	1.2	0.6	1.3	1.0	0.9	0.0	0.9	0.9	16.8	14.1	0.9	0.9	0.9	0.9	0.0	0.9	33.2	0.9	1.6	2.1	1.9	0.9	0.9	2.5	0.3	5.9	0.9	2.0	6.2	2.2	0.9	0.9	0.9	7.2	0.9	8.9	2.3	0.9	0.0	4.6	77.7	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	4.5	2.6	0.1	0.3	0.0	36.6	0.0	1.9	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.2	0.0	0.1	0.0	0.1	0.0	4.5	0.1	77.7	0.0	0.2	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.9	0.9	0.9	0.9	0.9	0.0	0.9	0.9	0.9	0.9	0.0	0.3	0.0	0.0	0.3	0.0	0.2	0.0	0.0	3.4	0.0	0.0	0.0	0.0	2.5	2.6	0.9	0.0	0.0	6.7	0.0	0.2	0.4	0.0	0.0	0.8	0.0	0.0	0.0	8.2	1.3	0.0	6.0	0.0	4555.6	0.0	3.0	0.6	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.4
IL20RB	"DIRS1, FNDC6, IL-20R2, MGC34923"	ENSG00000174564	"Interleukin 20 receptor subunit beta"	Q6UXL0	3	136946230-137011085	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"esophagus: 64.5;skin 1: 61.2"	"Group enriched"	"Detected in some"	7	"Basal keratinocytes: 32.6;Early spermatids: 38.8;Late spermatids: 24.0;Suprabasal keratinocytes: 33.2"	"Group enriched"	"Detected in many"	5	"cervical cancer: 54.5;head and neck cancer: 50.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"hTCEpi: 106.6"	"Region enriched"	"Detected in single"	9	"cerebellum: 0.6"	"Not detected"	"Not detected"			HPA063914			Approved	Vesicles,Cytosol		NA	NA			Vesicles	Cytosol	"HPA063914: AB_2732709"	"unprognostic (1.35e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.43e-4)"	"unprognostic (2.48e-4)"	"unprognostic (2.74e-1)"	"unprognostic (3.31e-1)"	"unprognostic (7.43e-4)"	"unprognostic (4.08e-3)"	"unprognostic (7.64e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (3.57e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.55e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.33e-2)"	"unprognostic (5.57e-2)"	1.6	0.0	0.0	0.1	0.0	0.1	4.6	0.0	0.1	13.2	0.2	0.0	0.0	0.0	1.3	0.3	64.5	0.1	0.1	0.3	0.0	0.0	0.1	2.1	0.2	0.1	0.0	0.0	0.3	0.0	0.1	0.2	2.8	0.0	1.6	0.3	0.4	4.1	0.2	0.4	61.2	0.1	0.1	0.3	0.0	0.1	0.9	0.0	0.5	0.2	22.6	17.1	0.9	19.2	0.1	0.4	0.0	0.3	0.0	0.6	0.0	4.9	0.0	0.0	0.0	3.0	12.9	0.5	0.1	0.3	0.0	0.2	0.4	0.6	0.0	2.8	1.8	0.1	16.0	0.0	26.4	0.1	0.0	0.0	0.0	3.3	0.0	17.8	0.0	0.0	2.2	106.6	0.8	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.5	0.8	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.6	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	32.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.7	38.8	1.0	0.6	0.0	0.2	1.1	0.8	1.1	0.0	0.8	0.3	0.0	0.0	0.0	0.0	24.0	0.3	0.8	3.3	2.8	0.7	0.0	0.8	0.0	0.7	0.1	0.0	0.0	2.3	0.6	1.5	33.2	1.4	0.0	0.5	4.8
IL2RB	"CD122, IL15RB"	ENSG00000100385	"Interleukin 2 receptor subunit beta"	P14784	22	37125838-37175054	"Cancer-related genes, CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"	Receptor	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 51.6;lymphoid tissue: 35.0;placenta: 58.5"	"Group enriched"	"Detected in many"	8	"Extravillous trophoblasts: 80.1;T-cells: 97.0"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"gdT-cell: 14.7;NK-cell: 51.6"	"Group enriched"	"Detected in many"	32	"NK-cells: 51.6;T-cells: 14.7"	"Cell line enriched"	"Detected in some"	8	"HDLM-2: 106.6"	"Region enriched"	"Detected in single"	7	"basal ganglia: 1.6"	"Low region specificity"	"Detected in single"			HPA062657	Enhanced					NA	NA					"HPA062657: AB_2684822"	"unprognostic (3.38e-3)"	"unprognostic (1.21e-2)"	"prognostic favorable (6.76e-4)"	"prognostic favorable (3.18e-5)"	"unprognostic (2.44e-2)"	"unprognostic (9.69e-3)"	"unprognostic (2.60e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.03e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (3.50e-7)"	"unprognostic (4.63e-2)"	"unprognostic (7.96e-2)"	"unprognostic (3.94e-3)"	"unprognostic (2.46e-2)"	2.2	1.0	0.8	20.5	0.8	12.3	1.6	0.6	0.7	1.3	5.5	0.6	1.4	1.8	4.3	2.8	2.6	1.8	5.8	3.7	0.7	0.8	1.9	6.0	7.4	20.8	0.8	0.2	1.5	1.0	0.0	1.1	58.5	0.7	3.5	1.8	2.9	3.7	2.1	0.9	4.0	7.3	0.6	1.1	35.0	2.3	1.1	0.2	21.0	2.1	1.8	28.7	4.0	1.5	0.3	0.0	1.0	0.1	51.6	14.7	7.9	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	106.6	0.1	0.2	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.8	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.2	0.0	0.0	2.8	0.0	0.1	7.7	13.2	0.0	0.1	0.0	0.1	1.0	0.0	0.1	14.7	0.1	8.1	0.1	3.3	8.2	0.0	0.3	1.1	4.3	0.3	51.6	0.1	0.0	6.8	7.9	0.8	0.8	0.6	0.7	0.7	0.8	0.8	0.2	0.7	0.2	3.0	11.6	1.5	0.8	2.9	0.0	1.1	0.0	1.4	1.2	1.8	0.0	0.4	0.0	0.0	1.7	0.0	0.0	0.0	0.2	80.1	1.1	0.1	9.3	1.0	2.1	0.0	0.0	8.6	1.6	0.9	0.3	0.5	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	1.0	97.0	0.0	0.0
ISLR	HsT17563	ENSG00000129009	"Immunoglobulin superfamily containing leucine rich repeat"	O14498	15	74173671-74176872	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Fibroblasts: 63.6;Leydig cells: 199.0;Peritubular cells: 150.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 33.9;ASC TERT1: 18.2;fHDF/TERT166: 76.1;HSkMC: 13.8;RPMI-8226: 23.3"	"Region enriched"	"Detected in all"	5	"olfactory region: 145.0"	"Low region specificity"	"Detected in many"			"HPA040326, HPA050811"	Approved		Approved	"Golgi apparatus,Plasma membrane"	"Secreted - unknown location"	NA	NA		110000000	"Plasma membrane"	"Golgi apparatus"	"HPA040326: AB_2676928, HPA050811: AB_2681243"	"unprognostic (2.58e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.54e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.76e-3)"	"unprognostic (1.16e-2)"	"unprognostic (6.81e-2)"	"unprognostic (8.93e-3)"	"prognostic unfavorable (4.89e-8)"	"unprognostic (1.64e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.28e-1)"	"unprognostic (9.86e-3)"	24.6	6.8	3.3	10.4	4.6	0.1	21.4	2.0	12.1	72.8	19.7	2.9	13.2	4.1	67.3	36.3	23.0	22.1	29.6	17.7	1.7	1.7	8.0	2.5	10.2	5.8	3.3	7.2	80.2	3.4	1.2	13.8	31.5	3.9	32.2	4.0	36.4	10.0	17.9	12.5	13.6	8.8	27.5	9.0	9.8	10.3	16.3	0.6	1.3	18.9	17.0	9.9	27.9	35.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	33.9	18.2	0.1	5.2	0.0	0.0	0.0	0.0	2.1	0.0	0.3	76.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	23.3	0.0	0.0	0.2	3.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	4.0	0.0	0.1	0.5	0.0	0.2	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	4.6	2.0	12.1	1.7	1.7	3.3	7.2	3.9	0.6	0.0	2.2	0.0	0.1	10.4	0.0	3.1	0.0	2.7	1.2	0.0	0.0	1.1	0.0	0.2	1.7	8.7	0.0	0.0	0.2	1.6	63.6	0.1	0.0	0.0	3.5	0.0	0.0	7.4	0.0	3.2	199.0	0.8	11.8	0.0	0.0	0.1	1.3	0.0	150.3	0.0	0.3	25.8	21.7	0.9	0.5	7.8	0.8	0.0	0.0	0.2
ITGA5	"CD49e, FNRA"	ENSG00000161638	"Integrin subunit alpha 5"	P08648	12	54395261-54419460	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 137.7"	"Cell type enriched"	"Detected in many"	4	"Extravillous trophoblasts: 377.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 31.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 67.2;HUVEC TERT2: 141.7;TIME: 134.9;U-87 MG: 67.3"	"Region enriched"	"Detected in single"	7	"basal ganglia: 9.3"	"Not detected"	"Not detected"			"HPA002642, CAB009008"	Enhanced					NA	NA		23000000			"CAB009008: AB_647474, HPA002642: AB_1078469"	"unprognostic (7.51e-3)"	"prognostic unfavorable (4.07e-6)"	"prognostic unfavorable (8.43e-4)"	"unprognostic (1.58e-1)"	"unprognostic (8.51e-3)"	"prognostic unfavorable (2.91e-4)"	"prognostic unfavorable (2.23e-5)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (2.76e-2)"	"unprognostic (6.19e-2)"	"unprognostic (8.99e-2)"	"unprognostic (8.28e-2)"	"prognostic unfavorable (1.32e-8)"	"unprognostic (2.11e-3)"	"unprognostic (3.35e-2)"	"prognostic unfavorable (8.89e-4)"	"unprognostic (2.18e-3)"	23.3	7.9	2.1	32.2	2.8	9.2	30.5	1.2	2.2	16.0	66.9	2.2	19.0	3.4	19.3	13.8	18.2	12.0	12.4	20.3	2.9	0.8	4.6	15.2	20.4	9.2	3.2	1.2	13.6	5.3	3.7	1.8	57.7	3.3	26.6	10.2	4.9	4.4	28.9	10.0	8.8	14.9	137.7	3.5	3.1	19.7	6.6	2.5	3.0	7.3	5.8	4.5	82.1	20.6	0.1	22.2	31.5	22.9	9.1	5.6	12.4	6.6	2.4	4.6	0.0	14.4	30.6	12.1	30.2	31.4	31.1	23.0	1.7	1.5	0.0	22.0	31.5	15.7	1.0	1.2	8.4	21.6	0.0	1.2	2.9	3.4	0.1	19.9	9.0	4.6	22.1	4.2	36.5	28.0	67.2	141.7	1.5	2.4	0.0	17.6	0.6	1.4	10.1	1.9	0.4	2.0	1.4	3.1	0.6	4.9	0.1	0.0	0.0	6.0	0.4	0.2	10.6	0.7	8.2	134.9	37.9	6.7	9.2	12.5	0.0	0.3	0.0	67.3	8.6	12.3	5.6	22.9	0.1	5.6	10.0	4.4	0.0	4.2	4.2	22.2	0.1	3.1	2.6	31.5	9.1	7.6	1.2	1.7	12.4	2.1	2.8	1.2	2.2	2.9	0.8	3.2	1.2	3.3	2.5	3.0	4.1	1.4	2.7	12.7	0.8	13.2	5.1	1.4	4.5	0.0	0.0	2.7	0.0	32.2	0.1	93.4	0.0	0.0	3.0	377.0	54.1	3.6	19.6	20.7	27.5	0.0	0.0	77.3	18.7	0.4	6.1	35.5	10.1	9.0	0.0	0.0	7.2	0.0	4.2	0.0	1.3	12.9	33.1	0.0	0.7	9.4	28.9	8.2	0.0	1.7
JAML	"AMICA, AMICA1, Gm638"	ENSG00000160593	"Junction adhesion molecule like"	Q86YT9	11	118193740-118225094	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"blood: 202.6"	"Cell type enhanced"	"Detected in some"	19	"Alveolar cells type 2: 48.3;Kupffer cells: 117.5;Macrophages: 185.0;T-cells: 45.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 202.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 60.5;granulocytes: 202.6;monocytes: 59.0"	"Cell line enriched"	"Detected in some"	5	"HMC-1: 24.9"	"Region enriched"	"Detected in single"	9	"cerebellum: 7.0"	"Region enriched"	"Detected in many"	12	"cerebellum: 113.6"	"HPA005854, HPA047919"	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA		1400000	"Plasma membrane"	Nucleoplasm	"HPA005854: , HPA047919: AB_2680209"	"unprognostic (3.91e-3)"	"unprognostic (1.55e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.28e-3)"	"unprognostic (2.87e-3)"	"prognostic favorable (3.11e-4)"	"unprognostic (2.80e-1)"	"prognostic favorable (3.92e-4)"	"unprognostic (1.14e-1)"	"unprognostic (3.17e-1)"	"unprognostic (8.69e-2)"	"unprognostic (5.08e-1)"	"unprognostic (6.43e-3)"	"unprognostic (8.96e-2)"	"unprognostic (3.12e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.58e-2)"	6.7	2.1	0.9	23.1	1.1	6.6	2.1	5.3	0.8	4.1	8.4	0.7	1.3	6.1	3.8	9.6	4.0	3.1	8.9	3.1	0.9	0.9	3.4	4.3	34.4	43.2	3.7	0.5	2.1	1.8	0.0	2.7	4.2	2.3	3.4	8.3	6.7	6.7	1.1	1.0	2.2	14.0	4.7	1.8	43.4	3.9	1.9	0.6	14.3	2.6	5.9	25.0	9.8	3.0	0.3	60.5	202.6	59.0	1.4	25.2	40.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	5.1	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.7	0.0	0.0	24.9	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.3	2.3	0.3	2.7	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.2	0.0	5.8	59.0	202.6	3.9	36.6	25.2	0.3	7.0	7.4	60.5	0.1	8.3	6.7	126.6	1.4	17.1	46.6	11.1	40.1	0.9	1.1	5.3	0.8	0.9	0.9	3.7	0.5	2.3	0.6	6.0	48.3	15.4	0.1	0.0	0.0	0.0	0.0	4.0	10.3	1.8	0.0	0.1	0.0	0.1	0.7	0.0	0.0	0.0	0.3	0.2	0.4	0.1	14.0	2.1	29.9	0.0	0.0	8.0	117.5	0.9	0.0	185.0	0.0	11.8	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.1	1.4	0.0	0.3	45.3	0.0	0.1
KCNK15	"dJ781B1.1, K2p15.1, KCNK11, KCNK14, KIAA0237, KT3.3, TASK-5, TASK5"	ENSG00000124249	"Potassium two pore domain channel subfamily K member 15"	Q9H427	20	44745780-44752313	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"ductus deferens: 24.2"	"Cell type enhanced"	"Detected in some"	9	"Cholangiocytes: 5.1;Collecting duct cells: 8.7;Exocrine glandular cells: 6.4;Leydig cells: 6.1;Urothelial cells: 7.0"	"Cancer enriched"	"Detected in many"	7	"ovarian cancer: 47.5"	"Region enhanced"	"Detected in some"		"basal ganglia: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"MCF7: 32.2"	"Region enriched"	"Detected in single"	18	"olfactory region: 8.4"	"Region enriched"	"Detected in many"	8	"olfactory region: 9.3"	HPA064861	Uncertain					NA	NA					"HPA064861: AB_2685373"	"unprognostic (8.70e-2)"	"prognostic unfavorable (3.68e-4)"	"unprognostic (1.05e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.50e-2)"	"unprognostic (4.22e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.60e-2)"	"unprognostic (6.27e-2)"	"unprognostic (6.11e-2)"	"unprognostic (7.38e-4)"	"unprognostic (4.76e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.21e-3)"	"unprognostic (2.11e-1)"	6.0	4.5	0.4	1.3	3.4	0.5	5.9	0.0	1.2	6.2	2.3	0.0	24.2	1.1	4.3	10.6	3.2	15.1	10.7	3.8	0.6	0.4	3.5	7.0	3.0	2.2	0.6	0.0	12.6	7.4	0.6	4.2	1.1	1.1	2.7	0.8	2.1	3.4	9.6	2.6	2.0	0.9	3.8	0.3	0.6	4.1	10.6	0.0	0.0	6.5	0.5	0.9	2.6	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.2	0.2	0.1	0.1	0.2	0.0	0.0	0.6	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	32.2	0.0	0.0	0.0	0.1	3.2	0.0	0.0	0.0	0.3	0.0	0.9	0.4	3.1	0.0	0.3	0.0	1.6	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.4	0.0	1.2	0.6	0.4	0.6	0.0	1.1	0.0	0.0	0.0	0.0	1.7	0.5	0.0	0.6	5.1	0.0	0.0	8.7	0.0	0.0	0.0	3.2	0.2	0.7	0.0	0.0	6.4	0.0	1.3	2.3	0.0	0.0	0.1	0.0	1.2	0.6	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.5	1.8	0.0	0.4	0.1	0.0	0.0	0.2	0.1	0.4	0.6	0.0	0.0	0.8	7.0
KLHL30	FLJ43374	ENSG00000168427	"Kelch like family member 30"	Q0D2K2	2	238138722-238152947	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"skeletal muscle: 62.8"	"Group enriched"	"Detected in some"	11	"Cardiomyocytes: 11.5;Smooth muscle cells: 5.0"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 6.1;CAPAN-2: 3.2;EFO-21: 3.1;REH: 2.6;RH-30: 8.8;THP-1: 4.3"	"Region enriched"	"Detected in single"	35	"olfactory region: 11.6"	"Low region specificity"	"Detected in all"			HPA062095			Approved	"Centriolar satellite"		NA	NA			"Centriolar satellite"		"HPA062095: AB_2684680"	"unprognostic (3.42e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.07e-4)"	"unprognostic (6.02e-5)"	"unprognostic (1.29e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.54e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.57e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.17e-4)"	"unprognostic (2.75e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.06e-1)"	4.4	0.1	0.1	0.3	0.1	0.1	2.4	0.1	0.1	1.2	0.5	0.1	0.1	0.2	1.2	2.3	1.3	0.4	0.4	6.1	0.1	0.1	0.3	0.1	0.3	0.1	0.1	0.1	0.4	0.1	0.0	0.1	0.7	0.3	1.4	0.1	0.8	1.7	0.6	62.8	0.2	0.3	1.5	0.1	0.1	0.3	0.4	0.0	0.0	0.9	8.7	0.2	1.6	1.4	0.7	1.4	1.1	2.5	0.5	0.3	0.3	0.1	0.1	0.0	0.1	0.0	0.0	6.1	0.0	0.1	0.1	0.0	0.2	3.2	0.0	3.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.6	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.5	0.0	0.3	2.2	0.2	0.0	0.0	2.6	8.8	1.4	0.7	0.0	0.1	0.2	0.1	0.8	0.3	0.5	0.0	4.3	0.0	0.1	0.5	0.2	0.0	0.3	0.3	0.1	0.2	0.5	0.1	0.5	2.5	0.3	0.2	0.5	0.2	0.7	0.1	0.1	1.4	0.6	0.2	0.3	1.1	0.5	0.3	0.4	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KLK10	"NES1, PRSSL1"	ENSG00000129451	"Kallikrein related peptidase 10"	O43240	19	51012739-51020175	"Cancer-related genes, Enzymes, Predicted secreted proteins"	"Cell cycle"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 78.6;lymphoid tissue: 58.6;tongue: 136.3"	"Cell type enhanced"	"Detected in many"	13	"Alveolar cells type 1: 29.8;Club cells: 77.3;Glandular cells: 41.6;Pancreatic endocrine cells: 43.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.1"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"CAPAN-2: 50.7;HaCaT: 76.9;OE19: 49.9"	"Region enriched"	"Detected in single"	4	"hippocampal formation: 1.7"	"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA		670000				"prognostic favorable (8.32e-4)"	"unprognostic (6.06e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.26e-3)"	"unprognostic (3.81e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.94e-1)"	"unprognostic (3.38e-2)"	"prognostic unfavorable (6.46e-5)"	"unprognostic (2.71e-2)"	"unprognostic (2.46e-6)"	"unprognostic (9.34e-2)"	"unprognostic (7.81e-2)"	"unprognostic (2.66e-3)"	"unprognostic (1.52e-2)"	1.5	0.5	0.2	1.7	0.3	0.3	2.4	0.7	0.4	20.8	0.9	0.3	0.5	0.2	2.9	0.8	78.6	7.8	36.0	0.7	0.2	0.5	0.2	0.3	4.3	0.2	0.2	0.3	7.2	0.2	0.0	0.2	0.8	0.6	1.6	0.4	0.3	11.0	0.6	0.4	17.7	0.4	0.4	0.4	0.2	0.5	1.6	0.2	1.0	0.3	136.3	58.6	0.5	33.4	0.4	0.5	2.1	0.4	0.4	0.3	0.1	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	50.7	0.0	2.8	0.0	0.0	76.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	49.9	0.2	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.2	0.3	0.2	0.3	0.2	0.3	0.2	0.1	0.4	0.3	0.3	2.1	0.4	0.4	0.5	0.3	0.1	0.2	0.3	0.7	0.4	0.2	0.5	0.2	0.3	0.6	0.2	29.8	1.6	0.0	13.6	6.6	0.6	0.4	7.6	10.7	77.3	0.0	0.0	0.0	0.0	3.4	0.2	0.3	0.0	0.0	14.1	0.0	0.5	41.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	10.6	1.1	0.0	1.0	0.0	0.2	43.5	0.0	5.6	0.0	0.4	0.0	0.9	0.9	1.2	3.8	0.0	0.0	0.0	18.7
KLK8	"HNP, neuropsin, ovasin, PRSS19, TADG14"	ENSG00000129455	"Kallikrein related peptidase 8"	O60259	19	50996007-51002711	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 43.6;skin 1: 40.4;tongue: 46.9"	"Group enriched"	"Detected in some"	13	"Basal keratinocytes: 58.6;Suprabasal keratinocytes: 157.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 29.9;ovarian cancer: 30.7"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"A-431: 32.2;CAPAN-2: 42.3;HaCaT: 31.2"	"Region enriched"	"Detected in many"	5	"hippocampal formation: 39.6"					"CAB019393, HPA035761"	Enhanced		Approved	Vesicles	"Secreted in other tissues"	NA	NA		950000	Vesicles		"CAB019393: , HPA035761: AB_2674769"	"unprognostic (4.27e-3)"	"unprognostic (2.59e-1)"	"unprognostic (2.54e-1)"	"prognostic unfavorable (2.31e-4)"		"unprognostic (5.46e-2)"		"prognostic unfavorable (5.72e-4)"	"unprognostic (2.95e-1)"	"unprognostic (9.02e-2)"	"prognostic unfavorable (1.10e-4)"			"unprognostic (4.29e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (6.17e-4)"	1.6	0.0	0.1	0.4	0.1	0.0	4.5	1.0	0.3	8.1	0.7	0.1	0.1	0.0	1.1	0.7	43.6	6.7	0.3	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	1.1	0.1	0.0	0.1	0.4	0.6	0.3	0.0	0.3	6.0	0.1	0.3	40.4	0.1	0.1	0.6	0.3	0.0	0.7	0.1	0.5	0.3	46.9	11.1	0.3	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.2	0.0	0.0	0.2	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.6	42.3	0.0	0.8	0.0	0.0	31.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	3.8	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.0	0.3	0.1	0.0	0.1	0.1	0.6	0.1	0.0	0.0	0.0	0.0	58.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.4	1.7	0.0	8.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	3.4	157.5	0.0	0.0	0.0	0.1
KMO		ENSG00000117009	"Kynurenine 3-monooxygenase"	O15229	1	241532134-241595642	"Enzymes, Predicted membrane proteins"	"Pyridine nucleotide biosynthesis"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 20.3;liver: 58.6;placenta: 26.0"	"Cell type enhanced"	"Detected in many"	23	"Hepatocytes: 43.2;Proximal tubular cells: 45.1;Syncytiotrophoblasts: 150.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	79	"classical monocyte: 5.2;intermediate monocyte: 14.7;memory B-cell: 16.1;myeloid DC: 5.3;naive B-cell: 20.3;non-classical monocyte: 14.7;plasmacytoid DC: 11.1"	"Group enriched"	"Detected in many"	97	"B-cells: 20.3;dendritic cells: 11.1;monocytes: 14.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 5.4;RPMI-8226: 7.8;RPTEC TERT1: 20.0;SK-BR-3: 10.4;U-698: 8.3"	"Region enriched"	"Detected in single"	4	"thalamus: 1.3"	"Not detected"	"Not detected"			"HPA031115, HPA056942"	Enhanced					NA	NA					"HPA031115: AB_10601924, HPA056942: AB_2683281"	"unprognostic (4.27e-2)"	"unprognostic (3.35e-2)"	"unprognostic (3.95e-2)"	"unprognostic (7.48e-3)"	"unprognostic (8.37e-3)"	"unprognostic (2.63e-1)"	"unprognostic (9.79e-2)"	"unprognostic (3.65e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.75e-3)"	"unprognostic (8.07e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (6.49e-8)"	"unprognostic (1.60e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.36e-2)"	"unprognostic (6.81e-2)"	3.7	0.6	0.5	3.3	0.6	0.3	2.4	0.2	0.9	0.3	0.4	0.2	0.0	0.0	2.7	0.1	0.3	0.4	0.5	0.4	0.8	0.4	14.2	58.6	6.5	3.2	0.3	0.3	0.4	0.3	0.0	0.4	26.0	0.3	0.4	0.3	0.3	0.5	0.0	0.2	0.3	1.0	0.1	0.5	8.0	0.4	0.6	0.1	0.7	0.4	0.1	4.5	1.4	0.3	20.3	11.1	0.1	14.7	0.0	0.0	2.8	0.1	1.6	0.1	0.0	0.0	0.2	0.2	0.1	0.1	0.2	0.4	0.0	0.2	5.4	0.4	0.0	0.1	2.2	0.0	0.2	0.0	0.9	0.0	0.0	0.1	0.1	0.0	0.5	0.2	0.2	0.7	0.1	0.1	0.5	0.0	0.4	0.1	0.8	0.0	0.2	0.0	2.3	0.9	0.8	0.4	1.4	0.1	7.8	20.0	4.1	0.3	0.1	0.0	10.4	0.0	2.1	4.0	1.7	0.0	0.0	0.1	0.1	1.4	0.3	0.5	8.3	0.2	2.0	1.6	0.0	5.2	0.1	0.0	14.7	0.0	16.1	0.0	0.0	5.3	20.3	0.0	0.0	0.1	0.0	14.7	11.1	0.0	2.8	0.5	0.6	0.2	0.9	0.8	0.4	0.3	0.3	0.3	0.1	0.0	0.3	22.3	0.0	0.9	0.0	0.4	2.5	0.0	0.0	0.0	0.0	3.0	5.0	2.2	3.5	0.0	0.0	0.0	0.2	1.6	0.5	0.3	0.0	43.2	7.1	0.0	0.0	1.3	17.4	0.4	0.0	18.4	0.0	3.6	0.0	0.0	2.5	0.0	0.0	45.1	0.0	0.0	0.0	0.5	0.1	1.3	150.6	0.0	0.0	0.0
KRT24	"FLJ20261, MGC138169, MGC138173"	ENSG00000167916	"Keratin 24"	Q2M2I5	17	40697991-40703750	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"esophagus: 62.1;lymphoid tissue: 68.9;placenta: 48.6"	"Group enriched"	"Detected in some"	5	"Cytotrophoblasts: 4.0;Extravillous trophoblasts: 1.2;Leydig cells: 2.8;Syncytiotrophoblasts: 3.3"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 15.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	24	"T-reg: 2.4"	"Lineage enriched"	"Detected in single"	24	"T-cells: 2.4"	"Cell line enriched"	"Detected in single"	14	"SK-BR-3: 12.8"	"Region enriched"	"Detected in single"	18	"cerebellum: 1.1"	"Not detected"	"Not detected"			HPA022978	Uncertain		Approved	"Intermediate filaments,Cytosol"		No	NA			"Intermediate filaments, Cytosol"		"HPA022978: AB_1852230"	"unprognostic (2.74e-2)"	"unprognostic (1.05e-2)"		"unprognostic (1.45e-1)"		"unprognostic (3.16e-2)"		"unprognostic (2.47e-1)"			"unprognostic (3.75e-1)"	"unprognostic (2.74e-1)"		"unprognostic (2.95e-1)"			"unprognostic (3.37e-2)"	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	9.2	4.1	0.0	0.0	0.0	0.7	9.3	62.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	48.6	0.0	0.1	3.1	0.0	1.2	0.8	0.1	0.1	0.2	3.4	0.1	0.1	1.1	0.1	0.0	0.0	0.1	1.4	68.9	0.6	3.4	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0
KRT25	KRT25A	ENSG00000204897	"Keratin 25"	Q7Z3Z0	17	40748021-40755332	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Hypotrichosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"skin 1: 44.5"	"Group enriched"	"Detected in some"	9	"Early spermatids: 8.0;Late spermatids: 6.8"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebral cortex: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RPTEC TERT1: 5.6"	"Region enriched"	"Detected in single"	7	"cerebellum: 9.7"	"Group enriched"	"Detected in some"	5	"cerebral cortex: 8.3;hippocampal formation: 6.1"	"HPA053977, HPA058943"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA053977: AB_2682329, HPA058943: AB_2683859"						"unprognostic (8.19e-2)"							"unprognostic (5.89e-8)"		"unprognostic (1.79e-1)"			1.6	0.0	0.0	0.0	0.9	0.0	8.6	0.0	3.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	44.5	0.1	0.3	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	3.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0
KRT28	KRT25D	ENSG00000173908	"Keratin 28"	Q7Z3Y7	17	40792203-40799959	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"breast: 4.6;skin 1: 14.6"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"cervical cancer: 0.6;endometrial cancer: 0.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SK-BR-3: 1.4"	"Region enriched"	"Detected in single"	6	"cerebellum: 3.6"	"Low region specificity"	"Detected in single"			HPA066890	Enhanced					NA	NA					"HPA066890: AB_2685742"																		0.6	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
LCT		ENSG00000115850	Lactase	P09848	2	135787840-135837180	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Glycosidase, Hydrolase, Multifunctional enzyme"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	133	"intestine: 255.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	19	"plasmacytoid DC: 1.9"	"Lineage enriched"	"Detected in single"	19	"dendritic cells: 1.9"	"Group enriched"	"Detected in some"	4	"JURKAT: 3.6;MOLT-4: 6.9;RPMI-8226: 13.7"	"Region enriched"	"Detected in single"	16	"hippocampal formation: 17.3"											NA	NA						"unprognostic (2.21e-2)"	"unprognostic (1.65e-4)"	"unprognostic (2.54e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.39e-2)"	"unprognostic (8.03e-4)"	"unprognostic (3.55e-3)"	"unprognostic (6.71e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.64e-4)"	"unprognostic (4.90e-2)"	"unprognostic (8.92e-2)"	"unprognostic (8.97e-2)"	"unprognostic (1.02e-1)"	0.1	0.1	0.2	0.0	0.1	0.0	0.1	0.2	0.1	0.1	209.8	0.0	0.0	67.7	0.1	0.0	0.1	0.1	0.0	0.1	0.3	0.2	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	255.5	0.0	0.1	0.1	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.7	0.0	0.0	6.9	1.1	0.0	0.0	0.0	1.6	0.0	13.7	0.0	0.0	0.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.2	0.1	0.2	0.1	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LDHAL6B	"LDH6B, LDHAL6, LDHL"	ENSG00000171989	"Lactate dehydrogenase A like 6B"	Q9BYZ2	15	59206823-59208515	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	69	"testis: 56.6"	"Cell type enriched"	"Detected in some"	20	"Spermatocytes: 103.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.2;CAPAN-2: 1.5;HaCaT: 1.6;HeLa: 4.4"	"Region enriched"	"Detected in single"	6	"olfactory region: 1.7"					HPA053962	Enhanced					NA	NA					"HPA053962: AB_2682324"	"unprognostic (1.59e-1)"	"unprognostic (9.41e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.46e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.13e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.12e-7)"	"unprognostic (3.47e-2)"	"unprognostic (1.49e-2)"	"unprognostic (8.53e-2)"	"unprognostic (7.80e-2)"	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	56.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.8	0.0	0.4	0.0	0.0	0.0	0.4	1.2	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.0	1.5	0.4	0.0	0.0	0.3	1.6	0.0	0.0	0.0	0.1	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.1	0.5	0.0	0.5	0.1	0.0	0.0	0.4	0.4	0.8	0.3	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	103.7	0.6	0.0	0.0	0.0	0.0	0.0
LDOC1	"BCUR1, Mar7, Mart7, RTL7, SIRH7"	ENSG00000182195	"LDOC1, regulator of NFKB signaling"	O95751	X	141175745-141177125	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Distal tubular cells: 36.5;Peritubular cells: 36.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 19.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 29.8;MCF7: 40.1;PC-3: 50.3;U-251 MG: 29.9"	"Region enriched"	"Detected in many"	5	"cerebellum: 21.5"	"Low region specificity"	"Detected in all"			"HPA051768, HPA061842"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA051768: AB_2681599, HPA061842: AB_2684624"	"unprognostic (4.09e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.73e-3)"	"unprognostic (2.47e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.92e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.40e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.38e-3)"	"unprognostic (2.76e-2)"	21.1	24.2	24.4	5.9	31.8	2.0	9.9	18.3	51.2	24.2	5.5	21.0	11.0	5.1	17.3	12.1	10.0	30.3	10.4	6.7	27.3	25.6	15.6	3.1	9.7	5.5	23.2	23.3	31.8	18.3	13.0	54.9	1.8	30.2	23.1	3.5	13.5	47.9	36.4	3.8	17.9	5.2	12.5	19.5	9.3	7.8	6.6	16.6	1.8	22.6	3.7	5.7	11.2	9.9	8.2	4.8	8.2	0.0	19.2	8.9	3.0	0.0	29.8	4.6	12.8	8.0	9.8	0.0	7.1	8.8	9.7	13.6	0.0	11.7	0.0	5.6	11.6	9.6	14.0	5.0	10.4	6.9	0.0	9.2	0.0	16.1	0.0	3.1	0.0	2.8	17.3	5.4	8.4	4.5	7.8	8.2	0.0	0.2	0.0	8.7	40.1	0.0	0.0	4.8	0.0	50.3	0.0	4.1	0.0	11.9	7.0	0.0	4.0	0.0	6.2	0.0	2.6	7.9	0.0	14.8	0.0	9.6	0.0	29.9	0.0	0.0	0.0	5.0	0.0	0.0	8.2	0.0	0.1	4.3	0.0	3.1	3.3	8.9	3.3	0.8	8.2	7.9	5.1	0.2	19.2	0.0	4.8	8.1	3.0	24.4	31.8	18.3	47.4	27.3	25.6	23.2	23.3	30.2	16.6	0.0	4.0	0.0	15.7	5.4	25.2	1.6	22.9	5.3	10.3	22.7	7.9	1.9	36.5	12.0	0.5	11.3	0.0	0.0	12.3	1.6	11.7	14.6	2.3	0.0	0.8	19.1	5.2	11.1	0.8	0.9	20.4	1.6	3.3	0.0	0.2	20.6	11.6	0.0	36.4	26.8	9.6	12.9	19.4	0.9	7.7	5.9	1.3	5.7	0.0	14.0
LGR5	"FEX, GPR49, GPR67, HG38"	ENSG00000139292	"Leucine rich repeat containing G protein-coupled receptor 5"	O75473	12	71439770-71586310	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.3;fallopian tube: 19.9;placenta: 21.6;skeletal muscle: 26.6"	"Cell type enhanced"	"Detected in some"	23	"Cytotrophoblasts: 46.3;Syncytiotrophoblasts: 22.1;Undifferentiated cells: 11.5"	"Group enriched"	"Detected in many"	7	"colorectal cancer: 16.8;endometrial cancer: 26.8;ovarian cancer: 9.8;stomach cancer: 6.1"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.1"	"Lineage enriched"	"Detected in single"	10	"B-cells: 1.1"	"Group enriched"	"Detected in some"	5	"Hep G2: 16.2;SH-SY5Y: 47.7"	"Region enriched"	"Detected in some"	8	"olfactory region: 41.8"	"Low region specificity"	"Detected in many"			HPA012530	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA012530: AB_1849329"	"unprognostic (5.19e-2)"	"unprognostic (3.79e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.49e-3)"	"unprognostic (1.52e-1)"	"prognostic favorable (5.09e-4)"	"unprognostic (1.46e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.71e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.01e-5)"	"unprognostic (1.50e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.28e-2)"	"unprognostic (6.25e-3)"	2.3	2.2	3.5	0.8	18.1	0.4	2.1	0.9	9.5	2.2	4.2	24.5	0.0	6.1	4.9	1.7	0.6	19.9	0.8	0.8	5.0	3.4	0.9	1.4	1.4	0.4	32.3	5.1	1.5	0.6	1.0	2.0	21.6	10.8	1.8	4.6	0.9	3.1	9.0	26.6	4.0	6.5	0.7	15.0	0.6	2.9	0.7	25.7	0.0	0.9	0.9	2.1	0.7	1.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	5.3	0.0	0.4	16.2	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	5.3	0.7	1.0	0.0	0.0	0.0	6.5	0.1	47.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	18.1	0.9	9.5	5.0	3.4	32.3	5.1	10.8	25.7	0.0	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	46.3	0.0	0.0	0.3	0.1	0.4	0.0	0.0	1.7	1.7	0.0	0.0	0.4	5.5	0.0	4.7	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.1	22.1	0.0	11.5	0.0
LGR6	FLJ14471	ENSG00000133067	"Leucine rich repeat containing G protein-coupled receptor 6"	Q9HBX8	1	202193901-202319781	"G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Wnt signaling pathway"	"G-protein coupled receptor, Receptor, Transducer"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 49.6"	"Cell type enhanced"	"Detected in some"	12	"Basal glandular cells: 2.8;Cardiomyocytes: 8.3;Late spermatids: 3.2;Spermatocytes: 6.0;Spermatogonia: 3.3"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 17.8"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"gdT-cell: 14.3;memory CD8 T-cell: 8.3;naive CD8 T-cell: 4.7"	"Lineage enriched"	"Detected in single"	41	"T-cells: 14.3"	"Cell line enhanced"	"Detected in some"		"A549: 16.6;CAPAN-2: 14.8;HaCaT: 8.0;HeLa: 4.0"	"Region enriched"	"Detected in some"	9	"olfactory region: 30.0"					HPA008556	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA008556: "	"unprognostic (4.72e-3)"	"unprognostic (5.29e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (4.35e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.13e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.54e-2)"	"unprognostic (4.01e-2)"	"unprognostic (7.89e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.83e-2)"	1.1	0.1	0.9	0.8	3.2	1.8	7.9	6.0	2.4	2.6	2.2	1.5	0.5	0.2	1.6	7.3	4.4	13.8	49.6	12.3	0.7	3.3	0.9	1.4	6.9	1.1	6.8	0.2	2.2	0.5	0.1	15.9	0.9	9.3	6.7	1.1	0.8	8.5	2.5	0.3	3.2	1.6	2.6	1.6	5.3	0.7	4.9	3.9	0.2	4.1	2.6	3.4	3.2	2.9	0.0	0.0	0.0	0.0	0.3	14.3	2.5	0.0	16.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.0	1.7	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.0	0.9	0.0	1.7	8.3	0.0	0.0	0.7	4.7	0.0	0.3	0.0	0.0	0.4	2.5	0.9	3.2	6.0	2.4	0.7	3.3	6.8	0.2	9.3	3.9	0.0	0.0	0.0	2.8	1.1	0.0	8.3	0.0	0.0	1.2	0.0	0.0	0.5	0.0	0.0	2.4	0.0	0.2	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.6	0.0	3.2	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	6.0	3.3	0.1	0.7	0.5	1.7	0.3
LIPF	"HGL, HLAL"	ENSG00000182333	"Lipase F, gastric type"	P07098	10	88664441-88678814	"Enzymes, FDA approved drug targets, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"stomach 1: 762.9"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	75	"stomach cancer: 278.5"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.9"	"Cell type enriched"	"Detected in single"	16	"eosinophil: 1.5"	"Lineage enriched"	"Detected in single"	16	"granulocytes: 1.5"	"Cell line enhanced"	"Detected in some"		"HMC-1: 6.4;MOLT-4: 5.0;NTERA-2: 5.3;REH: 3.1;THP-1: 10.0;U-2 OS: 3.6;U-266/70: 4.9"	"Region enriched"	"Detected in single"	51	"olfactory region: 9.9"					HPA045930	Enhanced				"Secreted to digestive system"	NA	NA					"HPA045930: AB_10959518"										"unprognostic (1.53e-1)"				"unprognostic (1.83e-1)"				0.1	0.0	0.1	0.1	0.5	0.0	0.1	0.1	1.9	0.1	0.2	28.2	0.1	8.2	0.1	0.1	31.6	0.1	0.6	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.0	0.1	9.9	0.1	0.1	0.0	0.1	0.1	0.1	0.1	762.9	0.1	0.1	0.2	0.1	1.1	0.1	0.1	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.1	5.3	0.0	0.0	3.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	3.6	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	1.9	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
LRRC10B		ENSG00000204950	"Leucine rich repeat containing 10B"	A6NIK2	11	61508800-61511018	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	7	"brain: 27.8;fallopian tube: 36.2;pituitary gland: 14.8"	"Cell type enhanced"	"Detected in some"	13	"Ciliated cells: 20.1;Muller glia cells: 7.8;Sertoli cells: 19.4;Smooth muscle cells: 11.8"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 27.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AF22: 12.2;RH-30: 13.2;SCLC-21H: 6.8"	"Region enriched"	"Detected in many"	7	"basal ganglia: 202.0"	"Group enriched"	"Detected in many"	5	"basal ganglia: 39.3;hippocampal formation: 35.0"	HPA047619	Uncertain		Approved	Nucleoplasm,Nucleoli		No	NA			Nucleoplasm	Nucleoli	"HPA047619: AB_2680106"	"unprognostic (9.95e-2)"	"unprognostic (2.67e-2)"	"unprognostic (4.92e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.10e-2)"	"unprognostic (9.22e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.62e-1)"	"unprognostic (9.21e-3)"	"unprognostic (2.52e-2)"	"unprognostic (5.27e-4)"	"unprognostic (5.07e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.63e-2)"	2.4	1.6	4.8	0.9	27.8	0.5	1.9	0.2	5.8	3.4	1.6	1.2	1.0	0.9	2.2	3.7	1.1	36.2	0.8	1.2	5.2	1.9	0.9	0.6	3.7	0.5	1.1	4.3	3.0	1.5	2.1	14.8	1.2	1.2	0.9	1.0	0.0	1.1	1.2	0.7	0.5	0.9	2.5	0.2	0.6	1.0	2.4	8.3	0.9	0.8	0.2	0.5	0.9	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.9	0.0	0.3	0.0	0.0	0.0	13.2	0.0	0.0	0.0	6.8	0.6	0.3	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.0	0.0	2.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	27.8	0.2	5.8	5.2	1.9	1.1	4.3	1.2	8.3	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	20.1	4.5	1.8	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	7.8	0.1	0.0	0.0	0.0	0.0	19.4	11.8	0.5	0.9	0.3	0.1	0.0	0.0	0.0
MAEL	"CT128, FLJ14904, SPATA35"	ENSG00000143194	"Maelstrom spermatogenic transposon silencer"	Q96JY0	1	166975582-167022214	"Predicted intracellular proteins"	"Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	26	"testis: 90.7"	"Cell type enhanced"	"Detected in some"	27	"Early spermatids: 1028.7;Late spermatids: 292.6;Spermatocytes: 368.4"	"Cancer enhanced"	"Detected in many"		"testis cancer: 3.9"	"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	19	"plasmacytoid DC: 1.9"	"Lineage enriched"	"Detected in single"	19	"dendritic cells: 1.9"	"Cell line enriched"	"Detected in some"	8	"NTERA-2: 8.8"	"Region enriched"	"Detected in single"	5	"thalamus: 1.2"	"Not detected"	"Not detected"			HPA078602	Approved					NA	NA					"HPA078602: AB_2732386"	"unprognostic (1.36e-1)"	"unprognostic (7.01e-2)"	"unprognostic (5.81e-2)"	"unprognostic (3.15e-1)"	"unprognostic (9.78e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.68e-3)"	"unprognostic (4.99e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.00e-3)"	"unprognostic (3.04e-1)"	"unprognostic (8.88e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.32e-1)"	"unprognostic (8.67e-2)"	"unprognostic (1.85e-1)"	0.1	0.0	0.8	0.1	0.2	0.0	0.1	0.6	1.3	0.1	0.3	0.1	0.1	0.0	0.1	0.7	0.2	0.0	0.2	2.1	0.7	0.5	0.6	0.3	0.1	0.1	0.4	0.1	0.1	0.6	0.0	0.2	3.5	0.2	0.2	0.0	0.2	0.1	0.4	0.2	0.0	0.1	0.1	0.1	0.1	0.0	90.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.3	8.8	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.3	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.4	0.8	0.2	0.6	1.3	0.7	0.5	0.4	0.1	0.2	0.1	0.0	0.0	0.0	0.4	0.1	1.3	4.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1028.7	0.1	0.0	0.0	0.2	0.4	0.4	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	292.6	10.0	0.0	0.0	0.0	0.0	42.7	0.0	0.0	9.6	4.3	1.3	0.0	0.3	368.4	143.2	0.0	0.2	0.0	0.0	0.1
MAP3K1	"MAPKKK1, MEKK, MEKK1"	ENSG00000095015	"Mitogen-activated protein kinase kinase kinase 1"	Q13233	5	56815574-56896152	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 81.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 27.5;THP-1: 25.7"	"Region enriched"	"Detected in many"	6	"olfactory region: 22.5"	"Low region specificity"	"Detected in all"			"CAB004500, HPA046509"	Approved		Approved	Cytosol		NA	NA			Cytosol		"CAB004500: AB_627926, HPA046509: AB_2679678"	"unprognostic (1.77e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.09e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.48e-2)"	"unprognostic (5.39e-3)"	"unprognostic (5.20e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.05e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.97e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.58e-1)"	"unprognostic (9.92e-3)"	"unprognostic (1.11e-1)"	6.7	4.9	5.4	14.6	4.8	15.2	14.9	8.0	4.5	7.6	6.7	5.4	7.3	4.3	7.1	9.4	12.7	7.2	5.9	4.3	3.7	3.2	9.5	4.4	8.8	21.4	6.4	3.1	8.4	9.2	6.3	7.9	8.1	4.5	8.3	4.5	12.6	15.4	9.7	3.5	21.8	11.2	4.0	3.8	21.3	5.5	8.5	5.1	11.7	19.2	6.6	18.2	6.0	11.7	6.6	2.8	6.7	7.2	2.7	5.8	2.3	6.6	4.0	6.3	4.2	1.0	0.8	10.6	1.3	1.7	4.0	5.6	18.7	5.0	5.9	0.4	1.5	3.4	3.4	5.2	2.3	5.6	2.0	2.3	3.3	1.8	8.8	2.5	5.2	9.2	1.0	2.5	1.2	2.0	1.1	1.7	2.0	2.8	10.7	1.0	2.9	3.6	7.1	2.9	3.4	0.5	5.7	4.4	20.3	7.0	6.9	2.6	27.5	3.9	4.9	11.2	5.8	13.4	25.7	5.0	0.4	3.4	1.5	2.4	7.8	4.0	11.3	0.6	3.1	6.8	6.7	4.5	1.0	1.2	6.8	1.2	6.6	3.8	1.8	2.8	5.1	2.5	0.9	2.6	2.7	7.2	1.5	5.8	2.3	5.4	4.8	8.0	4.5	3.7	3.2	6.4	3.1	4.5	5.1	6.0	9.8	47.7	14.5	46.5	15.2	2.7	50.9	4.0	12.5	34.9	45.2	12.9	6.6	14.2	1.6	13.5	6.6	0.0	12.8	7.7	11.3	11.9	7.0	12.1	26.3	27.0	9.8	17.2	81.7	1.9	4.9	40.3	35.4	45.9	10.1	10.6	13.0	7.0	1.8	20.1	34.7	6.5	5.2	10.0	15.0	47.8	5.6	16.6	8.9	10.0
MARVELD2	"DFNB49, FLJ30532, MRVLDC2, TRIC"	ENSG00000152939	"MARVEL domain containing 2"	Q8N4S9	5	69415065-69444330	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Hearing		"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 18.4;CAPAN-2: 15.9;HaCaT: 12.3;hTCEpi: 10.3;RT4: 14.2;SCLC-21H: 16.7;T-47d: 12.4"	"Region enriched"	"Detected in single"	8	"cerebellum: 8.8"	"Low region specificity"	"Detected in all"			"HPA018119, HPA061726"	Uncertain		Supported	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA018119: AB_2669771, HPA061726: AB_2684595"	"unprognostic (4.11e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.44e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.84e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.47e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.75e-1)"	"prognostic favorable (2.84e-13)"	"unprognostic (1.78e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.82e-1)"	0.6	0.7	1.1	2.3	1.4	0.2	4.5	0.7	1.3	2.6	13.2	1.6	9.5	9.4	1.6	6.4	9.1	4.4	9.2	0.9	1.4	1.2	12.2	24.2	11.2	0.4	1.7	0.8	1.0	18.9	3.9	8.0	9.9	2.1	5.0	7.3	5.2	10.9	7.4	0.4	5.4	21.8	1.4	1.3	0.6	8.9	2.7	0.7	1.1	25.7	6.4	7.3	4.7	4.1	1.4	0.4	1.5	0.8	1.1	2.3	1.0	6.6	2.5	0.0	0.0	0.0	0.0	18.4	0.1	0.0	0.1	0.4	8.6	15.9	0.0	1.8	1.1	0.0	12.3	0.0	9.2	0.3	0.1	3.5	0.0	0.8	4.6	1.1	0.0	0.0	0.3	10.3	0.1	1.4	0.4	0.7	0.1	0.0	0.1	0.0	6.6	0.0	0.0	1.3	3.9	0.2	0.0	0.0	0.4	6.9	14.2	16.7	0.0	1.7	1.7	0.2	3.2	12.4	0.0	1.0	0.0	0.0	0.0	0.0	0.1	2.2	0.0	0.0	0.1	0.0	1.5	0.8	0.2	0.4	0.2	1.1	1.2	2.3	0.2	0.3	1.4	0.7	0.5	0.9	1.1	0.1	0.4	0.1	1.0	1.1	1.4	0.7	1.3	1.4	1.2	1.7	0.8	2.1	0.7	20.8	21.6	0.8	16.8	4.4	0.1	2.5	25.5	30.8	20.5	15.7	2.0	19.2	14.9	19.8	4.6	3.1	25.7	0.0	22.9	7.1	0.8	23.1	1.1	33.9	1.6	0.0	16.1	3.7	0.6	1.6	0.0	0.8	1.7	13.6	23.4	0.8	23.3	31.9	0.0	5.3	0.2	0.0	1.0	3.8	1.9	5.6	10.1	0.0	24.5	33.8
MBL2	"COLEC1, MBL"	ENSG00000165471	"Mannose binding lectin 2"	P11226	10	52765380-52771700	"Plasma proteins, Predicted secreted proteins"	"Complement activation lectin pathway, Complement pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	825	"liver: 82.5"	"Cell type enriched"	"Detected in some"	62	"Hepatocytes: 190.6"	"Cancer enriched"	"Detected in single"	275	"liver cancer: 22.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	10	"Hep G2: 7.0"	"Region enriched"	"Detected in single"	5	"pons and medulla: 0.5"	"Not detected"	"Not detected"			"HPA002027, CAB016782"	Enhanced				"Secreted to blood"	NA	NA	1220000000	1700000000			"CAB016782: , HPA002027: AB_1079324"							"unprognostic (1.72e-2)"		"unprognostic (3.03e-1)"									0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	82.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	7.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	190.6	0.0	0.0	0.0	3.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MCOLN2	"FLJ36691, TRP-ML2, TRPML2"	ENSG00000153898	"Mucolipin 2"	Q8IZK6	1	84925583-84997113	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Adaptive immunity, Calcium transport, Immunity, Innate immunity, Ion transport, Protein transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 18.9;epididymis: 18.4;lymphoid tissue: 31.9"	"Cell type enhanced"	"Detected in many"	14	"Early spermatids: 34.6;Macrophages: 15.1;monocytes: 53.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 18.9"	"Group enriched"	"Detected in many"	12	"B-cells: 6.6;dendritic cells: 18.9;T-cells: 5.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 14.1;HAP1: 10.1;HDLM-2: 16.8;THP-1: 20.1;U-698: 12.5"	"Region enriched"	"Detected in single"	5	"amygdala: 0.4"	"Low region specificity"	"Detected in all"			HPA019114	Uncertain					NA	NA					"HPA019114: AB_1853645"	"unprognostic (3.02e-2)"	"unprognostic (5.67e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.47e-1)"	"unprognostic (5.66e-3)"	"unprognostic (2.38e-1)"	"prognostic favorable (2.56e-4)"	"unprognostic (8.92e-2)"	"unprognostic (1.48e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.21e-2)"	"unprognostic (3.12e-4)"	"unprognostic (3.68e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.23e-2)"	1.3	12.5	0.4	31.9	0.4	2.2	1.1	0.2	0.4	1.7	8.5	0.5	1.6	1.2	1.4	18.4	1.3	2.9	3.8	2.0	0.6	0.4	1.4	0.6	7.5	18.4	0.6	0.0	1.0	1.8	0.0	1.2	2.1	1.5	1.5	14.0	1.6	3.2	0.9	0.6	1.8	7.5	0.5	1.7	9.7	1.7	2.7	0.4	4.1	1.0	2.8	27.5	2.3	1.3	6.6	18.9	0.2	0.8	0.4	5.9	1.4	1.0	1.1	0.1	3.0	0.6	0.2	0.4	0.7	3.8	0.9	1.2	0.0	0.1	14.1	0.4	0.0	1.8	0.1	10.1	1.2	1.1	16.8	7.5	1.4	0.4	0.0	0.8	0.3	1.3	0.2	0.0	0.9	0.8	0.1	0.1	3.7	0.0	0.3	0.2	0.4	0.2	0.1	1.1	0.0	1.9	0.1	2.3	0.0	0.1	0.3	0.7	0.0	0.1	0.2	6.2	0.2	1.8	20.1	0.1	1.0	1.6	0.1	2.6	0.1	0.0	12.5	0.9	0.1	2.4	0.1	0.2	0.0	4.1	0.8	1.3	6.6	3.3	5.9	4.5	1.9	0.5	3.4	0.2	0.4	0.1	18.9	0.2	1.4	0.4	0.4	0.2	0.4	0.6	0.4	0.6	0.0	1.5	0.4	0.0	1.1	9.8	0.5	3.9	0.0	0.5	0.0	2.7	2.3	1.8	0.0	0.1	0.0	0.0	34.6	0.1	6.0	0.0	1.2	0.1	2.1	0.7	0.0	0.0	0.7	0.0	2.4	1.3	0.6	14.2	0.0	15.1	8.5	53.3	4.1	0.0	0.4	5.8	0.0	0.3	0.0	0.0	0.1	0.2	3.7	2.9	0.2	8.2	2.3	0.1
MDFI	I-mfa	ENSG00000112559	"MyoD family inhibitor"	Q99750	6	41636882-41654246	"Predicted intracellular proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	12	"Cytotrophoblasts: 196.5;Extravillous trophoblasts: 103.1;Pancreatic endocrine cells: 86.6;Syncytiotrophoblasts: 116.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 23.6;HBEC3-KT: 29.3;OE19: 24.7;REH: 77.3"	"Region enriched"	"Detected in single"	8	"cerebellum: 19.0"	"Low region specificity"	"Detected in all"			HPA049973	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA049973: AB_2680975"	"unprognostic (9.74e-3)"	"unprognostic (4.25e-2)"	"unprognostic (6.82e-2)"	"unprognostic (6.26e-3)"	"unprognostic (9.18e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (1.32e-5)"	"prognostic unfavorable (9.11e-4)"	"unprognostic (1.66e-1)"	"unprognostic (3.27e-2)"	"unprognostic (4.04e-2)"	"prognostic unfavorable (2.85e-6)"	"unprognostic (2.66e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.22e-2)"	29.5	2.1	2.9	5.3	3.1	0.4	10.5	0.9	10.8	14.0	3.2	2.5	3.5	1.9	4.8	4.6	20.5	4.1	12.3	4.0	2.3	2.1	2.5	2.3	10.1	4.5	2.4	1.3	15.7	1.6	0.9	4.2	17.8	3.4	13.3	0.6	6.3	10.1	4.7	1.0	6.7	1.3	2.9	2.0	0.7	3.2	4.6	1.3	0.8	7.0	31.0	19.6	8.4	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.9	0.0	12.9	0.0	0.0	0.0	23.6	0.0	0.0	0.0	0.0	0.0	7.1	0.0	5.4	0.0	0.0	13.6	3.5	29.3	0.0	0.0	0.0	0.1	0.0	0.6	0.5	0.0	0.0	0.9	13.6	0.1	6.4	0.0	9.7	4.0	0.0	0.0	0.0	0.0	10.1	0.1	8.8	24.7	0.5	77.3	7.4	0.1	0.8	2.2	2.4	5.9	0.1	11.0	0.0	9.3	0.0	0.9	10.7	0.0	12.6	0.1	0.4	0.0	0.0	0.0	0.1	0.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	3.1	0.9	2.0	2.3	2.1	2.4	1.3	3.4	1.3	0.0	0.0	0.0	26.4	21.8	0.0	0.8	0.0	0.0	0.0	5.2	0.0	196.5	0.0	24.1	0.5	3.0	0.0	0.0	44.9	103.1	11.5	36.3	0.0	0.0	16.7	0.0	0.0	3.7	0.0	0.0	36.2	0.5	0.0	1.0	0.0	0.0	86.6	0.0	5.6	0.0	0.0	0.0	1.9	0.1	1.5	8.0	116.0	0.0	0.0	51.1
MEGF11	"DKFZp434L121, KIAA1781"	ENSG00000157890	"Multiple EGF like domains 11"	A6BM72	15	65895079-66253747	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 34.7;fallopian tube: 16.3"	"Group enriched"	"Detected in many"	6	"Early spermatids: 136.6;Horizontal cells: 119.2;Late spermatids: 159.9"	"Cancer enhanced"	"Detected in some"		"glioma: 2.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 4.6;HEK 293: 3.6;RPTEC TERT1: 12.7;SCLC-21H: 9.9"	"Region enriched"	"Detected in many"	4	"cerebellum: 39.2"	"Region enriched"	"Detected in all"	7	"cerebellum: 62.2"							NA	NA						"unprognostic (2.97e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.95e-2)"	"unprognostic (1.84e-2)"	"unprognostic (9.02e-3)"	"unprognostic (6.45e-3)"	"unprognostic (1.51e-1)"	"unprognostic (4.08e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.79e-3)"	"unprognostic (6.81e-3)"	"unprognostic (5.71e-5)"	"unprognostic (7.94e-2)"	"unprognostic (9.78e-3)"	"unprognostic (2.03e-1)"	"unprognostic (4.89e-2)"	0.6	0.8	8.7	0.9	5.4	1.3	0.6	34.7	17.1	0.6	0.7	5.3	0.0	0.6	0.8	2.3	0.7	16.3	0.7	0.6	11.6	5.7	4.6	0.6	1.6	0.9	6.5	2.5	0.7	1.0	0.5	1.5	0.6	9.2	0.7	0.6	3.4	0.6	0.8	0.6	3.2	0.7	0.6	9.2	0.9	1.0	2.6	5.5	0.0	0.7	0.0	0.7	0.6	0.2	0.3	0.1	0.5	0.2	0.0	1.5	0.0	0.0	0.1	0.5	4.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.8	0.0	0.3	0.1	0.3	0.0	0.1	0.2	3.6	0.2	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	1.1	0.2	0.0	1.5	0.0	0.1	12.7	0.3	9.9	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.1	0.0	2.6	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.3	0.3	0.0	0.0	0.1	0.4	1.5	0.5	0.0	0.0	0.1	0.1	0.0	8.7	5.4	34.7	4.7	11.6	5.7	6.5	2.5	9.2	5.5	0.0	3.0	0.0	0.5	1.9	4.9	0.6	0.0	1.4	0.0	3.5	7.9	0.2	0.0	0.0	136.6	0.7	0.0	0.0	0.2	0.1	1.1	0.3	0.0	0.0	0.1	119.2	0.0	1.3	0.3	159.9	2.3	0.9	0.0	0.0	0.0	3.5	0.1	0.0	1.4	0.8	25.0	0.0	0.5	2.1	2.0	3.3	0.5	0.0	0.0	0.4
METRN	"C16orf23, MGC2601"	ENSG00000103260	"Meteorin, glial cell differentiation regulator"	Q9UJH8	16	715115-719655	"Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 58.9"	"Cell type enriched"	"Detected in many"	8	"Muller glia cells: 554.6"	"Cancer enhanced"	"Detected in all"		"glioma: 69.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 53.4;PC-3: 41.3"	"Region enriched"	"Detected in all"	5	"cerebellum: 549.1"	"Low region specificity"	"Detected in all"			HPA051164	Approved		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"	"Secreted in brain"	NA	NA			"Nuclear membrane"	"Nucleoplasm, Cytosol"	"HPA051164: AB_2681369"	"unprognostic (1.60e-2)"	"unprognostic (3.49e-1)"	"unprognostic (4.47e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.45e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.59e-1)"	"unprognostic (8.13e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.12e-2)"	"unprognostic (3.32e-1)"	"unprognostic (5.03e-3)"	"unprognostic (3.62e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.17e-2)"	7.7	14.9	44.7	5.1	58.9	2.6	4.6	14.2	45.4	4.1	7.0	24.1	19.8	5.6	5.3	7.8	3.1	27.4	6.4	12.4	39.6	31.6	10.5	8.5	6.0	4.2	45.7	15.1	2.7	43.1	5.2	15.1	5.3	15.3	7.4	2.5	9.2	27.3	16.8	21.5	3.9	5.9	4.4	39.5	5.4	8.3	4.6	19.0	2.5	6.6	3.4	3.0	3.9	5.0	3.2	0.9	0.8	1.0	1.7	2.9	0.5	2.6	22.5	4.4	22.5	7.9	4.4	7.2	5.3	2.7	2.1	1.4	3.3	6.6	0.4	12.5	3.7	8.2	9.9	0.6	5.2	0.3	1.4	9.9	0.9	4.1	17.0	4.8	1.9	2.9	10.7	5.7	0.6	1.3	6.7	0.7	6.3	1.5	0.5	1.6	53.4	0.7	6.5	1.6	2.9	41.3	7.3	5.1	7.3	5.5	0.7	7.0	8.9	2.1	5.9	27.4	0.5	8.9	3.8	2.4	6.1	11.7	7.1	4.6	3.4	0.9	0.4	9.6	1.4	14.4	0.0	0.3	0.8	2.9	1.0	1.7	3.2	1.5	2.7	0.2	0.5	0.9	1.9	0.0	1.7	1.0	0.9	2.8	0.5	44.7	58.9	14.2	27.4	39.6	31.6	45.7	15.1	15.3	19.0	0.0	2.1	4.2	14.7	3.4	38.6	14.0	50.9	2.7	0.0	15.7	13.7	0.6	43.1	6.3	6.5	12.6	15.0	0.0	4.2	1.8	8.7	28.3	0.0	27.2	5.2	66.7	26.2	19.0	5.1	14.5	10.3	4.8	10.1	0.0	8.1	554.6	5.4	14.7	8.9	43.5	29.1	25.8	15.3	3.9	11.3	2.6	0.3	6.4	8.6	14.2
MGAM	MGA	ENSG00000257335	Maltase-glucoamylase	O43451	7	141907813-142106747	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase, Multifunctional enzyme"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"intestine: 155.5"	"Cell type enhanced"	"Detected in some"	24	"Early spermatids: 50.7;Late spermatids: 90.5;Proximal tubular cells: 18.9"	"Cancer enriched"	"Detected in some"	7	"renal cancer: 4.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	8	"neutrophil: 14.1"	"Lineage enriched"	"Detected in single"	104	"granulocytes: 14.1"	"Cell line enhanced"	"Detected in some"		"A549: 3.7;BJ hTERT+: 3.3;HL-60: 5.5;U-937: 8.7;WM-115: 2.1"	"Region enriched"	"Detected in single"	12	"olfactory region: 3.1"					HPA002270	Enhanced					NA	NA		68000			"HPA002270: AB_1079366"	"unprognostic (1.02e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.95e-3)"	"unprognostic (2.80e-1)"	"unprognostic (7.81e-2)"	"unprognostic (7.32e-3)"	"unprognostic (3.83e-2)"	"unprognostic (4.97e-1)"	"unprognostic (2.17e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.99e-1)"	"prognostic favorable (6.16e-5)"	"unprognostic (1.82e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.34e-3)"	"unprognostic (3.03e-1)"	0.9	0.2	0.3	0.8	0.2	6.9	0.3	0.2	0.2	0.2	59.4	0.1	7.6	25.2	0.2	36.0	0.2	1.0	0.1	0.3	0.2	0.2	8.7	0.4	2.1	0.1	0.3	0.1	0.2	0.2	0.0	0.2	0.1	0.1	0.6	0.0	0.1	0.2	3.2	0.2	0.1	155.5	0.1	0.3	8.3	0.7	4.3	0.1	0.1	0.2	0.1	0.1	0.2	0.2	0.0	0.0	14.1	0.1	0.0	0.0	0.0	0.0	3.7	0.2	0.1	0.0	0.0	0.5	0.1	3.3	0.3	0.2	0.1	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.3	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.3	1.0	0.4	0.1	0.3	0.0	0.1	0.0	8.7	2.1	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.2	0.2	0.2	0.3	0.1	0.1	0.1	0.0	4.5	0.0	0.0	0.0	0.0	1.1	0.0	2.7	2.3	12.2	0.0	0.0	1.7	0.0	50.7	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	90.5	0.6	1.8	0.0	0.0	0.4	0.5	0.2	0.0	0.4	18.9	0.0	0.0	0.0	1.6	1.2	0.0	0.0	0.0	0.2	0.2
MMP19	"MMP18, RASI-1"	ENSG00000123342	"Matrix metallopeptidase 19"	Q99542	12	55835433-55842966	"Disease related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins"	"Angiogenesis, Collagen degradation, Differentiation"	"Developmental protein, Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 60.7"	"Cell type enhanced"	"Detected in many"	8	"Extravillous trophoblasts: 42.0;Hofbauer cells: 31.2;Kupffer cells: 30.5;Macrophages: 48.2;monocytes: 38.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	16	"classical monocyte: 3.2;myeloid DC: 1.0"	"Group enriched"	"Detected in many"	16	"dendritic cells: 1.0;monocytes: 3.2"	"Cell line enriched"	"Detected in many"	6	"BEWO: 57.2"	"Region enriched"	"Detected in single"	6	"olfactory region: 8.8"	"Low region specificity"	"Detected in all"			HPA070804			Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	NA	NA		800000	"Endoplasmic reticulum, Vesicles"		"HPA070804: AB_2686315"	"unprognostic (2.61e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.42e-1)"	"unprognostic (4.77e-3)"	"unprognostic (4.77e-3)"	"unprognostic (2.01e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.85e-2)"	"unprognostic (4.30e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (8.56e-9)"	"unprognostic (5.06e-3)"	"unprognostic (1.28e-3)"	"unprognostic (2.73e-2)"	"unprognostic (4.00e-2)"	60.7	1.9	0.2	10.9	0.7	0.0	9.9	0.2	0.5	7.6	3.9	0.4	1.4	0.8	12.7	6.0	3.6	11.8	30.3	4.7	0.6	0.1	4.1	3.0	14.0	15.5	0.5	0.2	7.4	8.1	0.0	0.5	24.5	1.0	2.9	2.8	3.1	2.0	3.5	2.1	2.7	4.1	7.7	0.8	27.4	5.0	2.9	0.2	2.7	3.3	1.8	7.1	5.9	3.5	0.0	1.0	0.1	3.2	0.0	0.0	0.6	0.8	0.0	0.0	0.0	6.3	8.1	57.2	6.0	7.1	2.5	2.9	0.3	0.2	0.0	0.0	8.4	0.1	0.0	0.0	1.8	3.4	0.3	0.0	0.0	0.0	0.1	5.2	0.0	0.2	8.4	0.2	1.5	1.6	3.0	0.4	0.0	0.1	0.0	8.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.4	0.0	1.1	2.9	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.1	9.7	1.5	3.3	0.0	0.2	0.0	0.0	0.0	4.5	0.0	0.0	0.0	3.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.2	0.7	0.2	0.5	0.6	0.1	0.5	0.2	1.0	0.2	0.0	5.8	0.9	0.2	6.4	0.5	0.6	5.1	2.7	5.7	0.0	3.9	14.4	0.0	0.3	0.4	2.1	0.0	0.0	0.4	42.0	24.0	0.4	2.3	0.5	31.2	0.0	0.0	4.9	30.5	0.4	5.5	48.2	11.8	38.7	0.0	0.3	0.1	0.0	4.9	0.0	1.7	0.0	9.6	0.0	0.2	3.8	15.7	0.0	0.0	0.1
MMP23B	"MIFR, MIFR-1, MMP22"	ENSG00000189409	"Matrix metallopeptidase 23B"	O75900	1	1632095-1635263	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 51.8"	"Group enriched"	"Detected in many"	6	"Fibroblasts: 124.0;Leydig cells: 90.9;Peritubular cells: 167.3"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	5	"plasmacytoid DC: 12.3"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 12.3"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.4;HHSteC: 8.3;NTERA-2: 3.6;PC-3: 3.6;U-266/70: 6.5"	"Region enriched"	"Detected in some"	5	"cerebellum: 8.7"	"Not detected"	"Not detected"									NA	NA						"unprognostic (2.19e-2)"	"unprognostic (6.31e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.99e-2)"	"unprognostic (9.31e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.06e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.26e-11)"	"unprognostic (1.60e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.44e-2)"	"unprognostic (6.66e-2)"	4.7	2.4	0.3	3.9	0.3	2.1	2.3	0.5	0.4	19.6	3.2	0.1	4.2	3.9	17.3	20.1	4.7	6.4	28.5	14.4	0.2	0.3	3.6	2.3	11.0	3.3	0.1	0.0	51.8	0.7	0.0	3.1	10.5	0.1	32.1	0.2	1.2	1.4	6.3	0.9	2.5	2.7	11.7	0.2	4.1	4.3	13.5	0.0	0.4	1.2	0.9	2.8	13.9	7.0	0.2	12.3	0.1	0.2	2.2	1.8	1.3	1.0	0.0	0.3	3.4	0.0	0.0	1.7	0.0	0.0	0.2	0.0	0.7	1.0	0.2	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.7	2.6	1.0	0.3	2.2	8.3	0.4	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.4	0.3	0.3	0.0	0.9	0.0	0.6	3.6	0.0	3.6	1.3	0.1	1.6	0.0	0.1	0.6	0.2	0.5	0.0	0.2	0.1	1.0	0.0	0.7	0.5	0.3	0.7	0.0	6.5	0.3	1.1	0.1	0.4	0.3	0.0	0.2	0.0	1.8	0.0	1.1	0.0	0.4	1.1	0.0	0.2	0.1	0.9	0.1	2.2	0.1	12.3	0.2	1.3	0.3	0.3	0.5	0.4	0.2	0.3	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.9	11.8	1.1	9.0	2.5	0.0	0.0	1.8	0.0	2.7	0.0	0.8	0.8	1.5	1.7	0.0	0.5	1.6	124.0	0.4	0.0	1.0	5.1	3.2	2.9	20.9	1.5	3.2	90.9	1.0	18.6	1.0	1.7	0.8	3.4	0.0	167.3	0.6	5.7	0.0	8.2	1.6	10.7	13.8	8.6	9.2	1.2	0.7
MRGPRF	"GPR140, GPR168, MGC21621, mrgF"	ENSG00000172935	"MAS related GPR family member F"	Q96AM1	11	69004395-69013409	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"Fibroblasts: 34.7;Leydig cells: 61.2;Peritubular cells: 94.7;Sertoli cells: 51.8;Smooth muscle cells: 90.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	4	"cerebellum: 7.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 26.8;ASC TERT1: 12.0;BJ: 15.1;BJ hTERT+: 38.1;BJ hTERT+ SV40 Large T+: 14.3;fHDF/TERT166: 11.6;U-2197: 18.2"	"Region enriched"	"Detected in some"	5	"cerebellum: 16.6"	"Low region specificity"	"Detected in all"			HPA028811	Approved		Supported	"Nuclear membrane,Plasma membrane"		NA	NA			"Nuclear membrane, Plasma membrane"		"HPA028811: AB_10603875"	"unprognostic (2.49e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.03e-2)"	"unprognostic (5.16e-2)"	"unprognostic (6.52e-3)"	"unprognostic (3.20e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.55e-7)"	"unprognostic (2.75e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.86e-2)"	"unprognostic (3.62e-3)"	10.8	1.7	0.8	7.6	1.2	0.0	26.6	7.8	1.5	61.9	39.5	1.2	13.9	4.8	49.2	22.3	28.2	28.0	30.6	6.2	0.7	0.4	4.2	2.1	4.8	5.6	1.1	1.3	25.6	0.9	0.4	1.1	5.9	1.8	29.6	4.8	5.8	2.9	25.5	3.1	4.0	10.1	41.1	1.0	8.2	14.2	13.1	0.6	0.1	3.8	6.4	2.7	42.2	19.6	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	26.8	12.0	0.5	15.1	38.1	14.3	9.5	0.0	0.6	0.0	0.3	11.6	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	1.1	0.0	3.3	0.0	0.0	8.8	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.6	0.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	8.8	0.0	18.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.2	7.8	1.5	0.7	0.4	1.1	1.3	1.8	0.6	0.0	0.0	0.0	0.2	4.4	0.0	0.6	2.5	0.0	0.0	10.4	0.0	0.6	0.0	0.0	3.6	0.6	0.0	0.0	0.0	0.6	34.7	0.3	0.0	3.4	0.9	0.0	0.0	5.5	0.0	5.2	61.2	0.0	6.8	0.0	0.0	2.8	0.1	0.0	94.7	0.6	0.2	51.8	90.4	1.0	0.5	3.3	0.9	0.0	0.0	0.2
MRLN	"Linc-RAM, LINC00948, M1, MLN, MUSER1"	ENSG00000227877	Myoregulin	P0DMT0	10	59736692-59756041	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 14.1;skeletal muscle: 59.2;tongue: 22.0"	"Group enriched"	"Detected in some"	5	"Ciliated cells: 65.6;Rod photoreceptor cells: 27.6"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.4"					"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	10	"RH-30: 22.7"	"Region enriched"	"Detected in single"	11	"cerebellum: 24.2"	"Low region specificity"	"Detected in some"									NA	NA							"unprognostic (2.32e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.54e-1)"	"unprognostic (3.17e-3)"		"unprognostic (9.77e-2)"		"unprognostic (1.09e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.12e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.46e-1)"	0.8	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.7	2.2	0.0	0.0	0.0		4.5	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	4.4	0.0	0.9	0.4	0.0	1.2	0.1	0.0	59.2	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.9	22.0	0.7	0.0	0.0	2.5	1.7	4.2	1.4	1.7	2.4	0.4	0.0	0.8	0.4	0.9	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.8	0.6	1.1	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.5	0.7	0.2	1.9	0.3	0.1	0.0	1.1	1.9	0.0	0.6	0.0	0.1	0.0	0.1	0.1	1.3	0.0	2.1	0.0	0.9	0.2	0.2	1.6	0.5	22.7	0.0	0.0	0.1	0.6	0.2	0.3	0.1	0.1	0.1	0.4	0.7	0.0	0.3	0.8	0.9	0.6	1.1	0.1	0.1	0.4	0.3	0.0	4.2	1.4	1.6	2.4	1.0	1.7	2.0	1.7	1.5	1.2	2.5	1.2	2.1	4.2	1.7	1.0	1.7	1.5	0.4											0.0	0.3	0.0	0.0	0.0	2.2	0.9	0.0	65.6	3.4	0.0	2.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.2	4.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	3.3	0.4	0.0	0.4	10.2	27.6	0.0	0.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0
MRVI1	"IRAG, JAW1L"	ENSG00000072952	"Murine retrovirus integration site 1 homolog"	Q9Y6F6	11	10573091-10693988	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Peritubular cells: 82.0;Sertoli cells: 51.8;Smooth muscle cells: 82.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"neutrophil: 18.5"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 18.5"	"Cell line enhanced"	"Detected in some"		"ASC diff: 18.0;BJ: 12.7;BJ hTERT+: 14.7;fHDF/TERT166: 5.7;REH: 5.5"	"Region enriched"	"Detected in many"	5	"thalamus: 8.3"	"Low region specificity"	"Detected in many"			HPA008704	Uncertain		Approved	"Nuclear bodies,Cytosol"		NA	NA		280000	Cytosol	"Nuclear bodies"	"HPA008704: AB_1079413"	"unprognostic (2.18e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.86e-3)"	"prognostic favorable (5.78e-4)"	"unprognostic (5.30e-1)"	"unprognostic (3.37e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.63e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.98e-2)"	"prognostic unfavorable (9.70e-4)"	"unprognostic (3.72e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.97e-3)"	15.7	6.3	19.4	12.4	22.0	1.5	6.6	4.4	13.7	31.6	26.7	15.5	10.7	6.3	42.1	17.1	27.1	19.6	23.2	6.3	13.8	12.0	5.3	1.7	5.5	2.9	21.3	10.6	16.4	1.9	2.8	1.8	8.7	18.2	24.8	12.9	37.6	3.3	29.0	4.1	4.0	9.4	47.3	12.1	3.5	16.4	8.3	10.3	0.0	4.5	2.3	1.8	27.3	10.4	0.7	0.4	18.5	4.1	0.0	0.0	0.5	0.1	0.0	3.6	0.0	18.0	3.5	0.1	12.7	14.7	0.0	0.0	0.3	1.4	0.0	0.1	5.7	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.6	0.0	0.1	0.2	0.0	0.2	4.1	0.3	0.0	0.1	0.0	1.0	0.0	0.5	0.1	0.2	0.0	0.1	0.3	0.4	0.0	0.0	5.5	0.0	0.2	0.0	0.0	0.0	2.6	0.0	2.2	0.0	3.9	0.0	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	4.9	0.0	0.6	1.7	1.2	0.0	2.9	0.0	0.5	0.0	0.0	0.4	0.7	0.0	0.0	18.5	0.0	4.1	0.1	0.0	0.5	19.4	22.0	4.4	13.2	13.8	12.0	21.3	10.6	18.2	10.3	0.0	4.5	0.5	0.3	1.8	6.8	6.1	0.0	0.0	2.3	0.0	3.9	0.3	1.7	0.0	25.8	1.6	0.0	0.0	0.0	0.1	3.1	0.3	1.1	0.0	8.4	7.9	0.0	3.1	12.0	23.3	19.8	2.1	1.7	0.0	0.0	2.1	0.0	0.0	82.0	0.0	1.0	51.8	82.4	1.7	2.2	1.6	1.4	0.0	0.0	0.6
MS4A15		ENSG00000166961	"Membrane spanning 4-domains A15"	Q8N5U1	11	60756953-60776732	"Predicted membrane proteins"		Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	9	"blood: 9.9;lung: 32.4"	"Cell type enriched"	"Detected in some"	8	"Alveolar cells type 1: 89.3"	"Cancer enhanced"	"Detected in many"		"lung cancer: 6.3"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 9.9"	"Lineage enriched"	"Detected in single"	15	"T-cells: 9.9"	"Cell line enhanced"	"Detected in some"		"HEL: 9.2;JURKAT: 3.4;Karpas-707: 3.8;MOLT-4: 4.1;U-266/70: 13.5;U-266/84: 5.7"	"Region enriched"	"Detected in single"	28	"olfactory region: 205.0"	"Region enriched"	"Detected in single"	30	"olfactory region: 39.1"	HPA054563			Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA054563: "	"unprognostic (1.85e-1)"	"unprognostic (4.31e-3)"	"unprognostic (8.59e-2)"	"unprognostic (5.89e-4)"	"unprognostic (4.49e-1)"	"unprognostic (1.09e-3)"		"unprognostic (3.92e-3)"	"unprognostic (5.43e-3)"	"unprognostic (1.20e-1)"	"unprognostic (7.30e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.04e-9)"	"unprognostic (7.02e-2)"	"unprognostic (8.63e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.47e-1)"	0.3	0.2	0.3	0.3	0.3	0.0	1.3	0.3	0.3	0.3	0.3	0.3	0.3	0.6	1.8	0.3	0.4	1.0	0.3	0.3	0.3	0.2	0.3	0.3	32.4	0.3	0.3	0.3	2.4	0.3	0.0	0.3	1.1	0.3	0.3	0.5	0.3	0.3	1.9	0.3	0.2	1.4	1.7	0.3	0.3	0.2	0.6	0.3	0.3	0.3	0.3	1.0	0.7	0.3	0.2	0.0	0.0	0.0	0.6	9.9	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	9.2	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	3.4	1.6	3.8	0.0	0.0	4.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	1.1	0.0	0.0	0.0	0.5	0.0	0.0	13.5	5.7	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	2.9	0.5	0.0	0.0	1.8	0.7	0.0	0.6	0.0	0.0	9.9	0.7	0.3	0.3	0.3	0.3	0.3	0.2	0.3	0.3	0.3	0.3	89.3	4.8	0.0	0.0	0.0	0.0	0.2	0.0	2.7	11.4	0.0	0.0	0.7	0.0	0.0	4.7	0.0	0.0	0.0	0.0	2.2	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.9	0.0	1.7	0.0	0.0	0.0
MSX2	"CRS2, FPP, HOX8, MSH, PFM, PFM1"	ENSG00000120149	"Msh homeobox 2"	P35548	5	174724533-174730893	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Osteogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Craniosynostosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 44.7;urinary bladder: 18.2"	"Group enriched"	"Detected in many"	16	"Cytotrophoblasts: 123.2;Syncytiotrophoblasts: 195.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	4	"BEWO: 84.9"	"Region enriched"	"Detected in single"	7	"cerebellum: 6.9"	"Low region specificity"	"Detected in some"			HPA005652	Uncertain		Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA005652: AB_1079418"	"unprognostic (1.29e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.84e-1)"	"prognostic favorable (8.43e-5)"	"unprognostic (2.50e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.13e-1)"	"prognostic unfavorable (6.93e-4)"	"unprognostic (2.08e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.51e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.36e-4)"	"unprognostic (7.64e-3)"	"unprognostic (5.06e-2)"	"unprognostic (2.12e-6)"	"unprognostic (1.43e-2)"	2.0	0.4	0.3	0.4	0.5	0.0	7.6	6.3	1.6	2.6	0.9	2.0	0.0	0.3	6.2	0.2	0.9	1.1	1.5	1.7	2.5	0.5	0.3	0.1	0.9	0.1	1.5	1.2	0.4	0.6	9.4	0.5	44.7	7.2	6.3	0.1	6.6	0.9	0.8	2.1	6.4	0.9	10.4	6.6	1.1	2.6	5.2	1.3	0.0	0.8	0.2	0.3	18.2	2.4	0.0	0.0	0.0	0.0	0.2	0.5	0.1	0.1	1.0	0.3	0.8	0.0	0.0	84.9	0.5	0.9	0.2	0.0	14.4	5.9	0.0	2.2	0.0	5.2	1.6	4.5	1.6	0.0	0.0	2.8	0.0	0.3	0.0	0.6	0.0	0.8	1.0	1.2	0.8	0.9	0.0	0.0	0.0	0.0	0.0	1.2	6.9	0.0	0.1	0.6	9.6	2.2	0.0	2.3	0.0	1.0	9.0	0.0	0.6	0.0	11.2	0.7	19.3	6.7	0.0	0.0	0.2	1.4	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.3	0.5	6.3	1.6	2.5	0.5	1.5	1.2	7.2	1.3	0.0	0.0	0.0	2.4	8.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	123.2	0.0	0.6	0.1	0.5	0.5	0.0	0.0	7.6	5.0	2.6	4.6	0.0	9.9	0.0	0.0	0.6	0.6	0.2	0.0	0.0	1.7	0.0	1.0	1.2	0.8	0.0	0.0	0.0	0.0	0.0	3.1	1.1	4.9	9.9	195.5	0.0	0.4	8.3
MYBPC3	"CMH4, FHC, MYBP-C"	ENSG00000134571	"Myosin binding protein C, cardiac"	Q14896	11	47331397-47352702	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"	"Actin-binding, Muscle protein"	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	108	"heart muscle: 199.6"	"Cell type enriched"	"Detected in some"	61	"Cardiomyocytes: 1683.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.8"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.8"	"Cell line enriched"	"Detected in single"	17	"U-937: 12.0"	"Region enriched"	"Detected in single"	33	"cerebellum: 38.5"	"Not detected"	"Not detected"			"HPA040147, HPA043898"	Enhanced					NA	NA		44000			"HPA040147: AB_2676861, HPA043898: AB_2678720"	"unprognostic (1.06e-1)"	"unprognostic (1.47e-6)"	"unprognostic (2.17e-1)"	"unprognostic (6.16e-2)"	"unprognostic (3.00e-3)"	"unprognostic (1.40e-4)"	"unprognostic (7.47e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.53e-2)"	"unprognostic (4.22e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.15e-1)"	"unprognostic (3.21e-2)"	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	199.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	12.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.2	0.0	0.0	0.0	0.0	1683.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	14.7	0.3	0.8	0.0	1.8	1.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.6	0.0
MYO3B		ENSG00000071909	"Myosin IIIB"	Q8WXR4	2	170178145-170655171	"Enzymes, Predicted intracellular proteins"	"Hearing, Sensory transduction, Vision"	"Actin-binding, Kinase, Motor protein, Myosin, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 20.0;parathyroid gland: 12.6;retina: 21.6"	"Cell type enhanced"	"Detected in some"	20	"Cone photoreceptor cells: 80.5;Early spermatids: 23.6;Late spermatids: 18.5;Rod photoreceptor cells: 57.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.4;naive CD8 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.4"	"Group enriched"	"Detected in some"	10	"HDLM-2: 11.3;HEL: 10.4;RT4: 11.7"	"Region enriched"	"Detected in single"	5	"basal ganglia: 4.7"	"Not detected"	"Not detected"			HPA045483	Approved					NA	NA					"HPA045483: AB_2679344"	"unprognostic (1.65e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.15e-3)"	"unprognostic (5.07e-2)"	"unprognostic (2.61e-2)"	"unprognostic (5.84e-3)"	"unprognostic (2.12e-1)"	"unprognostic (7.99e-3)"	"unprognostic (2.59e-1)"	"unprognostic (4.25e-5)"	"unprognostic (2.34e-1)"	"unprognostic (8.12e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.07e-1)"	0.2	0.2	0.3	0.0	0.3	0.0	0.2	0.2	0.3	0.6	0.2	0.0	4.6	0.0	0.3	20.0	0.3	0.5	0.0	0.3	0.3	0.5	8.5	0.2	0.3	0.5	0.3	0.3	0.4	2.2	12.6	1.0	0.0	0.3	0.3	0.0	21.6	1.4	1.1	0.2	0.5	0.2	0.5	0.2	0.3	0.2	4.2	0.0	0.0	2.2	0.0	0.8	4.4	0.3	0.1	0.3	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	11.3	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.5	0.3	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.2	0.3	0.3	0.5	0.3	0.3	0.3	0.0	0.0	0.3	0.0	0.3	0.6	2.9	0.4	0.0	0.0	0.0	3.5	80.5	0.0	11.6	0.3	23.6	0.3	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	1.7	0.0	0.3	18.5	0.3	0.2	0.0	0.0	0.2	1.6	0.1	0.0	0.4	0.1	57.8	0.0	0.1	0.9	0.2	0.4	0.1	0.0	0.0	0.1
MYOZ1	"CS-2, FATZ, MYOZ"	ENSG00000177791	"Myozenin 1"	Q9NP98	10	73631654-73641757	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	24	"skeletal muscle: 387.8;tongue: 133.0"	"Cell type enhanced"	"Detected in some"	10	"Cardiomyocytes: 5.6;Collecting duct cells: 5.2;Distal tubular cells: 6.6;Hofbauer cells: 6.6;Peritubular cells: 7.1;Sertoli cells: 12.9"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 7.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"BEWO: 30.4"	"Region enriched"	"Detected in single"	17	"olfactory region: 4.9"	"Low region specificity"	"Detected in all"			"HPA037848, HPA038437"	Enhanced					NA	NA					"HPA037848: AB_10670156, HPA038437: AB_2676009"	"unprognostic (4.55e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.90e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.08e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.22e-4)"	"unprognostic (1.18e-1)"	"unprognostic (9.25e-2)"	"unprognostic (2.55e-2)"	"unprognostic (5.59e-2)"	"unprognostic (5.14e-2)"	"unprognostic (2.64e-2)"	"unprognostic (6.78e-2)"	"unprognostic (7.17e-2)"	"unprognostic (1.09e-1)"	8.1	0.1	0.2	0.1	0.2	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	10.9	4.2	0.1	0.1	4.1	0.2	0.2	0.2	0.1	0.4	0.1	0.2	0.0	0.2	0.1	0.1	0.2	0.4	0.0	1.3	0.1	0.0	5.6	0.3	387.8	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.0	0.0	1.4	133.0	5.0	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	30.4	0.3	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.2	0.1	5.3	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.3	0.7	0.2	0.0	0.8	0.8	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.2	0.0	0.1	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.2	2.3	5.6	0.0	0.0	2.3	5.2	0.0	0.1	6.6	0.1	0.1	0.0	0.0	0.0	0.2	1.7	0.5	0.1	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.8	0.9	0.0	0.0	0.0	0.0	3.5	0.0	0.0	7.1	0.2	0.4	12.9	5.0	0.3	1.4	0.3	0.1	0.0	0.0	0.3
NEUROD1	"BETA2, BHF-1, bHLHa3, MODY6, NeuroD"	ENSG00000162992	"Neuronal differentiation 1"	Q13562	2	181673088-181680876	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	7	"brain: 101.9"	"Cell type enhanced"	"Detected in some"	26	"Cone photoreceptor cells: 141.4;Intestinal endocrine cells: 408.1;Rod photoreceptor cells: 170.4"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 4.3"	"Region enriched"	"Detected in many"	16	"cerebellum: 101.9"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	72	"SCLC-21H: 81.2"	"Region enriched"	"Detected in many"	14	"cerebellum: 242.4"	"Region enriched"	"Detected in many"	20	"cerebellum: 447.6"	"HPA003278, CAB022450"	Approved					NA	NA					"CAB022450: , HPA003278: AB_1845331"			"unprognostic (1.29e-1)"		"prognostic favorable (1.34e-4)"						"unprognostic (6.92e-3)"			"unprognostic (1.27e-1)"				0.2	0.2	6.3	0.2	0.8	0.1	0.2	101.9	5.6	0.2	3.1	0.0	0.0	8.9	0.2	0.1	0.2	0.2	0.0	0.2	4.7	0.4	0.2	0.2	0.2	0.0	0.4	1.2	0.2	13.3	0.0	0.8	0.0	3.9	0.2	1.9	14.4	0.2	0.0	0.2	0.2	5.8	0.0	1.4	0.2	7.6	0.7	0.0	0.0	0.2	0.0	0.0	0.2	0.2	1.1	1.0	3.5	1.8	1.4	1.5	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	81.2	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.6	1.0	0.8	1.1	1.5	1.1	1.1	0.8	0.8	1.0	1.3	1.4	1.8	1.4	1.8	1.0	1.0	0.7	6.3	0.8	101.9	2.5	4.7	0.4	0.4	1.2	3.9	0.0	0.0	0.0	0.0	0.1	0.0	61.1	0.3	0.0	0.0	0.0	0.0	141.4	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.4	408.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	17.4	2.8	0.2	0.0	0.0	170.4	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.6	0.1
NKX2-4	"NKX2.4, NKX2D"	ENSG00000125816	"NK2 homeobox 4"	Q9H2Z4	20	21395367-21398028	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.5;pituitary gland: 1.2;testis: 5.2"	"Group enriched"	"Detected in some"	21	"Cardiomyocytes: 1.2;Early spermatids: 2.4;Late spermatids: 1.9;Spermatocytes: 3.8;Spermatogonia: 1.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 3.7;HEK 293: 7.8;SCLC-21H: 5.1;SK-MEL-30: 5.9;WM-115: 1.8"	"Region enriched"	"Detected in single"	22	"hypothalamus: 3.1"	"Region enriched"	"Detected in single"	32	"hypothalamus: 1.4"	HPA074996			Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA074996: AB_2686725"					"unprognostic (3.77e-1)"				"unprognostic (2.15e-1)"						"unprognostic (1.68e-1)"			0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.1		0.0	0.0	0.0	1.2	0.0		0.0	0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	5.1	0.0	0.0	0.0	5.9	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	1.2	0.0	0.0	0.0	0.0	0.0
NMB	"MGC17211, MGC2277, MGC3936"	ENSG00000197696	"Neuromedin B"	P08949	15	84655129-84658563	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"adipose tissue: 37.2;brain: 28.5;breast: 59.9"	"Cell type enhanced"	"Detected in many"	6	"Ductal cells: 91.4"	"Cancer enhanced"	"Detected in all"		"glioma: 93.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 28.0"	"Region enriched"	"Detected in many"	16	"olfactory region: 206.6"	"Group enriched"	"Detected in many"	6	"olfactory region: 80.6;pons and medulla: 17.5"	CAB019302	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"	"Secreted to blood"	NA	NA			"Nucleoplasm, Vesicles"	"Plasma membrane"	"CAB019302: "	"unprognostic (2.44e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.34e-3)"	"unprognostic (3.79e-1)"	"prognostic favorable (3.43e-4)"	"unprognostic (3.81e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.36e-1)"	"unprognostic (7.24e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (2.25e-4)"	"unprognostic (7.92e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.00e-1)"	37.2	8.0	4.6	2.8	7.5	3.3	59.9	2.4	28.5	4.0	6.5	13.7	1.0	2.3	3.1	3.2	2.5	5.0	4.5	7.0	7.0	12.2	4.4	1.9	3.8	3.6	6.6	3.5	3.4	3.3	2.7	4.2	1.4	5.6	1.9	2.1	2.6	4.6	1.8	2.0	1.8	1.4	2.9	9.9	2.0	2.5	6.4	4.8	2.2	8.9	4.9	1.9	4.7	8.5	7.0	10.4	5.9	0.8	1.3	6.4	2.6	28.0	10.7	2.0	0.4	5.5	2.5	0.2	1.7	3.3	3.8	5.2	3.7	7.7	1.2	4.5	4.4	0.0	5.0	10.7	2.2	2.2	10.5	13.5	4.3	4.2	17.4	1.4	2.9	4.7	2.5	0.9	5.9	2.3	2.5	5.5	7.7	0.0	0.4	2.1	16.4	2.7	9.5	7.9	5.9	3.1	8.4	0.0	12.4	3.6	2.2	1.1	12.2	2.8	1.6	12.7	2.1	1.9	11.2	1.4	0.7	3.7	3.5	2.7	0.2	3.0	2.6	8.7	16.2	4.5	0.0	0.8	5.9	6.3	0.6	2.3	4.9	5.0	6.4	3.5	7.0	4.8	3.6	1.2	1.3	0.3	10.4	5.6	2.6	4.6	7.5	2.4	8.5	7.0	12.2	6.6	3.5	5.6	4.8	3.0	2.4	14.3	22.9	13.9	1.6	2.2	7.6	10.7	7.9	29.6	0.0	1.7	11.6	91.4	24.0	11.3	1.7	0.0	50.2	7.5	17.3	30.7	5.7	2.9	30.9	4.8	17.9	4.9	4.8	7.5	4.0	28.4	32.1	29.7	4.9	7.0	39.2	7.0	3.5	22.5	2.3	12.9	29.9	11.1	21.2	11.2	2.6	11.4	8.0	39.6
NPFF	FMRFAL	ENSG00000139574	"Neuropeptide FF-amide peptide precursor"	O15130	12	53506690-53507638	"Predicted secreted proteins"		Neuropeptide		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	28	"epididymis: 154.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"cerebellum: 2.0;hypothalamus: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"HHSteC: 17.7"	"Region enriched"	"Detected in single"	7	"pons and medulla: 11.9"	"Region enriched"	"Detected in all"	7	"cerebellum: 143.2"						"Secreted in male reproductive system"	NA	NA																							0.3	0.1	0.1	0.1	0.3	0.0	0.1	2.0	0.1	0.5	0.2	0.1	1.1	0.2	0.1	154.7	0.1	0.2	0.1	0.1	0.1	1.4	0.1	0.1	0.5	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	5.5	0.2	0.1	1.1	0.1	0.2	0.1	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	0.7	0.2	0.8	0.2	0.0	0.0	0.0	0.2	0.2	0.1	0.2	0.0	0.3	0.1	2.0	0.4	0.0	0.8	0.3	0.0	0.3	0.2	0.5	2.0	0.1	0.0	0.2	0.0	0.7	0.2	2.4	0.0	0.0	0.3	0.0	0.3	0.1	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	2.0	0.1	0.1	1.4	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NPFFR2	"GPR74, NPFF2, NPGPR"	ENSG00000056291	"Neuropeptide FF receptor 2"	Q9Y5X5	4	72031804-72148067	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 15.4;seminal vesicle: 10.1"	"Group enriched"	"Detected in some"	6	"Cytotrophoblasts: 5.4;Extravillous trophoblasts: 7.3;Horizontal cells: 3.2;Muller glia cells: 4.8;Syncytiotrophoblasts: 8.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 2.3"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	7	"GAMG: 22.5;NTERA-2: 7.3;RPTEC TERT1: 9.5;SH-SY5Y: 11.2;U-2 OS: 11.2"	"Region enriched"	"Detected in single"	4	"olfactory region: 5.3"	"Low region specificity"	"Detected in many"			HPA026825			Approved	"Plasma membrane,Actin filaments"	"Intracellular and membrane"	NA	NA			"Plasma membrane"	"Actin filaments"	"HPA026825: AB_10603123"	"unprognostic (1.28e-1)"		"unprognostic (1.05e-2)"		"unprognostic (1.53e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.07e-2)"	"unprognostic (4.68e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.40e-5)"	"unprognostic (5.75e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.48e-1)"	0.9	0.2	5.5	0.7	2.6	0.2	1.4	0.2	3.5	0.5	0.5	0.0	0.0	0.5	0.1	2.8	0.3	0.8	0.4	0.4	0.9	2.9	0.6	0.2	0.2	0.6	0.5	4.0	0.3	1.2	0.1	1.0	4.6	1.5	3.2	0.9	1.4	0.3	10.1	0.3	0.7	0.5	0.2	0.6	0.5	0.4	1.6	0.0	15.4	1.2	0.0	0.6	2.5	0.7	0.6	0.3	2.3	0.3	0.8	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	11.2	0.0	0.0	0.0	1.6	0.0	0.0	1.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.2	0.4	0.2	0.2	0.1	0.3	0.2	0.1	0.1	0.6	0.2	0.2	1.1	0.8	0.3	0.3	0.2	0.1	5.5	2.6	0.2	3.5	0.9	2.9	0.5	4.0	1.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.2	0.4	0.1	0.0	0.0	0.2	7.3	1.0	0.0	0.0	0.0	0.9	3.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	4.8	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	8.1	0.0	0.0	0.0
NPPA	"ANP, PND"	ENSG00000175206	"Natriuretic peptide A"	P01160	1	11845709-11848345	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hormone, Vasoactive, Vasodilator"	"Atrial fibrillation, Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	418	"heart muscle: 1267.7"	"Cell type enriched"	"Detected in some"	14450	"Cardiomyocytes: 19644.9"	"Cancer enriched"	"Detected in some"	9	"glioma: 7.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 12.5;SH-SY5Y: 12.0"	"Region enriched"	"Detected in some"	8	"olfactory region: 28.1"	"Not detected"	"Not detected"			"HPA058269, HPA064007"	Enhanced				"Secreted to blood"	NA	NA		190000			"HPA058269: AB_2683660, HPA064007: "	"unprognostic (1.27e-3)"	"unprognostic (3.12e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.25e-2)"	"unprognostic (9.72e-3)"	"unprognostic (2.21e-1)"	"unprognostic (5.93e-4)"	"unprognostic (2.31e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.70e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.0	0.1	1267.7	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	1.7	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.6	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.3	0.0	0.3	0.8	0.0	0.5	3.0	1.1	1.7	2.6	2.1	0.0	0.0	1.6	0.9	0.0	0.0	0.0	6.7	2.7	4.3	0.3	0.0	1.5	4.0	0.0	0.0	0.0	1.0	2.6	2.7	1.5	6.6	0.0	1.4	4.6	0.0	0.0	0.0	0.0	0.6	0.0	1.2	5.9	5.1	0.0	0.9	0.5	7.7	1.9	0.1	0.7	0.6	0.8	0.8	0.0	1.8	12.5	12.0	0.7	0.0	2.2	1.2	1.6	0.2	0.4	2.1	4.3	3.4	0.3	1.3	3.2	4.9	0.3	3.5	1.1	0.0	0.4	0.0	0.1	0.8	0.4	1.3	0.0	0.0	0.0	0.0	0.1	0.5	0.3	0.0	0.5	0.0	0.0	3.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	19644.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NPR1	"ANPa, ANPRA, GUCY2A, NPRA"	ENSG00000169418	"Natriuretic peptide receptor 1"	P16066	1	153678637-153693992	"Enzymes, FDA approved drug targets, Predicted membrane proteins"	"cGMP biosynthesis"	"Lyase, Receptor, Vasoactive"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 98.4"	"Cell type enriched"	"Detected in many"	10	"Ito cells: 136.2"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 39.2"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"ASC diff: 60.5"	"Region enriched"	"Detected in many"	5	"olfactory region: 23.0"	"Region enhanced"	"Detected in single"		"olfactory region: 11.1"	HPA031087			Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA			Nucleoli	"Nucleoplasm, Plasma membrane"	"HPA031087: AB_10601975"	"unprognostic (2.54e-1)"	"unprognostic (3.03e-3)"	"unprognostic (6.31e-2)"	"prognostic unfavorable (3.97e-4)"	"unprognostic (1.55e-1)"	"unprognostic (6.60e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.27e-2)"	"prognostic favorable (2.49e-4)"	"unprognostic (1.27e-1)"	"unprognostic (6.69e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.06e-1)"	"unprognostic (1.74e-2)"	41.1	4.3	0.5	5.9	0.9	0.1	98.4	0.5	0.8	8.1	8.2	0.3	7.3	1.2	16.8	11.1	8.7	25.0	9.3	19.6	0.9	0.5	28.7	3.7	34.8	8.6	0.7	0.0	19.5	4.2	7.8	4.5	11.8	2.5	4.9	1.5	2.0	2.0	9.0	6.9	3.4	4.6	15.6	2.2	1.2	5.0	6.4	0.2	0.8	7.6	5.1	1.1	11.6	26.5	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	60.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	10.0	0.0	7.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	5.7	0.0	0.0	0.8	0.0	0.0	0.0	0.6	0.0	2.0	0.4	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.9	0.5	0.8	0.9	0.5	0.7	0.0	2.5	0.2	0.0	5.8	0.0	0.4	1.3	0.0	4.8	5.1	0.0	0.0	14.0	0.0	0.1	0.0	0.6	8.0	14.2	0.0	0.0	0.0	0.9	3.9	0.4	0.0	1.5	0.2	0.0	0.0	136.2	6.0	7.9	9.5	0.0	0.0	9.0	0.0	0.0	0.7	0.0	3.9	2.8	0.0	0.0	0.9	0.2	0.1	0.9	0.6	0.0	0.0	0.0
NPVF	"C7orf9, RFRP"	ENSG00000105954	"Neuropeptide VF precursor"	Q9HCQ7	7	25224570-25228486	"Predicted secreted proteins"		Neuropeptide		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	30	"brain: 9.5;lymphoid tissue: 2.9;retina: 7.0"	"Cell type enriched"	"Detected in some"	44	"Muller glia cells: 336.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	95	"hypothalamus: 9.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	17	"hypothalamus: 7.2"	"Region enriched"	"Detected in some"	4	"hypothalamus: 3.8"	HPA041733	Enhanced				"Secreted in other tissues"	NA	NA					"HPA041733: AB_10794524"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	336.5	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NR0B2	SHP	ENSG00000131910	"Nuclear receptor subfamily 0 group B member 2"	Q15466	1	26911489-26913966	"Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Receptor, Repressor"	"Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"intestine: 47.2;liver: 49.4;pancreas: 52.8"	"Cell type enhanced"	"Detected in many"	17	"Cholangiocytes: 56.0;Distal tubular cells: 44.7;Exocrine glandular cells: 37.2;Hepatocytes: 149.9"	"Group enriched"	"Detected in many"	5	"liver cancer: 52.3;stomach cancer: 11.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	32	"Hep G2: 41.9"	"Region enriched"	"Detected in single"	6	"cerebellum: 1.9"	"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (2.99e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.95e-3)"	"unprognostic (4.68e-3)"	"unprognostic (9.21e-2)"	"unprognostic (8.22e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.44e-2)"		"unprognostic (1.83e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.11e-2)"	"unprognostic (6.74e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.12e-3)"	"unprognostic (1.10e-2)"	0.1	7.5	0.1	0.1	0.2	0.0	0.1	0.2	0.1	0.1	11.8	0.3	0.1	32.6	0.1	0.8	0.1	0.0	18.5	16.6	0.1	0.0	9.3	49.4	2.4	0.1	0.1	0.1	0.1	52.8	0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.3	0.1	3.5	0.0	47.2	0.1	0.1	5.3	8.5	0.4	0.1	0.1	0.1	0.2	0.1	0.1	0.1	1.0	0.6	0.0	0.4	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	41.9	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.6	1.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.2	0.2	0.1	0.1	0.0	0.1	0.1	0.2	0.1	3.0	12.0	1.5	0.0	0.0	0.0	7.4	56.0	0.0	1.2	12.2	0.0	0.0	44.7	17.4	0.4	0.0	1.7	23.3	37.2	0.0	0.0	0.0	0.0	149.9	0.1	27.0	23.4	1.8	2.2	0.0	0.0	0.0	0.0	0.0	5.8	0.2	19.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	5.7	0.0
NR5A1	"AD4BP, ELP, FTZ1, FTZF1, hSF-1, SF-1"	ENSG00000136931	"Nuclear receptor subfamily 5 group A member 1"	Q13285	9	124481236-124507430	"Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"Disease mutation, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 47.7;lymphoid tissue: 50.8"	"Group enriched"	"Detected in some"	10	"Leydig cells: 10.9;Peritubular cells: 7.1;Sertoli cells: 12.9"	"Group enriched"	"Detected in some"	5	"head and neck cancer: 1.7;ovarian cancer: 2.4;testis cancer: 2.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	13	"plasmacytoid DC: 1.3"	"Lineage enriched"	"Detected in single"	13	"dendritic cells: 1.3"	"Cell line enhanced"	"Detected in some"		"HEL: 39.1;Hep G2: 25.3;K-562: 9.3"	"Region enriched"	"Detected in single"	20	"hypothalamus: 6.1"	"Not detected"	"Not detected"			HPA079181			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA079181: "	"unprognostic (1.66e-1)"	"unprognostic (3.08e-1)"	"unprognostic (6.13e-5)"	"unprognostic (2.32e-7)"	"unprognostic (3.95e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.60e-2)"	"unprognostic (9.74e-2)"	"unprognostic (4.14e-2)"			"unprognostic (4.75e-3)"	"unprognostic (1.14e-1)"		"unprognostic (1.49e-2)"	0.2	47.7	0.2	0.2	0.5	0.0	0.2	0.2	0.4	0.2	0.2	1.3	0.2	0.0	0.2	0.4	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	13.1	0.2	0.0	5.8	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	50.8	0.0	9.4	0.2	0.2	0.2	0.2	0.2	0.2	0.8	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.1	0.0	25.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.5	0.2	0.4	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	12.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
NRK	DKFZp686A17109	ENSG00000123572	"Nik related kinase"	Q7Z2Y5	X	105822543-105958610	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 42.2;placenta: 64.8"	"Group enriched"	"Detected in some"	4	"Cytotrophoblasts: 56.0;Leydig cells: 105.0;Syncytiotrophoblasts: 56.8"	"Cancer enriched"	"Detected in some"	8	"testis cancer: 6.1"	"Region enriched"	"Detected in single"	10	"cerebellum: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 30.7;HSkMC: 5.9;RH-30: 7.0;RPTEC TERT1: 18.9;SuSa: 23.1"	"Region enriched"	"Detected in single"	28	"cerebellum: 16.0"	"Low region specificity"	"Detected in many"			HPA017238	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA017238: AB_1854645"	"unprognostic (2.64e-4)"	"unprognostic (9.82e-2)"	"unprognostic (5.98e-3)"	"unprognostic (5.52e-2)"		"unprognostic (3.87e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.08e-2)"	"unprognostic (3.24e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.47e-3)"	"unprognostic (1.14e-1)"	"unprognostic (4.28e-2)"	"unprognostic (6.80e-3)"	2.6	12.7	0.4	2.7	0.4	0.0	0.8	4.3	0.3	3.5	1.5	0.1	4.6	0.0	4.3	15.6	1.6	1.3	7.5	2.9	0.4	0.4	9.9	0.4	0.5	0.0	0.3	0.0	42.2	0.5	0.0	2.9	64.8	0.2	22.0	0.1	0.0	2.1	1.6	0.4	0.4	0.5	2.8	0.4	0.3	0.9	10.6	0.0	0.0	0.5	3.1	0.3	1.9	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	5.9	0.0	0.0	0.0	1.9	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	7.0	0.0	18.9	0.3	0.0	0.1	0.0	1.0	0.0	23.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	4.3	0.3	0.4	0.4	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	56.0	16.6	0.2	0.9	0.3	0.0	0.0	0.0	7.2	0.5	0.3	0.0	0.0	6.1	0.0	0.0	0.0	0.0	1.1	105.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.1	0.0	0.0	0.0	0.6	1.4	0.0	56.8	0.0	0.0	0.1
OLFML2B	DKFZP586L151	ENSG00000162745	"Olfactomedin like 2B"	Q68BL8	1	161983192-162023854	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 56.2;Hofbauer cells: 31.7;Kupffer cells: 20.4;Leydig cells: 19.2;Peritubular cells: 27.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"intermediate monocyte: 8.8;non-classical monocyte: 6.5"	"Lineage enriched"	"Detected in single"	10	"monocytes: 8.8"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 16.0;HSkMC: 45.3;RH-30: 34.6"	"Region enriched"	"Detected in many"	6	"hippocampal formation: 45.1"	"Low region specificity"	"Detected in many"			"HPA054136, HPA062739"	Approved		Approved	Cytosol	"Secreted - unknown location"	NA	NA			Cytosol		"HPA054136: AB_2682397, HPA062739: AB_2684858"	"unprognostic (2.97e-2)"	"unprognostic (1.79e-1)"	"unprognostic (8.91e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.22e-2)"	"prognostic unfavorable (4.67e-4)"	"unprognostic (5.97e-3)"	"unprognostic (7.32e-2)"	"unprognostic (7.68e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (1.01e-12)"	"unprognostic (1.64e-3)"	"unprognostic (2.11e-2)"	"unprognostic (4.53e-3)"	"unprognostic (1.97e-2)"	19.6	6.6	1.7	12.8	3.0	0.3	12.3	0.6	4.1	13.0	14.5	2.9	6.5	1.5	14.2	21.8	3.2	9.8	33.7	25.4	2.9	1.6	3.9	1.2	12.8	24.1	2.9	1.2	7.0	2.3	3.2	2.6	27.6	2.2	6.6	2.2	14.5	9.0	6.1	6.1	8.9	5.0	15.1	3.6	22.4	3.4	12.5	2.1	1.9	18.3	13.7	8.5	12.4	7.3	0.0	0.8	0.3	8.8	0.0	0.1	0.2	0.0	0.1	2.6	0.8	8.4	16.0	0.0	0.8	4.1	1.7	4.6	0.0	0.0	0.0	0.1	9.7	1.7	0.0	0.2	0.0	1.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.3	45.3	0.0	2.0	0.0	0.8	0.2	0.0	0.0	0.4	7.4	0.0	0.0	0.1	0.8	0.0	0.4	0.0	34.6	3.3	0.6	0.0	0.3	0.1	3.4	0.0	0.2	8.0	0.0	0.0	0.0	1.0	0.2	1.5	1.3	0.0	0.0	0.0	9.9	1.0	0.5	0.0	0.6	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.1	0.3	0.0	6.5	0.0	0.0	0.2	1.7	3.0	0.6	4.1	2.9	1.6	2.9	1.2	2.2	2.1	0.0	1.1	0.0	0.0	3.0	0.0	2.5	0.0	0.0	1.2	1.8	0.0	0.2	0.0	0.0	56.2	0.0	0.0	0.0	0.0	0.3	9.3	0.1	1.1	0.0	31.7	0.0	0.0	1.8	20.4	4.5	19.2	9.9	1.7	1.0	0.0	0.9	0.0	0.0	27.6	0.0	0.0	6.5	12.6	1.5	0.9	1.9	0.2	0.0	0.0	0.0
OMP		ENSG00000254550	"Olfactory marker protein"	P47874	11	77102840-77103331	"Predicted intracellular proteins"	"Olfaction, Sensory transduction"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 5.4;liver: 3.9"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 2.7;CACO-2: 3.3;OE19: 4.5"	"Region enriched"	"Detected in single"	63	"olfactory region: 119.4"											NA	NA							"unprognostic (2.22e-1)"	"unprognostic (2.44e-1)"	"unprognostic (8.53e-2)"	"unprognostic (3.54e-1)"		"unprognostic (1.14e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.52e-3)"	"unprognostic (2.10e-1)"	"unprognostic (3.20e-2)"	"unprognostic (4.23e-1)"	"unprognostic (5.33e-3)"	"unprognostic (3.94e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.17e-2)"	0.0	0.8	0.1	0.2	0.2	1.9	0.0	0.1	0.1	0.4	3.0			5.4	0.0	0.0	1.3	0.2	2.3	0.2	0.0	0.1	0.6	3.9	0.2	0.0	0.0		0.3	0.5	0.0	0.2	0.0		0.5	3.8		0.3	0.1	0.0	0.0	5.0	0.1	0.1	0.1	1.9	0.7			0.2		0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	1.1	0.0	0.0	1.1	0.0	2.7	0.4	3.3	0.0	0.0	0.6	0.8	1.9	0.0	0.0	0.0	0.0	0.0	0.8	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	1.3	0.3	0.2	0.0	0.7	0.0	0.3	0.0	0.0	4.5	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.7	0.6	0.0	0.0	0.7	0.7	0.0	0.0	1.5	0.3	1.1	1.1	0.0	1.3	0.5	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OSTN		ENSG00000188729	Osteocrin	P61366	3	191199241-191265615	"Predicted secreted proteins"	Differentiation	"Developmental protein, Hormone"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 7.8;brain: 7.9;prostate: 8.0"	"Cell type enhanced"	"Detected in single"	31	"Early spermatids: 2.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	4	"memory B-cell: 7.8"	"Lineage enriched"	"Detected in single"	10	"B-cells: 7.8"	"Cell line enriched"	"Detected in some"	24	"U-2197: 30.2"	"Region enriched"	"Detected in single"	4	"cerebellum: 1.2"	"Low region specificity"	"Detected in all"			"CAB024997, CAB025649, HPA030878"	Uncertain				"Secreted in other tissues"	NA	NA					"CAB024997: , CAB025649: , HPA030878: AB_2673642"					"unprognostic (2.35e-2)"		"unprognostic (9.12e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.52e-1)"	"unprognostic (8.11e-3)"	"unprognostic (2.90e-1)"	"unprognostic (1.45e-1)"			0.9	0.4	1.9	1.6	2.1	0.0	0.6	0.2	7.9	7.1	0.4	0.0	0.0	0.0	0.2	4.4	0.1	1.9	1.9	1.5	1.8	1.9	0.5	1.6	1.0	1.3	1.5	2.4	0.5	0.1	0.0	0.3	1.1	0.4	8.0	0.1	0.0	0.4	0.2	2.3	3.4	0.3	2.3	1.1	0.5	0.6	1.1	0.0	0.0	0.6	0.7	0.0	3.7	1.0	7.8	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.2	0.0	1.2	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	1.9	2.1	0.2	7.9	1.8	1.9	1.5	2.4	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0
OTOP2		ENSG00000183034	"Otopetrin 2"	Q7RTS6	17	74924275-74933912	"Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 20.4;testis: 5.1"	"Cell type enriched"	"Detected in some"	48	"Paneth cells: 508.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.4"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 1.4"	"Cell line enriched"	"Detected in single"	47	"HDLM-2: 15.2"	"Region enriched"	"Detected in single"	13	"olfactory region: 15.6"	"Low region specificity"	"Detected in all"			"HPA024524, HPA053090"	Uncertain		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA024524: AB_2671592, HPA053090: AB_2682041"		"unprognostic (1.62e-2)"	"unprognostic (1.45e-1)"			"unprognostic (7.25e-2)"		"unprognostic (3.21e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.30e-1)"			"unprognostic (2.85e-2)"	"unprognostic (3.81e-1)"	"unprognostic (9.04e-2)"		"unprognostic (2.04e-2)"	0.1	0.0	0.1	2.9	0.1	0.0	0.1	0.1	0.1	0.1	20.4	0.1	0.1	0.2	0.5	0.1	1.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	10.9	0.1	0.1	0.1	0.1	0.2	11.3	0.2	0.1	0.1	0.0	5.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	1.4	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	15.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	10.6	0.0	0.0	0.0	0.0	2.7	0.0	0.0	508.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.5	0.0
OTOS	OTOSP	ENSG00000178602	Otospiralin	Q8NHW6	2	240139026-240144562	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	7	"pituitary gland: 39.1;thyroid gland: 41.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"glioma: 6.5;thyroid cancer: 28.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 2.1;hTEC/SVTERT24-B: 1.8;U-138 MG: 2.2"	"Region enriched"	"Detected in single"	4	"hippocampal formation: 1.8"	"Low region specificity"	"Detected in all"								"Secreted in other tissues"	NA	NA						"unprognostic (8.52e-2)"			"unprognostic (1.73e-1)"	"unprognostic (9.01e-3)"					"unprognostic (1.35e-1)"					"unprognostic (2.72e-1)"	"unprognostic (3.27e-3)"		0.3	0.3	4.5	0.3	4.6	0.3	0.4	0.3	3.8	0.5	0.3	0.7	0.0	0.3	0.4	0.7	0.3	0.4	0.3	0.3	2.4	1.1	0.3	0.3	0.3	0.3	0.6	2.0	0.3	0.3	0.3	39.1	0.3	5.5	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.8	0.3	0.3	0.4	0.8	0.0	41.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.3	0.0	0.9	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.2	0.7	0.0	0.5	0.0	0.1	0.0	0.4	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	4.6	0.3	3.8	2.4	1.1	0.6	2.0	5.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OTP		ENSG00000171540	"Orthopedia homeobox"	Q5XKR4	5	77628712-77639688	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	10	"brain: 16.2"	"Group enriched"	"Detected in some"	8	"Sertoli cells: 6.5;Spermatocytes: 2.6"	"Cancer enriched"	"Detected in single"	6	"glioma: 1.2"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 3.3;SCLC-21H: 1.6;THP-1: 1.5"	"Region enriched"	"Detected in some"	7	"hypothalamus: 23.4"	"Region enhanced"	"Detected in some"		"hypothalamus: 24.0"	HPA059342	Enhanced	Supported	Supported	"Nucleoplasm,Nucleoli fibrillar center,Nuclear bodies"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center, Nuclear bodies"	"HPA059342: AB_2732635"	"unprognostic (1.00e-1)"	"unprognostic (2.40e-2)"		"unprognostic (6.25e-2)"	"unprognostic (8.06e-3)"	"unprognostic (1.16e-1)"		"unprognostic (7.77e-2)"	"unprognostic (7.77e-2)"	"unprognostic (2.39e-2)"	"unprognostic (9.66e-2)"	"unprognostic (4.64e-2)"	"unprognostic (7.76e-14)"	"unprognostic (3.38e-2)"	"unprognostic (1.84e-1)"		"unprognostic (9.49e-3)"	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	16.2	0.0	0.0	1.5	0.0	0.0		0.0	0.3	0.0	0.0	0.0		0.1	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.9	0.1	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.0	0.3	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	2.6	0.5	0.0	0.0	0.0	0.0	0.0
OXT	"OT, OT-NPI, OXT-NPI"	ENSG00000101405	"Oxytocin/neurophysin I prepropeptide"	P01178	20	3071620-3072517	"Plasma proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"brain: 232.0"	"Cell type enhanced"	"Detected in many"	16	"Early spermatids: 9.2;Hepatocytes: 37.5;Late spermatids: 23.3;Proximal tubular cells: 10.5"	"Cancer enriched"	"Detected in some"	5	"testis cancer: 12.1"	"Region enriched"	"Detected in some"	59	"hypothalamus: 232.0"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"CACO-2: 5.2;HL-60: 1.3;HMC-1: 3.8;PC-3: 2.7"	"Region enriched"	"Detected in some"	5	"hypothalamus: 210.0"	"Group enriched"	"Detected in some"	1042	"basal ganglia: 840.1;hypothalamus: 2453.1"	HPA071892	Supported	Supported			"Secreted to blood"	NA	NA	1500000				"HPA071892: AB_2732190"	"unprognostic (7.45e-3)"	"unprognostic (1.99e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.82e-2)"	"unprognostic (8.22e-2)"	"unprognostic (8.36e-2)"	"unprognostic (6.02e-2)"	"unprognostic (3.05e-2)"	"unprognostic (6.65e-2)"	"unprognostic (6.18e-1)"	"unprognostic (3.81e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.10e-1)"	5.0	0.2	0.0	0.1	3.9	0.2	0.2	0.0	0.3	0.1	0.0	0.4	0.0	2.6	0.0	3.8	0.0	0.0	0.0	0.0	0.1	232.0	1.6	24.0	0.2	0.2	0.0	0.0	0.2	0.0	0.0	1.8	0.6	0.2	0.2	0.0	0.0	0.4	0.2	0.2	0.2	2.4	0.0	0.0	0.2	0.2	1.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.7	1.5	6.3	0.4	0.4	3.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	6.3	0.8	0.4	1.0	3.7	1.7	1.1	0.9	3.6	3.2	3.6	1.1	0.4	0.0	1.5	2.4	0.9	0.0	3.9	0.0	0.3	0.1	232.0	0.0	0.0	0.2	0.0	0.0	2.6	3.7	0.6	0.7	0.0	0.2	0.0	1.4	2.3	5.2	0.0	0.0	1.7	0.1	9.2	0.0	0.3	0.0	0.0	0.0	1.3	0.1	0.0	37.5	0.2	0.0	0.0	0.0	0.3	23.3	0.9	0.3	3.3	0.0	0.3	0.0	0.2	1.4	1.1	10.5	0.0	0.0	1.0	0.9	4.5	0.9	0.0	0.0	0.0	0.1
PAX5	BSAP	ENSG00000196092	"Paired box 5"	Q02548	9	36833275-37034185	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 21.6;lymphoid tissue: 33.4"	"Cell type enriched"	"Detected in some"	27	"B-cells: 57.6"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	5	"midbrain: 1.6"	"Group enriched"	"Detected in some"	209	"memory B-cell: 20.1;naive B-cell: 21.6"	"Lineage enriched"	"Detected in single"	216	"B-cells: 21.6"	"Group enriched"	"Detected in some"	8	"Daudi: 21.5;REH: 62.5;U-698: 28.2"	"Region enriched"	"Detected in single"	11	"midbrain: 4.7"	"Group enriched"	"Detected in some"	6	"hippocampal formation: 3.8;midbrain: 10.8;pons and medulla: 3.2"	"CAB026269, CAB026869, HPA056394, HPA068498"	Enhanced	Supported	Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			Nucleoplasm	"Vesicles, Cytosol"	"CAB026269: , CAB026869: , HPA056394: AB_2683116, HPA068498: AB_2685997"	"unprognostic (4.69e-4)"	"unprognostic (3.83e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.11e-3)"	"unprognostic (3.15e-1)"	"unprognostic (8.96e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.01e-1)"	0.4	0.2	0.2	33.4	0.2	5.5	0.2	0.2	0.2	0.2	0.7	0.1	0.0	0.0	0.2	0.0	0.7	0.2	0.4	0.2	0.2	0.3	0.5	0.3	0.3	23.2	1.6	0.0	0.2	0.2	0.0	0.5	0.1	0.2	0.3	0.3	0.4	2.5	0.0	0.6	0.2	8.7	0.0	0.3	16.5	0.7	0.9	0.0	2.3	0.4	0.2	30.1	1.3	0.2	21.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.6	0.1	0.1	62.5	0.1	0.1	0.0	0.0	4.4	1.0	0.0	0.2	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.1	0.0	0.0	0.0	21.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.2	0.2	0.2	0.3	1.6	0.0	0.2	0.0	0.0	0.0	57.6	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1
PAX7	Hup1	ENSG00000009709	"Paired box 7"	P23759	1	18631006-18748866	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Myogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skeletal muscle: 12.9;tongue: 12.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"breast cancer: 0.5;cervical cancer: 1.5;lung cancer: 1.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"A549: 3.4;CAPAN-2: 3.8;U-2 OS: 8.2"	"Region enriched"	"Detected in single"	17	"midbrain: 5.5"	"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (8.41e-4)"	"unprognostic (2.07e-1)"			"unprognostic (5.35e-2)"	"unprognostic (3.96e-2)"		"unprognostic (4.21e-1)"						"unprognostic (1.96e-1)"	"unprognostic (1.34e-1)"			0.4	0.1	0.6	0.0	0.6	0.0	0.0	0.0	3.4	0.1	0.0	0.0	0.0	0.1	0.0	2.3	0.5	0.1	0.0	0.0	0.8	0.8	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	2.4	0.0	3.4	0.3	0.0	0.0	0.1	0.1	12.9	0.0	0.1	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.0	12.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.0	3.4	0.8	0.8	2.4	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PAX8		ENSG00000125618	"Paired box 8"	Q06710	2	113215997-113278950	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Congenital hypothyroidism, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"kidney: 69.3;thyroid gland: 120.5"	"Group enriched"	"Detected in many"	4	"Collecting duct cells: 233.8;Proximal tubular cells: 100.4"	"Group enriched"	"Detected in many"	12	"endometrial cancer: 60.6;ovarian cancer: 63.5;renal cancer: 33.2;thyroid cancer: 122.2"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"EFO-21: 27.1;GAMG: 16.8;RPTEC TERT1: 63.8"	"Region enriched"	"Detected in some"	4	"pons and medulla: 5.8"					"HPA030062, CAB055097, CAB061888, HPA064554"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB055097: AB_2236705, CAB061888: AB_10895719, HPA030062: AB_10603982, HPA064554: AB_2685283"	"unprognostic (2.63e-3)"	"unprognostic (3.80e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (1.75e-5)"	"unprognostic (7.24e-2)"	"unprognostic (5.16e-5)"	"unprognostic (1.56e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.16e-1)"	"unprognostic (4.13e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.37e-1)"	"unprognostic (8.93e-3)"	"unprognostic (1.02e-1)"	0.9	1.4	1.1	0.5	0.4	0.0	0.6	0.2	0.8	3.8	0.4	0.2	11.7	0.1	2.2	15.2	0.6	9.6	0.8	0.6	0.5	0.5	69.3	0.4	0.5	0.7	0.4	0.3	3.8	0.6	0.1	0.7	0.8	1.5	1.1	0.1	0.5	0.5	10.0	0.3	0.5	0.6	0.4	0.8	0.3	0.4	1.9	0.2	0.4	120.5	0.0	0.2	0.8	1.9	4.4	2.8	1.5	3.4	1.9	2.5	1.1	2.9	0.2	0.1	0.0	0.1	0.0	1.0	0.8	2.7	0.2	0.4	1.8	0.5	0.5	27.1	0.2	16.8	0.0	0.5	0.8	0.2	1.2	0.0	0.4	0.2	1.0	0.3	0.0	0.0	0.7	0.1	0.2	0.6	3.3	0.0	0.0	0.4	2.0	0.8	0.6	0.3	1.2	0.1	0.7	1.8	0.0	0.2	0.6	63.8	4.7	0.5	0.0	3.4	0.0	1.8	0.0	0.0	1.1	0.9	4.6	0.1	0.8	2.3	0.4	1.4	0.1	4.0	0.6	0.0	1.5	3.4	0.0	0.6	1.8	1.5	4.4	1.5	1.1	2.8	1.9	2.5	1.5	0.5	1.9	1.3	1.1	0.8	1.1	1.1	0.4	0.2	0.8	0.5	0.5	0.4	0.3	1.5	0.2	3.0	1.3	0.8	1.7	0.6	0.6	0.8	2.5	0.0	4.5	233.8	0.0	2.1	39.7	9.6	1.5	0.5	5.8	0.0	2.6	2.0	1.9	1.0	0.0	0.0	4.5	0.0	4.6	1.3	1.3	3.1	4.6	2.6	0.0	2.8	2.3	3.3	17.3	7.0	0.4	100.4	0.7	6.5	0.1	4.2	5.8	0.6	0.7	1.0	3.7	1.7
PCBP3	"FLJ44028, PCBP3-OT1, PCBP3OT"	ENSG00000183570	"Poly(rC) binding protein 3"	P57721	21	45643694-45942454	"Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 47.4"	"Cell type enhanced"	"Detected in many"	13	"Bipolar cells: 151.7;Cone photoreceptor cells: 47.1;Horizontal cells: 109.7;Late spermatids: 60.8;Rod photoreceptor cells: 75.1"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in all"	5	"cerebellum: 47.4;pons and medulla: 23.0"	"Cell type enhanced"	"Detected in many"		"eosinophil: 5.9"	"Group enriched"	"Detected in many"	6	"B-cells: 2.9;granulocytes: 5.9;T-cells: 1.6"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 14.9;HDLM-2: 27.2;HSkMC: 20.9;SH-SY5Y: 23.6;U-87 MG: 12.6;U-937: 15.1"	"Region enriched"	"Detected in all"	5	"olfactory region: 280.8"	"Region enhanced"	"Detected in all"		"olfactory region: 184.8"	"HPA030247, HPA073145"	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"	Vesicles	"HPA030247: AB_10601244, HPA073145: "	"unprognostic (3.88e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.01e-4)"	"unprognostic (9.89e-4)"	"unprognostic (2.74e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.12e-3)"	"unprognostic (1.97e-2)"	"unprognostic (1.96e-6)"	"unprognostic (8.67e-2)"	"unprognostic (2.32e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.97e-2)"	6.5	11.7	6.0	11.2	6.7	12.3	6.3	47.4	12.6	3.8	7.9	7.0	2.2	3.1	9.3	12.4	1.4	3.2	4.4	2.7	6.5	7.3	2.2	1.1	1.8	5.0	6.9	3.7	3.4	3.5	0.6	14.8	2.3	23.0	1.5	3.0	20.2	1.7	1.9	1.1	1.6	4.8	12.3	7.3	11.6	3.4	20.5	6.1	22.6	0.8	0.0	4.6	2.3	1.8	2.9	0.0	5.9	0.4	0.6	1.6	0.5	0.0	0.0	0.2	0.0	6.9	14.9	0.0	0.8	0.2	1.6	0.7	0.0	0.0	0.0	0.3	4.0	1.9	0.0	0.8	0.0	0.2	27.2	0.1	0.0	0.0	0.0	7.0	0.0	0.0	20.9	0.1	0.2	0.4	0.0	0.0	1.0	0.0	0.1	0.9	0.3	7.7	1.6	0.4	0.0	1.3	0.0	0.0	1.1	0.0	0.0	2.6	23.6	0.5	0.0	0.0	0.7	0.0	4.2	0.0	0.0	0.0	6.1	0.0	0.3	1.5	0.0	12.6	15.1	0.5	4.4	0.4	5.9	1.6	0.3	0.3	2.9	0.9	0.0	0.0	1.9	1.5	0.2	1.4	0.6	0.2	0.0	0.8	0.5	6.0	6.7	47.4	6.0	6.5	7.3	6.9	3.7	23.0	6.1	0.0	0.0	1.4	0.1	0.2	151.7	2.8	0.0	0.0	1.2	1.8	47.1	0.0	0.0	0.1	29.4	0.5	0.0	0.0	0.2	0.1	1.3	0.9	0.0	0.0	0.4	109.7	2.9	2.5	0.0	60.8	7.8	0.2	3.3	0.0	0.0	29.6	1.4	0.0	12.0	0.0	75.1	0.0	5.3	25.0	12.0	0.0	0.0	0.0	0.0	0.3
PCP2	"GPSM4, MGC41903"	ENSG00000174788	"Purkinje cell protein 2"	Q8IVA1	19	7631611-7633748	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 45.5;retina: 20.2;testis: 80.7"	"Cell type enriched"	"Detected in many"	5	"Late spermatids: 3770.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	14	"cerebellum: 45.5"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HMC-1: 9.1;Karpas-707: 4.6;NB-4: 18.4"	"Region enriched"	"Detected in some"	43	"cerebellum: 2422.3"	"Region enriched"	"Detected in some"	18	"cerebellum: 135.0"	HPA057428			Approved	"Nuclear speckles,Vesicles"		Yes	NA			"Nuclear speckles"	Vesicles	"HPA057428: AB_2683436"	"prognostic favorable (7.93e-4)"	"unprognostic (6.06e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.79e-4)"	"unprognostic (1.19e-1)"	"unprognostic (4.88e-5)"	"unprognostic (1.11e-1)"	"unprognostic (6.23e-2)"	"unprognostic (9.15e-3)"	"unprognostic (6.01e-2)"	"unprognostic (1.36e-2)"	"unprognostic (8.17e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.70e-2)"	"prognostic favorable (2.76e-5)"	0.5	0.4	0.5	0.5	0.5	1.9	3.3	45.5	0.6	1.0	0.5	0.5	0.5	0.6	0.5	2.0	0.5	1.3	1.2	0.5	0.5	0.0	2.5	1.0	1.2	1.4	0.5	0.5	0.5	1.6	0.3	0.5	0.5	3.2	2.0	0.0	20.2	10.6	1.0	0.5	4.2	0.5	0.5	1.9	1.1	0.9	80.7	0.5	0.5	1.9	0.5	0.6	0.5	0.5	1.0	1.7	2.6	0.3	0.7	1.2	5.2	1.8	0.4	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.7	1.7	0.8	1.2	0.0	0.0	1.4	0.0	0.2	0.0	0.8	0.6	2.8	2.5	0.1	0.0	0.3	9.1	0.0	0.6	0.0	0.0	0.0	0.0	0.7	0.2	4.6	0.0	0.3	0.4	18.4	0.4	0.3	0.0	0.8	0.2	0.7	0.9	0.1	0.1	0.0	1.5	1.6	0.0	0.4	4.0	3.4	0.2	0.0	0.6	0.4	0.1	1.6	0.6	0.2	0.0	2.1	0.0	0.0	0.3	0.0	0.9	0.1	1.2	0.4	0.5	0.5	0.5	1.0	0.8	1.0	2.6	0.7	0.0	1.7	0.2	5.2	0.5	0.5	45.5	0.6	0.5	0.0	0.5	0.5	3.2	0.5	0.0	2.9	0.0	0.8	0.7	166.8	0.0	0.0	0.0	2.3	5.2	21.6	0.2	8.3	0.6	765.5	0.0	0.6	0.0	0.2	0.0	0.0	1.2	1.1	0.0	0.4	22.3	0.0	0.0	1.2	3770.2	9.8	1.0	1.7	1.8	0.2	24.5	0.5	0.0	12.4	0.3	79.8	19.4	0.0	11.1	6.4	1.0	0.0	1.5	0.5	0.6
PDE10A		ENSG00000112541	"Phosphodiesterase 10A"	Q9Y233	6	165327287-165986603	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"Allosteric enzyme, Hydrolase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.8"	"Cell type enhanced"	"Detected in many"	7	"Horizontal cells: 15.9;Muller glia cells: 21.0"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"basal ganglia: 36.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 7.7;LHCN-M2: 14.0;RH-30: 8.2;RT4: 8.5;SH-SY5Y: 8.6;TIME: 14.5;U-2 OS: 7.9"	"Region enriched"	"Detected in many"	11	"basal ganglia: 307.0"	"Group enriched"	"Detected in all"	4	"basal ganglia: 155.2;cerebellum: 80.7"	"CAB045998, HPA047200"	Supported					NA	NA					"CAB045998: AB_2162589, HPA047200: AB_2679981"	"unprognostic (1.02e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.36e-2)"	"unprognostic (6.03e-2)"	"unprognostic (3.79e-2)"	"unprognostic (9.24e-2)"	"prognostic unfavorable (4.44e-7)"	"unprognostic (3.59e-3)"	"unprognostic (2.37e-2)"	"unprognostic (3.44e-2)"	"unprognostic (5.90e-3)"	3.1	1.9	1.7	1.0	36.8	0.0	3.4	4.5	6.9	2.2	1.0	1.1	4.3	0.8	2.9	7.5	0.7	3.1	3.2	3.6	2.6	2.1	8.8	0.9	4.3	1.4	2.7	1.1	3.4	0.8	1.2	2.5	5.3	1.7	2.6	0.5	0.6	0.7	4.9	0.9	0.6	0.8	4.3	1.1	2.5	1.2	8.7	16.0	0.0	12.2	1.0	0.8	7.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	6.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.8	0.0	0.0	0.0	5.0	0.0	2.8	0.0	0.0	0.0	3.4	0.0	7.7	0.0	0.5	0.0	0.0	0.1	0.0	0.6	0.0	0.0	7.5	0.0	0.0	0.0	14.0	0.1	1.1	0.0	1.5	0.0	5.6	1.7	8.2	0.0	7.4	8.5	2.2	8.6	0.0	0.0	0.4	0.6	0.0	0.0	14.5	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	36.8	4.5	6.9	2.6	2.1	2.7	1.1	1.7	16.0	0.0	0.0	0.0	2.8	0.3	8.8	6.9	0.0	1.4	1.2	5.2	2.0	6.0	3.3	1.7	8.9	10.3	0.0	0.0	0.0	5.2	2.0	11.7	1.1	0.0	0.7	15.9	0.0	9.8	0.0	11.8	0.0	0.0	1.7	0.0	0.0	21.0	0.2	0.0	0.4	6.5	0.6	0.0	2.1	6.6	0.5	0.3	2.4	0.0	0.0	2.2
PDE1B	PDES1B	ENSG00000123360	"Phosphodiesterase 1B"	Q01064	12	54549350-54579239	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 52.6"	"Cell type enhanced"	"Detected in many"	11	"Erythroid cells: 23.3;Kupffer cells: 11.5;Sertoli cells: 12.9;Smooth muscle cells: 9.5"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"basal ganglia: 52.6"	"Cell type enriched"	"Detected in single"	4	"naive CD4 T-cell: 1.6"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.6"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 11.5;HL-60: 6.4;HMC-1: 12.3;NB-4: 8.1;THP-1: 7.8;U-937: 6.5"	"Region enriched"	"Detected in all"	6	"basal ganglia: 895.2"	"Region enriched"	"Detected in all"	7	"basal ganglia: 253.8"	HPA018492	Enhanced					NA	NA					"HPA018492: AB_1855119"	"unprognostic (2.90e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.67e-4)"	"unprognostic (5.63e-3)"	"unprognostic (7.02e-2)"	"unprognostic (7.51e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.39e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.84e-3)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (4.77e-6)"	"unprognostic (6.64e-4)"	"unprognostic (2.14e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.83e-2)"	12.3	1.4	9.9	4.6	52.6	5.6	2.7	3.1	19.4	2.6	3.7	1.4	0.0	1.2	3.9	2.5	1.7	2.4	2.9	1.9	3.7	3.8	1.3	1.6	2.9	1.6	3.0	9.3	12.5	0.6	11.0	0.5	0.5	5.8	1.0	1.7	0.5	1.3	2.1	0.7	1.0	2.6	4.9	1.2	4.8	2.5	1.1	7.7	0.0	2.7	0.0	1.1	2.8	1.1	0.2	0.3	0.1	0.3	0.1	1.6	0.4	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.1	0.1	0.0	0.0	0.0	1.8	0.0	0.0	11.5	0.3	4.7	0.0	0.0	0.0	6.4	12.3	0.7	0.0	0.0	0.0	0.0	0.0	4.6	0.0	1.9	0.0	0.0	0.7	8.1	3.4	0.0	0.0	2.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	7.8	0.0	0.0	0.2	0.0	0.0	0.0	0.1	2.4	0.0	6.5	1.3	0.0	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.2	1.6	0.0	0.1	0.1	0.0	0.0	0.0	0.4	9.9	52.6	3.1	19.4	3.7	3.8	3.0	9.3	5.8	7.7	0.0	0.6	0.0	0.2	0.9	0.1	3.1	0.0	0.0	1.2	3.5	0.0	0.0	0.0	0.0	4.8	0.3	0.0	23.3	0.0	0.0	0.4	0.3	0.0	0.0	7.3	4.8	1.7	0.0	11.5	3.4	2.0	5.2	0.0	1.8	0.0	0.0	0.0	0.0	2.8	0.0	0.1	12.9	9.5	0.9	0.5	0.4	0.2	1.5	0.0	0.1
PDE7B		ENSG00000171408	"Phosphodiesterase 7B"	Q9NP56	6	135851696-136195574	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Collecting duct cells: 21.0;Endothelial cells: 18.2;Ito cells: 35.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 4.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 7.3;ASC TERT1: 8.6;EFO-21: 13.4;HeLa: 7.8;HSkMC: 18.7;HUVEC TERT2: 8.7;U-2197: 9.3"	"Region enriched"	"Detected in all"	5	"basal ganglia: 112.3"	"Low region specificity"	"Detected in all"			HPA023967	Uncertain		Approved	Nucleoplasm		No	NA			Nucleoplasm		"HPA023967: AB_1855128"	"unprognostic (3.18e-1)"	"unprognostic (3.47e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.79e-3)"	"unprognostic (3.34e-1)"	"unprognostic (3.22e-4)"	"unprognostic (1.37e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.80e-1)"	"unprognostic (6.73e-3)"	"unprognostic (1.11e-2)"	"unprognostic (7.85e-2)"	"prognostic favorable (1.59e-4)"	"unprognostic (3.14e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.34e-2)"	5.8	4.3	7.3	4.0	21.9	0.8	3.6	1.6	12.8	6.2	4.0	2.3	25.2	3.6	14.2	4.9	2.8	4.2	6.1	7.9	5.1	7.4	9.6	6.4	3.3	2.8	6.4	4.2	22.7	1.6	3.7	8.7	2.2	5.9	6.8	5.0	5.4	5.0	28.5	7.2	1.5	3.7	13.5	5.3	2.3	5.2	2.9	7.1	7.7	8.3	6.1	1.9	10.6	5.1	4.3	2.6	0.6	0.9	0.7	1.8	0.3	0.0	4.5	0.1	0.0	7.3	8.6	0.0	0.4	2.3	1.7	0.9	0.0	0.0	0.0	13.4	2.9	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	7.8	0.0	3.1	0.1	0.0	18.7	0.0	3.4	0.0	0.7	8.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	3.0	0.5	3.2	3.0	0.1	0.1	0.0	0.0	1.5	0.0	1.9	0.0	9.3	0.0	0.1	0.0	0.0	0.5	0.0	0.7	0.2	0.9	0.6	0.2	0.2	0.1	1.5	0.4	0.2	2.6	4.3	1.8	1.0	0.3	0.7	0.1	0.2	0.2	0.3	7.3	21.9	1.6	12.8	5.1	7.4	6.4	4.2	5.9	7.1	0.0	0.3	3.0	0.2	0.3	2.3	8.5	2.5	0.0	0.0	21.0	0.0	0.1	0.0	0.1	0.4	18.2	0.0	0.0	1.5	0.0	3.3	0.3	10.3	4.7	0.3	6.4	7.0	35.0	1.5	0.0	11.2	0.5	0.0	0.0	0.0	13.8	0.1	0.0	7.4	1.2	0.7	12.9	3.1	0.1	0.2	1.3	0.0	0.0	0.0	0.1
PENK		ENSG00000181195	Proenkephalin	P01210	8	56436674-56446734	"Plasma proteins, Predicted secreted proteins, Transporters"		"Endorphin, Neuropeptide, Opioid peptide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 124.3;brain: 171.5"	"Cell type enhanced"	"Detected in some"	32	"Leydig cells: 1053.7;Peritubular cells: 212.2;Spermatocytes: 309.0"	"Cancer enhanced"	"Detected in many"		"lung cancer: 4.5"	"Region enriched"	"Detected in many"	12	"basal ganglia: 171.5"	"Cell type enhanced"	"Detected in some"		"naive B-cell: 3.1"	"Group enriched"	"Detected in many"	19	"B-cells: 3.1;dendritic cells: 1.2;monocytes: 1.2"	"Cell line enhanced"	"Detected in some"		"ASC diff: 16.6;ASC TERT1: 9.9;BJ: 9.2;THP-1: 8.6"	"Region enriched"	"Detected in all"	7	"basal ganglia: 3244.3"	"Region enriched"	"Detected in all"	7	"basal ganglia: 1049.6"	"HPA013138, CAB016390"	Enhanced				"Secreted in other tissues"	NA	NA		35000			"CAB016390: AB_2161515, HPA013138: AB_1855191"	"unprognostic (6.89e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.56e-2)"	"unprognostic (3.58e-3)"		"unprognostic (1.31e-2)"	"unprognostic (3.60e-1)"	"unprognostic (6.34e-2)"	"unprognostic (5.73e-2)"	"unprognostic (3.47e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.11e-1)"	"unprognostic (4.48e-2)"	"unprognostic (3.98e-3)"	2.5	124.3	2.8	1.7	171.5	0.3	0.9	3.9	7.8	14.3	2.2	0.9	0.1	0.6	3.0	0.9	0.9	2.6	4.0	9.1	1.2	9.1	0.3	0.2	1.0	0.3	2.5	0.4	8.2	0.6	0.2	1.5	1.1	8.4	11.7	0.9	2.2	0.9	8.1	1.1	0.5	0.9	1.7	7.0	0.3	1.1	29.9	14.7	0.0	0.6	0.3	0.3	0.5	0.6	3.1	1.2	0.0	1.2	0.0	0.0	0.5	0.0	0.0	0.1	0.0	16.6	9.9	0.0	9.2	2.9	1.7	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.2	3.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.5	2.8	171.5	3.9	7.8	1.2	9.1	2.5	0.4	8.4	14.7	0.0	1.0	0.0	0.0	0.1	0.0	0.6	0.0	1.4	4.5	0.0	0.0	0.0	0.0	0.0	56.7	0.5	0.0	0.0	0.0	0.0	3.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	37.9	1053.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	212.2	0.0	0.0	6.5	0.4	309.0	17.5	0.4	0.0	0.0	0.0	0.0
PHOX2A	"ARIX, CFEOM2, FEOM2, PMX2A"	ENSG00000165462	"Paired like homeobox 2a"	O14813	11	72239077-72245664	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 24.6;brain: 12.1;lymphoid tissue: 9.7"	"Cell type enriched"	"Detected in single"	9	"Spermatogonia: 3.6"	"Cancer enriched"	"Detected in some"	9	"ovarian cancer: 9.3"	"Region enriched"	"Detected in single"	96	"pons and medulla: 12.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	228	"SH-SY5Y: 115.5"	"Region enriched"	"Detected in single"	9	"pons and medulla: 0.8"	"Not detected"	"Not detected"			"HPA053810, HPA065621, HPA078004"	Enhanced		Supported	Nucleoplasm		No	NA			Nucleoplasm		"HPA053810: , HPA065621: AB_2685522, HPA078004: AB_2732367"			"unprognostic (5.84e-2)"		"unprognostic (8.51e-2)"					"unprognostic (5.07e-2)"	"unprognostic (2.19e-1)"		"unprognostic (2.13e-1)"	"unprognostic (9.92e-4)"	"unprognostic (3.03e-2)"			0.4	24.6	0.0	9.7	0.0	0.0	0.0	0.0	0.1	0.2	3.3	0.5	0.0	0.4	0.1	0.0	1.4	0.1	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.8	0.0	12.1	0.9	0.7	1.7	0.7	3.7	0.0	0.0	3.2	0.3	2.1	0.1	1.6	5.2	0.0	0.0	0.0	0.0	0.0	2.6	0.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	115.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0
PHOX2B	"NBPhox, Phox2b, PMX2B"	ENSG00000109132	"Paired like homeobox 2b"	Q99453	4	41744082-41748970	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 14.5;brain: 24.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	99	"pons and medulla: 24.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	91	"SH-SY5Y: 53.6"	"Region enriched"	"Detected in single"	17	"pons and medulla: 5.9"	"Region enriched"	"Detected in single"	27	"pons and medulla: 2.0"	"HPA074325, HPA074941"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA074325: AB_2686678, HPA074941: AB_2732272"			"unprognostic (1.01e-1)"								"unprognostic (2.47e-1)"			"unprognostic (5.27e-2)"				0.0	14.5	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.2	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.4	0.0	0.0	0.0	24.8	0.2	1.4	0.8	0.0	0.0	0.0	0.0	3.2	0.5	0.4	0.0	0.9	0.1	0.0	0.1	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	53.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	24.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PKP2		ENSG00000057294	"Plakophilin 2"	Q99959	12	32790745-32896840	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"		"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"heart muscle: 134.7"	"Cell type enhanced"	"Detected in many"	16	"Cardiomyocytes: 399.9;Extravillous trophoblasts: 148.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 10.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 56.3;OE19: 20.4;SuSa: 45.7"	"Region enriched"	"Detected in many"	4	"hippocampal formation: 22.1"	"Low region specificity"	"Detected in all"			"HPA014314, CAB037336, HPA056908"	Enhanced		Enhanced	"Nucleoplasm,Cell Junctions"		NA	NA			"Cell Junctions"	Nucleoplasm	"CAB037336: , HPA014314: AB_1855451, HPA056908: AB_2683272"	"unprognostic (1.89e-1)"	"unprognostic (1.70e-2)"	"prognostic favorable (8.55e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (6.79e-4)"	"unprognostic (2.90e-1)"	"unprognostic (1.83e-2)"	"unprognostic (5.94e-3)"	"unprognostic (2.22e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.76e-2)"	3.1	0.7	1.4	7.9	5.2	1.1	3.3	2.2	1.8	6.1	14.2	1.4	6.9	6.5	1.2	2.0	3.3	21.6	4.4	134.7	3.9	0.9	3.6	13.6	1.1	3.4	0.7	2.0	9.5	5.4	9.6	14.7	24.1	3.8	3.5	13.3	12.6	24.6	5.0	3.4	1.9	13.3	1.3	1.3	2.4	4.8	3.4	0.4	2.7	0.6	2.3	4.3	2.0	2.1	0.6	3.9	10.4	2.1	1.5	1.0	0.6	15.7	3.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	56.3	14.2	0.0	9.7	0.0	2.1	14.0	1.9	12.4	0.0	0.0	4.5	0.1	0.6	14.7	8.8	0.8	0.2	0.0	11.7	0.0	13.6	6.3	0.5	0.0	2.8	4.4	1.3	4.1	0.0	0.1	8.6	20.4	2.7	0.0	6.8	4.7	4.1	7.5	1.7	1.5	0.6	3.3	0.0	45.7	7.1	0.2	0.1	0.0	6.3	0.0	3.8	3.7	0.0	0.1	0.0	0.0	0.7	5.1	1.4	10.4	0.4	1.6	1.0	0.2	0.6	0.4	3.9	0.6	0.9	0.5	1.2	1.5	2.1	0.8	0.6	0.6	1.4	5.2	2.2	1.8	3.9	0.9	0.7	2.0	3.8	0.4	0.0	0.0	2.4	42.2	6.3	1.0	399.9	15.3	12.0	19.4	1.8	3.9	39.7	3.3	12.2	3.0	3.5	74.7	0.0	8.6	148.3	17.6	16.8	4.6	39.3	7.7	1.6	26.0	3.7	13.1	1.3	10.9	7.4	10.1	0.0	60.1	13.0	16.5	52.6	2.1	8.4	1.1	0.0	1.4	5.4	7.2	2.9	34.7	0.7	87.1	25.7
PKP3		ENSG00000184363	"Plakophilin 3"	Q9Y446	11	392614-404908	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 69.0;skin 1: 48.4;tongue: 59.0"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 206.5;Extravillous trophoblasts: 144.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 1.6;NK-cell: 2.3"	"Group enriched"	"Detected in many"	5	"NK-cells: 2.3;T-cells: 1.6"	"Cell line enhanced"	"Detected in many"		"A-431: 37.6;CAPAN-2: 26.4;HaCaT: 50.7;hTCEpi: 33.2;MCF7: 23.7;SK-BR-3: 38.5"	"Region enriched"	"Detected in single"	37	"cerebellum: 10.0"	"Low region specificity"	"Detected in many"			"CAB012993, HPA062937"	Enhanced		Enhanced	"Nucleoplasm,Cell Junctions"		NA	NA			"Cell Junctions"	Nucleoplasm	"CAB012993: AB_2533221, HPA062937: AB_2684908"	"unprognostic (4.74e-2)"	"unprognostic (5.28e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.88e-3)"	"prognostic unfavorable (2.89e-5)"	"unprognostic (1.25e-1)"	"unprognostic (6.73e-3)"	"prognostic unfavorable (3.93e-4)"	"unprognostic (3.55e-2)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (2.16e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.15e-2)"	0.6	0.0	0.2	3.7	0.3	0.0	3.3	0.2	0.3	14.5	14.6	0.3	5.0	11.2	1.9	6.2	69.0	2.6	8.9	0.5	0.3	0.1	0.6	0.2	4.3	0.2	0.2	0.2	1.1	10.2	3.9	3.8	23.2	0.2	4.5	3.6	0.2	12.5	2.5	0.6	48.4	25.4	1.0	0.2	0.3	10.4	0.5	0.2	2.2	5.8	59.0	29.9	2.8	21.5	0.3	0.0	0.0	0.0	2.3	1.6	0.1	37.6	7.3	0.0	0.1	0.0	0.0	15.8	0.3	0.2	0.8	0.4	15.0	26.4	0.0	1.5	0.3	1.7	50.7	0.0	19.2	0.1	0.0	9.5	0.0	4.3	10.4	0.1	0.0	0.0	0.1	33.2	0.1	8.1	0.1	0.1	0.0	11.2	0.2	0.1	23.7	0.1	0.0	0.0	19.0	12.7	0.2	0.0	0.1	0.4	7.6	10.8	0.1	10.9	38.5	0.0	0.5	13.9	0.1	1.3	0.2	1.4	0.7	0.2	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.2	0.8	0.0	0.3	0.0	0.7	0.0	2.3	0.0	0.0	0.0	0.1	0.2	0.3	0.2	0.3	0.3	0.1	0.2	0.2	0.2	0.2	14.9	15.4	0.0	43.7	64.1	0.0	1.1	7.6	9.4	12.5	12.2	0.0	112.3	0.0	83.2	0.0	0.4	206.5	0.0	54.5	144.7	3.5	34.6	13.8	0.0	11.6	0.0	20.8	0.0	0.0	0.0	0.9	1.8	1.7	3.6	76.4	0.5	96.8	93.0	0.0	0.7	0.1	0.0	1.6	0.0	0.4	77.5	91.8	0.0	83.6	52.6
PLA2G2F		ENSG00000158786	"Phospholipase A2 group IIF"	Q9BZM2	1	20139326-20150386	"Enzymes, Predicted membrane proteins, RAS pathway related proteins"	"Immunity, Innate immunity, Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 11.1;skin 1: 13.7;urinary bladder: 19.5"	"Cell type enhanced"	"Detected in some"	13	"Cardiomyocytes: 1.0;Collecting duct cells: 1.8;Suprabasal keratinocytes: 1.5"	"Cancer enriched"	"Detected in some"	18	"urothelial cancer: 17.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	67	"RT4: 56.2"	"Region enriched"	"Detected in single"	4	"hippocampal formation: 3.3"	"Not detected"	"Not detected"								"Intracellular and membrane"	NA	NA						"unprognostic (1.95e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.79e-2)"		"unprognostic (5.11e-2)"		"unprognostic (4.63e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.61e-2)"	"unprognostic (3.36e-5)"		"unprognostic (7.06e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.69e-1)"	"prognostic favorable (3.86e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.8	0.0	7.7	0.0	0.0	0.0	0.0	0.0	13.7	0.1	6.5	0.0	0.0	0.3	0.1	0.0	2.8	0.0	6.3	11.1	19.5	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	56.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.7	0.0	0.0	0.7
PLEKHG1	"ARHGEF41, KIAA1209"	ENSG00000120278	"Pleckstrin homology and RhoGEF domain containing G1"	Q9ULL1	6	150599883-150843665	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 39.7"	"Cell type enhanced"	"Detected in many"	9	"Endothelial cells: 43.2;Ito cells: 39.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	28	"memory B-cell: 14.7;naive B-cell: 15.9"	"Lineage enriched"	"Detected in single"	29	"B-cells: 15.9"	"Cell line enhanced"	"Detected in many"		"AF22: 12.5;HAP1: 18.4;Karpas-707: 16.4;U-698: 11.4"	"Region enriched"	"Detected in many"	5	"thalamus: 56.1"	"Low region specificity"	"Detected in all"			"HPA027128, HPA027319, HPA028270"	Approved		Enhanced	Nucleoplasm		Yes	No			Nucleoplasm		"HPA027128: AB_2672124, HPA027319: AB_10600306, HPA028270: AB_10611388"	"unprognostic (2.93e-1)"	"unprognostic (3.44e-1)"	"unprognostic (3.04e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.80e-3)"	"unprognostic (1.85e-1)"	"unprognostic (4.82e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.62e-3)"	"unprognostic (3.63e-1)"	"unprognostic (4.30e-2)"	"unprognostic (3.83e-1)"	"unprognostic (2.15e-2)"	27.5	2.2	7.3	10.6	7.3	2.3	10.0	2.4	7.1	8.3	5.8	10.1	4.8	4.8	7.8	14.1	9.6	8.9	8.1	5.9	7.7	6.7	4.5	5.1	12.1	13.5	10.5	3.0	4.7	2.8	8.2	5.1	13.9	11.1	4.1	6.2	3.4	3.5	5.4	6.4	8.9	6.0	5.7	19.6	28.9	4.5	7.3	7.7	39.7	6.0	5.8	13.3	7.4	8.5	15.9	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.1	12.5	0.1	0.0	0.0	8.9	0.0	0.0	0.0	0.0	6.9	3.0	4.9	4.8	0.0	1.2	1.8	18.4	1.6	0.0	7.7	2.0	0.3	0.9	0.0	0.0	0.0	1.4	0.8	4.7	0.0	0.1	0.0	7.7	4.1	0.0	16.4	0.0	0.2	1.5	0.0	0.9	4.8	0.5	0.8	0.0	0.0	3.6	8.2	0.4	0.1	0.0	2.2	1.5	1.4	0.0	0.0	7.7	0.0	1.7	0.0	3.3	0.0	0.0	11.4	0.0	0.0	2.5	0.0	0.0	0.0	0.1	0.0	0.5	14.7	0.3	0.4	0.0	15.9	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.4	7.3	7.3	2.4	7.1	7.7	6.7	10.5	3.0	11.1	7.7	0.0	3.8	8.1	0.6	3.8	0.2	1.6	2.5	5.3	3.4	7.0	0.0	4.2	3.3	2.3	2.7	43.2	4.3	0.0	1.0	1.3	9.9	0.7	0.0	3.0	0.5	0.0	5.2	39.9	6.1	1.3	0.3	0.8	5.0	8.2	9.0	8.3	6.3	10.5	0.4	2.8	0.5	0.0	2.3	1.0	0.9	3.1	2.4	3.2	4.2	2.4
POU4F2	"Brn-3b, BRN3B"	ENSG00000151615	"POU class 4 homeobox 2"	Q12837	4	146638893-146642474	"Predicted intracellular proteins, Transcription factors"	"Apoptosis, Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	13	"brain: 5.7;testis: 5.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	29	"midbrain: 1.8;pons and medulla: 5.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.6;SCLC-21H: 6.4;THP-1: 1.0"	"Region enriched"	"Detected in single"	6	"midbrain: 5.2"	"Group enriched"	"Detected in some"	15	"midbrain: 4.7;pons and medulla: 1.3;thalamus: 1.8"							NA	NA										"unprognostic (4.18e-2)"													0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PPM1J	"DKFZp434P1514, FLJ35951, MGC19531, PP2Czeta, PPP2CZ"	ENSG00000155367	"Protein phosphatase, Mg2+/Mn2+ dependent 1J"	Q5JR12	1	112709994-112715477	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 30.9;skeletal muscle: 45.1;testis: 31.9"	"Group enriched"	"Detected in many"	8	"Early spermatids: 105.4;Late spermatids: 189.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	9	"plasmacytoid DC: 30.9"	"Lineage enriched"	"Detected in many"	17	"dendritic cells: 30.9"	"Cell line enhanced"	"Detected in many"		"T-47d: 20.4"	"Region enriched"	"Detected in some"	8	"olfactory region: 33.6"	"Low region specificity"	"Detected in all"			HPA046045	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA046045: AB_2679516"	"unprognostic (8.68e-2)"	"unprognostic (5.65e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.93e-3)"	"unprognostic (2.34e-2)"	"unprognostic (3.55e-2)"	"unprognostic (3.74e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.30e-3)"	"unprognostic (3.36e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.28e-2)"	"unprognostic (9.96e-4)"	0.8	2.3	6.4	0.9	4.8	0.8	1.9	7.8	6.8	0.9	0.7	2.1	1.6	0.7	1.4	14.8	3.0	2.4	1.3	5.4	4.3	4.8	1.2	0.7	0.7	2.4	3.7	4.4	1.3	3.8	2.4	1.1	0.8	3.9	1.4	0.7	1.5	2.3	2.3	45.1	13.3	0.6	1.3	1.6	1.3	0.7	31.9	0.7	1.4	1.6	5.3	1.9	1.6	1.5	0.4	30.9	0.0	1.7	0.0	0.0	0.3	2.7	0.1	1.6	1.7	0.8	1.6	1.2	0.3	0.8	0.3	1.0	1.2	0.8	0.4	0.5	0.8	0.9	5.1	1.1	4.8	0.4	0.0	2.8	0.8	0.2	0.2	1.0	0.0	0.2	1.8	3.2	0.9	4.9	1.1	2.2	0.2	1.0	0.0	1.2	2.9	0.0	0.0	1.7	1.5	2.4	0.1	0.2	0.0	2.9	0.1	0.8	0.2	0.6	4.6	1.4	2.4	20.4	0.0	1.2	0.3	3.0	0.0	0.2	0.1	0.0	0.0	2.5	0.6	2.7	0.0	0.1	0.0	0.0	0.6	0.0	0.3	0.0	0.0	3.2	0.4	0.0	0.0	0.0	0.0	1.7	30.9	0.0	0.3	6.4	4.8	7.8	6.8	4.3	4.8	3.7	4.4	3.9	0.7	0.0	0.3	0.0	3.5	1.9	3.1	4.8	0.0	0.0	1.2	1.8	9.8	0.9	8.3	2.0	105.4	2.2	0.5	0.0	3.7	1.1	1.3	3.3	0.0	0.0	0.6	0.0	0.0	0.6	0.8	189.5	2.8	1.8	0.0	1.0	0.7	19.0	1.6	3.2	2.5	0.6	8.4	6.5	2.7	2.3	11.5	2.5	0.5	0.0	0.6	2.3
PPP1R17	"C7orf16, GSBS"	ENSG00000106341	"Protein phosphatase 1 regulatory subunit 17"	O96001	7	31686715-31708455	"Predicted intracellular proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"adrenal gland: 10.5;blood: 24.5;brain: 29.7"	"Group enriched"	"Detected in some"	126	"Early spermatids: 30.6;Late spermatids: 68.0"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Group enriched"	"Detected in many"	6	"cerebellum: 29.7;hypothalamus: 8.5"	"Cell type enriched"	"Detected in some"	4	"non-classical monocyte: 24.5"	"Lineage enriched"	"Detected in many"	19	"monocytes: 24.5"	"Group enriched"	"Detected in some"	197	"NTERA-2: 15.7;SCLC-21H: 47.7"	"Region enriched"	"Detected in some"	32	"cerebellum: 483.2"	"Region enriched"	"Detected in many"	4	"cerebellum: 339.5"	"HPA047819, HPA073123"	Enhanced					NA	NA					"HPA047819: AB_2680166, HPA073123: AB_2732219"					"unprognostic (1.50e-1)"			"unprognostic (1.33e-1)"					"unprognostic (6.56e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.33e-1)"			0.6	10.5	0.9	0.6	1.3	0.8	0.1	29.7	4.6	0.1	0.1	1.7	0.0	0.1	0.8	0.3	0.1	0.1	0.1	0.4	0.6	8.5	0.1	0.2	1.1	0.1	1.1	0.9	0.1	0.1	0.1	2.9	0.1	2.6	0.3	0.1	0.3	0.4	0.1	0.1	0.1	0.1	0.4	1.0	0.3	0.3	1.7	3.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	1.2	0.0	24.5	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.8	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	24.5	0.0	0.0	0.4	0.9	1.3	29.7	3.3	0.6	8.5	1.1	0.9	2.6	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	68.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0
PPP1R1B	"DARPP-32, FLJ20940"	ENSG00000131771	"Protein phosphatase 1 regulatory inhibitor subunit 1B"	Q9UD71	17	39626740-39636626	"Predicted intracellular proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 173.9;salivary gland: 105.3"	"Cell type enhanced"	"Detected in many"	12	"Melanocytes: 128.2;Mucus-secreting cells: 299.8;Undifferentiated cells: 342.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	4	"basal ganglia: 173.9"	"Cell type enriched"	"Detected in single"	37	"eosinophil: 3.6"	"Lineage enriched"	"Detected in single"	37	"granulocytes: 3.6"	"Cell line enhanced"	"Detected in some"		"ASC diff: 5.5;CAPAN-2: 8.7;HSkMC: 23.1;OE19: 10.7;SCLC-21H: 19.3"	"Region enriched"	"Detected in many"	8	"basal ganglia: 1113.7"	"Region enriched"	"Detected in all"	20	"basal ganglia: 1698.9"	"CAB004026, HPA048630, HPA061142"	Approved	Approved				NA	NA					"CAB004026: AB_2169007, HPA048630: AB_2680468, HPA061142: AB_2684438"	"unprognostic (2.71e-1)"	"unprognostic (4.09e-2)"	"unprognostic (6.91e-3)"	"unprognostic (2.42e-1)"	"unprognostic (3.01e-1)"	"unprognostic (7.69e-2)"	"unprognostic (6.00e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.75e-2)"	"unprognostic (6.13e-2)"	"unprognostic (6.07e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.55e-1)"	26.2	10.0	25.6	5.8	173.9	0.6	23.3	14.6	24.1	7.4	64.1	16.2	39.4	25.7	1.8	2.2	1.9	9.4	4.6	0.7	17.3	11.2	2.0	0.5	5.1	0.5	21.9	22.2	2.6	19.1	0.6	1.7	0.5	17.9	19.9	63.3	6.9	105.3	49.6	0.5	5.7	20.9	4.1	12.4	0.5	13.6	4.6	40.0	0.0	0.5	0.3	0.8	3.6	1.5	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	3.3	0.1	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.6	10.7	0.6	0.0	0.0	0.4	0.0	0.0	19.3	0.4	0.0	1.0	0.0	1.8	0.4	0.7	0.0	0.0	1.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.6	173.9	14.6	24.1	17.3	11.2	21.9	22.2	17.9	40.0	0.0	26.7	0.0	99.4	1.1	0.3	1.1	0.0	0.0	0.0	1.8	0.0	0.0	102.8	13.3	0.7	0.1	36.6	0.0	3.1	0.0	1.3	59.5	4.6	0.0	0.2	0.0	92.9	3.1	0.0	2.2	31.9	1.0	128.2	0.0	299.8	28.7	1.0	94.7	5.3	0.4	0.9	0.0	0.6	0.5	3.2	0.4	0.0	0.0	342.5	101.6
PPP1R3A	"GM, PPP1R3"	ENSG00000154415	"Protein phosphatase 1 regulatory subunit 3A"	Q16821	7	113876777-114075920	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Carbohydrate metabolism, Glycogen metabolism"		"Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	20	"heart muscle: 24.1;skeletal muscle: 69.4;tongue: 75.4"	"Cell type enriched"	"Detected in some"	13	"Cardiomyocytes: 136.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	64	"THP-1: 18.1"	"Region enriched"	"Detected in single"	19	"thalamus: 1.2"	"Not detected"	"Not detected"			"HPA070440, HPA073138"	Enhanced					NA	NA					"HPA070440: , HPA073138: "						"unprognostic (8.96e-3)"												1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	1.7	0.0	0.0	24.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	1.4	0.0	69.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	75.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	136.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0
PRDM1	"BLIMP1, PRDI-BF1"	ENSG00000057657	"PR/SET domain 1"	O75626	6	106086320-106109939	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Adaptive immunity, Immunity, Innate immunity, Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, Repressor, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 49.9"	"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 49.1;T-cells: 100.2;Urothelial cells: 77.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"eosinophil: 5.6;gdT-cell: 12.6;MAIT T-cell: 19.3;memory CD4 T-cell: 12.0;memory CD8 T-cell: 11.6;naive CD8 T-cell: 6.8;neutrophil: 6.8;T-reg: 15.4"	"Group enriched"	"Detected in many"	5	"granulocytes: 6.8;T-cells: 19.3"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 68.5;RPMI-8226: 12.8;U-266/70: 25.7;U-266/84: 16.6"	"Region enriched"	"Detected in single"	6	"olfactory region: 4.4"	"Low region specificity"	"Detected in all"			"HPA030033, HPA075427"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA030033: AB_10601050, HPA075427: "	"unprognostic (9.60e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.98e-2)"	"unprognostic (4.03e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.50e-2)"	"unprognostic (7.56e-2)"	"prognostic unfavorable (9.81e-5)"	"unprognostic (1.52e-1)"	"unprognostic (3.51e-1)"	"unprognostic (2.45e-3)"	"unprognostic (7.90e-2)"	11.6	1.5	1.6	26.3	3.2	10.4	7.0	5.3	1.6	14.0	16.5	1.9	1.4	5.4	11.6	2.2	33.4	3.8	8.1	2.3	1.9	2.0	3.1	2.4	18.8	33.3	2.1	0.5	4.2	1.8	1.2	2.1	9.0	4.9	3.6	11.0	4.3	10.6	3.0	2.0	8.9	18.2	3.4	7.4	24.2	8.6	3.0	1.5	3.1	7.7	35.7	49.9	12.8	18.0	1.5	0.2	6.8	0.6	2.5	19.3	1.3	0.4	0.1	0.3	0.0	0.5	0.7	0.0	2.3	7.2	0.7	1.3	0.4	2.8	0.6	0.1	4.6	0.1	0.1	0.0	1.1	0.8	6.4	0.0	0.1	1.4	0.0	1.1	0.2	0.5	0.7	3.6	1.0	3.0	0.2	0.9	0.3	0.4	68.5	0.1	0.0	0.0	0.1	0.2	0.4	0.0	0.1	0.0	12.8	0.6	0.1	0.0	0.0	0.3	0.3	0.0	0.5	0.3	0.7	0.4	1.1	0.6	0.6	2.1	25.7	16.6	1.5	1.6	0.4	0.6	1.2	0.4	5.6	12.6	0.6	19.3	1.5	12.0	11.6	0.2	0.5	1.1	6.8	6.8	2.5	0.1	0.2	15.4	1.3	1.6	3.2	5.3	1.6	1.9	2.0	2.1	0.5	4.9	1.5	0.0	9.0	19.7	8.0	17.3	0.8	1.4	0.0	2.7	7.9	3.5	49.1	0.4	0.0	0.3	0.8	20.4	7.3	23.3	0.2	0.5	5.1	3.1	3.5	1.5	19.3	0.0	1.7	8.0	24.7	0.0	0.0	38.5	35.4	47.7	3.1	0.5	4.8	4.3	1.1	0.1	0.4	0.0	16.4	0.3	1.3	36.3	0.6	100.2	2.5	77.0
PRDM12		ENSG00000130711	"PR/SET domain 12"	Q9H4Q4	9	130664594-130682981	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, Transferase"	"Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in single"		"brain: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	20	"RH-30: 19.4"	"Region enriched"	"Detected in single"	7	"basal ganglia: 11.2"	"Group enriched"	"Detected in some"	33	"basal ganglia: 6.1;hypothalamus: 2.0"	HPA043143	Uncertain		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA043143: AB_10806379"	"unprognostic (3.25e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.81e-4)"	"unprognostic (7.90e-2)"	"unprognostic (4.75e-3)"	"unprognostic (2.48e-3)"	"unprognostic (4.18e-2)"	"unprognostic (4.61e-1)"	"unprognostic (2.70e-1)"	"unprognostic (6.43e-2)"	"unprognostic (7.58e-2)"	"unprognostic (4.03e-3)"	"unprognostic (3.01e-2)"	"unprognostic (4.79e-2)"	"unprognostic (6.30e-4)"	"unprognostic (1.40e-1)"	0.1	0.7	1.0	0.3	1.5	0.0	0.1	1.1	2.2	0.0	0.1			0.3	0.0	0.9	0.0	0.0	0.0	0.0	1.0	3.7	0.0	0.2	0.0	0.0	0.5		0.0	0.8	0.1	0.2	0.0		0.0	0.3		0.5	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.2	0.7			0.0		0.0	0.0	0.0	0.1	0.6	0.3	0.1	0.0	0.4	0.0	0.0	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.3	0.1	0.0	0.2	0.3	0.2	0.1	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.9	0.0	0.8	0.0	0.1	0.1	0.0	19.4	0.5	0.0	0.0	0.9	0.3	0.4	0.1	0.1	0.0	0.3	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0											0.0	0.0	0.0	0.1	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0
PRDM16	"KIAA1675, KMT8F, MEL1, MGC166915, PFM13"	ENSG00000142611	"PR/SET domain 16"	Q9HAZ2	1	3069168-3438621	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Cancer-related genes, Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	13	"Alveolar cells type 1: 32.8;Cholangiocytes: 17.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	13	"NK-cell: 5.4"	"Lineage enriched"	"Detected in single"	13	"NK-cells: 5.4"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.5;HEK 293: 2.9;HHSteC: 3.4;hTERT-RPE1: 11.5;MCF7: 2.6;OE19: 5.7"	"Region enriched"	"Detected in many"	5	"basal ganglia: 16.1"	"Low region specificity"	"Detected in many"			"HPA050343, HPA060467"			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA050343: AB_2681099, HPA060467: AB_2684287"	"unprognostic (2.44e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.31e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.95e-2)"	"unprognostic (9.15e-3)"	"unprognostic (5.68e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.07e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.71e-1)"	"unprognostic (7.80e-6)"	"unprognostic (2.14e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (4.70e-5)"	"unprognostic (4.06e-2)"	2.7	0.7	5.3	1.4	5.6	0.5	1.6	0.5	4.7	2.1	6.2	3.3	12.8	14.1	1.5	4.5	1.1	2.0	11.7	5.1	5.2	1.9	7.0	0.6	4.2	1.4	2.9	3.1	3.6	12.7	1.2	1.1	0.6	3.3	1.1	0.9	16.1	1.3	15.0	1.2	0.9	8.0	1.5	2.5	4.2	14.8	1.4	4.8	0.0	10.7	0.0	0.9	1.1	1.5	0.3	0.1	0.0	0.0	5.4	0.4	0.0	0.0	0.0	0.9	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.4	0.5	0.0	0.4	0.0	0.4	0.0	2.2	0.0	0.0	0.2	2.9	0.0	0.0	0.5	3.4	0.0	1.2	0.0	0.0	0.0	0.0	11.5	0.0	0.2	0.0	0.0	0.0	2.6	0.2	0.0	0.3	5.7	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.4	0.0	5.4	0.0	0.0	0.0	0.0	5.3	5.6	0.5	4.7	5.2	1.9	2.9	3.1	3.3	4.8	32.8	8.0	0.0	0.2	0.6	0.0	4.8	17.8	2.7	9.1	7.0	0.0	0.0	5.0	7.6	0.0	0.7	0.0	0.0	4.3	2.9	0.0	0.3	0.0	0.0	0.0	1.6	5.2	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.3	1.3	5.3	0.0	1.8	0.2	0.0	0.0	5.3	0.2	1.1	0.0	0.0	0.0	1.2	0.1
PROK1	"EGVEGF, PK1, PRK1"	ENSG00000143125	"Prokineticin 1"	P58294	1	110451200-110457354	"Predicted secreted proteins"	Angiogenesis	"Growth factor, Mitogen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"ovary: 107.6;testis: 52.8"	"Group enriched"	"Detected in some"	50	"Leydig cells: 160.2;Peritubular cells: 627.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 4.7"	"Region enriched"	"Detected in single"	9	"basal ganglia: 4.9"	"Group enriched"	"Detected in some"	8	"MAIT T-cell: 1.5;NK-cell: 1.0"	"Group enriched"	"Detected in many"	8	"NK-cells: 1.0;T-cells: 1.5"	"Cell line enriched"	"Detected in some"	11	"ASC diff: 23.8"	"Region enriched"	"Detected in single"	11	"pons and medulla: 1.4"	"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA						"unprognostic (2.66e-1)"	"unprognostic (2.71e-2)"		"unprognostic (1.30e-1)"	"unprognostic (1.42e-1)"		"unprognostic (1.37e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.86e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.74e-2)"	"unprognostic (7.39e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.38e-1)"	0.8	2.8	0.1	0.1	4.9	0.0	1.2	0.1	0.3	3.4	0.2	0.2	0.5	0.0	0.3	1.5	0.3	1.0	0.1	1.4	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	107.6	0.1	0.0	0.1	18.0	0.5	3.6	0.0	0.1	0.1	4.0	0.2	0.4	0.1	0.1	0.4	0.3	0.0	52.8	0.1	0.1	0.2	0.2	0.1	1.5	6.8	0.1	0.0	0.0	0.1	1.0	1.5	0.0	0.0	0.0	0.0	0.1	23.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	4.9	0.1	0.2	0.1	0.0	0.1	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	7.8	160.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	627.9	0.0	0.0	0.0	0.0	3.1	1.1	0.0	0.8	0.0	0.0	0.1
PRR35	C16orf11	ENSG00000161992	"Proline rich 35"	P0CG20	16	560422-565528	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	6	"brain: 51.1"	"Cell type enriched"	"Detected in some"	16	"Collecting duct cells: 34.9"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	27	"cerebellum: 51.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 2.3;HMC-1: 1.0;K-562: 2.1;NTERA-2: 1.0;RT4: 1.3;U-2 OS: 1.4"	"Region enriched"	"Detected in single"	5	"cerebellum: 4.8"	"Region enhanced"	"Detected in single"		"cerebellum: 0.9"	HPA069297	Uncertain					NA	NA					"HPA069297: AB_2686113"		"unprognostic (6.96e-2)"		"unprognostic (3.08e-2)"	"unprognostic (5.25e-1)"	"unprognostic (8.11e-2)"				"unprognostic (2.56e-1)"				"unprognostic (3.38e-2)"	"unprognostic (1.17e-1)"			0.0	0.0	0.0	0.0	0.0	0.1	0.0	51.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	1.8	0.0	0.0	1.1	0.1	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.1	0.1	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.0	0.2	0.0	0.1	1.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.5	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	51.1	0.2	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	34.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0
PSMB11	beta5t	ENSG00000222028	"Proteasome subunit beta 11"	A5LHX3	14	23042167-23044276	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	13	"lymphoid tissue: 32.7"	"Group enriched"	"Detected in some"	7	"Early spermatids: 1.3;Late spermatids: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	6	"naive CD4 T-cell: 2.1"	"Lineage enriched"	"Detected in single"	21	"T-cells: 2.1"	"Cell line enriched"	"Detected in single"	4	"PC-3: 1.8"	"Region enriched"	"Detected in single"	7	"olfactory region: 2.3"	"Not detected"	"Not detected"			"HPA028967, HPA056970"	Enhanced					NA	NA					"HPA028967: AB_2732444, HPA056970: AB_2683293"				"unprognostic (7.96e-2)"	"unprognostic (2.77e-1)"													0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	2.4	0.0	32.7	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PTH2	TIP39	ENSG00000142538	"Parathyroid hormone 2"	Q96A98	19	49422414-49423441	"Predicted secreted proteins"		Neuropeptide		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	28	"blood: 2.4;brain: 4.1;testis: 1.7"	"Cell type enhanced"	"Detected in some"	16	"Early spermatids: 1.6;Late spermatids: 1.1;Muller glia cells: 2.6;Spermatocytes: 1.1"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	18	"naive B-cell: 2.4"	"Lineage enriched"	"Detected in single"	18	"B-cells: 2.4"	"Cell line enhanced"	"Detected in some"		"Hep G2: 1.4;REH: 3.8;SCLC-21H: 3.3;U-266/84: 1.1;U-937: 1.0"	"Region enriched"	"Detected in single"	10	"olfactory region: 3.5"	"Region enriched"	"Detected in many"	4	"cerebellum: 36.9"						"Secreted in brain"	NA	NA																				"unprognostic (3.41e-1)"			0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.1	0.3	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.7		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7			0.0		0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	3.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.5	1.1	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.7	0.0	0.0	0.0	0.0	0.0
PTPN22	"Lyp, Lyp1, Lyp2, PTPN8"	ENSG00000134242	"Protein tyrosine phosphatase, non-receptor type 22"	Q9Y2R2	1	113813811-113871759	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Immunity"	"Hydrolase, Protein phosphatase"	"Diabetes mellitus, Disease mutation, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 23.6;lymphoid tissue: 46.0"	"Cell type enhanced"	"Detected in many"	15	"B-cells: 29.6;granulocytes: 26.6;Kupffer cells: 19.2;Macrophages: 20.5;T-cells: 65.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 33.5;HL-60: 13.3;U-266/70: 14.4;U-698: 18.0;U-937: 13.6"	"Region enriched"	"Detected in single"	10	"cerebellum: 5.9"	"Not detected"	"Not detected"			"HPA004912, CAB012209, HPA013350"	Approved		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			Nucleoplasm	"Vesicles, Plasma membrane"	"CAB012209: , HPA004912: AB_10602069, HPA013350: AB_10601570"	"unprognostic (2.25e-2)"	"unprognostic (5.31e-3)"	"unprognostic (3.48e-1)"	"unprognostic (3.33e-4)"	"unprognostic (9.14e-2)"	"unprognostic (2.47e-3)"	"unprognostic (9.60e-2)"	"unprognostic (8.14e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.75e-6)"	"unprognostic (3.19e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.22e-2)"	4.2	1.4	0.5	17.1	0.8	23.6	1.9	1.0	0.5	2.4	3.3	0.3	1.0	4.1	2.0	2.2	2.0	1.7	3.2	2.5	0.6	0.7	3.4	1.8	9.0	14.9	0.7	0.4	1.5	2.4	0.0	0.9	0.9	1.0	1.7	2.8	1.3	2.7	3.0	0.6	1.0	9.9	0.9	2.1	19.0	3.1	1.1	0.4	46.0	1.5	2.4	12.8	4.8	1.7	7.2	6.2	17.2	3.5	7.5	14.9	4.6	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.2	0.0	0.3	0.0	0.2	33.5	0.0	0.1	0.0	0.0	0.0	0.0	0.2	3.1	0.0	4.7	0.0	0.0	0.1	13.3	10.5	3.0	0.0	1.4	0.1	2.7	5.2	8.4	0.0	7.7	5.1	0.1	9.4	7.5	0.0	0.0	0.0	0.5	3.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.8	2.4	8.0	0.1	0.1	0.2	14.4	3.0	18.0	5.5	13.6	0.0	10.2	3.5	17.2	12.8	0.9	14.9	7.2	6.5	10.1	6.2	4.7	3.9	9.4	1.7	7.5	0.4	3.7	10.0	4.6	0.5	0.8	1.0	0.5	0.6	0.7	0.7	0.4	1.0	0.4	0.0	9.2	29.6	0.2	2.3	0.4	0.5	0.0	4.0	0.0	1.8	2.0	0.0	0.0	0.0	0.3	0.0	2.3	0.0	0.5	0.2	0.9	0.2	26.6	0.6	7.1	0.0	0.0	0.6	19.2	0.6	0.0	20.5	3.3	1.8	1.0	0.0	0.6	0.0	0.0	0.0	0.4	12.9	0.9	0.3	0.2	2.4	0.1	65.4	1.7	0.2
PTPN7	"HEPTP, LC-PTP"	ENSG00000143851	"Protein tyrosine phosphatase, non-receptor type 7"	P35236	1	202147013-202161588	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 24.5;lymphoid tissue: 63.7"	"Group enriched"	"Detected in many"	5	"B-cells: 40.6;granulocytes: 137.4;T-cells: 156.8"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basal ganglia: 9.4;thalamus: 2.9"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"granulocytes: 17.0;NK-cells: 9.9;T-cells: 10.6"	"Cell line enhanced"	"Detected in some"		"HEL: 16.7;HL-60: 36.3;HMC-1: 48.9;NB-4: 15.8;THP-1: 16.7;U-937: 26.2"	"Region enriched"	"Detected in single"	10	"basal ganglia: 5.5"	"Region enriched"	"Detected in all"	4	"basal ganglia: 10.9"	"CAB009530, HPA019118"	Approved		Supported	"Microtubules,Mitotic spindle,Cytosol"		NA	NA			Cytosol	"Microtubules, Mitotic spindle"	"CAB009530: AB_2173845, HPA019118: AB_1855755"	"unprognostic (4.19e-3)"	"unprognostic (1.08e-3)"	"unprognostic (3.09e-2)"	"prognostic favorable (1.52e-4)"	"unprognostic (2.91e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (3.01e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.43e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (2.42e-8)"	"unprognostic (1.46e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.39e-2)"	2.6	3.1	0.5	27.1	9.4	24.5	0.6	0.4	0.5	0.6	2.3	0.6	0.0	3.0	0.7	0.6	1.7	0.8	2.9	0.5	0.6	0.8	1.1	0.9	3.2	16.5	1.2	0.2	0.6	0.6	0.0	0.7	0.4	0.8	1.3	1.9	0.7	5.3	0.3	0.4	0.6	3.7	0.9	1.6	15.4	1.4	12.7	2.9	63.7	0.9	0.6	24.8	2.9	0.8	2.6	2.6	17.0	1.1	9.9	10.6	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	16.7	0.0	0.0	0.0	36.3	48.9	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.7	1.5	0.0	0.0	4.9	15.8	0.0	0.0	0.0	0.7	0.0	12.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	16.7	0.0	0.0	0.1	0.0	0.0	7.4	1.8	10.5	0.0	26.2	0.0	11.5	1.1	17.0	10.6	1.1	9.5	1.9	7.1	10.5	2.0	2.6	5.3	6.4	7.1	9.9	0.4	2.6	9.0	2.8	0.5	9.4	0.4	0.5	0.6	0.8	1.2	0.2	0.8	2.9	3.0	9.0	40.6	1.0	2.1	2.4	0.7	0.0	0.0	1.2	0.0	0.0	0.4	0.0	0.2	0.4	2.9	0.0	0.0	0.0	0.1	1.7	0.5	137.4	0.5	15.6	0.0	0.0	4.9	6.2	1.3	4.9	23.4	8.5	9.0	0.0	5.6	0.1	0.0	2.1	0.6	4.4	0.0	0.9	0.9	0.4	2.0	0.7	156.8	0.0	0.5
PTPRR	"EC-PTP, PCPTP1, PTP-SL, PTPBR7, PTPRQ"	ENSG00000153233	"Protein tyrosine phosphatase, receptor type R"	Q15256	12	70638073-70920843	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 56.1"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 11.2;Club cells: 5.7;Enterocytes: 7.3;Horizontal cells: 15.9;Paneth cells: 11.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"cerebellum: 56.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HDLM-2: 14.3;RT4: 27.4"	"Region enriched"	"Detected in all"	5	"cerebellum: 100.5"	"Low region specificity"	"Detected in all"			"CAB011461, HPA011851, HPA071067"	Uncertain		Supported	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Plasma membrane, Cell Junctions, Cytosol"		"CAB011461: AB_298890, HPA011851: AB_1855939, HPA071067: AB_2686340"	"unprognostic (4.98e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.63e-3)"	"unprognostic (3.48e-5)"	"unprognostic (5.44e-3)"	"unprognostic (1.77e-3)"	"unprognostic (1.13e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.37e-3)"	"unprognostic (8.06e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.92e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.72e-1)"	"prognostic favorable (1.40e-5)"	0.4	3.8	18.8	1.6	11.3	0.3	0.4	56.1	20.9	0.5	11.2	0.1	0.0	5.1	8.4	0.3	0.4	0.5	1.9	0.4	8.6	4.9	0.4	0.4	0.4	0.4	1.3	13.2	0.4	0.6	0.3	0.9	0.7	3.3	0.5	7.8	0.8	0.4	2.1	0.4	0.4	11.3	4.9	3.1	0.4	4.4	0.4	1.4	0.0	0.4	0.0	0.3	4.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.4	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	27.4	0.1	4.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	18.8	11.3	56.1	20.9	8.6	4.9	1.3	13.2	3.3	1.4	0.0	0.0	0.0	0.1	0.5	11.2	2.5	0.0	0.0	5.7	0.0	0.0	0.0	0.0	2.1	1.7	1.5	7.3	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	15.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	1.9	11.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.4	0.3
PVALB	D22S749	ENSG00000100362	Parvalbumin	P20472	22	36800684-36819479	"Predicted intracellular proteins"		"Muscle protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 125.0;parathyroid gland: 137.5"	"Group enriched"	"Detected in some"	10	"Distal tubular cells: 543.8;Horizontal cells: 1442.9"	"Group enriched"	"Detected in many"	10	"breast cancer: 14.2;renal cancer: 59.5;urothelial cancer: 12.3"	"Region enhanced"	"Detected in all"		"cerebellum: 125.0"	"Cell type enriched"	"Detected in single"	6	"neutrophil: 3.4"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.4"	"Cell line enriched"	"Detected in single"	198	"RPMI-8226: 134.1"	"Region enriched"	"Detected in many"	5	"cerebellum: 2377.5"	"Low region specificity"	"Detected in all"			"CAB002515, HPA048536"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"		No	NA			Nucleoplasm	"Nucleoli, Cell Junctions"	"CAB002515: AB_563948, HPA048536: AB_2680433"	"unprognostic (4.41e-2)"	"unprognostic (1.60e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.79e-3)"	"unprognostic (7.80e-2)"	"unprognostic (2.49e-2)"	"unprognostic (2.52e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.21e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.65e-2)"	"unprognostic (8.99e-3)"	0.9	0.8	1.2	0.9	3.9	0.8	4.3	125.0	47.2	0.8	0.8	6.6	0.0	0.8	1.1	0.9	0.8	0.8	0.9	0.8	4.5	9.4	16.7	1.8	1.2	1.2	28.6	2.5	0.8	0.8	137.5	0.2	1.2	22.9	0.9	0.9	27.3	1.2	1.0	5.0	0.8	0.8	0.9	12.6	1.2	0.9	1.1	1.2	0.0	0.9	0.0	1.4	1.2	1.0	0.0	0.5	3.4	0.4	0.0	0.3	12.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	134.1	0.0	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	3.4	0.0	0.0	0.5	0.3	12.2	1.2	3.9	125.0	47.2	4.5	9.4	28.6	2.5	22.9	1.2	0.0	0.0	0.0	0.0	0.0	39.1	0.2	0.0	0.0	0.0	36.6	9.8	0.2	543.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	10.5	0.0	40.7	1442.9	0.0	40.5	3.7	0.0	0.6	0.9	0.0	0.0	0.0	41.2	0.0	0.0	0.0	0.8	104.1	0.0	0.0	0.0	0.6	0.0	0.3	1.0	0.0	0.0
PYY	PYY1	ENSG00000131096	"Peptide YY"	P10082	17	43952738-44004469	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"intestine: 40.0"	"Cell type enriched"	"Detected in some"	360	"Intestinal endocrine cells: 18684.3"	"Group enriched"	"Detected in many"	8	"endometrial cancer: 7.9;ovarian cancer: 15.2;testis cancer: 18.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HMC-1: 7.9"	"Region enriched"	"Detected in single"	22	"pons and medulla: 1.4"	"Not detected"	"Not detected"			"HPA010973, CAB016734"	Enhanced				"Secreted to blood"	NA	NA	87100				"CAB016734: AB_876471, HPA010973: AB_1855194"	"unprognostic (8.17e-3)"	"unprognostic (5.41e-2)"	"unprognostic (9.93e-2)"	"unprognostic (1.81e-3)"	"unprognostic (2.48e-4)"	"unprognostic (5.26e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.69e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.20e-1)"	0.1	0.8	0.1	2.0	0.2	0.0	0.2	0.1	0.1	0.1	40.0	0.1	0.1	1.2	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.2	0.6	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.5	0.1	20.6	0.1	0.1	0.3	0.1	0.0	24.8	0.1	0.1	0.1	0.1	1.0	0.1	4.2	0.2	0.1	0.1	0.1	0.1	0.9	0.1	0.0	0.1	0.0	0.4	0.0	0.2	0.6	0.7	1.3	1.0	1.7	0.2	1.2	0.3	1.4	0.8	1.3	0.9	0.7	1.6	1.4	1.1	0.7	1.1	0.4	0.9	3.2	0.6	1.8	0.5	0.2	1.2	0.5	7.9	2.3	0.4	1.3	0.6	1.7	0.3	0.7	0.4	1.3	1.2	1.7	0.5	1.0	1.6	1.2	0.7	0.4	0.3	0.2	2.1	0.1	1.3	0.3	0.7	0.0	2.1	1.1	1.2	0.1	1.3	1.6	1.4	0.3	1.1	0.1	1.2	0.2	1.8	0.1	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.8	0.0	27.6	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	18684.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	51.9	0.0	0.0	25.9	0.0	0.0	0.0	0.0	0.0	2.3	4.5	0.1	0.0	0.0	32.3	0.0
QRFP	"26RFa, P518"	ENSG00000188710	"Pyroglutamylated RFamide peptide"	P83859	9	130892702-130896812	"Predicted secreted proteins"		Neuropeptide		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"	20	"Alveolar cells type 1: 3.0"	"Low cancer specificity"	"Detected in some"							"Group enriched"	"Detected in some"	10	"classical monocyte: 1.8;intermediate monocyte: 3.3;non-classical monocyte: 1.5"	"Lineage enriched"	"Detected in single"	15	"monocytes: 3.3"	"Cell line enhanced"	"Detected in many"		"U-138 MG: 7.5"	"Region enriched"	"Detected in single"	18	"hypothalamus: 1.0"	"Low region specificity"	"Detected in all"			HPA043377	Uncertain				"Secreted in other tissues"	NA	NA					"HPA043377: AB_10959754"	"unprognostic (1.79e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.28e-3)"	"unprognostic (4.14e-3)"	"unprognostic (7.78e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.67e-3)"	"unprognostic (5.11e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.28e-1)"	"unprognostic (5.43e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.65e-1)"	"unprognostic (7.04e-3)"	0.9	0.3	0.0	0.9	0.1	0.6	0.3	0.0	0.4	1.4	3.7			0.7	1.1	0.0	4.2	0.8	1.1	0.5	0.1	0.2	0.4	0.0	0.5	0.4	0.0		1.0	4.9	0.0	1.8	0.4		3.2	0.2		0.3	0.0	0.4	0.7	1.3	0.0	0.2	0.2	1.7	1.8			1.1		0.0	3.0	1.0	0.0	0.0	0.0	3.3	0.0	0.2	0.5	1.3	0.7	0.5	3.3	0.0	0.0	1.7	1.3	0.0	0.0	0.0	2.1	0.8	0.5	0.5	0.0	2.1	0.5	0.0	0.0	0.0	0.2	0.4	0.1	1.8	1.0	0.0	1.3	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.3	2.7	0.0	0.0	4.4	0.5	3.0	2.9	0.4	0.4	3.1	1.9	1.3	0.0	1.1	1.1	1.4	1.1	0.4	1.3	1.0	1.8	1.0	0.4	7.5	1.9	3.0	3.5	0.3	1.2	1.5	1.3	0.9	3.8	0.0	1.8	0.0	0.0	3.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.5											3.0	0.6	0.0	0.2	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
RARB	"HAP, NR1B2, RRB2"	ENSG00000077092	"Retinoic acid receptor beta"	P10826	3	25174332-25597932	"Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Microphthalmia, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"retina: 39.1"	"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 17.9;Cone photoreceptor cells: 23.6;Ito cells: 20.3;Muller glia cells: 27.5"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 22.6"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 7.0;HEK 293: 7.9;hTERT-RPE1: 41.7;WM-115: 18.1"	"Region enriched"	"Detected in many"	9	"basal ganglia: 97.9"	"Low region specificity"	"Detected in all"			"CAB002617, HPA004174"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB002617: , HPA004174: AB_1079744"	"unprognostic (2.04e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.56e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.43e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.86e-1)"	"prognostic favorable (3.43e-5)"	"unprognostic (9.24e-3)"	"unprognostic (2.28e-1)"	"unprognostic (9.99e-2)"	"unprognostic (6.56e-3)"	3.9	7.1	2.4	2.3	22.6	0.0	6.8	1.5	9.1	13.4	6.0	2.2	6.8	1.7	14.4	7.5	8.1	6.2	5.3	13.6	2.6	2.2	17.5	6.2	5.6	5.6	2.0	3.7	12.2	1.5	12.8	18.9	13.9	3.2	13.0	2.3	39.1	13.7	11.8	2.5	1.4	2.4	14.7	4.6	7.7	4.8	1.7	4.8	0.0	10.0	2.9	4.6	12.1	10.2	1.0	0.4	0.1	0.6	0.1	0.8	0.0	0.0	0.9	0.6	3.1	7.0	1.8	0.0	0.8	0.4	0.0	0.3	0.1	0.0	0.0	0.1	1.2	0.1	0.2	0.0	0.1	0.0	0.0	7.9	0.0	0.0	0.5	0.1	0.1	0.0	3.7	0.0	0.0	0.0	41.7	6.6	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	4.2	0.0	0.1	0.0	4.9	0.0	0.0	0.0	0.5	0.0	1.1	3.4	0.1	0.0	0.0	2.8	0.1	18.1	0.0	0.6	0.0	0.8	0.1	0.3	0.3	0.5	0.5	0.4	1.0	0.6	0.8	0.1	0.1	0.1	0.4	0.0	0.0	2.4	22.6	1.5	9.1	2.6	2.2	2.0	3.7	3.2	4.8	0.0	0.3	0.0	17.9	0.1	4.2	9.3	7.6	6.7	12.5	10.4	23.6	0.1	0.0	1.4	1.3	3.8	0.0	0.0	0.8	0.1	3.1	5.5	0.0	2.0	0.3	4.8	0.0	20.3	4.1	0.4	0.0	0.0	0.0	0.0	0.0	27.5	1.1	0.0	0.0	0.5	6.1	0.0	9.2	0.2	1.1	0.1	0.2	0.0	0.0	7.1
RASD2	"MGC:4834, Rhes, TEM2"	ENSG00000100302	"RASD family member 2"	Q96D21	22	35540868-35554001	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 71.0;seminal vesicle: 25.2"	"Cell type enriched"	"Detected in some"	4	"Sertoli cells: 45.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"basal ganglia: 71.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 4.3;hTERT-RPE1: 13.4;SK-BR-3: 7.6;U-2 OS: 4.4;U-87 MG: 5.5"	"Region enriched"	"Detected in many"	8	"basal ganglia: 527.8"	"Region enriched"	"Detected in all"	8	"basal ganglia: 265.8"	HPA005839	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA005839: AB_1079745"	"unprognostic (1.76e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.33e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.43e-1)"	"unprognostic (7.07e-3)"	"unprognostic (9.76e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.00e-3)"	"prognostic unfavorable (2.22e-5)"	"unprognostic (3.75e-2)"	"unprognostic (1.61e-1)"	"unprognostic (8.42e-3)"	"unprognostic (6.22e-2)"	1.6	7.9	8.6	2.5	71.0	3.4	1.3	1.8	23.5	1.1	8.3	2.2	3.2	2.5	3.5	16.4	5.2	6.2	2.5	2.8	4.1	5.0	0.8	0.5	1.5	0.6	3.4	8.0	0.8	1.0	0.9	1.0	0.4	2.1	9.6	4.4	3.5	4.0	25.2	13.6	0.8	3.4	7.5	2.2	0.4	1.8	0.6	15.3	0.0	1.4	0.1	1.4	3.8	1.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	2.8	0.0	0.5	0.0	0.0	0.1	0.7	0.2	1.1	0.9	0.1	0.5	0.0	0.2	2.4	4.3	0.1	0.2	0.0	1.0	0.0	0.7	0.0	0.1	0.0	1.4	0.0	0.0	0.2	3.3	2.2	0.3	13.4	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.2	0.2	0.3	1.3	0.0	0.9	0.0	0.0	2.0	0.3	2.2	7.6	0.0	0.2	0.6	0.2	0.1	1.8	4.4	0.2	0.8	1.9	0.6	0.0	5.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	8.6	71.0	1.8	23.5	4.1	5.0	3.4	8.0	2.1	15.3	0.0	0.0	0.0	0.2	0.0	0.6	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.4	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.2	0.7	0.0	0.1	45.3	4.1	0.0	0.1	0.1	0.0	0.0	0.2	0.1
RBP2	"CRABP-II, CRBP2, CRBPII, RBPC2"	ENSG00000114113	"Retinol binding protein 2"	P50120	3	139452884-139480747	"Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	198	"intestine: 333.2"	"Cell type enhanced"	"Detected in some"	10	"Alveolar cells type 1: 8.9;Collecting duct cells: 12.2;Cone photoreceptor cells: 7.9;Enterocytes: 17.1;Pancreatic endocrine cells: 9.4;Paneth cells: 14.4"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 8.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"CACO-2: 41.9"	"Region enriched"	"Detected in single"	4	"basal ganglia: 4.6"	"Not detected"	"Not detected"			HPA035866	Enhanced		Approved	"Golgi apparatus"		NA	NA		96000	"Golgi apparatus"		"HPA035866: AB_10672232"	"unprognostic (1.74e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.34e-2)"	"unprognostic (6.72e-6)"	"unprognostic (2.33e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.24e-1)"	"unprognostic (8.51e-3)"	"unprognostic (3.92e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.24e-3)"	"unprognostic (5.57e-3)"	"unprognostic (1.10e-1)"	"unprognostic (9.23e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.21e-1)"	0.1	0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.2	130.1	0.0	0.0	221.8	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.4	0.1	1.6	0.0	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.1	333.2	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.9	0.0	0.0	0.1	0.1	0.1	0.0	0.0	3.9	0.0	0.0	0.0	0.0	41.9	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.1	0.0	0.1	0.0	0.0	0.0	5.9	0.0	0.0	2.2	5.5	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	8.9	0.3	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.0	12.2	7.9	0.0	0.0	0.5	0.0	0.0	17.1	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	9.4	14.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0
RGL3	FLJ32585	ENSG00000205517	"Ral guanine nucleotide dissociation stimulator like 3"	Q3MIN7	19	11384341-11419342	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 65.1;thyroid gland: 38.2"	"Cell type enhanced"	"Detected in many"	7	"Collecting duct cells: 48.8;Muller glia cells: 28.8;Sertoli cells: 38.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.4"	"Cell line enhanced"	"Detected in many"		"BEWO: 14.8;CACO-2: 8.4;RT4: 17.4;SK-BR-3: 7.7;T-47d: 12.8"	"Region enriched"	"Detected in single"	6	"cerebellum: 10.1"					"HPA042763, HPA043615, HPA064578"	Uncertain		Uncertain	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042763: AB_10968569, HPA043615: AB_10959470, HPA064578: "	"prognostic favorable (7.35e-4)"	"unprognostic (3.12e-2)"	"unprognostic (2.92e-1)"	"unprognostic (5.69e-2)"	"unprognostic (2.08e-1)"	"unprognostic (6.60e-2)"	"unprognostic (3.82e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.19e-3)"	"unprognostic (5.99e-2)"	"prognostic favorable (6.61e-4)"	"unprognostic (4.17e-2)"	"unprognostic (3.37e-1)"	"unprognostic (3.21e-2)"	"unprognostic (7.12e-3)"	4.3	6.2	5.3	1.2	7.9	0.7	4.3	1.9	6.8	7.6	1.9	3.4	23.3	1.8	4.9	14.5	1.1	5.3	6.5	5.2	8.2	1.3	20.7	6.0	7.5	1.2	6.7	3.0	1.6	12.1	65.1	9.1	5.8	7.9	4.1	1.8	7.3	3.5	23.9	5.0	1.1	1.2	1.4	9.5	5.1	6.8	1.1	7.3	0.0	38.2	0.4	0.9	4.5	4.5	0.3	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.9	0.1	14.8	0.9	1.1	0.5	1.6	8.4	6.0	0.0	5.4	1.0	2.1	3.7	0.0	0.0	0.0	0.0	0.0	0.1	3.1	2.6	2.3	0.0	0.0	0.0	0.1	0.1	0.0	3.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.3	1.1	0.0	0.6	1.6	5.1	17.4	0.8	4.4	0.2	7.7	2.6	3.1	12.8	0.0	0.0	2.7	0.0	2.0	0.7	0.0	0.4	0.7	0.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	5.3	7.9	1.9	6.8	8.2	1.3	6.7	3.0	7.9	7.3	17.9	15.2	0.0	2.0	0.1	0.1	2.5	5.1	2.7	22.7	48.8	0.0	12.2	10.0	8.3	0.0	3.9	0.0	0.0	3.6	9.6	4.6	1.0	1.1	4.3	2.6	0.0	9.9	25.8	4.3	0.0	3.4	0.6	5.0	0.0	7.1	28.8	5.8	5.3	0.4	3.0	0.4	38.8	12.4	0.5	1.2	0.0	10.1	0.0	2.7	1.4
RGS16	"A28-RGS14, RGS-r"	ENSG00000143333	"Regulator of G protein signaling 16"	O15492	1	182598623-182604408	"Predicted intracellular proteins"		"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"thyroid gland: 67.5"	"Cell type enhanced"	"Detected in many"	11	"Bipolar cells: 519.8;Smooth muscle cells: 484.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 11.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 32.0;NB-4: 17.6;SCLC-21H: 33.4;U-266/70: 37.8;U-698: 47.2"	"Region enriched"	"Detected in many"	5	"thalamus: 87.4"	"Group enriched"	"Detected in many"	6	"midbrain: 92.1;pons and medulla: 72.2;thalamus: 126.3"	"HPA053250, HPA055824"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA053250: AB_2682090, HPA055824: AB_2682934"	"unprognostic (4.03e-2)"	"unprognostic (6.08e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.04e-2)"	"unprognostic (8.39e-2)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (1.93e-2)"	"unprognostic (3.65e-2)"	"unprognostic (9.07e-3)"	"unprognostic (5.39e-2)"	17.8	7.5	4.5	18.6	9.8	3.0	5.2	3.3	9.9	2.4	6.4	20.7	7.2	2.3	2.6	3.7	4.5	8.0	10.8	3.6	7.4	12.3	6.7	6.8	13.3	10.8	12.0	1.3	2.9	4.3	6.0	28.1	7.9	16.5	3.7	4.1	9.1	3.3	40.8	5.2	3.0	3.5	8.0	25.0	6.1	5.1	1.2	10.7	0.3	67.5	16.2	4.9	6.1	4.2	5.8	11.5	2.2	0.9	3.4	5.4	1.4	0.2	0.0	1.9	0.0	0.3	0.0	14.8	0.0	0.5	0.0	0.0	0.0	0.1	32.0	0.1	0.0	0.0	0.1	3.5	0.3	0.0	3.6	2.6	3.3	0.3	0.0	0.5	5.3	2.9	0.7	5.4	0.0	0.2	0.0	0.0	1.1	0.1	5.6	0.0	3.5	0.1	17.6	10.3	0.2	1.0	0.0	10.6	7.6	0.0	1.5	33.4	3.5	0.0	2.7	0.0	2.0	1.1	4.2	0.0	0.1	0.7	0.9	1.6	37.8	1.7	47.2	0.1	3.4	1.7	2.2	0.4	0.7	0.4	0.5	0.8	5.8	5.4	0.6	0.6	2.3	2.5	0.8	1.4	3.4	0.9	11.5	3.2	1.4	4.5	9.8	3.3	9.9	7.4	12.3	12.0	1.3	16.5	10.7	125.0	148.7	13.4	6.7	73.2	519.8	16.5	0.0	4.0	31.8	8.7	17.7	6.1	0.0	1.6	0.4	67.1	1.3	23.3	2.0	125.4	54.3	12.1	72.5	1.0	15.6	30.2	48.3	25.8	3.7	0.0	0.3	13.9	77.6	20.8	3.8	129.8	2.8	0.9	0.4	0.3	30.5	64.7	484.2	0.0	1.5	55.2	28.8	5.7	1.9	9.0
RGS9	"MGC111763, MGC26458, PERRS, RGS9L"	ENSG00000108370	"Regulator of G protein signaling 9"	O75916	17	65100812-65227703	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Signal transduction inhibitor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 47.3"	"Group enriched"	"Detected in many"	7	"Cone photoreceptor cells: 306.3;Rod photoreceptor cells: 472.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	6	"basal ganglia: 47.3"	"Group enriched"	"Detected in many"	6	"gdT-cell: 11.0;MAIT T-cell: 2.8;memory CD8 T-cell: 7.4;naive CD8 T-cell: 3.6;NK-cell: 3.7"	"Group enriched"	"Detected in many"	74	"NK-cells: 3.7;T-cells: 11.0"	"Group enriched"	"Detected in some"	4	"HDLM-2: 23.2;HEL: 9.5"	"Region enriched"	"Detected in many"	9	"basal ganglia: 222.4"	"Region enriched"	"Detected in all"	9	"basal ganglia: 79.8"	"HPA013550, HPA014137"	Enhanced	Supported	Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA013550: , HPA014137: AB_2668943"	"unprognostic (4.43e-3)"	"unprognostic (7.49e-3)"	"unprognostic (5.12e-2)"	"unprognostic (3.09e-5)"	"unprognostic (1.07e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.88e-2)"	"prognostic favorable (1.35e-4)"	"unprognostic (1.07e-1)"	"unprognostic (5.07e-2)"	"unprognostic (4.94e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.49e-1)"	1.1	1.9	3.3	4.4	47.3	1.0	2.3	4.1	8.9	3.4	5.2	7.2	2.7	3.3	4.2	7.2	4.1	9.5	3.9	1.3	5.4	7.4	2.0	5.0	5.9	5.3	3.5	3.7	6.7	3.7	7.3	7.9	3.0	4.5	8.6	3.4	24.1	3.2	9.2	1.6	1.5	3.6	4.0	3.4	4.3	3.7	1.7	6.6	0.4	4.2	0.5	7.5	5.1	2.4	0.0	0.0	0.0	0.0	3.7	11.0	1.4	0.2	0.0	1.1	0.1	0.1	0.2	0.0	0.0	2.1	0.0	0.2	0.1	0.0	0.7	1.6	0.0	0.0	0.1	0.0	0.1	0.2	23.2	0.5	9.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	3.7	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.2	3.6	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	11.0	0.0	2.8	0.0	1.0	7.4	0.0	0.0	0.0	3.6	0.0	3.7	0.0	0.0	0.0	1.4	3.3	47.3	4.1	4.5	5.4	7.4	3.5	3.7	4.5	6.6	3.0	1.0	0.0	0.9	0.3	21.5	0.4	0.0	1.4	2.3	1.8	306.3	0.0	3.3	6.8	0.6	0.3	0.0	0.0	2.8	0.1	2.3	0.2	0.0	0.0	0.1	49.3	57.3	1.8	0.0	1.7	0.9	3.2	1.7	33.3	2.2	27.8	3.9	0.0	4.6	8.1	472.2	0.0	0.9	0.0	0.4	0.1	0.1	9.2	0.4	0.1
RHCG	"C15orf6, PDRC2, RHGK, SLC42A3"	ENSG00000140519	"Rh family C glycoprotein"	Q9UBD6	15	89471398-89496613	"Predicted membrane proteins, Transporters"	"Ammonia transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 304.0;lymphoid tissue: 185.9;tongue: 115.4;vagina: 91.8"	"Group enriched"	"Detected in some"	4	"Muller glia cells: 63.6;Urothelial cells: 75.2"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 152.9;head and neck cancer: 154.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 8.0;hTCEpi: 4.5;RT4: 4.5;SK-MEL-30: 2.7"	"Region enriched"	"Detected in some"	5	"olfactory region: 10.4"	"Low region specificity"	"Detected in many"			"HPA041874, HPA043317"	Enhanced					NA	NA					"HPA041874: AB_2677719, HPA043317: AB_2678424"	"unprognostic (1.60e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.86e-3)"	"unprognostic (1.98e-2)"	"unprognostic (9.39e-3)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (3.80e-4)"	"unprognostic (1.07e-1)"	"unprognostic (9.82e-2)"	"unprognostic (1.39e-2)"	"unprognostic (4.84e-2)"	"unprognostic (2.55e-3)"	"unprognostic (2.68e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.45e-3)"	0.3	0.3	0.2	0.2	0.2	0.2	0.3	0.0	0.5	60.6	0.2	0.0	0.0	0.2	4.4	0.2	304.0	0.3	0.3	0.3	0.2	0.0	8.6	0.3	0.2	0.2	0.1	0.2	0.2	0.3	0.2	0.0	0.2	0.1	0.3	0.2	0.1	37.3	0.3	0.2	0.7	0.2	0.3	0.2	0.2	0.2	0.3	0.0	0.0	0.2	115.4	185.9	0.5	91.8	0.6	0.3	0.0	0.2	0.0	0.6	0.0	0.0	8.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.6	1.6	0.6	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.4	1.3	0.0	0.0	1.1	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	4.5	0.3	0.3	0.8	0.0	2.7	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.4	0.6	0.1	0.6	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.2	0.6	0.1	0.1	0.6	0.4	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.2	0.2	0.0	0.3	0.2	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	8.8	1.1	0.8	0.4	0.0	0.0	0.0	14.0	0.0	0.0	13.3	1.1	1.6	0.0	0.0	0.0	0.3	0.0	0.1	7.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	63.6	1.2	4.0	0.0	0.0	2.4	0.0	0.4	0.1	0.1	15.6	0.0	0.0	0.0	75.2
RPS6KA1	"HU-1, p90Rsk, RSK, RSK1"	ENSG00000117676	"Ribosomal protein S6 kinase A1"	Q15418	1	26529761-26575030	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 45.2"	"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 85.8;monocytes: 68.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 29.9;U-937: 32.2"	"Region enriched"	"Detected in all"	5	"cerebellum: 60.4"	"Low region specificity"	"Detected in all"			"CAB003852, HPA007981"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"CAB003852: AB_289590, HPA007981: AB_1079850"	"unprognostic (1.04e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.61e-3)"	"prognostic favorable (7.20e-7)"	"unprognostic (7.35e-2)"	"unprognostic (3.69e-1)"	"unprognostic (6.93e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.51e-3)"	"unprognostic (2.37e-2)"	"unprognostic (9.64e-2)"	"prognostic favorable (1.84e-4)"	"prognostic favorable (4.58e-4)"	"unprognostic (4.77e-2)"	"unprognostic (7.61e-2)"	"prognostic favorable (8.33e-4)"	11.0	8.2	6.3	24.2	9.7	15.8	5.0	14.4	6.3	4.9	23.2	11.1	4.4	24.5	2.1	3.6	8.9	6.0	8.0	3.4	5.3	5.1	13.6	5.4	26.1	32.7	10.3	3.5	2.1	10.1	10.0	7.4	3.3	8.6	8.6	15.8	3.6	19.0	5.5	1.1	9.0	45.2	2.8	7.9	27.0	9.7	2.7	9.0	15.9	13.9	4.9	17.3	6.2	4.5	5.0	22.0	40.1	18.0	7.9	8.3	17.1	9.9	3.5	2.8	3.7	0.1	0.0	3.8	0.8	1.6	4.2	4.1	4.0	8.2	18.5	4.6	0.5	5.1	11.7	6.4	22.9	3.0	15.3	4.1	20.3	8.6	7.1	1.3	23.9	29.9	0.7	8.4	3.9	7.0	1.9	1.8	7.4	3.4	6.7	0.2	5.5	0.8	23.6	7.3	19.3	11.1	12.8	3.6	8.1	12.1	2.7	4.1	1.6	7.0	6.6	3.2	3.1	4.2	20.6	1.2	0.2	5.4	0.7	3.3	4.2	4.9	10.1	2.5	32.2	4.1	9.6	18.0	40.1	8.3	16.4	6.9	4.9	6.1	7.3	22.0	5.0	3.9	5.5	34.5	7.9	17.3	8.6	6.0	17.1	6.3	9.7	14.4	6.3	5.3	5.1	10.3	3.5	8.6	9.0	14.9	23.5	13.7	7.4	16.6	1.3	1.2	10.2	10.7	5.7	8.7	3.9	1.2	6.6	15.5	1.8	4.2	85.8	0.0	16.3	14.5	1.9	13.9	32.2	3.8	43.9	0.0	15.6	12.3	57.1	0.5	0.0	36.8	1.7	68.5	34.3	0.4	21.8	41.9	0.0	13.6	1.7	6.5	2.1	1.1	2.7	10.2	3.4	41.5	32.9	6.8
RXRG	NR2B3	ENSG00000143171	"Retinoid X receptor gamma"	P48443	1	165400917-165445355	"Cancer-related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 14.9;pituitary gland: 29.8;retina: 13.5;skeletal muscle: 44.8"	"Cell type enhanced"	"Detected in some"	15	"Cone photoreceptor cells: 23.6;Melanocytes: 27.0;Muller glia cells: 9.1;Sertoli cells: 12.9"	"Group enriched"	"Detected in many"	13	"melanoma: 25.7;thyroid cancer: 34.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"SK-MEL-30: 29.0"	"Region enriched"	"Detected in many"	5	"basal ganglia: 89.8"	"Low region specificity"	"Detected in all"			"CAB002615, HPA012933"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"CAB002615: , HPA012933: AB_2732406"	"unprognostic (2.29e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.29e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.05e-2)"	"unprognostic (9.13e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.95e-2)"	"unprognostic (5.41e-3)"	"unprognostic (2.52e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.18e-1)"	"prognostic favorable (9.40e-5)"	"unprognostic (5.03e-2)"	1.9	3.9	5.4	1.0	14.9	0.6	1.0	0.3	5.9	4.0	2.5	5.3	0.6	1.3	1.8	1.3	1.7	3.6	1.2	5.8	7.5	8.9	0.7	0.8	3.4	0.8	4.1	4.3	1.7	2.7	0.8	29.8	1.3	14.1	1.1	2.7	13.5	1.9	2.1	44.8	2.9	2.0	1.8	8.9	1.0	1.1	1.5	5.4	0.0	1.1	2.5	0.6	1.2	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.3	0.0	0.0	0.0	29.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	14.9	0.3	5.9	7.5	8.9	4.1	4.3	14.1	5.4	0.0	0.0	0.0	0.0	0.6	0.3	2.0	0.0	0.0	0.0	0.0	23.6	0.0	0.0	0.0	2.2	0.5	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.9	4.6	0.0	27.0	0.0	0.0	9.1	0.1	0.0	2.1	0.0	4.0	12.9	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0
S100A5	S100D	ENSG00000196420	"S100 calcium binding protein A5"	P33763	1	153537147-153541765	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 7.6;thyroid gland: 9.1"	"Group enriched"	"Detected in some"	5	"Collecting duct cells: 3.5;Distal tubular cells: 3.3;Extravillous trophoblasts: 7.2"	"Group enriched"	"Detected in many"	5	"ovarian cancer: 3.7;thyroid cancer: 11.7;urothelial cancer: 2.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"OE19: 24.3;PC-3: 7.1;RPTEC TERT1: 8.6;RT4: 14.2;SCLC-21H: 12.7"	"Region enriched"	"Detected in single"	85	"olfactory region: 1210.8"	"Region enriched"	"Detected in single"	30	"olfactory region: 16.8"	HPA064184			Approved	Nucleoplasm		Yes	NA			Nucleoplasm		"HPA064184: AB_2685206"	"unprognostic (6.09e-2)"	"unprognostic (2.92e-2)"	"unprognostic (8.92e-2)"	"unprognostic (1.63e-5)"	"unprognostic (2.43e-3)"	"unprognostic (2.45e-2)"		"unprognostic (1.52e-3)"	"unprognostic (4.11e-2)"	"unprognostic (2.69e-1)"	"unprognostic (7.39e-3)"	"unprognostic (3.08e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.07e-2)"	"unprognostic (9.53e-2)"	"unprognostic (5.70e-2)"	"unprognostic (4.68e-3)"	0.5	0.1	0.8	2.4	0.2	0.9	0.4	0.2	0.9	0.6	0.3	0.2	0.2	2.3	1.0	0.2	1.3	0.7	1.6	0.2	0.4	0.1	2.3	0.2	3.0	4.6	0.2	0.2	0.2	0.2	0.0	0.4	1.1	0.2	1.5	0.0	0.2	3.8	0.2	0.2	6.0	0.5	0.2	0.2	1.1	1.9	0.2	0.2	1.6	9.1	0.2	2.6	1.8	0.6	0.9	4.6	2.3	1.2	0.0	7.6	1.2	1.5	4.1	0.0	0.0	0.4	0.3	0.3	0.7	0.9	0.5	1.0	0.4	3.0	0.0	2.7	1.5	0.3	1.2	0.1	0.7	0.6	0.3	0.0	1.9	1.5	0.1	0.3	0.0	2.5	0.0	0.8	2.0	0.6	0.3	0.4	0.0	0.5	0.1	2.2	0.1	0.3	0.9	0.1	24.3	7.1	0.0	1.3	0.7	8.6	14.2	12.7	0.0	0.1	6.5	0.6	1.2	0.0	0.4	0.3	0.1	0.9	1.9	1.2	0.0	0.6	0.0	0.4	0.5	0.2	0.0	1.2	2.3	2.0	0.2	7.6	0.9	4.2	2.2	2.8	0.5	2.4	1.1	1.9	0.0	0.6	4.6	6.1	1.2	0.8	0.2	0.2	0.9	0.4	0.1	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	3.3	0.2	0.0	0.0	0.0	0.0	0.2	7.2	0.7	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.8	0.0	0.3	0.3	0.0	1.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.9	0.2	0.0	0.0	0.4
S100G	"CABP1, CABP9K, CALB3"	ENSG00000169906	"S100 calcium binding protein G"	P29377	X	16650158-16654670	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	44	"intestine: 74.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"breast cancer: 4.7;renal cancer: 0.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.5"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.5"	"Cell line enhanced"	"Detected in some"		"EFO-21: 1.1;PC-3: 2.2;RPMI-8226: 7.0;SH-SY5Y: 1.3"	"Region enriched"	"Detected in single"	5	"pons and medulla: 1.2"	"Low region specificity"	"Detected in many"			"CAB017688, HPA028920, HPA055873"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"CAB017688: AB_1119899, HPA028920: , HPA055873: AB_2682952"	"unprognostic (2.68e-2)"									"unprognostic (2.78e-1)"				"unprognostic (9.88e-3)"				0.0	0.3	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.2	18.0	0.0	0.0	74.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	9.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.3	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	2.2	0.0	0.0	7.0	0.0	0.0	0.5	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.4	0.0	0.3	0.0	0.0	1.5	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
S100Z	"Gm625, S100-zeta"	ENSG00000171643	"S100 calcium binding protein Z"	Q8WXG8	5	76850001-76921650	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 18.7;lymphoid tissue: 9.5"	"Group enriched"	"Detected in some"	5	"B-cells: 3.4;Hofbauer cells: 6.4;Kupffer cells: 13.2;Macrophages: 5.5;Melanocytes: 3.3"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.1"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"classical monocyte: 17.6;eosinophil: 15.0;intermediate monocyte: 15.9;myeloid DC: 9.5;neutrophil: 5.9;non-classical monocyte: 18.7"	"Group enriched"	"Detected in many"	6	"dendritic cells: 9.5;granulocytes: 15.0;monocytes: 18.7"	"Cell line enriched"	"Detected in some"	6	"U-698: 42.4"	"Region enriched"	"Detected in single"	5	"olfactory region: 1.6"	"Low region specificity"	"Detected in all"			HPA051929	Approved					NA	NA					"HPA051929: AB_2732571"	"unprognostic (4.17e-3)"	"unprognostic (4.10e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.61e-4)"	"unprognostic (1.86e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.89e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.54e-3)"	"unprognostic (1.32e-1)"	"unprognostic (9.47e-5)"	"unprognostic (3.39e-4)"	"unprognostic (8.94e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.62e-1)"	1.0	1.0	3.5	5.3	3.3	5.7	1.1	0.6	2.2	0.6	0.9	3.8	0.4	1.0	0.8	0.4	0.8	0.7	1.9	0.7	4.1	1.7	1.0	1.0	5.1	6.2	2.1	2.6	0.6	2.4	0.2	0.7	3.2	3.2	1.0	1.4	0.3	1.1	0.5	0.9	0.6	2.3	1.5	6.2	9.5	1.1	0.7	4.5	2.1	0.7	0.0	6.2	1.8	0.9	2.5	9.5	15.0	18.7	0.3	0.4	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.5	0.0	42.4	1.8	0.0	0.0	1.4	17.6	15.0	0.4	15.9	0.1	2.5	0.3	0.0	9.5	0.6	0.0	0.0	5.9	0.3	18.7	0.1	0.3	4.6	3.5	3.3	0.6	2.2	4.1	1.7	2.1	2.6	3.2	4.5	0.0	0.0	3.4	0.1	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.6	13.2	0.0	0.0	5.5	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	1.0	0.0	0.0
SALL1	"Hsal1, TBS, ZNF794"	ENSG00000103449	"Spalt like transcription factor 1"	Q9NSC2	16	51135975-51151367	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	Deafness	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.9;kidney: 26.8;liver: 32.0"	"Group enriched"	"Detected in some"	14	"Cholangiocytes: 7.6;Collecting duct cells: 8.7;Cone photoreceptor cells: 23.6;Distal tubular cells: 10.0;Hepatocytes: 27.2;Proximal tubular cells: 16.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 15.2;BJ hTERT+: 12.9;NTERA-2: 24.6;RPTEC TERT1: 20.9;U-87 MG: 24.1"	"Region enriched"	"Detected in many"	5	"olfactory region: 64.6"	"Low region specificity"	"Detected in many"			"HPA049829, HPA074673"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nuclear speckles,Cytosol"		NA	NA			Nucleoplasm	"Nucleoli, Nuclear speckles, Cytosol"	"HPA049829: AB_2680902, HPA074673: "	"unprognostic (9.91e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.82e-6)"	"prognostic favorable (1.28e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.96e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.71e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.96e-1)"	"prognostic favorable (1.91e-7)"	"unprognostic (1.86e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.76e-1)"	0.8	0.7	12.2	1.2	14.5	0.7	0.9	1.7	18.9	16.1	3.1	31.9	0.0	1.6	17.8	1.5	0.8	10.4	1.1	1.2	13.6	5.5	26.8	32.0	0.6	0.6	21.8	9.1	5.2	1.6	0.9	4.3	4.3	17.6	1.3	3.2	0.0	0.9	2.3	0.6	0.7	1.4	9.4	19.7	0.7	3.0	2.2	19.4	0.0	23.7	0.0	0.6	2.2	4.8	1.0	1.9	2.3	3.1	0.1	1.1	1.1	0.0	0.8	15.2	0.1	0.4	0.3	0.0	5.0	12.9	0.3	0.7	0.0	0.0	0.0	5.8	7.1	4.5	0.0	9.4	0.0	0.4	0.0	5.7	0.0	0.0	9.1	0.3	0.0	4.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.6	0.0	0.0	1.8	0.9	0.0	20.9	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	24.1	0.0	5.0	0.6	3.1	2.3	0.7	2.0	0.7	1.0	1.0	0.9	1.9	0.8	0.6	0.6	1.8	0.1	1.5	1.9	1.1	1.1	12.2	14.5	1.7	10.3	13.6	5.5	21.8	9.1	17.6	19.4	0.0	0.0	0.0	0.0	0.2	0.0	1.1	7.6	0.0	0.0	8.7	23.6	0.0	10.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	27.2	0.1	0.0	0.0	0.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	16.7	0.2	0.0	0.2	0.2	0.4	0.1	0.0	0.0	0.0	0.1
SALL3	ZNF796	ENSG00000256463	"Spalt like transcription factor 3"	Q9BXA9	18	78980275-79002677	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 11.6;vagina: 6.6"	"Group enriched"	"Detected in some"	5	"Cone photoreceptor cells: 45.2;Horizontal cells: 23.8"	"Cancer enriched"	"Detected in some"	6	"glioma: 6.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 6.8;HEK 293: 4.0;NTERA-2: 13.8;SuSa: 2.5"	"Region enriched"	"Detected in many"	4	"olfactory region: 15.4"	"Low region specificity"	"Detected in many"			HPA016656	Uncertain					NA	NA					"HPA016656: AB_1856546"	"unprognostic (3.96e-2)"	"unprognostic (3.41e-3)"			"unprognostic (8.16e-2)"	"unprognostic (1.87e-2)"		"unprognostic (2.37e-1)"	"unprognostic (4.23e-1)"			"unprognostic (2.12e-1)"		"unprognostic (1.11e-1)"	"unprognostic (3.22e-1)"	"unprognostic (5.86e-3)"		0.7	0.7	7.3	0.7	7.6	0.7	0.7	0.3	11.6	0.9	0.7	8.3	0.0	0.7	0.7	2.1	0.7	0.7	0.7	1.2	7.1	5.4	4.4	0.7	0.7	0.7	5.7	3.3	0.7	0.7	0.7	1.1	0.8	6.8	6.0	0.7	0.2	0.7	1.2	0.7	0.7	0.7	0.7	8.8	0.7	0.7	2.4	4.6	0.0	0.9	0.0	0.7	0.8	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	6.8	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.5	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	7.6	0.3	6.6	7.1	5.4	5.7	3.3	6.8	4.6	0.0	0.0	0.0	7.0	0.0	0.5	1.4	0.0	0.0	0.0	1.8	45.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.3	23.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	6.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	5.2
SAMSN1	"HACS1, NASH1, SASH2, SH3D6B, SLy2"	ENSG00000155307	"SAM domain, SH3 domain and nuclear localization signals 1"	Q9NSI8	21	14485228-14658821	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 53.6;bone marrow: 72.1;lymphoid tissue: 43.6"	"Group enriched"	"Detected in many"	6	"granulocytes: 1107.2;monocytes: 1399.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 53.6;eosinophil: 49.9"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"HEL: 60.9;K-562: 72.4;Karpas-707: 31.6"	"Region enriched"	"Detected in some"	7	"olfactory region: 25.4"	"Low region specificity"	"Detected in all"			"HPA010645, HPA017055, HPA046639"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA010645: AB_1856559, HPA017055: AB_1856560, HPA046639: AB_2679732"	"unprognostic (7.62e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.17e-1)"	"unprognostic (6.13e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (4.52e-6)"	"unprognostic (9.14e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.68e-2)"	14.4	3.9	5.8	33.0	10.4	72.1	4.2	1.1	5.1	2.9	4.7	4.9	0.0	3.1	3.4	4.6	4.1	6.8	10.1	5.1	4.4	3.4	5.9	7.2	27.9	28.3	11.1	1.4	3.3	2.3	1.0	2.7	6.7	6.7	4.1	7.0	3.4	3.4	1.2	1.6	1.9	13.6	4.7	17.5	43.6	5.0	2.4	7.1	12.6	2.6	2.8	16.7	11.8	4.5	6.5	5.6	53.6	17.3	3.7	12.9	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	3.1	0.0	60.9	0.0	0.0	0.0	7.1	2.9	0.0	0.0	0.0	9.0	2.4	0.8	1.1	72.4	31.6	0.0	0.0	3.4	8.7	0.0	0.0	0.0	5.9	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	7.9	0.0	0.0	0.0	0.0	13.6	0.1	0.0	0.3	4.6	0.0	53.6	8.8	49.9	5.3	11.6	3.6	6.5	10.3	7.8	5.6	2.6	6.6	4.6	11.0	3.7	17.3	0.2	12.9	6.8	5.8	10.4	1.1	5.1	4.4	3.4	11.1	1.4	6.7	7.1	20.8	87.5	39.7	0.8	13.9	54.7	1.2	2.5	14.7	20.5	34.9	0.0	0.4	0.0	0.4	0.0	7.1	0.0	23.3	5.4	0.5	6.2	0.4	1107.2	0.9	57.4	0.0	0.0	3.1	159.2	0.0	0.6	220.5	20.3	1399.5	0.1	1.5	0.6	0.0	0.0	0.4	4.2	0.0	3.3	0.0	0.0	11.5	0.5	120.4	0.0	0.7
SBK1	Sbk	ENSG00000188322	"SH3 domain binding kinase 1"	Q52WX2	16	28292519-28323849	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 31.1;lymphoid tissue: 22.1;skeletal muscle: 39.6"	"Cell type enriched"	"Detected in many"	8	"Cone photoreceptor cells: 76.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"gdT-cell: 4.3;MAIT T-cell: 1.4;memory CD4 T-cell: 1.2;memory CD8 T-cell: 2.4;naive CD4 T-cell: 1.4;naive CD8 T-cell: 3.0;NK-cell: 1.4;T-reg: 1.4"	"Group enriched"	"Detected in many"	10	"NK-cells: 1.4;T-cells: 4.3"	"Cell line enhanced"	"Detected in some"		"AF22: 15.3;AN3-CA: 11.0;NTERA-2: 15.8;REH: 16.7;SCLC-21H: 24.3;SH-SY5Y: 22.9"	"Region enriched"	"Detected in all"	5	"cerebellum: 306.7"											NA	NA						"unprognostic (5.15e-2)"	"prognostic favorable (6.88e-4)"	"unprognostic (2.08e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.71e-2)"	"unprognostic (5.71e-3)"	"unprognostic (3.66e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.87e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.19e-3)"	"unprognostic (3.99e-2)"	"unprognostic (3.50e-2)"	"unprognostic (7.91e-2)"	"unprognostic (5.03e-3)"	0.9	2.0	8.0	1.8	7.3	2.0	1.7	31.1	17.5	1.7	1.2	1.5	0.0	1.1	1.9	1.3	1.5	1.6	1.0	1.8	9.9	5.6	1.6	0.9	1.8	2.7	6.0	4.0	1.1	2.7	4.2	4.1	0.8	8.3	2.6	1.2	1.4	3.8	1.0	39.6	1.4	1.1	0.9	3.1	2.8	1.6	2.3	3.1	22.1	2.6	0.0	1.7	1.2	0.3	0.2	0.2	0.2	0.1	1.4	4.3	0.4	0.1	0.2	15.3	11.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.1	0.7	0.3	0.1	0.0	0.3	0.3	4.6	0.1	0.0	1.5	0.5	0.0	0.1	0.4	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.1	0.1	5.8	0.0	1.0	0.0	1.8	7.0	0.1	15.8	1.0	0.1	16.7	0.8	0.1	0.1	0.9	24.3	22.9	0.4	1.4	0.2	1.9	1.7	0.0	0.4	0.0	2.4	0.2	0.1	0.2	0.0	0.2	0.1	0.2	0.9	0.2	0.1	0.1	4.3	0.0	1.4	0.0	1.2	2.4	0.0	0.2	1.4	3.0	0.1	1.4	0.1	0.2	1.4	0.4	8.0	7.3	31.1	17.5	9.9	5.6	6.0	4.0	8.3	3.1	3.0	0.3	0.0	0.8	0.6	9.4	3.1	2.5	2.7	3.4	0.0	76.6	0.0	1.7	6.1	1.0	0.0	0.0	0.0	4.8	0.0	0.4	1.5	0.0	0.2	0.1	0.0	5.8	0.0	0.0	3.1	0.6	0.0	0.0	0.0	0.3	4.2	4.7	0.0	0.0	0.5	2.7	0.0	0.3	1.4	2.3	0.1	0.1	2.5	0.8	0.3
SCGN	"CALBL, DJ501N12.8, SECRET, SEGN"	ENSG00000079689	"Secretagogin, EF-hand calcium binding protein"	O76038	6	25652201-25701783	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.3;pancreas: 39.7;pituitary gland: 47.9"	"Cell type enriched"	"Detected in some"	6	"Intestinal endocrine cells: 576.5"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 38.2"	"Group enriched"	"Detected in many"	11	"cerebellum: 22.3;hippocampal formation: 6.2;hypothalamus: 22.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 23.6"	"Region enriched"	"Detected in single"	16	"olfactory region: 100.5"	"Region enriched"	"Detected in some"	9	"olfactory region: 282.4"	"CAB004005, HPA006641, CAB044060, CAB062563, CAB068232"	Enhanced	Supported	Supported	Cytosol	"Intracellular and membrane"	NA	NA			Cytosol		"CAB004005: , CAB044060: , CAB062563: AB_2665612, CAB068232: AB_2665613, HPA006641: AB_1079874"	"unprognostic (8.15e-2)"		"unprognostic (4.31e-3)"		"unprognostic (1.46e-1)"		"unprognostic (1.25e-2)"	"unprognostic (4.70e-1)"			"unprognostic (1.78e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.14e-2)"	"unprognostic (5.41e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.19e-1)"		1.5	2.1	0.7	6.0	0.8	0.1	2.0	22.3	1.5	0.4	10.5	0.5	0.9	7.2	0.1	0.3	0.3	0.0	0.5	5.0	6.2	22.0	3.8	2.5	0.4	0.1	0.5	1.2	0.2	39.7	0.0	47.9	1.8	1.4	1.1	11.7	1.8	3.7	3.0	0.1	0.3	8.0	0.7	1.0	0.1	12.5	0.6	0.1	0.5	1.1	0.3	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.2	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	23.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.8	22.3	1.5	6.2	22.0	0.5	1.2	1.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	99.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	1.0	0.0	0.3	0.1	0.0	4.7	0.0	0.0	0.1	0.0	576.5	1.8	0.0	0.0	0.6	0.0	0.0	1.8	2.8	0.0	7.8	2.9	0.0	2.2	0.0	12.9	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0
SCN4B	LQT10	ENSG00000177098	"Sodium voltage-gated channel beta subunit 4"	Q8IWT1	11	118133377-118152888	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Atrial fibrillation, Disease mutation, FDA approved drug targets, Long QT syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.4;skeletal muscle: 25.6"	"Cell type enriched"	"Detected in some"	4	"Sertoli cells: 45.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.9;HBEC3-KT: 3.0;NTERA-2: 4.4;SH-SY5Y: 1.7;U-2 OS: 4.0"	"Region enriched"	"Detected in many"	11	"basal ganglia: 731.2"	"Region enhanced"	"Detected in many"		"basal ganglia: 122.8"	HPA017293	Approved					NA	NA					"HPA017293: AB_2184174"	"unprognostic (1.98e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.82e-3)"	"unprognostic (9.17e-3)"	"unprognostic (1.20e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.07e-2)"	"unprognostic (2.18e-3)"	"unprognostic (1.53e-1)"	"unprognostic (5.31e-4)"	20.5	5.4	1.9	1.2	36.4	0.1	6.1	11.7	21.7	2.4	2.6	2.0	0.5	2.4	3.7	1.8	5.4	5.5	3.2	11.0	3.1	2.9	1.4	0.6	8.7	2.0	5.3	2.1	0.7	5.0	6.4	2.4	1.9	28.7	2.1	2.2	4.3	2.8	2.6	25.6	3.8	4.6	7.0	5.5	0.5	3.0	0.8	8.7	1.5	10.4	9.5	1.1	3.4	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.9	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.6	0.3	3.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.1	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.7	0.4	0.0	0.0	1.1	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	36.4	11.7	21.7	3.1	2.9	5.3	2.1	28.7	8.7	0.0	0.0	0.0	0.3	1.1	1.1	2.8	0.0	6.7	1.2	0.0	0.0	0.0	0.0	0.0	1.3	0.7	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	3.3	2.0	0.8	0.0	0.0	0.0	0.3	0.0	0.0	1.4	0.0	0.3	45.3	10.8	0.0	0.6	1.0	0.0	0.0	0.0	0.1
SCN9A	"ETHA, Nav1.7, NE-NA, NENA, PN1"	ENSG00000169432	"Sodium voltage-gated channel alpha subunit 9"	Q15858	2	166195185-166376001	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Exocrine glandular cells: 27.7;Hofbauer cells: 50.6;Intestinal endocrine cells: 31.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	17	"plasmacytoid DC: 18.6"	"Lineage enriched"	"Detected in single"	24	"dendritic cells: 18.6"	"Cell line enhanced"	"Detected in many"		"BJ: 17.2;BJ hTERT+: 12.8;HHSteC: 14.8;hTERT-RPE1: 12.0"	"Region enriched"	"Detected in some"	5	"hypothalamus: 10.9"	"Low region specificity"	"Detected in all"			"CAB013679, HPA061843"	Uncertain		Approved	"Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA			"Plasma membrane, Actin filaments, Focal adhesion sites"		"CAB013679: , HPA061843: AB_2684625"	"unprognostic (2.10e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.98e-5)"	"unprognostic (1.47e-3)"	"unprognostic (9.43e-3)"	"unprognostic (2.28e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (2.30e-5)"	"unprognostic (1.69e-3)"	"unprognostic (6.74e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.46e-1)"	6.6	4.2	3.8	2.8	9.1	4.2	2.7	0.9	4.4	1.8	10.2	0.5	0.1	1.4	0.9	3.8	2.6	1.2	5.8	2.9	2.8	15.9	4.8	8.3	4.5	3.5	4.1	2.3	2.1	4.8	0.6	11.3	9.2	7.3	2.0	7.0	1.7	1.8	1.9	0.9	1.8	4.2	5.2	2.5	12.4	1.7	16.2	0.4	10.3	1.4	1.9	1.2	3.6	1.8	0.0	18.6	0.7	0.1	0.4	0.0	0.0	0.0	1.9	0.1	0.0	7.4	6.5	0.0	17.2	12.8	4.0	1.3	0.5	0.0	0.0	0.0	2.1	0.2	0.0	4.9	0.6	6.6	0.0	1.6	1.3	1.5	1.4	14.8	0.0	0.0	0.4	0.2	6.8	1.3	12.0	0.8	0.9	4.3	5.0	0.6	0.0	2.6	0.0	1.5	0.0	0.5	0.7	2.5	6.5	1.8	7.2	0.8	7.2	0.0	0.0	0.3	3.8	0.2	0.0	0.0	0.0	1.1	0.1	0.3	0.1	0.0	0.0	2.5	0.0	1.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.7	0.4	0.1	18.6	0.0	0.0	3.8	9.1	0.9	4.4	2.8	15.9	4.1	2.3	7.3	0.4	11.9	18.4	0.9	0.2	0.9	0.2	1.6	5.1	4.0	7.9	5.2	0.0	0.2	3.3	14.9	1.7	2.2	11.3	0.0	27.7	0.4	1.2	0.2	3.5	6.0	50.6	0.0	31.7	20.3	1.5	1.9	1.1	4.3	3.3	0.0	14.6	1.3	18.8	8.6	0.0	12.2	0.0	0.0	1.0	0.0	0.4	0.4	0.9	0.0	10.7	0.1
SCNN1G	"ENaCgamma, SCNEG"	ENSG00000166828	"Sodium channel epithelial 1 gamma subunit"	P51170	16	23182715-23216883	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sensory transduction, Sodium transport, Taste, Transport"	"Ion channel, Sodium channel"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 42.9;salivary gland: 26.8"	"Cell type enhanced"	"Detected in some"	29	"Alveolar cells type 1: 17.9;Club cells: 21.6;Collecting duct cells: 85.5"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 15.6"	"Region enriched"	"Detected in some"	6	"cerebellum: 9.7"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.8"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.8"	"Group enriched"	"Detected in some"	7	"hTCEpi: 31.4;RT4: 14.2"	"Region enriched"	"Detected in single"	13	"cerebellum: 2.8"	"Low region specificity"	"Detected in all"			HPA071194			Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA071194: AB_2686359"	"unprognostic (2.90e-1)"	"unprognostic (5.21e-3)"	"unprognostic (5.79e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.92e-3)"	"unprognostic (1.71e-3)"		"unprognostic (1.97e-1)"	"unprognostic (4.85e-2)"	"unprognostic (7.84e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.57e-2)"	"prognostic unfavorable (3.20e-7)"	"unprognostic (2.80e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.17e-3)"	1.1	0.3	0.6	0.2	0.0	0.4	2.5	9.7	0.4	14.0	5.5	0.0	4.8	0.2	3.2	1.7	10.3	0.5	0.2	0.2	1.5	0.0	42.9	0.2	15.6	0.2	0.0	0.3	0.2	3.8	0.2	6.5	0.7	0.7	10.2	1.1	0.0	26.8	12.8	2.2	6.6	0.2	0.3	0.3	0.2	6.9	0.3	0.0	1.5	25.5	3.3	3.9	1.7	11.3	0.3	0.3	1.8	0.2	0.2	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	14.2	1.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.2	0.3	0.2	0.1	0.1	0.1	0.1	0.0	0.3	0.2	0.1	1.8	0.2	0.1	0.3	0.1	0.0	0.6	0.0	9.7	0.4	1.5	0.0	0.0	0.3	0.7	0.0	17.9	3.4	0.0	4.0	0.3	0.0	0.8	0.0	2.7	21.6	85.5	0.0	0.1	0.0	1.3	0.0	0.0	0.3	0.0	1.5	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	1.4
SERPINA9	"CENTERIN, GCET1, SERPINA11b"	ENSG00000170054	"Serpin family A member 9"	Q86WD7	14	94462717-94479689	"Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"lymphoid tissue: 37.6"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"stomach cancer: 2.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"non-classical monocyte: 1.2"	"Lineage enhanced"	"Detected in single"		"monocytes: 1.2"	"Cell line enriched"	"Detected in single"	64	"Daudi: 39.7"	"Region enriched"	"Detected in single"	18	"basal ganglia: 64.3"										"Secreted to blood"	NA	NA						"unprognostic (1.32e-2)"	"unprognostic (1.05e-1)"				"unprognostic (1.94e-2)"	"unprognostic (3.89e-3)"	"unprognostic (6.10e-2)"	"unprognostic (6.67e-2)"		"unprognostic (1.38e-2)"			"unprognostic (1.16e-1)"				0.1	0.1	0.1	37.6	0.1	0.0	0.2	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.1	1.8	0.2	0.2	0.0	0.1	0.1	0.1	0.1	0.6	0.2	20.3	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.9	0.0	0.1	6.0	2.7	0.0	0.1	0.6	0.1	0.1	0.0	0.4	0.3	0.3	36.0	0.1	0.2	0.0	0.5	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	39.7	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SERPINB2	"HsT1201, PAI2, PLANH2"	ENSG00000197632	"Serpin family B member 2"	P05120	18	63871692-63903890	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Plasminogen activation"	"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 70.6;placenta: 222.1"	"Cell type enhanced"	"Detected in many"	27	"Basal keratinocytes: 1993.2;Suprabasal keratinocytes: 920.9;Syncytiotrophoblasts: 367.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 26.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 16.3;eosinophil: 7.6"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 16.3"	"Cell line enhanced"	"Detected in some"		"GAMG: 33.9;HaCaT: 81.3;U-138 MG: 97.3;U-2197: 147.8"	"Region enriched"	"Detected in single"	14	"cerebellum: 2.9"	"Low region specificity"	"Detected in all"			"HPA015480, HPA076608"	Enhanced				"Intracellular and membrane"	NA	NA		110000			"HPA015480: AB_1855456, HPA076608: "	"unprognostic (2.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.46e-2)"	"unprognostic (1.36e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.65e-2)"		"unprognostic (1.37e-1)"	"unprognostic (1.92e-1)"	"unprognostic (9.69e-2)"	"unprognostic (3.76e-3)"	"unprognostic (1.90e-1)"	"unprognostic (4.33e-6)"	"unprognostic (3.89e-2)"	"unprognostic (3.94e-1)"	"unprognostic (3.29e-1)"	"prognostic unfavorable (1.55e-5)"	6.0	0.0	0.1	2.9	0.2	8.7	2.6	0.2	0.1	6.4	0.8	0.1	0.1	0.0	0.7	0.4	70.6	3.1	0.1	0.4	0.1	0.0	0.1	0.1	0.9	0.1	0.1	0.1	0.6	0.3	0.0	0.1	222.1	0.2	0.3	0.0	0.1	11.3	0.2	0.3	25.7	0.2	0.3	0.1	0.3	0.1	0.2	0.1	0.9	0.2	49.0	37.7	1.1	13.8	0.0	0.2	16.3	3.9	0.0	0.0	1.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	19.7	21.0	0.7	1.5	0.1	0.0	0.0	0.0	0.7	33.9	81.3	0.0	16.7	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.6	9.7	4.4	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	1.6	97.3	0.0	147.8	0.0	0.0	0.0	0.0	2.6	0.2	11.3	16.3	3.9	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.0	0.1	0.2	0.2	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.3	0.0	2.4	1993.2	0.0	0.4	0.0	21.4	34.2	0.0	0.0	3.1	0.0	76.7	0.0	0.5	0.0	0.0	6.1	1.5	3.5	3.8	0.0	0.0	2.8	0.0	0.0	0.0	5.6	0.0	0.0	59.8	89.4	2.8	0.0	0.0	100.0	0.0	0.0	0.0	0.0	0.0	26.8	0.0	0.0	920.9	367.4	0.0	0.0	42.5
SH3RF2	"FLJ23654, Hepp1, POSHER, PPP1R39, RNF158"	ENSG00000156463	"SH3 domain containing ring finger 2"	Q8TEC5	5	145936579-146081791	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Protein phosphatase inhibitor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 40.8"	"Cell type enriched"	"Detected in many"	5	"Late spermatids: 7204.3"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"basal ganglia: 11.5;cerebral cortex: 2.9"	"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"dendritic cells: 1.4;T-cells: 1.6"	"Cell line enhanced"	"Detected in many"		"CACO-2: 34.6;GAMG: 15.3;hTERT-RPE1: 17.2"	"Region enriched"	"Detected in single"	14	"basal ganglia: 23.9"	"Region enhanced"	"Detected in some"		"basal ganglia: 14.5"	"HPA035903, HPA058119"	Uncertain		Enhanced	Nucleoplasm		NA	Yes			Nucleoplasm		"HPA035903: AB_10696515, HPA058119: AB_2683611"	"unprognostic (8.90e-3)"	"unprognostic (2.00e-3)"	"unprognostic (5.11e-3)"	"unprognostic (1.66e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.47e-2)"	"unprognostic (9.96e-3)"	"unprognostic (8.22e-2)"	"unprognostic (3.92e-1)"	"unprognostic (7.37e-3)"	"unprognostic (2.44e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.98e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.64e-2)"	"unprognostic (4.13e-3)"	2.6	0.6	1.2	6.2	11.5	0.0	2.9	0.2	2.9	6.4	19.1	0.4	0.4	9.2	2.9	2.2	22.2	3.6	40.8	23.5	0.8	0.3	0.8	4.6	1.9	0.0	0.3	1.1	1.0	14.3	0.0	3.3	0.3	0.1	2.2	8.5	0.9	16.9	1.0	21.7	33.1	21.4	1.2	0.5	0.2	11.9	6.4	0.6	0.6	3.8	19.6	16.1	0.9	10.0	0.0	1.4	0.3	0.1	0.0	1.6	0.3	10.2	2.8	0.1	0.6	0.0	0.0	0.0	0.1	0.8	2.1	0.8	34.6	9.5	0.0	5.4	0.4	15.3	9.5	0.0	11.2	2.0	0.1	0.1	0.0	4.1	4.6	0.6	0.0	0.0	0.1	6.0	3.2	7.6	17.2	0.1	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.8	8.5	0.7	0.0	0.1	0.0	4.4	1.0	0.0	0.0	0.6	0.2	0.2	0.5	3.3	0.0	4.9	0.4	8.9	0.7	3.3	0.0	0.0	0.0	5.5	0.0	0.0	0.3	0.0	0.0	1.2	0.0	0.0	0.0	1.6	0.7	1.4	0.0	0.0	1.5	0.2	0.0	0.1	0.0	0.8	0.3	1.2	11.5	0.2	2.9	0.8	0.3	0.3	1.1	0.1	0.6	14.9	2.9	0.0	4.5	48.9	0.6	414.9	2.5	2.7	2.3	1.8	0.0	0.0	0.0	6.5	1412.5	1.5	27.7	0.0	7.6	0.0	0.5	1.3	1.1	8.3	0.2	0.0	1.2	0.6	0.0	7204.3	23.9	0.0	8.5	1.0	12.2	1.9	13.6	17.5	32.5	0.6	0.0	12.9	1.4	32.0	16.2	43.7	0.0	0.0	27.1	6.4
SHF		ENSG00000138606	"Src homology 2 domain containing F"	Q7M4L6	15	45167214-45201175	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 84.3"	"Cell type enhanced"	"Detected in many"	11	"Bipolar cells: 46.9"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"cerebellum: 84.3"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 50.7;SH-SY5Y: 22.6"	"Region enriched"	"Detected in all"	5	"cerebellum: 269.9"					HPA057381			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA057381: AB_2683423"	"unprognostic (4.05e-2)"	"unprognostic (2.02e-3)"	"unprognostic (7.59e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.38e-1)"	"unprognostic (7.61e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.50e-2)"	"unprognostic (6.88e-2)"	"unprognostic (5.12e-2)"	"unprognostic (6.89e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.09e-3)"	"unprognostic (1.83e-2)"	2.9	19.3	6.9	3.3	10.4	0.6	3.3	84.3	14.5	7.3	6.3	3.9	2.2	10.5	8.5	4.0	4.1	6.2	5.3	4.5	5.9	7.2	1.8	18.9	2.9	1.8	4.5	6.7	20.5	2.5	2.5	3.5	1.5	7.1	5.3	4.4	6.3	5.3	5.2	2.6	6.5	7.9	6.3	5.2	2.3	2.9	4.1	3.2	1.6	4.9	2.4	1.8	5.8	5.5	3.3	2.6	2.5	1.9	5.1	4.2	1.5	0.0	0.6	10.0	0.3	0.7	0.4	4.7	1.2	0.8	2.8	4.0	1.4	4.7	0.5	4.0	1.7	2.7	0.8	3.8	0.3	1.3	0.8	1.7	0.3	0.9	9.8	0.4	0.0	3.3	0.9	0.2	0.3	0.0	2.1	2.1	4.9	1.9	0.2	3.9	1.6	2.1	0.3	3.9	1.8	0.2	6.0	7.9	0.2	0.9	0.2	50.7	22.6	0.3	0.3	0.2	3.2	0.5	0.9	0.1	0.3	4.3	0.3	0.1	0.4	0.3	0.4	0.1	0.2	1.5	0.3	1.9	1.2	3.8	1.7	4.2	2.4	1.6	2.4	1.8	3.3	2.2	1.7	2.5	5.1	1.7	2.6	0.3	1.5	6.9	10.4	84.3	12.1	5.9	7.2	4.5	6.7	7.1	3.2	0.0	1.1	0.0	4.9	3.2	46.9	2.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.9	6.1	3.7	4.2	0.0	1.1	0.4	3.0	2.5	2.3	9.7	0.6	9.5	12.5	3.7	1.0	9.8	4.0	2.8	8.5	0.0	8.6	5.7	0.5	5.8	3.9	1.0	4.5	6.5	5.0	4.7	2.7	2.3	0.6	0.7	4.5	7.1
SHISA3	hShisa3	ENSG00000178343	"Shisa family member 3"	A0PJX4	4	42397839-42402487	"Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 30.0"	"Group enriched"	"Detected in some"	9	"Distal tubular cells: 36.5;Ito cells: 23.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	23	"memory B-cell: 2.1;naive B-cell: 2.4"	"Lineage enriched"	"Detected in single"	25	"B-cells: 2.4"	"Group enriched"	"Detected in some"	7	"AN3-CA: 70.7;PC-3: 41.0"	"Region enriched"	"Detected in single"	24	"olfactory region: 63.3"	"Low region specificity"	"Detected in some"			HPA054754			Approved	"Lipid droplets,Cytosol"		NA	NA			Cytosol	"Lipid droplets"	"HPA054754: AB_2682593"	"unprognostic (9.04e-3)"	"unprognostic (3.47e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.26e-1)"	"unprognostic (6.78e-3)"	"unprognostic (1.26e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.37e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.99e-2)"	"unprognostic (5.32e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.99e-3)"	4.5	2.1	1.0	2.3	3.5	0.1	1.8	0.7	1.3	0.9	5.0	0.1	2.9	2.9	0.3	6.2	8.6	0.4	4.2	12.9	0.9	1.5	30.0	1.0	4.7	15.4	8.3	0.7	1.4	0.3	0.1	0.5	0.2	3.3	2.6	4.1	0.3	1.2	1.5	3.4	0.4	8.4	10.7	1.0	0.6	3.5	2.0	2.2	0.0	4.6	2.6	1.1	6.8	4.7	2.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	70.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.3	0.0	3.1	0.0	41.0	0.0	0.0	0.0	3.0	0.0	0.0	0.1	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	3.5	0.7	1.3	0.9	1.5	8.3	0.7	3.3	2.2	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.0	0.0	3.5	0.0	0.0	36.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	23.9	0.8	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0
SIM1	bHLHe14	ENSG00000112246	"Single-minded family bHLH transcription factor 1"	P81133	6	100385015-100464929	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"ductus deferens: 13.2;kidney: 21.6;seminal vesicle: 17.5"	"Group enriched"	"Detected in some"	4	"Collecting duct cells: 19.2;Distal tubular cells: 6.6"	"Cancer enhanced"	"Detected in single"		"renal cancer: 1.8"	"Region enriched"	"Detected in single"	21	"hypothalamus: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 8.0;BJ: 12.8;BJ hTERT+: 18.7;BJ hTERT+ SV40 Large T+: 5.8;HDLM-2: 5.5;RPTEC TERT1: 14.7"	"Region enriched"	"Detected in single"	7	"hypothalamus: 6.1"	"Group enriched"	"Detected in some"	5	"basal ganglia: 2.6;hypothalamus: 5.2"	HPA024385			Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA024385: AB_1856879"	"unprognostic (1.04e-1)"			"unprognostic (4.34e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.64e-2)"	"unprognostic (3.76e-2)"		"prognostic favorable (5.32e-7)"	"unprognostic (1.00e-1)"	"unprognostic (1.19e-1)"			5.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.6	0.0	0.0	13.2	0.0	0.0	8.1	0.0	0.1	0.0	0.0	0.0	2.2	21.6	0.5	0.0	0.0	0.1	0.0	0.0	5.8	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	17.5	4.7	0.8	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.3	8.0	0.0	12.8	18.7	5.8	5.4	0.0	0.0	0.0	0.0	4.0	1.2	0.0	0.0	0.0	4.9	5.5	1.7	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	14.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.0	19.2	0.0	0.0	6.6	3.0	1.5	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.2	1.6	0.0	0.4	0.0	0.0	0.0	0.0
SKOR2	"CORL2, Fussel-18, FUSSEL18"	ENSG00000215474	"SKI family transcriptional corepressor 2"	Q2VWA4	18	47206322-47251603	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"brain: 1.5;testis: 3.3"	"Cell type enhanced"	"Detected in some"	18	"Bipolar cells: 1.9;Spermatocytes: 1.8;Spermatogonia: 2.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"NTERA-2: 9.5"	"Region enriched"	"Detected in single"	5	"cerebellum: 2.7"	"Region enhanced"	"Detected in single"		"cerebellum: 1.3"	HPA046206	Uncertain					NA	NA					"HPA046206: AB_2679588"					"unprognostic (1.53e-1)"					"unprognostic (1.93e-1)"				"unprognostic (1.92e-1)"	"unprognostic (6.31e-2)"			0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.1	0.0	0.2			0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0		0.0	0.2	0.0	0.0	0.0		0.0	0.0		0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.5	3.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	1.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	2.5	0.0	0.0	0.0	0.0	0.0
SLC13A1	"NAS1, NaSi-1"	ENSG00000081800	"Solute carrier family 13 member 1"	Q9BZW2	7	123113531-123199986	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Sulfate transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"kidney: 67.5"	"Cell type enriched"	"Detected in some"	17	"Proximal tubular cells: 400.4"	"Cancer enriched"	"Detected in single"	219	"renal cancer: 10.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"BEWO: 1.0"	"Region enriched"	"Detected in single"	5	"cerebellum: 0.9"	"Low region specificity"	"Detected in all"			"HPA053615, HPA062714"	Enhanced					NA	NA					"HPA053615: AB_2682207, HPA062714: AB_2684846"											"unprognostic (1.86e-1)"		"prognostic favorable (8.95e-5)"	"unprognostic (1.71e-1)"	"unprognostic (3.76e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	67.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	1.0	0.9	0.0	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.1	0.0	0.0	0.0	0.2	0.3	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.1	0.0	0.8	0.1	0.6	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	7.0	0.0	0.0	23.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	400.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC14A2	"HUT2, UT2"	ENSG00000132874	"Solute carrier family 14 member 2"	Q15849	18	45212995-45683686	"Plasma proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 3.3;kidney: 5.7"	"Cell type enriched"	"Detected in some"	5	"Collecting duct cells: 73.3"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 1.1"					"Cell type enhanced"	"Detected in some"		"eosinophil: 3.3"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	6	"U-266/70: 7.2"	"Region enriched"	"Detected in some"	4	"basal ganglia: 17.9"	"Not detected"	"Not detected"									NA	NA						"unprognostic (2.33e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.80e-2)"	"unprognostic (1.11e-2)"	"unprognostic (7.89e-3)"	"unprognostic (3.76e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.27e-3)"	"unprognostic (8.96e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.20e-1)"	"unprognostic (7.64e-2)"	"unprognostic (7.52e-2)"	"unprognostic (6.62e-2)"	1.8	1.0	0.0	0.1	0.4	0.6	0.9	0.0	0.7	0.1	0.0			0.3	0.1	0.3	0.0	0.0	0.1	0.3	0.1	0.1	5.7	0.0	0.2	0.1	0.0		0.1	0.0	0.3	0.1	0.0		0.2	0.0		0.2	0.0	0.3	0.4	1.2	0.0	0.0	0.2	0.1	1.3			1.0		0.0	0.1	0.1	0.4	0.4	3.3	0.3	0.4	0.8	0.1	0.2	0.4	0.4	0.2	0.1	0.1	0.4	0.2	0.1	0.1	0.0	0.4	0.4	0.8	0.2	0.1	0.4	0.3	0.0	0.0	0.1	0.4	0.2	0.4	0.7	0.0	0.1	1.1	0.4	0.1	0.1	0.1	0.1	0.4	0.2	0.4	0.3	0.6	0.0	0.3	0.4	0.5	0.3	0.2	0.4	0.3	0.1	0.7	0.1	0.4	0.6	0.1	0.2	0.1	0.1	0.2	0.1	0.3	0.3	0.4	0.3	1.0	0.4	7.2	0.4	0.3	0.4	1.1	0.3	1.4	0.3	3.3	0.3	0.2	0.2	0.4	0.2	0.3	0.1	0.4	0.2	0.3	0.8	0.4	0.2	0.4	0.8	0.1											6.0	14.8	0.0	0.5	0.6	1.2	0.5	0.0	2.7	3.4	73.3	2.0	0.3	0.0	0.0	0.9	0.7	1.1	0.0	0.0	0.2	1.1	0.3	3.5	0.0	0.3	1.6	0.0	1.8	0.3	1.0	0.6	0.8	1.7	0.0	0.3	0.8	0.1	0.0	0.7	0.0	1.7	0.0	0.0	0.5	0.4	0.1	0.7	0.0	0.0	0.4
SLC1A6	EAAT4	ENSG00000105143	"Solute carrier family 1 member 6"	P48664	19	14950034-15022990	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 52.1;testis: 23.3"	"Cell type enhanced"	"Detected in some"	11	"Bipolar cells: 12.3;Early spermatids: 29.3;Horizontal cells: 22.3;Late spermatids: 27.3;Syncytiotrophoblasts: 33.4"	"Cancer enriched"	"Detected in some"	7	"urothelial cancer: 5.2"	"Region enriched"	"Detected in many"	5	"cerebellum: 52.1"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HAP1: 6.6;NTERA-2: 5.4;U-698: 24.6"	"Region enriched"	"Detected in many"	6	"cerebellum: 152.9"	"Low region specificity"	"Detected in all"			"HPA041505, HPA044066"	Enhanced	Supported	Supported	"Plasma membrane,Intermediate filaments"		NA	NA			"Plasma membrane"	"Intermediate filaments"	"HPA041505: AB_2677520, HPA044066: AB_2678796"	"unprognostic (3.62e-2)"	"unprognostic (1.35e-1)"		"unprognostic (4.41e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-1)"		"unprognostic (5.94e-3)"	"unprognostic (8.90e-2)"	"unprognostic (6.52e-4)"	"unprognostic (1.55e-1)"	"unprognostic (5.40e-3)"	"unprognostic (1.11e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.35e-1)"	"unprognostic (5.57e-2)"	"prognostic unfavorable (6.88e-6)"	0.4	0.5	3.2	0.5	9.6	1.2	0.8	52.1	12.8	0.4	0.5	0.6	0.0	0.6	0.8	4.2	0.4	0.5	0.5	0.4	4.8	4.0	0.4	0.5	0.5	0.5	1.6	3.4	0.6	0.9	0.6	0.0	4.3	3.0	0.9	0.6	0.1	0.7	0.9	0.5	9.2	0.5	0.5	1.4	0.7	0.5	23.3	0.9	0.0	0.6	0.0	0.6	0.4	0.0	2.0	0.7	2.2	0.7	0.5	0.6	0.1	0.1	0.1	0.3	0.3	0.2	0.2	0.8	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.2	0.1	1.2	6.6	0.1	0.1	0.2	0.1	0.2	0.3	0.2	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.1	0.2	0.1	0.6	0.1	0.5	0.0	0.3	5.4	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.4	0.2	0.2	2.6	0.0	1.1	0.3	0.1	0.0	0.3	1.0	0.2	0.1	0.4	0.1	24.6	0.1	0.3	0.1	1.6	0.7	0.5	0.6	0.4	0.4	1.0	0.5	0.3	0.3	2.0	0.6	0.6	2.2	0.5	0.4	0.7	0.3	0.1	3.2	9.6	52.1	6.5	4.8	4.0	1.6	3.4	3.0	0.9	0.0	0.0	0.0	0.6	2.9	12.3	1.6	0.0	0.0	0.0	1.8	0.0	0.5	0.0	0.0	29.3	0.0	0.0	0.0	0.3	8.5	1.0	0.2	0.0	0.0	0.4	22.3	0.0	0.0	0.0	27.3	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.0	0.7	0.0	0.3	1.7	1.5	5.9	33.4	0.0	0.0	0.1
SLC26A4	"DFNB4, PDS"	ENSG00000091137	"Solute carrier family 26 member 4"	O43511	7	107660635-107717809	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"thyroid gland: 79.2"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 2: 11.4;Glandular cells: 8.7;Intestinal endocrine cells: 7.0;Melanocytes: 6.8"	"Cancer enriched"	"Detected in some"	8	"thyroid cancer: 37.6"	"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	5	"naive B-cell: 3.1"	"Lineage enriched"	"Detected in single"	5	"B-cells: 3.1"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 3.5;hTERT-RPE1: 8.3;LHCN-M2: 4.6"	"Region enriched"	"Detected in some"	4	"hippocampal formation: 10.6"	"Low region specificity"	"Detected in all"			HPA042860	Approved					NA	NA					"HPA042860: AB_10796680"	"unprognostic (1.19e-2)"	"unprognostic (4.84e-2)"	"unprognostic (5.44e-2)"	"unprognostic (8.44e-2)"	"unprognostic (3.25e-2)"	"unprognostic (3.26e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.72e-2)"	"unprognostic (9.58e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.46e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.39e-1)"	0.1	0.0	0.8	0.2	0.5	0.0	0.2	0.0	2.9	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.2	3.3	0.0	0.2	0.0	0.1	0.6	0.1	0.1	0.1	0.1	0.0	0.0	1.8	0.0	1.4	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.2	79.2	0.0	0.1	0.8	0.1	3.1	0.1	0.1	0.2	0.1	0.5	0.3	0.7	0.3	0.5	0.0	0.7	1.5	0.4	0.3	0.2	0.3	0.1	0.0	0.1	0.1	2.5	0.3	0.0	0.2	0.5	0.2	0.1	3.5	0.9	0.0	0.3	0.2	0.4	0.4	1.1	0.0	0.9	0.4	0.0	8.3	0.1	0.8	0.0	0.4	4.6	0.7	0.0	0.4	0.0	0.0	0.8	0.2	1.3	0.0	0.0	0.1	2.5	0.1	0.0	0.0	1.7	0.2	0.0	0.4	0.7	0.7	0.5	0.2	2.8	0.7	0.7	0.3	0.8	0.4	1.7	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.0	0.0	3.1	0.0	0.1	0.1	0.1	0.2	0.1	0.5	0.3	0.8	0.5	0.0	1.4	0.5	0.2	0.1	0.6	0.0	0.0	3.0	11.4	0.0	0.6	1.4	5.6	0.7	0.0	1.4	4.5	0.0	2.0	0.2	0.0	0.1	2.6	0.7	0.0	0.0	0.0	0.1	1.1	8.7	4.7	0.0	0.2	1.6	7.0	0.6	0.3	2.0	0.9	1.4	6.8	1.0	0.0	0.4	0.1	0.0	1.1	0.0	1.1	0.0	0.9	1.7	0.3	1.3	0.0	1.0	0.0	1.2
SLC30A2	ZNT2	ENSG00000158014	"Solute carrier family 30 member 2"	Q9BRI3	1	26037252-26046133	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 78.0;placenta: 20.0"	"Cell type enhanced"	"Detected in many"	16	"Cytotrophoblasts: 23.2;Exocrine glandular cells: 18.5;Proximal tubular cells: 27.2;Syncytiotrophoblasts: 71.2"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 19.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"BEWO: 4.7;RPTEC TERT1: 10.6;WM-115: 6.5"	"Region enriched"	"Detected in single"	5	"olfactory region: 1.5"	"Not detected"	"Not detected"			HPA017979			Approved	Vesicles		NA	NA			Vesicles		"HPA017979: AB_1857085"	"unprognostic (4.87e-2)"	"unprognostic (6.70e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.79e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.25e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.99e-2)"	"unprognostic (1.10e-1)"	"prognostic favorable (2.86e-6)"	"unprognostic (9.38e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.01e-2)"	0.1	0.7	0.1	0.1	0.1	0.2	0.4	0.1	0.1	0.1	0.1	0.1	0.6	0.0	1.3	1.1	0.1	0.1	4.0	2.2	0.1	0.1	10.4	0.1	0.2	0.1	0.1	0.1	0.1	78.0	0.1	0.1	20.0	0.1	0.3	0.0	2.0	1.0	1.4	1.7	0.4	0.6	0.1	0.1	0.1	0.1	0.4	0.1	0.1	12.8	0.2	0.1	0.5	0.1	1.5	1.1	3.1	1.0	1.5	0.9	0.4	0.2	0.2	0.2	1.0	0.3	0.1	4.7	0.4	0.2	0.1	0.1	0.9	1.0	0.2	0.9	0.1	0.2	0.9	0.2	0.3	0.1	0.6	0.3	0.6	0.7	0.1	0.1	0.6	0.7	0.0	0.2	0.1	0.1	0.3	0.0	0.3	0.6	1.5	0.1	0.8	0.5	0.9	0.8	0.4	0.2	0.3	0.7	0.7	10.6	0.4	0.9	0.5	0.6	1.1	0.4	1.6	0.7	0.5	0.6	0.7	1.2	0.6	0.3	1.1	0.6	0.8	0.5	0.6	6.5	3.1	1.0	0.4	0.9	0.4	0.5	0.7	0.6	0.8	0.2	1.5	0.6	0.8	3.1	1.5	0.5	1.1	0.5	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	3.0	4.0	0.0	0.7	0.3	2.4	5.1	15.3	0.0	0.0	8.7	0.0	23.2	5.0	6.8	0.0	0.5	0.4	0.0	18.5	2.4	0.6	0.6	4.6	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	3.3	1.8	0.1	0.5	5.4	0.0	0.0	27.2	1.8	6.5	0.9	0.2	0.4	0.6	71.2	0.0	0.6	0.7
SLC43A3	"DKFZp762A227, Eeg1, FOAP-13, PRO1659, SEEEG-1"	ENSG00000134802	"Solute carrier family 43 member 3"	Q8NBI5	11	57406954-57427580	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 149.9;thyroid gland: 69.0"	"Cell type enhanced"	"Detected in many"	5	"granulocytes: 63.7;Hofbauer cells: 71.5;Sertoli cells: 64.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HL-60: 71.0;HMC-1: 62.7;RPMI-8226: 80.1;WM-115: 76.4"	"Region enriched"	"Detected in many"	4	"olfactory region: 12.7"	"Low region specificity"	"Detected in all"			"HPA030551, HPA077244"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			Vesicles	"Nucleoplasm, Plasma membrane"	"HPA030551: AB_10604094, HPA077244: AB_2732335"	"unprognostic (2.64e-1)"	"unprognostic (7.63e-2)"	"unprognostic (9.67e-3)"	"unprognostic (7.41e-3)"	"unprognostic (6.59e-3)"	"unprognostic (5.30e-3)"	"unprognostic (1.29e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.26e-1)"	"unprognostic (5.73e-2)"	"unprognostic (3.97e-2)"	"prognostic unfavorable (3.97e-13)"	"unprognostic (8.16e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.00e-1)"	32.3	6.3	2.5	12.4	4.3	18.8	16.8	2.2	3.0	11.9	9.6	3.6	2.4	2.7	10.1	6.5	12.6	8.9	11.4	12.5	3.1	1.5	4.2	149.9	16.5	8.8	4.0	1.8	16.0	7.2	1.2	1.8	5.1	3.4	11.6	4.2	9.4	12.2	3.1	15.4	11.0	6.2	10.3	4.7	11.6	6.9	6.8	2.3	10.4	69.0	11.5	13.8	20.3	15.4	2.7	23.6	6.1	36.8	1.1	7.8	14.0	40.0	0.0	2.3	0.0	7.8	11.5	0.1	3.1	13.3	4.6	7.9	0.0	8.8	23.1	1.4	7.3	2.4	23.1	6.7	4.1	9.3	0.1	0.0	36.0	13.7	0.0	15.9	71.0	62.7	34.5	0.1	44.6	0.5	3.3	12.9	10.7	41.1	22.4	17.8	0.0	14.9	45.6	3.5	0.0	0.7	30.9	0.4	80.1	11.0	0.0	5.5	0.0	8.8	0.2	37.4	0.2	3.4	10.8	6.8	0.2	12.0	30.4	8.7	0.0	0.1	5.8	27.5	25.8	76.4	3.2	28.8	6.1	5.7	34.5	6.5	2.7	4.0	7.8	23.6	2.0	3.1	3.2	2.5	1.1	36.8	23.6	6.9	14.0	2.5	4.3	2.2	3.0	3.1	1.5	4.0	1.8	3.4	2.3	14.9	41.4	4.5	6.7	41.6	0.5	2.8	30.6	5.3	34.2	1.8	0.0	0.5	0.0	47.0	1.0	23.3	0.0	0.0	5.5	2.2	20.2	3.4	63.7	53.8	71.5	0.0	0.0	11.6	17.3	1.4	9.2	55.1	28.7	0.0	0.5	0.9	10.9	0.0	11.7	0.0	0.0	64.7	18.4	1.0	0.2	15.4	0.7	15.0	0.6	2.5
SLC5A1	"D22S675, NAGT, SGLT1"	ENSG00000100170	"Solute carrier family 5 member 1"	P13866	22	32043032-32113029	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Sugar transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"intestine: 274.9"	"Cell type enhanced"	"Detected in many"	13	"Cardiomyocytes: 111.5;Cholangiocytes: 117.2;Early spermatids: 40.8;Late spermatids: 54.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"OE19: 27.0"	"Region enriched"	"Detected in single"	26	"cerebellum: 8.6"	"Not detected"	"Not detected"			"CAB015467, HPA051805, HPA055106"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Golgi apparatus,Cytosol"		NA	NA			"Nucleoplasm, Golgi apparatus"	"Nuclear membrane, Cytosol"	"CAB015467: , HPA051805: AB_2681618, HPA055106: AB_2682695"	"unprognostic (1.96e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.24e-2)"	"prognostic favorable (2.59e-4)"	"unprognostic (3.85e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.22e-2)"	"unprognostic (4.83e-2)"	"unprognostic (6.21e-2)"	"unprognostic (9.53e-2)"	"prognostic favorable (6.97e-7)"	"unprognostic (4.68e-3)"	"unprognostic (1.98e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.45e-2)"	0.2	0.0	0.2	1.3	0.2	0.0	1.5	0.2	0.2	2.2	181.5	0.2	2.9	95.5	0.3	0.8	1.9	0.0	14.1	24.5	0.2	0.0	1.0	0.9	0.3	0.2	0.2	0.2	0.2	0.4	0.0	1.0	0.2	0.2	0.8	1.6	0.2	5.7	3.5	0.2	4.6	274.9	0.2	0.2	0.7	1.2	0.8	0.2	0.2	0.2	3.5	1.5	0.2	2.0	0.3	0.1	0.6	0.8	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.1	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	27.0	0.0	0.0	0.0	1.6	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.2	0.6	0.3	0.8	0.1	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	1.8	0.6	0.0	111.5	117.2	0.0	4.5	0.0	0.0	0.0	0.0	2.4	40.8	0.0	26.1	0.0	1.2	0.0	0.2	19.7	0.0	0.0	0.0	0.0	24.5	0.0	0.0	54.9	1.1	0.0	0.0	0.0	8.7	0.0	0.6	14.7	1.4	1.9	0.0	0.0	0.0	4.2	0.5	4.8	0.0	0.0	19.6	4.8
SLC6A2	"NAT1, NET, NET1, SLC6A5"	ENSG00000103546	"Solute carrier family 6 member 2"	P23975	16	55655604-55706192	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 20.4;placenta: 41.8"	"Group enriched"	"Detected in some"	5	"Early spermatids: 3.2;Extravillous trophoblasts: 6.9;Late spermatids: 3.7;Spermatocytes: 10.4;Syncytiotrophoblasts: 4.7"	"Cancer enhanced"	"Detected in some"		"liver cancer: 1.9"	"Region enriched"	"Detected in single"	27	"pons and medulla: 9.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	30	"SH-SY5Y: 107.1"	"Region enriched"	"Detected in some"	4	"pons and medulla: 8.2"	"Region enriched"	"Detected in single"	32	"pons and medulla: 23.1"	"HPA004057, HPA076311, CAB078195"	Enhanced	Supported	Approved	Mitochondria,Cytosol		NA	NA			Cytosol	Mitochondria	"CAB078195: AB_2665806, HPA004057: AB_1080012, HPA076311: AB_2732307"	"unprognostic (9.58e-3)"	"unprognostic (5.48e-2)"		"unprognostic (1.26e-4)"	"unprognostic (4.07e-1)"	"unprognostic (4.16e-1)"	"unprognostic (8.38e-2)"	"unprognostic (2.97e-2)"	"unprognostic (3.29e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.02e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.43e-2)"	2.4	20.4	0.3	0.1	0.1	0.0	1.8	0.1	0.3	3.2	0.3	0.3	0.1	0.0	4.5	7.2	0.8	0.4	0.4	0.1	0.1	0.0	0.4	1.0	0.5	0.1	0.1	0.1	0.2	0.1	0.0	0.1	41.8	9.7	0.5	0.1	0.1	1.6	1.7	0.1	11.4	0.4	1.0	0.2	0.1	0.2	8.3	0.2	0.1	0.2	0.9	0.5	0.5	1.7	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.8	107.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.3	0.1	0.0	0.1	0.1	9.7	0.2	0.0	0.0	0.0	0.1	1.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.2	0.0	0.0	0.0	0.0	6.9	0.4	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.1	0.4	4.7	0.0	0.0	0.0
SLC6A4	"5-HTT, HTT, OCD1, SERT1"	ENSG00000108576	"Solute carrier family 6 member 4"	P31645	17	30194319-30236002	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 25.0;lung: 50.5"	"Group enriched"	"Detected in some"	6	"Cytotrophoblasts: 90.5;Syncytiotrophoblasts: 89.0"	"Cancer enhanced"	"Detected in some"		"breast cancer: 2.3"	"Region enriched"	"Detected in single"	36	"pons and medulla: 11.2"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.9;CACO-2: 5.5;Hep G2: 14.7"	"Region enriched"	"Detected in some"	5	"midbrain: 69.9"	"Low region specificity"	"Detected in all"			"HPA054723, HPA071354, HPA074728"	Supported	Supported	Supported	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA054723: , HPA071354: , HPA074728: AB_2686708"	"unprognostic (7.45e-2)"	"unprognostic (7.13e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.72e-4)"	"unprognostic (2.07e-1)"	"unprognostic (8.42e-3)"	"unprognostic (2.73e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.37e-3)"	"unprognostic (1.17e-3)"	"unprognostic (2.70e-3)"	"unprognostic (1.16e-1)"	"unprognostic (8.78e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.05e-2)"	"unprognostic (7.18e-2)"	0.2	0.1	0.1	0.1	0.1	0.0	0.2	0.2	0.3	0.2	0.2	0.1	0.1	6.3	0.1	0.3	1.6	0.9	0.1	0.7	0.1	0.1	0.3	0.1	50.5	0.1	0.1	0.1	0.1	0.6	0.0	0.1	11.3	11.2	0.1	0.0	0.2	0.7	0.1	0.1	0.4	25.0	0.4	0.1	0.1	0.5	0.3	0.1	0.1	0.2	0.1	0.3	0.1	0.3	0.0	0.1	1.0	0.2	0.4	0.3	2.3	0.0	0.0	0.0	0.1	0.0	0.0	2.9	0.0	0.0	0.0	0.0	5.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	14.7	1.5	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.1	0.1	0.0	1.0	0.0	0.7	0.8	0.0	0.0	0.1	0.2	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.3	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.1	1.0	0.4	0.2	0.1	0.0	2.3	0.1	0.1	0.2	0.3	0.1	0.1	0.1	0.1	11.2	0.1	14.9	5.3	0.0	0.4	0.1	0.2	0.8	0.0	1.4	3.4	1.8	0.0	90.5	0.0	0.0	2.3	0.5	1.0	0.0	0.0	7.0	1.6	0.3	2.3	0.0	8.4	0.0	0.0	2.5	0.6	1.0	0.3	0.4	0.0	0.0	0.0	0.5	0.5	0.0	0.4	0.3	0.9	0.0	1.4	0.0	0.4	0.3	89.0	0.0	0.0	0.3
SLC6A5	"GLYT2, NET1"	ENSG00000165970	"Solute carrier family 6 member 5"	Q9Y345	11	20599400-20659285	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 21.3"	"Group enriched"	"Detected in some"	27	"Early spermatids: 20.8;Late spermatids: 40.6"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	6	"pons and medulla: 21.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"SCLC-21H: 2.6"	"Region enriched"	"Detected in some"	9	"pons and medulla: 51.6"	"Region enriched"	"Detected in some"	9	"pons and medulla: 33.2"	CAB079052		Supported				NA	NA					"CAB079052: "					"unprognostic (6.94e-2)"	"unprognostic (2.28e-1)"									"unprognostic (4.75e-2)"			0.0	0.1	0.1	0.1	0.0	0.0	0.0	3.3	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	5.1	0.1	0.1	0.0	0.0	0.0	0.0	2.2	0.0	21.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	6.0	0.0	0.0	1.8	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.3	0.4	0.3	0.1	0.1	0.0	21.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0
SLC9A3	NHE3	ENSG00000066230	"Solute carrier family 9 member A3"	P48764	5	470458-524332	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 65.8;intestine: 85.1;kidney: 43.6"	"Cell type enhanced"	"Detected in some"	15	"Alveolar cells type 1: 14.9;Club cells: 10.3;Collecting duct cells: 15.7;Proximal tubular cells: 38.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 28.2"	"Region enriched"	"Detected in single"	14	"cerebellum: 4.6"	"Not detected"	"Not detected"			"HPA036493, HPA036669"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA036493: AB_10673353, HPA036669: AB_10670843"	"unprognostic (1.27e-1)"	"unprognostic (4.88e-1)"	"unprognostic (9.35e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.51e-1)"	"unprognostic (9.40e-2)"	"prognostic unfavorable (8.49e-4)"	"unprognostic (5.18e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.69e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.32e-1)"	0.6	0.6	0.5	16.2	1.0	0.0	0.6	4.2	0.9	0.9	27.5	0.7	1.1	12.7	0.9	3.4	2.4	0.8	65.8	0.6	0.6	0.6	43.6	0.5	0.5	0.9	0.9	0.7	0.8	1.1	0.6	0.9	0.5	1.2	1.4	2.3	1.2	2.1	0.8	0.7	4.2	85.1	1.1	0.6	0.5	22.7	1.1	0.5	0.6	0.7	2.4	2.7	0.8	2.0	1.9	2.0	0.2	1.2	3.5	6.8	2.9	4.2	3.8	7.0	7.4	1.7	2.0	5.5	4.2	2.5	5.2	3.3	9.3	4.9	10.2	5.5	1.9	3.8	7.0	3.9	2.5	2.5	28.2	7.3	4.6	16.5	3.4	2.6	3.4	5.9	2.7	5.2	2.3	3.5	2.6	1.5	4.2	6.1	5.4	1.8	6.6	3.7	16.7	2.6	12.2	6.3	5.6	6.6	5.3	1.8	3.6	7.9	3.3	12.6	3.5	2.6	3.2	8.0	2.7	1.9	6.0	5.3	4.1	2.7	9.1	3.6	5.8	3.8	15.3	3.8	0.0	1.2	0.1	4.3	0.5	3.8	1.6	5.6	4.1	1.4	1.9	6.8	5.2	0.2	3.5	0.4	2.0	4.2	2.9	0.5	1.0	4.2	0.9	0.6	0.6	0.9	0.7	1.2	0.5	14.9	4.3	0.0	0.0	0.0	0.0	0.6	0.0	5.3	10.3	15.7	0.0	0.0	5.0	7.5	0.0	0.0	1.0	0.0	7.7	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	8.2	0.0	0.0	6.5	0.0	0.0	38.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLCO4A1	"OATP-E, OATP4A1, SLC21A12"	ENSG00000101187	"Solute carrier organic anion transporter family member 4A1"	Q96BD0	20	62642445-62685785	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	17	"Extravillous trophoblasts: 195.5;Melanocytes: 57.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.3"	"Group enriched"	"Detected in many"	5	"B-cells: 2.3;dendritic cells: 2.6;T-cells: 4.3"	"Cell line enhanced"	"Detected in many"		"PC-3: 56.2;RPTEC TERT1: 53.9"	"Region enriched"	"Detected in single"	5	"cerebellum: 7.5"	"Low region specificity"	"Detected in some"			"HPA030669, HPA030670"	Uncertain		Supported	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA030669: AB_10601163, HPA030670: AB_10670033"	"unprognostic (8.94e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.46e-3)"	"unprognostic (3.34e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.84e-3)"	"prognostic unfavorable (4.74e-4)"	"unprognostic (4.94e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.49e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.84e-3)"	"unprognostic (9.27e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.25e-1)"	25.0	5.2	16.4	5.3	22.4	3.9	27.2	11.3	23.8	5.0	6.4	1.6	4.3	4.2	5.5	2.3	24.1	5.2	5.6	18.1	19.0	9.2	16.6	3.1	29.4	5.7	18.1	2.3	3.1	5.4	13.8	1.2	11.9	24.8	2.8	5.5	7.1	20.1	4.1	19.2	16.5	4.4	3.6	9.8	4.5	14.9	3.3	16.5	0.5	4.5	4.0	8.7	7.4	18.5	2.3	2.6	0.0	0.5	0.0	4.3	0.7	4.1	5.3	0.2	3.1	0.7	0.6	7.6	1.3	4.7	4.1	1.4	8.9	4.2	4.9	12.9	0.1	2.8	6.1	4.7	0.3	1.5	0.5	2.7	5.9	6.0	6.5	0.0	4.5	1.9	0.0	1.8	0.0	1.8	1.2	0.7	3.0	4.6	1.3	0.0	4.1	4.6	17.6	1.4	20.5	56.2	8.4	0.3	7.2	53.9	3.9	5.0	7.2	1.1	1.2	4.5	2.0	0.2	2.1	0.8	0.1	3.0	2.0	7.6	2.6	4.2	3.0	11.2	6.5	0.7	0.0	0.0	0.0	0.2	0.5	0.0	2.3	0.5	0.1	2.6	2.0	0.7	0.3	0.0	0.0	0.1	0.0	4.3	0.7	16.4	22.4	11.3	23.8	19.0	9.2	18.1	2.3	24.8	16.5	3.0	2.2	5.7	0.7	24.3	13.2	3.6	2.5	1.4	1.2	24.4	29.5	1.6	0.0	4.0	0.3	26.3	2.1	0.0	2.2	195.5	4.1	2.1	0.0	0.0	5.0	0.0	0.0	17.8	9.9	0.4	0.3	8.4	57.3	0.0	5.1	4.2	7.7	2.3	0.7	4.2	43.2	0.0	6.6	0.2	4.2	14.1	19.7	3.2	6.8	6.3
SLN	"MGC12301, MGC125854, MGC125855"	ENSG00000170290	Sarcolipin	O00631	11	107707378-107719693	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"skeletal muscle: 446.6"	"Group enriched"	"Detected in some"	21	"Cardiomyocytes: 248.9;Muller glia cells: 330.7"	"Group enriched"	"Detected in many"	13	"glioma: 21.6;head and neck cancer: 22.4;prostate cancer: 4.5"	"Region enhanced"	"Detected in some"		"basal ganglia: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.7;HSkMC: 6.0;Karpas-707: 2.8;PC-3: 2.7;SuSa: 6.2;U-2 OS: 2.7"	"Region enriched"	"Detected in some"	5	"basal ganglia: 19.0"	"Not detected"	"Not detected"			CAB011628			Approved	Microtubules		NA	NA			Microtubules		"CAB011628: AB_2195046"	"unprognostic (6.85e-2)"	"unprognostic (6.18e-8)"	"unprognostic (2.60e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.40e-3)"	"unprognostic (4.12e-3)"		"unprognostic (5.28e-3)"	"unprognostic (1.31e-2)"	"unprognostic (2.76e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (3.52e-9)"	"unprognostic (3.27e-2)"	"unprognostic (2.54e-1)"	"unprognostic (5.09e-4)"	"unprognostic (3.77e-2)"	4.8	0.5	0.2	0.0	1.9	0.0	0.1	0.4	1.0	0.0	0.2	0.0	0.0	0.0	0.0	5.3	9.1	0.1	0.0	72.9	0.2	0.0	0.1	0.0	0.2	0.2	0.0	0.0	1.1	0.1	0.0	0.0	0.1	0.1	2.3	0.0	0.4	4.3	0.0	446.6	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	1.9	40.1	6.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.3	0.4	0.2	0.0	0.1	0.6	1.1	0.1	0.2	0.0	0.0	0.5	1.5	0.0	0.0	0.0	0.0	0.3	0.3	6.0	0.0	0.8	0.0	0.4	0.0	0.0	0.1	2.8	0.0	0.4	0.3	0.4	0.1	0.1	2.7	0.0	0.0	0.2	0.0	0.0	1.8	0.0	0.0	0.1	0.0	6.2	0.0	0.0	0.0	0.0	2.7	0.0	0.2	1.1	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	1.9	0.4	1.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	1.7	248.9	0.0	0.0	0.0	0.0	2.0	1.0	0.0	0.0	7.3	0.0	0.0	0.0	0.4	1.7	0.5	0.0	0.0	0.0	0.3	3.2	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	330.7	0.2	0.0	0.4	0.1	14.1	0.0	0.4	0.0	0.0	1.3	4.8	0.0	0.0	0.0
SNX31	MGC39715	ENSG00000174226	"Sorting nexin 31"	Q8N9S9	8	100572882-100663415	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 21.4;prostate: 13.8;urinary bladder: 25.4;vagina: 16.0"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 73.9"	"Cancer enriched"	"Detected in many"	22	"urothelial cancer: 24.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.0"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in single"	50	"RT4: 42.9"	"Region enriched"	"Detected in single"	5	"thalamus: 2.9"	"Region enhanced"	"Detected in single"		"olfactory region: 3.1"	"HPA024284, HPA053466"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA024284: AB_1853894, HPA053466: AB_2682161"	"unprognostic (1.39e-1)"	"unprognostic (3.83e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.20e-5)"	"unprognostic (1.04e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.69e-1)"	"unprognostic (7.79e-3)"	"unprognostic (1.66e-1)"	"prognostic favorable (1.47e-4)"	"unprognostic (2.54e-1)"	"unprognostic (4.05e-2)"	0.5	0.0	0.6	0.1	0.7	0.1	0.4	0.6	2.3	1.7	0.3	0.3	0.1	0.2	0.3	0.2	6.2	0.3	0.9	1.8	0.8	0.7	0.3	0.4	0.3	0.3	0.9	0.3	0.3	0.2	0.1	0.2	0.1	0.6	13.8	0.1	0.4	1.4	0.1	1.0	0.5	0.1	7.4	0.8	0.1	0.6	3.3	0.5	0.1	0.4	2.6	21.4	25.4	16.0	1.1	0.3	3.0	0.5	1.6	0.3	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.9	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.1	2.5	0.5	0.2	0.3	0.2	0.1	1.1	0.1	0.2	0.2	0.5	0.1	0.3	3.0	1.6	0.0	0.3	0.0	0.0	0.6	0.7	0.6	0.3	0.8	0.7	0.9	0.3	0.6	0.5	0.0	0.0	0.0	3.6	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	73.9	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.0	0.4	0.4	0.4	0.0	0.0	0.0	1.0
SOX4		ENSG00000124766	"SRY-box 4"	Q06945	6	21592768-21598619	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 21.8"	"Cell type enhanced"	"Detected in many"	7	"Ductal cells: 757.4;Pancreatic endocrine cells: 1059.7"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 21.8"	"Group enriched"	"Detected in all"	4	"dendritic cells: 21.8;granulocytes: 12.8;monocytes: 10.0"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 55.4;MOLT-4: 47.6;SH-SY5Y: 31.2"	"Region enriched"	"Detected in many"	4	"olfactory region: 66.5"	"Low region specificity"	"Detected in many"			HPA029901	Approved		Supported	Nucleoplasm,Mitochondria		NA	Yes			Nucleoplasm	Mitochondria	"HPA029901: AB_10601592"	"unprognostic (4.01e-2)"	"unprognostic (3.06e-1)"	"unprognostic (9.28e-2)"	"unprognostic (5.18e-2)"	"unprognostic (5.00e-2)"	"unprognostic (1.08e-2)"	"prognostic unfavorable (2.57e-5)"	"unprognostic (1.78e-1)"	"unprognostic (8.01e-3)"	"unprognostic (1.98e-2)"	"unprognostic (3.88e-3)"	"unprognostic (1.18e-1)"	"unprognostic (8.73e-3)"	"unprognostic (3.66e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.01e-1)"	"unprognostic (9.27e-2)"	4.2	0.7	2.0	1.9	0.9	6.0	6.3	3.0	6.3	6.7	2.8			3.0	18.0	4.1	2.3	4.2	5.5	2.0	1.1	1.8	4.3	1.3	5.1	0.8	0.6		18.1	5.3	0.0	1.8	1.0		4.1	3.7		9.6	1.4	0.3	4.1	2.7	4.9	0.3	1.0	4.4	2.5			3.4		1.4	6.2	3.6	3.1	21.8	12.8	10.0	3.3	1.1	2.0	1.8	5.2	13.3	55.4	4.9	1.2	21.7	0.8	1.7	1.0	0.9	3.5	3.5	0.6	22.2	1.3	0.7	5.4	6.9	3.8	0.7	7.6	14.5	0.5	2.4	2.3	0.8	1.8	0.4	2.1	3.9	0.4	1.6	14.2	15.6	30.0	0.1	0.0	1.1	4.3	47.6	4.5	9.9	2.6	5.0	21.0	1.1	0.0	9.6	16.7	17.4	31.2	7.7	9.0	2.9	17.3	4.4	6.5	11.9	1.5	5.2	0.3	3.9	0.3	0.0	15.4	0.5	6.5	6.1	12.8	9.8	0.9	0.2	5.5	0.0	2.8	0.1	0.1	4.1	3.1	1.1	0.8	0.4	3.3	10.0	21.8	0.9	2.0											184.6	59.8	33.5	82.0	99.9	88.8	228.6	341.4	161.9	235.4	146.5	11.8	61.5	56.3	757.4	3.9	238.0	78.0	0.0	523.0	358.6	243.9	126.1	56.8	5.8	33.0	46.1	327.2	70.6	85.2	8.3	11.2	56.1	231.2	80.2	156.9	228.7	1059.7	155.6	10.6	77.4	25.8	6.5	198.6	3.7	175.2	81.3	25.3	23.5	265.6	178.0
SP7	"osterix, OSX"	ENSG00000170374	"Sp7 transcription factor"	Q8TDD2	12	53326575-53345315	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 4.0;lymphoid tissue: 3.3;testis: 4.2"	"Cell type enhanced"	"Detected in single"	28	"Cone photoreceptor cells: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.7;HSkMC: 2.1;MCF7: 1.0"	"Region enriched"	"Detected in single"	13	"olfactory region: 34.5"	"Low region specificity"	"Detected in all"			HPA063202	Enhanced					NA	NA					"HPA063202: AB_2684961"	"unprognostic (6.02e-1)"	"unprognostic (6.28e-3)"		"unprognostic (6.37e-2)"	"unprognostic (2.49e-2)"	"unprognostic (7.75e-2)"		"unprognostic (3.02e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.04e-2)"	"unprognostic (6.02e-1)"	"unprognostic (3.93e-7)"	"unprognostic (6.04e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.95e-1)"	1.0	0.2	1.7	0.0	2.8	0.4	0.1	0.3	4.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.4	0.5	0.0	0.1	1.1	0.5	0.1	0.0	0.2	3.3	0.7	0.0	0.2	0.0	1.9	0.0	0.1	0.0	0.0	0.0	1.7	0.4	0.1	0.1	0.1	0.0	0.2	1.6	0.3	0.3	4.2	0.0	0.0	1.7	0.0	0.4	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	1.7	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.1	0.4	0.0	0.0	0.0	0.1	2.1	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.5	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.2	0.4	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.2	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.4	0.0	0.0	0.0	0.0	0.6	0.1	1.7	2.8	0.3	4.0	1.1	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
SPINK8		ENSG00000229453	"Serine peptidase inhibitor, Kazal type 8 (putative)"	P0C7L1	3	48306842-48328341	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"breast: 33.5"	"Cell type enhanced"	"Detected in some"	19	"Early spermatids: 1.1;Exocrine glandular cells: 1.2;Glandular cells: 2.2"	"Group enriched"	"Detected in some"	10	"breast cancer: 8.6;glioma: 9.6;prostate cancer: 2.4"					"Group enriched"	"Detected in some"	10	"eosinophil: 3.3;neutrophil: 4.5"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 4.5"	"Cell line enriched"	"Detected in single"	62	"SK-BR-3: 41.2"	"Region enriched"	"Detected in some"	9	"hippocampal formation: 80.7"					HPA053151	Uncertain				"Secreted to blood"	NA	NA					"HPA053151: AB_2682059"	"prognostic unfavorable (8.47e-4)"			"unprognostic (1.98e-1)"	"unprognostic (1.75e-2)"					"unprognostic (1.99e-1)"		"unprognostic (1.15e-1)"					"unprognostic (1.20e-1)"	0.0	0.0	1.4	0.0	1.0	7.3	33.5	0.3	0.6	0.0	0.0			0.0	0.0	1.8	4.1	0.0	0.0	0.0	2.2	1.7	0.0	0.0	0.0	0.0	1.5		0.0	0.2	0.0	0.2	0.0		0.4	0.0		1.8	0.1	0.0	0.2	0.0	0.0	2.3	1.2	0.0	0.1			0.0		0.0	0.0	0.0	0.0	0.0	4.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	41.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.4	0.0	0.0	0.0											0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.1	0.0	0.0	0.0	1.2	0.0	0.0	2.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4
STAP1	"BRDG1, STAP-1"	ENSG00000035720	"Signal transducing adaptor family member 1"	Q9ULZ2	4	67558728-67607337	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 36.8;ductus deferens: 12.3;intestine: 9.3;kidney: 20.0;lymphoid tissue: 30.4"	"Cell type enhanced"	"Detected in some"	23	"B-cells: 31.9;granulocytes: 75.5;Melanocytes: 15.1"	"Cancer enriched"	"Detected in many"	7	"renal cancer: 13.0"	"Region enriched"	"Detected in single"	7	"hippocampal formation: 3.2"	"Cell type enhanced"	"Detected in many"		"memory B-cell: 28.1;naive B-cell: 36.8"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"Daudi: 63.5;U-698: 28.4"	"Region enriched"	"Detected in single"	5	"cerebellum: 2.6"	"Low region specificity"	"Detected in many"			HPA038529	Enhanced		Uncertain	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA038529: AB_10673011"	"unprognostic (1.14e-4)"	"unprognostic (1.49e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.63e-3)"	"unprognostic (6.30e-4)"	"unprognostic (1.95e-3)"	"unprognostic (6.95e-3)"	"unprognostic (5.18e-2)"	"unprognostic (6.38e-3)"	"unprognostic (1.47e-1)"	"unprognostic (8.43e-3)"	"unprognostic (3.11e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.40e-1)"	0.7	0.3	0.4	27.8	0.3	2.9	0.6	0.3	0.4	0.7	2.1	0.0	12.3	0.8	0.6	1.2	2.4	0.4	0.7	0.4	3.2	0.3	20.0	0.5	2.7	23.9	0.4	0.0	0.3	0.6	0.0	0.4	0.1	0.2	1.0	1.3	0.3	2.6	5.1	0.4	0.5	9.3	0.1	0.4	26.5	1.1	2.1	0.0	5.9	0.7	0.7	30.4	4.6	0.6	36.8	1.7	7.7	0.0	12.6	2.9	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	8.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.4	0.0	9.2	0.0	1.2	0.0	7.7	0.3	0.0	0.7	28.1	0.7	0.3	0.4	36.8	2.9	0.1	0.3	12.6	0.0	1.7	0.1	1.7	0.4	0.3	0.3	0.4	3.2	0.3	0.4	0.0	0.2	0.0	0.0	10.1	31.9	0.0	0.2	0.0	0.0	0.0	1.4	1.2	5.2	0.0	0.0	8.3	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	75.5	0.0	0.6	0.0	0.0	0.0	0.0	5.2	0.3	0.6	15.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	4.9	0.0	0.0
STAP2	"BKS, STAP-2"	ENSG00000178078	"Signal transducing adaptor family member 2"	Q9UGK3	19	4324043-4342786	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 54.9"	"Cell type enhanced"	"Detected in many"	8	"Enterocytes: 281.0;Paneth cells: 282.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"NK-cell: 10.8"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.9;NK-cells: 10.8;T-cells: 3.4"	"Cell line enhanced"	"Detected in many"		"A-431: 27.3;HaCaT: 22.7;MCF7: 32.5;RT4: 43.8"	"Region enriched"	"Detected in single"	13	"cerebellum: 32.8"	"Low region specificity"	"Detected in single"			"HPA002375, HPA027761"	Approved					NA	NA					"HPA002375: AB_1078285, HPA027761: AB_1845364"	"unprognostic (1.42e-1)"	"prognostic favorable (2.76e-4)"	"unprognostic (3.52e-1)"	"prognostic favorable (3.03e-5)"	"unprognostic (4.35e-2)"	"unprognostic (9.35e-3)"	"unprognostic (4.52e-1)"	"unprognostic (7.81e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.93e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.43e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.00e-2)"	"prognostic favorable (4.13e-4)"	2.5	6.6	0.7	12.6	1.1	0.0	5.8	0.9	1.0	8.8	26.0	0.7	23.3	28.4	4.9	12.0	31.6	5.4	10.9	1.7	0.7	0.4	12.9	24.7	6.8	4.0	0.7	0.6	7.0	12.5	6.4	2.5	7.6	1.5	12.8	21.7	3.3	23.9	19.4	1.6	24.0	54.9	2.5	0.7	1.2	8.3	1.7	0.8	5.1	13.3	28.1	21.9	7.6	12.8	0.9	2.9	0.3	0.2	10.8	3.4	1.2	27.3	0.1	2.1	2.0	0.1	1.5	11.8	0.5	3.0	0.9	0.8	16.4	11.4	0.0	4.6	0.9	6.2	22.7	0.3	16.2	0.5	4.8	0.2	0.0	0.1	11.4	3.9	0.0	0.2	1.2	14.0	1.6	4.2	2.4	3.0	0.7	1.0	6.3	0.5	32.5	0.4	0.2	1.6	17.6	6.8	1.1	0.2	0.7	9.6	43.8	0.7	1.2	0.0	8.8	4.7	0.8	19.9	0.1	4.3	0.0	0.4	0.2	0.6	0.0	0.4	0.4	0.1	0.1	2.0	0.3	0.2	0.0	0.8	0.0	3.4	0.9	1.1	0.1	0.9	0.2	3.4	1.9	0.2	10.8	0.0	2.9	3.3	1.2	0.7	1.1	0.9	1.0	0.7	0.4	0.7	0.6	1.5	0.8	8.9	15.6	5.6	42.4	35.9	0.4	5.3	38.2	14.7	17.0	27.9	0.0	13.4	21.6	117.7	0.9	7.4	281.0	0.0	89.4	1.7	3.8	76.9	9.2	28.4	1.6	0.0	82.5	3.1	3.3	0.5	4.4	2.3	18.6	21.6	127.6	1.0	113.4	282.0	1.8	66.6	0.7	0.0	4.0	0.5	1.5	54.1	10.4	4.9	144.6	95.3
STK17B	DRAK2	ENSG00000081320	"Serine/threonine kinase 17b"	O94768	2	196133566-196176503	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 62.0;bone marrow: 103.4;lymphoid tissue: 72.2"	"Cell type enhanced"	"Detected in many"	5	"B-cells: 158.6;granulocytes: 189.5;Kupffer cells: 142.8;Macrophages: 145.8;T-cells: 178.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 36.3;HMC-1: 36.8;Karpas-707: 34.1;U-698: 39.5"	"Region enriched"	"Detected in many"	6	"cerebellum: 71.1"	"Low region specificity"	"Detected in all"			HPA034858	Enhanced		Uncertain	"Plasma membrane,Cytosol"		NA	Yes			"Plasma membrane, Cytosol"		"HPA034858: AB_10670981"	"unprognostic (2.14e-1)"	"unprognostic (2.45e-3)"	"unprognostic (3.68e-2)"	"unprognostic (3.61e-2)"	"unprognostic (3.63e-2)"	"unprognostic (7.43e-3)"	"unprognostic (1.75e-1)"	"unprognostic (7.63e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (5.72e-8)"	"unprognostic (1.88e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.64e-2)"	"unprognostic (5.80e-2)"	21.0	4.1	3.2	42.8	3.8	103.4	10.1	3.2	3.3	8.2	18.8	1.1	3.8	8.5	3.4	3.9	8.9	6.3	8.6	5.7	3.3	2.2	7.2	2.9	26.2	53.7	2.3	1.8	3.1	5.0	0.7	3.8	6.5	1.7	6.8	5.7	3.5	16.7	6.1	3.4	10.9	31.8	5.3	2.7	59.3	6.0	4.6	1.4	72.2	7.5	7.0	56.2	11.3	6.0	16.9	13.6	62.0	27.0	10.3	28.4	19.0	3.2	2.2	3.4	1.2	15.0	5.7	3.8	7.7	11.6	8.5	8.9	6.8	1.1	36.3	7.1	4.4	2.2	2.2	1.4	3.3	10.4	6.4	3.8	3.4	2.9	0.6	4.5	13.7	36.8	7.2	3.3	10.5	5.5	12.1	3.5	8.6	2.6	34.1	21.1	1.7	17.8	31.0	1.9	5.9	5.2	2.9	20.7	11.0	5.0	7.6	1.3	1.3	1.9	1.9	1.6	5.5	1.3	7.2	4.2	8.3	4.1	5.9	4.3	14.0	22.6	39.5	6.2	4.7	3.6	35.9	19.7	40.2	12.0	20.7	15.3	13.3	21.5	14.5	13.6	16.9	28.4	23.1	62.0	10.3	27.0	9.7	18.5	19.0	3.2	3.8	3.2	3.3	3.3	2.2	2.3	1.8	1.7	1.4	83.4	80.3	158.6	22.9	53.1	0.3	2.2	10.2	34.8	52.4	10.4	0.0	5.9	3.3	5.2	4.6	11.6	59.1	46.7	2.5	20.9	21.2	28.7	189.5	2.4	23.5	0.0	2.9	7.4	142.8	2.0	5.2	145.8	55.6	40.5	11.0	0.9	7.9	38.6	4.2	1.4	0.2	6.5	20.5	28.6	24.9	55.5	4.2	178.5	10.5	39.9
STOML3	"Epb7.2l, SRO"	ENSG00000133115	"Stomatin like 3"	Q8TAV4	13	38965925-38991066	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.7;epididymis: 8.1;fallopian tube: 31.7;lung: 9.2"	"Cell type enriched"	"Detected in some"	24	"Ciliated cells: 133.8"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	39	"AF22: 19.0"	"Region enriched"	"Detected in some"	6	"olfactory region: 29.0"	"Low region specificity"	"Detected in all"			"HPA012892, HPA071011"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA012892: AB_1857610, HPA071011: AB_2732169"		"unprognostic (2.64e-1)"	"unprognostic (1.91e-2)"	"prognostic favorable (1.49e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.17e-1)"		"unprognostic (4.24e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.35e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.74e-1)"		"unprognostic (1.22e-1)"	0.1	0.1	2.9	0.1	3.8	0.1	0.2	0.0	0.2	1.7	0.2	6.6	0.0	0.2	1.1	8.1	0.1	31.7	0.1	0.1	4.4	4.1	0.1	0.1	9.2	0.1	0.0	0.0	7.6	0.1	0.1	0.0	0.3	9.7	0.2	0.2	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.3	0.1	0.1	0.6	2.1	0.0	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	3.8	0.0	0.2	4.4	4.1	0.0	0.0	9.7	2.1	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	133.8	5.7	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0
SYCP1	"CT8, HOM-TES-14, SCP1"	ENSG00000198765	"Synaptonemal complex protein 1"	Q15431	1	114854803-114995370	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Meiosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	51	"testis: 30.6"	"Cell type enriched"	"Detected in some"	14	"Spermatocytes: 1077.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	93	"THP-1: 19.5"	"Region enriched"	"Detected in single"	51	"cerebellum: 16.5"	"Not detected"	"Not detected"			HPA021083	Enhanced		Approved	"Nuclear bodies,Cytosol"		NA	NA			"Nuclear bodies, Cytosol"		"HPA021083: AB_1857685"	"unprognostic (2.91e-1)"									"unprognostic (6.89e-3)"				"unprognostic (4.87e-1)"	"unprognostic (8.74e-3)"			0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	79.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.7	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	6.5	0.0	1077.5	21.3	0.0	0.0	0.0	0.0	0.0
SYNDIG1L	"capucin, IFITMD4, TMEM90A"	ENSG00000183379	"Synapse differentiation inducing 1 like"	A6NDD5	14	74405893-74426102	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	27	"brain: 78.1;epididymis: 20.1"	"Group enriched"	"Detected in some"	7	"Alveolar cells type 2: 2.4;Bipolar cells: 8.5"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	5	"basal ganglia: 78.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 1.2;NTERA-2: 1.3;SuSa: 1.8;U-266/70: 1.7;U-266/84: 1.9"	"Region enriched"	"Detected in many"	8	"basal ganglia: 251.1"	"Region enriched"	"Detected in many"	6	"basal ganglia: 71.7"	"HPA042594, HPA048487"	Uncertain					NA	NA					"HPA042594: AB_2678069, HPA048487: AB_2680416"	"unprognostic (5.75e-2)"	"unprognostic (9.96e-3)"	"unprognostic (2.25e-2)"	"unprognostic (5.51e-2)"	"unprognostic (3.08e-3)"	"unprognostic (5.72e-2)"	"unprognostic (5.83e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.83e-2)"	"unprognostic (5.74e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.85e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.50e-1)"	"unprognostic (5.22e-2)"	"unprognostic (7.34e-2)"	0.6	0.4	0.3	0.4	78.1	0.2	0.6	0.0	4.0	0.5	0.6	1.1	0.0	0.3	0.6	20.1	0.5	0.4	0.7	0.4	2.4	1.6	0.6	0.3	1.8	0.4	3.5	0.2	0.4	0.5	0.2	0.0	0.3	0.5	0.6	0.6	0.1	0.4	0.6	0.3	0.5	0.9	0.8	0.4	0.4	0.3	0.4	16.6	0.0	0.3	0.0	0.3	0.4	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.8	0.0	0.9	0.0	0.1	0.4	0.0	0.0	0.5	0.0	0.0	0.7	0.0	0.3	0.1	0.3	0.2	0.0	0.0	0.0	0.5	0.1	0.0	0.2	0.2	0.0	0.5	1.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.5	0.0	1.7	1.9	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.2	0.3	78.1	0.0	4.0	2.4	1.6	3.5	0.2	0.5	16.6	0.0	2.4	0.0	0.0	0.3	8.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0
SYNE4	"C19orf46, DFNB76, FLJ36445, Nesp4, Nesprin-4"	ENSG00000181392	"Spectrin repeat containing nuclear envelope family member 4"	Q8N205	19	36003299-36008793	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Cytotrophoblasts: 28.4;Intestinal endocrine cells: 28.6;Syncytiotrophoblasts: 28.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 15.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"CACO-2: 18.6;Hep G2: 16.1;MCF7: 18.9;SK-BR-3: 23.1;T-47d: 17.6"	"Region enriched"	"Detected in single"	15	"cerebellum: 7.6"	"Not detected"	"Not detected"			HPA060253	Uncertain					NA	NA					"HPA060253: AB_2684233"	"unprognostic (8.54e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.42e-3)"	"unprognostic (3.76e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.15e-2)"	"unprognostic (3.36e-3)"	"unprognostic (6.02e-2)"	"prognostic favorable (8.64e-9)"	"unprognostic (1.25e-1)"	"unprognostic (2.54e-2)"	"unprognostic (4.50e-1)"	"unprognostic (1.97e-2)"	0.1	0.2	0.2	0.4	2.7	0.1	6.3	15.3	2.0	3.1	1.8	0.3	16.9	3.5	1.0	10.3	1.3	4.6	3.5	0.1	0.2	4.4	6.5	9.0	4.2	0.1	2.1	0.1	1.0	7.5	14.1	18.1	3.3	10.0	9.5	1.7	1.4	10.9	12.6	0.2	0.9	4.4	0.4	1.0	0.3	2.6	0.3	0.6	1.4	14.4	0.7	1.0	1.3	1.1	0.0	0.0	0.8	0.0	0.0	0.3	0.1	0.1	0.1	0.1	0.2	0.0	0.1	2.4	0.0	0.0	0.1	0.1	18.6	2.1	0.1	0.2	0.0	0.1	0.0	0.1	0.2	0.0	0.5	0.2	0.0	0.2	16.1	0.3	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.1	0.8	0.1	0.1	0.0	18.9	0.3	0.0	0.0	0.1	0.1	0.4	0.0	0.2	1.2	0.6	2.8	0.0	0.0	23.1	0.1	0.0	17.6	0.0	0.0	0.0	0.3	0.1	0.1	0.2	0.3	0.3	0.1	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	2.7	15.3	2.0	0.2	4.4	2.1	0.1	10.0	0.6	6.0	10.8	0.9	16.1	0.5	0.5	0.4	12.7	12.0	10.3	27.9	3.9	28.4	21.6	18.4	0.0	0.1	2.9	0.0	7.6	19.4	0.9	19.6	1.1	10.9	2.2	0.0	28.6	0.0	0.3	0.0	0.0	0.1	0.0	0.0	10.0	0.0	12.8	14.4	0.0	16.3	0.4	0.0	0.2	0.0	0.5	0.4	28.4	0.0	6.8	5.8
SYNPO2	MYOPODIN	ENSG00000172403	"Synaptopodin 2"	Q9UMS6	4	118850688-119061247	"Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 185.8"	"Group enriched"	"Detected in many"	6	"Cardiomyocytes: 123.7;Peritubular cells: 95.5;Sertoli cells: 129.4;Smooth muscle cells: 291.5"	"Cancer enhanced"	"Detected in all"		"stomach cancer: 27.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 26.4;LHCN-M2: 9.4;SH-SY5Y: 40.3"	"Region enriched"	"Detected in many"	5	"thalamus: 64.1"	"Low region specificity"	"Detected in many"			"HPA030665, CAB037231, HPA049707, HPA068563"	Enhanced		Enhanced	"Vesicles,Actin filaments"		NA	NA			"Vesicles, Actin filaments"		"CAB037231: AB_262098, HPA030665: AB_10696210, HPA049707: AB_2680857, HPA068563: AB_2686006"	"unprognostic (1.50e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.39e-1)"	"unprognostic (5.71e-4)"	"unprognostic (2.18e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (5.67e-5)"	"unprognostic (1.82e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (3.91e-4)"	11.4	2.3	1.8	9.6	3.9	0.0	7.3	1.0	5.6	26.5	56.0	4.4	20.5	6.5	37.5	23.9	37.0	14.2	19.4	29.0	2.6	1.5	2.4	1.7	3.7	5.7	1.9	5.2	27.9	1.4	0.9	2.6	3.8	3.8	35.9	11.1	21.2	4.1	58.8	185.8	3.7	14.5	88.7	4.0	6.1	29.5	9.6	3.1	3.0	3.7	12.8	2.1	50.7	15.5	1.8	0.2	2.0	0.4	1.2	2.3	0.4	0.1	1.9	0.1	0.0	5.6	1.9	0.3	5.9	6.4	0.2	0.2	0.0	0.3	0.6	0.0	26.4	0.4	0.1	0.2	0.1	0.3	2.5	0.0	0.3	0.4	0.0	1.3	0.0	0.1	6.8	0.1	1.8	0.1	2.0	0.0	0.1	0.0	0.3	9.4	0.1	0.3	3.6	0.6	0.0	0.0	0.2	0.7	0.2	0.1	0.1	0.2	40.3	0.2	0.1	0.0	1.7	0.0	3.4	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.5	0.3	0.0	1.9	0.3	2.0	1.2	0.1	1.9	1.3	2.0	1.2	0.1	1.8	2.1	1.3	0.9	1.2	0.4	0.2	2.3	0.4	1.8	3.9	1.0	5.6	2.6	1.5	1.9	5.2	3.8	3.1	3.0	1.4	0.8	19.5	11.9	0.3	123.7	0.0	4.0	0.0	1.8	0.0	1.0	0.0	0.0	1.5	7.7	0.0	0.0	1.7	0.7	19.8	3.2	0.0	0.5	1.3	0.0	0.0	15.4	0.8	3.9	25.0	1.9	5.0	22.6	0.0	0.0	0.2	0.0	95.5	0.3	0.3	129.4	291.5	0.5	0.4	7.0	0.7	0.0	0.0	2.7
SYTL4		ENSG00000102362	"Synaptotagmin like 4"	Q96C24	X	100674491-100732123	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"endometrium 1: 36.2;ovary: 47.3;pituitary gland: 41.9"	"Cell type enhanced"	"Detected in many"	8	"Leydig cells: 67.3;Peritubular cells: 39.3;Sertoli cells: 51.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"neutrophil: 5.1"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 5.1"	"Cell line enhanced"	"Detected in many"		"HAP1: 15.1;HMC-1: 31.3;RT4: 20.6;TIME: 17.7"	"Region enriched"	"Detected in single"	5	"hypothalamus: 35.1"	"Low region specificity"	"Detected in some"			"HPA001475, HPA001589, HPA075138"	Approved		Approved	Vesicles		NA	Yes		6100000	Vesicles		"HPA001475: AB_1080172, HPA001589: AB_1080174, HPA075138: "	"unprognostic (7.82e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.43e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.78e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.07e-3)"	"unprognostic (5.62e-2)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (1.30e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.60e-2)"	3.8	3.1	9.1	2.8	9.5	1.6	4.4	4.3	8.4	18.1	5.3	6.6	4.8	1.7	36.2	5.4	2.6	10.0	2.9	2.1	11.9	6.0	4.2	7.1	3.0	0.7	9.8	2.7	47.3	8.8	1.3	41.9	2.6	9.4	9.2	6.8	1.3	3.8	6.0	4.5	1.4	3.0	22.5	7.8	2.3	5.3	7.8	9.5	0.0	6.2	1.1	1.4	4.3	9.4	0.5	0.3	5.1	0.3	0.5	0.4	2.3	0.1	3.0	0.8	0.0	4.5	2.5	0.0	3.9	2.5	4.2	7.5	0.3	3.9	0.0	1.0	2.7	3.6	3.5	15.1	1.3	4.4	0.0	1.3	0.0	5.1	0.2	1.1	0.0	31.3	0.9	0.3	3.8	0.2	1.6	10.5	0.0	1.4	0.0	1.9	1.0	0.0	0.0	0.6	10.6	0.0	0.0	1.2	0.0	3.7	20.6	7.6	0.3	1.5	5.9	0.8	1.6	3.7	0.3	17.7	2.2	4.7	10.8	0.9	0.0	0.0	0.0	2.7	0.0	2.4	1.1	0.3	0.5	0.2	0.2	0.2	0.3	0.2	0.2	0.0	0.5	0.4	0.2	5.1	0.5	0.2	0.3	0.1	2.3	9.1	9.5	4.3	8.4	11.9	6.0	9.8	2.7	9.4	9.5	26.8	1.7	0.0	6.9	0.1	0.1	3.6	22.9	6.7	6.8	3.5	0.0	0.2	3.3	5.5	1.6	9.5	15.8	0.0	2.0	0.2	6.3	15.5	3.5	32.1	1.0	0.0	0.0	12.3	1.6	2.0	67.3	0.9	3.3	0.0	18.0	4.6	5.4	25.4	39.3	1.6	0.4	51.8	6.2	1.4	4.6	0.6	0.0	0.7	8.1	7.6
TAL1	"bHLHa17, SCL, TCL5"	ENSG00000162367	"TAL bHLH transcription factor 1, erythroid differentiation factor"	P17542	1	47216290-47232220	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 33.1"	"Cell type enhanced"	"Detected in some"	22	"Endothelial cells: 18.0;Erythroid cells: 93.5;granulocytes: 35.8;Ito cells: 30.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 3.2;neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 3.2"	"Cell line enhanced"	"Detected in some"		"HEL: 52.8;HMC-1: 25.4;HUVEC TERT2: 11.0;JURKAT: 21.1;K-562: 16.5;TIME: 12.0"	"Region enriched"	"Detected in some"	5	"midbrain: 17.1"	"Low region specificity"	"Detected in many"			"CAB017805, HPA047866, HPA073983"	Approved		Enhanced	Nucleoplasm		Yes	NA			Nucleoplasm		"CAB017805: , HPA047866: AB_2680192, HPA073983: AB_2732246"	"unprognostic (2.63e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.80e-3)"	"unprognostic (3.95e-3)"	"unprognostic (1.33e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.99e-2)"	"unprognostic (5.42e-3)"	"unprognostic (3.68e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.18e-2)"	9.1	2.7	7.0	1.8	5.7	33.1	7.1	1.6	6.9	3.3	2.4	12.0	2.3	1.6	3.7	3.3	2.5	4.1	4.2	3.9	8.8	3.5	4.5	2.4	14.6	2.2	11.1	4.4	1.5	1.3	2.2	2.1	9.8	7.3	2.4	2.4	2.1	1.4	3.0	3.1	2.0	3.3	4.4	9.4	8.5	2.1	1.8	9.2	0.0	6.7	4.1	1.5	2.5	5.5	0.3	0.1	3.2	0.3	0.4	0.4	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	52.8	0.0	0.0	0.0	0.0	25.4	0.0	0.0	0.0	0.0	0.0	11.0	21.1	16.5	0.0	0.0	0.0	8.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.1	0.2	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.3	0.4	0.1	1.2	0.4	0.1	0.1	0.1	2.2	7.0	5.7	1.6	6.9	8.8	3.5	11.1	4.4	7.3	9.2	0.0	0.0	0.0	0.0	0.8	0.0	1.7	2.5	0.0	2.3	1.8	0.0	0.1	0.0	0.0	4.8	18.0	0.0	93.5	0.0	0.1	0.9	0.0	35.8	0.0	7.9	0.0	0.0	30.7	2.1	10.2	0.0	0.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.4	0.9	0.0	0.0	0.0	0.0
TBX10	"TBX13, TBX7"	ENSG00000167800	"T-box 10"	O75333	11	67631303-67639560	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	14	"intestine: 12.1"	"Group enriched"	"Detected in some"	8	"Enterocytes: 18.4;Mucus-secreting cells: 66.7"	"Group enriched"	"Detected in some"	5	"breast cancer: 0.8;colorectal cancer: 2.6;liver cancer: 0.5;prostate cancer: 1.9;stomach cancer: 0.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 2.9;NTERA-2: 6.8;RPMI-8226: 4.4;SK-BR-3: 15.9;U-2 OS: 3.4"	"Region enriched"	"Detected in single"	7	"pons and medulla: 0.4"	"Low region specificity"	"Detected in many"			HPA047881	Uncertain				"Intracellular and membrane"	NA	NA					"HPA047881: AB_2680199"	"unprognostic (4.66e-2)"	"unprognostic (2.96e-2)"	"unprognostic (7.71e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.83e-4)"	"unprognostic (3.12e-1)"	"unprognostic (3.29e-2)"		"unprognostic (5.10e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.90e-1)"	"unprognostic (1.17e-10)"	"unprognostic (6.77e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.75e-1)"	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	9.9	0.2	0.2	6.4	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.8	0.2	0.2	0.2	0.2	0.2	0.4	0.0	0.2	0.2	0.2	0.2	9.1	0.2	0.4	0.2	0.2	0.0	12.1	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.5	0.0	0.0	0.1	0.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.1	0.0	6.8	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.1	0.0	15.9	0.0	0.1	0.0	0.1	0.0	0.0	3.4	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.4	0.0	0.0	0.0	0.0	0.1	0.0	2.8	0.0	0.0	1.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	66.7	0.0	0.2	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0
TBX21	"T-bet, TBLYM"	ENSG00000073861	"T-box 21"	Q9UL17	17	47733244-47746119	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	Asthma	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 13.5;bone marrow: 12.2;lymphoid tissue: 17.7"	"Cell type enriched"	"Detected in some"	9	"T-cells: 20.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 13.5;NK-cell: 10.8"	"Group enriched"	"Detected in many"	8	"NK-cells: 10.8;T-cells: 13.5"	"Cell line enriched"	"Detected in single"	113	"HDLM-2: 19.1"	"Region enriched"	"Detected in single"	27	"olfactory region: 27.1"	"Low region specificity"	"Detected in all"			"CAB009524, CAB030043"	Enhanced					NA	NA					"CAB009524: AB_2200557, CAB030043: AB_1595503"	"unprognostic (3.31e-3)"	"unprognostic (3.17e-3)"	"unprognostic (1.17e-2)"	"unprognostic (5.35e-6)"	"unprognostic (3.93e-1)"	"unprognostic (2.56e-4)"	"unprognostic (5.86e-4)"	"unprognostic (6.90e-2)"	"unprognostic (3.63e-3)"	"unprognostic (6.26e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.93e-2)"	"unprognostic (3.04e-4)"	"unprognostic (7.92e-2)"	"unprognostic (2.67e-1)"	"unprognostic (9.19e-3)"	"unprognostic (4.43e-3)"	2.9	0.6	0.5	5.7	0.5	12.2	0.9	0.4	0.4	2.3	4.3	0.9	0.4	1.3	2.0	1.7	1.4	1.0	1.8	0.9	0.5	0.5	1.3	1.9	11.1	9.3	2.6	0.3	1.2	0.6	0.0	0.6	0.2	0.7	3.3	0.7	2.2	3.0	0.4	1.5	0.5	2.7	1.4	0.8	17.7	1.6	0.7	0.4	4.1	1.4	1.6	8.1	2.6	1.8	1.5	0.0	0.2	0.0	10.8	13.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	3.1	1.5	2.8	7.4	0.0	0.4	0.4	7.1	0.2	10.8	0.0	0.0	0.1	1.6	0.5	0.5	0.4	0.4	0.5	0.5	2.6	0.3	0.7	0.4	0.0	1.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.2	0.1	0.0	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.1	0.0	20.3	0.0	0.0
TEAD4	"EFTR-2, RTEF-1, TCF13L1, TEF-3, TEFR-1"	ENSG00000197905	"TEA domain transcription factor 4"	Q15561	12	2959330-3040673	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 60.1"	"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 37.4;Exocrine glandular cells: 32.8;Ito cells: 31.3;Syncytiotrophoblasts: 28.9"	"Cancer enriched"	"Detected in all"	5	"testis cancer: 78.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 86.2"	"Region enriched"	"Detected in single"	4	"cerebellum: 3.5"	"Low region specificity"	"Detected in some"			HPA056896	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA056896: AB_2683268"	"unprognostic (3.68e-1)"	"unprognostic (3.98e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.68e-1)"	"unprognostic (9.20e-3)"	"unprognostic (2.21e-3)"	"unprognostic (3.01e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (9.78e-9)"	"unprognostic (5.05e-3)"	"unprognostic (8.43e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.23e-3)"	7.6	1.9	1.2	4.5	1.8	0.5	11.1	2.0	2.5	3.6	3.1	0.7	7.4	3.2	4.4	5.1	4.2	3.1	4.3	9.7	1.4	1.1	9.2	5.5	10.3	5.3	2.4	0.4	4.4	27.5	1.1	1.5	6.8	3.2	3.8	2.9	3.9	3.5	7.1	60.1	6.2	5.2	5.7	1.9	7.2	3.6	2.2	1.4	0.5	16.4	13.3	2.5	3.1	10.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	8.6	12.2	3.1	8.6	0.9	2.1	33.4	6.9	3.7	12.0	6.7	23.2	9.2	0.0	5.4	5.2	8.1	12.4	12.1	86.2	11.2	0.0	9.8	13.7	10.0	20.0	4.6	2.9	2.6	3.0	3.5	10.4	16.1	5.0	10.2	5.5	8.7	0.1	4.1	12.2	0.1	0.0	23.9	11.0	7.2	6.3	17.7	6.7	5.6	3.6	1.8	3.2	8.6	21.6	6.3	23.6	14.6	5.0	11.6	7.0	24.4	4.8	3.6	0.0	0.0	0.0	5.6	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.8	2.0	2.5	1.4	1.1	2.4	0.4	3.2	1.4	11.9	6.6	0.0	9.5	10.9	0.0	1.7	7.6	1.4	2.3	7.0	0.0	37.4	5.0	11.6	0.1	19.7	6.5	0.0	32.8	12.7	8.2	15.2	5.7	0.0	4.5	0.0	0.0	31.3	1.5	1.3	0.0	0.4	8.5	0.0	3.2	0.0	21.6	0.0	0.4	14.3	0.0	0.0	12.7	0.2	6.4	6.8	28.9	0.0	4.1	3.1
TEX36	"bA383C5.1, C10orf122"	ENSG00000175018	"Testis expressed 36"	Q5VZQ5	10	125576522-125683144	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	52	"testis: 24.6"	"Group enriched"	"Detected in some"	43	"Early spermatids: 289.0;Late spermatids: 264.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"U-2197: 14.0"	"Region enriched"	"Detected in single"	14	"cerebellum: 2.6"	"Low region specificity"	"Detected in all"									NA	NA									"unprognostic (7.72e-3)"											"unprognostic (3.77e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	24.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	14.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	289.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	264.5	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	6.5	0.0	3.4	1.3	0.0	0.0	0.0	0.0	0.0
TFAP2C	"AP2-GAMMA, ERF1, hAP-2g, TFAP2G"	ENSG00000087510	"Transcription factor AP-2 gamma"	Q92754	20	56629302-56639283	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 53.9;skin 1: 32.5"	"Cell type enhanced"	"Detected in many"	11	"Basal keratinocytes: 117.7;Cytotrophoblasts: 77.5;Extravillous trophoblasts: 49.1;Suprabasal keratinocytes: 130.6;Syncytiotrophoblasts: 88.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 54.3"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"BEWO: 45.8;MCF7: 38.8;SK-BR-3: 73.8;T-47d: 20.6;WM-115: 27.1"	"Region enriched"	"Detected in single"	13	"olfactory region: 2.9"	"Low region specificity"	"Detected in many"			"CAB016061, CAB016079, HPA055179, HPA057076"	Enhanced		Supported	Nucleoplasm		Yes	NA			Nucleoplasm		"CAB016061: AB_667770, CAB016079: AB_2199447, HPA055179: AB_2682729, HPA057076: AB_2683329"	"unprognostic (1.74e-2)"	"prognostic favorable (6.90e-4)"	"unprognostic (2.24e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.52e-2)"	"unprognostic (6.75e-2)"	"unprognostic (2.54e-2)"	"unprognostic (8.26e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.14e-3)"	"unprognostic (2.63e-1)"	"unprognostic (9.04e-5)"	"unprognostic (2.31e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.71e-2)"	"unprognostic (3.28e-2)"	1.1	0.3	0.7	0.2	0.4	0.0	16.1	0.4	0.9	17.3	2.4	0.2	7.7	0.0	3.7	3.4	19.6	1.6	2.0	0.4	1.4	0.2	0.7	0.1	2.8	0.0	0.2	0.5	0.3	1.6	0.0	0.6	53.9	0.4	5.7	0.7	1.9	19.7	7.9	1.0	32.5	0.3	0.6	0.4	0.1	0.3	0.7	0.2	0.3	4.2	21.0	10.1	2.1	11.1	0.1	0.2	0.8	0.1	0.2	0.2	0.0	2.9	3.7	0.0	0.0	0.0	0.0	45.8	4.7	8.6	6.0	1.1	0.7	0.0	0.0	0.3	3.1	3.2	10.0	6.4	1.3	4.1	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.4	0.0	5.1	1.7	1.7	0.0	0.0	1.9	0.0	0.7	0.0	38.8	4.7	0.2	2.2	2.3	4.9	0.0	0.0	1.6	0.0	2.3	1.2	0.0	3.1	73.8	4.8	7.1	20.6	1.0	0.0	3.9	0.1	2.0	3.5	0.0	0.0	0.0	0.9	0.0	27.1	0.4	0.1	0.2	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.8	0.2	0.1	0.2	0.1	0.0	0.7	0.4	0.4	0.9	1.4	0.2	0.2	0.5	0.4	0.2	0.0	7.4	0.0	26.2	117.7	0.4	0.9	0.0	5.3	4.5	8.7	0.0	77.5	0.0	0.2	0.2	1.0	0.0	0.0	0.0	49.1	11.3	18.8	0.0	0.0	6.8	0.0	2.9	1.3	0.3	0.0	0.0	0.9	20.3	0.0	1.5	0.0	1.2	0.0	0.0	0.0	0.0	0.0	3.6	0.0	1.5	130.6	88.3	0.0	1.7	12.8
TFAP2D	TFAP2BL1	ENSG00000008197	"Transcription factor AP-2 delta"	Q7Z6R9	6	50713828-50772988	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	5	"brain: 4.4"	"Cell type enhanced"	"Detected in single"	24	"Horizontal cells: 1.6"	"Cancer enriched"	"Detected in single"	10	"lung cancer: 0.5"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HAP1: 5.2;U-2197: 1.6"	"Region enriched"	"Detected in many"	4	"midbrain: 14.1"	"Region enriched"	"Detected in many"	7	"midbrain: 16.3"	HPA048962			Uncertain	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			Nucleoplasm	"Golgi apparatus, Vesicles"	"HPA048962: AB_2680573"																		0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0			0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.1	0.0	0.0	0.0	0.0		0.0	0.0		0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TFF3	"HITF, ITF"	ENSG00000160180	"Trefoil factor 3"		21	42311667-42315651	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"gallbladder: 230.9;thyroid gland: 258.3"	"Cell type enriched"	"Detected in many"	21	"Mucus-secreting cells: 36697.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	30	"eosinophil: 9.5"	"Lineage enriched"	"Detected in single"	63	"granulocytes: 9.5"	"Cell line enhanced"	"Detected in some"		"MCF7: 28.4;OE19: 44.4;SCLC-21H: 8.7;T-47d: 13.3;TIME: 36.9"	"Region enriched"	"Detected in single"	20	"cerebellum: 1.7"	"Not detected"	"Not detected"			"CAB020681, HPA035464"	Enhanced		Approved	Nucleoplasm,Nucleoli	"Secreted to blood"	No	NA	151000000		Nucleoplasm	Nucleoli	"CAB020681: , HPA035464: AB_2674636"	"unprognostic (2.84e-2)"	"unprognostic (3.61e-3)"	"unprognostic (1.07e-1)"	"prognostic favorable (5.60e-6)"	"unprognostic (1.28e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.13e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.71e-1)"	"unprognostic (6.90e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.86e-2)"	2.2	1.2	0.2	16.8	0.2	0.0	4.3	0.2	0.2	45.1	66.3	0.2	0.5	40.8	2.8	1.2	5.1	8.0	230.9	0.7	0.2	0.3	1.0	0.6	12.6	0.6	0.4	0.2	2.0	4.8	0.0	0.5	0.5	0.2	3.6	63.3	0.3	54.8	0.7	0.6	1.6	70.6	1.5	0.5	5.0	1.1	0.4	0.2	0.3	258.3	14.4	72.6	1.1	1.6	0.0	0.0	9.5	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	28.4	0.0	0.5	0.1	44.4	4.3	0.0	3.2	0.3	0.0	0.0	8.7	0.1	0.0	0.8	0.0	0.0	13.3	0.0	36.9	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.2	0.2	0.2	0.3	0.4	0.2	0.2	0.2	14.9	22.3	0.9	17.0	37.0	0.0	13.4	1110.8	464.4	316.2	21.0	0.0	0.3	0.0	9.0	0.0	51.4	1768.3	0.0	62.1	0.6	20.3	103.0	60.8	0.9	1.9	4.8	740.8	82.9	2.6	0.8	2.3	2.5	91.1	0.0	36697.4	0.0	28.0	1779.2	7.4	0.0	0.0	0.0	6.1	0.3	0.3	33.8	0.7	1.0	1243.2	29.6
TG	"AITD3, TGN"	ENSG00000042832	Thyroglobulin	P01266	8	132866958-133134903	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Thyroid hormones biosynthesis"	"Hormone, Thyroid hormone"	"Cancer-related genes, Congenital hypothyroidism, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	247	"thyroid gland: 994.3"	"Cell type enhanced"	"Detected in some"	11	"Basal glandular cells: 4.7;Cardiomyocytes: 2.8;Club cells: 2.3;Early spermatids: 2.1;Proximal tubular cells: 2.1"	"Cancer enriched"	"Detected in some"	1672	"thyroid cancer: 3072.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 3.5;HSkMC: 4.3;Karpas-707: 9.9;PC-3: 4.9;U-266/70: 3.6"	"Region enriched"	"Detected in single"	5	"cerebellum: 1.3"	"Not detected"	"Not detected"			"CAB000077, HPA002740, CAB056155"	Enhanced				"Secreted in other tissues"	NA	NA		1000000			"CAB000077: , CAB056155: AB_2665573, HPA002740: AB_1080277"	"unprognostic (1.18e-1)"	"unprognostic (6.86e-2)"	"unprognostic (7.40e-4)"	"unprognostic (1.20e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.77e-2)"	"unprognostic (7.38e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.82e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.64e-2)"	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.4	0.6	0.1	0.0	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.3	0.3	0.1	0.1	0.1	0.1	0.0	0.1	3.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	994.3	0.1	0.1	0.1	0.1	0.3	1.2	4.0	0.6	0.0	0.9	0.5	0.0	0.0	0.0	0.0	0.9	1.4	0.6	0.0	1.8	0.0	0.1	0.9	0.0	0.0	0.2	0.4	0.0	0.5	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	4.3	3.0	1.1	0.0	0.9	0.0	1.3	0.0	9.9	0.2	0.0	0.1	0.0	0.0	0.0	4.9	0.1	0.0	0.4	0.2	2.8	0.3	0.2	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.3	0.2	0.6	0.0	3.6	3.0	0.0	0.2	1.3	0.0	0.0	0.6	0.7	0.2	0.0	0.9	0.0	0.4	0.0	0.0	0.3	0.3	0.2	4.0	0.0	0.3	1.2	0.4	0.5	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	1.1	0.0	4.7	0.0	0.0	2.8	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.4	0.3	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	1.0	0.0	0.3	0.1	0.0	0.4	2.1	0.0	0.0	0.0	0.1	0.2	0.5	0.0	0.0	0.0	1.4
TGM5	TGX	ENSG00000104055	"Transglutaminase 5"	O43548	15	43232595-43266857	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 9.7;lymphoid tissue: 10.4;skin 1: 24.3;tongue: 13.1"	"Cell type enhanced"	"Detected in some"	21	"Early spermatids: 3.1;Late spermatids: 2.6;Suprabasal keratinocytes: 5.8;Urothelial cells: 12.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"HEL: 20.2"	"Region enriched"	"Detected in single"	11	"cerebellum: 2.9"	"Not detected"	"Not detected"									NA	NA						"unprognostic (3.17e-2)"	"unprognostic (1.03e-2)"		"unprognostic (5.92e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.24e-2)"		"unprognostic (1.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.44e-15)"	"unprognostic (1.94e-1)"	"unprognostic (3.14e-1)"	"unprognostic (7.22e-3)"	"unprognostic (5.71e-2)"	0.3	0.0	0.1	0.1	0.1	0.2	2.1	0.1	0.1	2.6	0.1	0.1	0.1	0.0	0.7	0.1	9.7	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.8	0.1	0.6	0.0	0.1	2.8	3.4	0.1	24.3	0.1	0.7	0.1	0.1	0.0	0.1	0.1	0.1	0.1	13.1	10.4	0.8	4.7	0.0	0.0	0.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	20.2	0.0	0.4	0.0	0.7	2.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	2.3	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.8	1.6	0.0	0.0	12.6
TLDC2	"C20orf118, dJ132F21.2"	ENSG00000101342	"TBC/LysM-associated domain containing 2"	A0PJX2	20	36876121-36894235	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 54.9"	"Cell type enhanced"	"Detected in some"	11	"Enterocytes: 13.4;granulocytes: 14.0;Paneth cells: 13.3;Undifferentiated cells: 6.5"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 9.4"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	5	"basophil: 7.1"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 7.1"	"Cell line enriched"	"Detected in some"	6	"HMC-1: 28.0"	"Region enriched"	"Detected in many"	4	"cerebellum: 6.3"	"Region enriched"	"Detected in single"	12	"cerebellum: 15.5"	HPA047468	Enhanced					NA	NA					"HPA047468: AB_2680059"	"unprognostic (9.06e-3)"	"unprognostic (3.35e-4)"	"unprognostic (4.60e-1)"	"unprognostic (1.07e-3)"	"unprognostic (1.40e-1)"	"unprognostic (6.51e-3)"	"unprognostic (1.09e-3)"	"unprognostic (5.55e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.82e-2)"	"unprognostic (3.67e-1)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (9.97e-5)"	"unprognostic (7.25e-2)"	"unprognostic (6.20e-2)"	"unprognostic (5.59e-2)"	"unprognostic (4.87e-2)"	5.5	1.2	0.9	11.3	0.9	1.4	3.4	0.9	0.9	2.1	21.1	0.9	1.6	18.4	2.5	1.8	1.8	2.7	16.0	3.5	0.9	0.2	3.2	0.9	6.0	2.5	0.9	0.9	2.8	2.1	0.0	1.1	0.9	0.9	2.8	12.8	1.6	2.1	0.9	0.9	2.3	54.9	1.8	0.9	4.5	1.5	1.9	0.9	1.1	2.0	1.7	1.3	2.3	2.6	0.8	1.4	7.1	1.0	1.4	1.2	0.7	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.2	0.4	0.2	0.1	0.5	0.1	0.3	0.0	0.0	0.0	0.1	0.2	1.0	0.1	2.9	0.0	0.3	28.0	0.0	0.2	0.1	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.8	0.0	4.6	0.5	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.5	0.2	0.1	0.0	0.0	0.0	0.1	0.1	7.1	1.0	0.1	0.3	0.9	0.6	0.3	0.5	0.2	1.4	0.8	1.2	0.3	0.0	1.4	0.9	0.4	0.7	0.7	0.9	0.9	0.9	0.9	0.9	0.2	0.9	0.9	0.9	0.9	0.0	1.7	0.0	0.1	0.0	0.0	0.5	2.5	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	13.4	0.0	0.0	0.0	0.2	0.0	14.0	0.0	0.2	0.0	3.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.7	0.0	0.3	13.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.5	0.0
TLX1	"HOX11, TCL3"	ENSG00000107807	"T cell leukemia homeobox 1"	P31314	10	101130505-101137789	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	8	"lymphoid tissue: 59.5;salivary gland: 19.5"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 5.4;HEK 293: 3.0;K-562: 15.4;SCLC-21H: 2.6;SH-SY5Y: 3.8;SiHa: 2.5"	"Region enriched"	"Detected in single"	13	"pons and medulla: 0.5"	"Not detected"	"Not detected"									NA	NA						"unprognostic (8.67e-2)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (7.32e-4)"	"unprognostic (1.06e-5)"	"unprognostic (1.06e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.07e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.69e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.81e-1)"		"unprognostic (2.63e-1)"	"unprognostic (3.26e-1)"	"unprognostic (3.06e-1)"	"unprognostic (7.35e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.1	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.1	0.1	0.2	0.0	0.0	19.5	0.0	0.1	0.0	0.6	0.0	0.0	59.5	0.0	0.1	0.1	0.0	0.0	4.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	5.4	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.6	3.8	2.5	0.0	0.0	0.3	0.2	0.5	0.2	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0
TLX3	"HOX11L2, RNX"	ENSG00000164438	"T cell leukemia homeobox 3"	O43711	5	171309284-171312134	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	59	"brain: 46.6"	"Cell type enriched"	"Detected in some"	5	"Extravillous trophoblasts: 5.2"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 1.7"	"Region enriched"	"Detected in some"	22	"cerebellum: 46.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SH-SY5Y: 24.6"	"Region enriched"	"Detected in single"	7	"cerebellum: 2.5"	"Region enriched"	"Detected in some"	10	"cerebellum: 48.1"	"HPA030504, HPA060957, HPA069359"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA030504: AB_2732458, HPA060957: AB_2732655, HPA069359: AB_2732130"		"unprognostic (3.52e-2)"		"unprognostic (2.43e-2)"					"unprognostic (2.09e-1)"	"unprognostic (3.11e-1)"				"unprognostic (9.80e-2)"	"unprognostic (2.76e-2)"		"unprognostic (4.48e-2)"	0.4	0.5	0.0	0.0	0.0	0.0	0.0	46.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.3	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.2	0.0	0.0	24.6	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.6	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0
TMEM171	PRP2	ENSG00000157111	"Transmembrane protein 171"	Q8WVE6	5	73120292-73131817	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 18.2;intestine: 20.1;kidney: 25.4;stomach 1: 16.7;thyroid gland: 25.9"	"Cell type enhanced"	"Detected in many"	10	"Cholangiocytes: 20.4;Enterocytes: 49.5;Paneth cells: 44.1;Undifferentiated cells: 49.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"MAIT T-cell: 18.2;memory CD8 T-cell: 6.3"	"Lineage enriched"	"Detected in single"	86	"T-cells: 18.2"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 20.9;RPTEC TERT1: 16.0;WM-115: 58.5"	"Region enriched"	"Detected in single"	5	"hippocampal formation: 0.9"	"Region enhanced"	"Detected in single"		"pons and medulla: 3.6"	HPA042308	Approved					NA	NA					"HPA042308: AB_10796901"	"unprognostic (7.34e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.74e-3)"	"unprognostic (2.81e-5)"	"unprognostic (1.12e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (3.93e-10)"	"unprognostic (6.13e-3)"	"unprognostic (2.43e-1)"	"unprognostic (9.10e-3)"	"unprognostic (1.57e-1)"	0.2	0.2	0.8	5.6	2.1	0.0	0.7	0.7	3.3	0.4	20.1	3.2	2.2	16.2	0.2	1.4	3.9	0.2	1.5	0.2	1.2	0.7	25.4	3.9	0.4	0.1	0.9	1.6	0.2	0.6	0.0	0.3	0.1	1.1	0.5	18.9	0.6	1.4	2.8	0.6	0.7	18.8	0.6	1.4	14.6	16.7	0.6	0.6	0.0	25.9	3.2	6.3	0.4	0.3	0.0	0.0	0.2	0.0	0.0	18.2	0.5	7.5	0.3	0.0	0.0	2.4	3.3	0.0	2.4	11.2	4.5	7.7	0.2	3.5	0.0	5.2	3.0	0.9	5.7	0.1	0.3	3.5	0.0	1.2	0.0	0.0	0.0	0.8	0.0	0.3	0.7	0.2	6.1	0.5	1.8	2.8	0.0	0.0	0.1	20.9	0.7	0.0	0.0	0.6	0.1	0.5	0.0	0.0	3.8	16.0	0.1	0.0	0.0	1.8	0.0	0.0	1.3	0.4	0.0	0.0	0.0	0.4	6.6	0.1	0.0	0.0	0.0	6.1	0.0	58.5	0.0	0.0	0.0	1.3	0.0	18.2	0.0	0.7	6.3	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.5	0.8	2.1	0.7	3.3	1.2	0.7	0.9	1.6	1.1	0.6	0.0	0.0	0.0	0.3	1.5	0.0	0.3	20.4	0.0	0.0	7.0	0.0	0.1	13.3	5.9	0.0	0.0	49.5	0.0	9.0	0.3	0.8	0.0	0.0	1.1	1.0	0.0	2.4	0.6	0.0	0.0	0.0	0.0	1.7	0.0	16.0	0.0	7.2	44.1	0.0	9.1	0.0	0.0	0.1	0.2	0.7	1.5	0.5	0.0	49.5	0.9
TMEM190	MDAC1	ENSG00000160472	"Transmembrane protein 190"	Q8WZ59	19	55376836-55378244	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 63.6;ovary: 17.7;testis: 21.5"	"Group enriched"	"Detected in some"	9	"Ciliated cells: 338.6;Early spermatids: 390.3;Late spermatids: 112.4"	"Group enriched"	"Detected in many"	8	"endometrial cancer: 11.5;lung cancer: 2.6;ovarian cancer: 2.6"	"Region enhanced"	"Detected in some"		"hypothalamus: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 14.0;hTERT-RPE1: 5.0;SCLC-21H: 7.0"	"Region enriched"	"Detected in single"	7	"cerebellum: 0.9"	"Region enriched"	"Detected in single"	6	"cerebellum: 5.6"							NA	NA						"unprognostic (1.16e-1)"	"unprognostic (2.35e-1)"	"unprognostic (5.00e-2)"	"unprognostic (6.58e-2)"	"unprognostic (6.24e-3)"	"unprognostic (3.97e-2)"		"unprognostic (1.42e-1)"	"unprognostic (5.02e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.38e-5)"	"unprognostic (1.44e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.93e-1)"	0.1	0.7	0.1	0.1	0.3	0.1	0.1	0.2	0.5	5.7	0.1	0.5	0.1	0.1	1.4	1.1	0.1	63.6	0.1	0.1	0.6	2.7	0.1	0.1	11.8	0.1	0.1	0.1	17.7	0.1	0.0	3.0	0.3	1.0	0.1	0.0	0.1	0.1	0.2	0.1	0.6	0.1	0.1	0.1	0.1	0.5	21.5	0.3	0.1	0.1	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.4	2.5	0.0	0.5	0.0	0.0	0.2	0.7	0.3	0.6	0.1	1.8	1.5	2.6	0.2	0.7	0.4	4.5	0.0	0.0	0.0	4.3	0.2	0.0	2.7	14.0	0.9	0.0	0.1	0.2	0.0	0.1	0.0	5.0	0.0	0.2	0.0	3.4	0.0	2.0	0.3	0.0	0.5	1.7	0.8	0.2	1.6	1.4	0.0	1.3	7.0	1.3	1.4	1.8	0.6	1.3	0.8	0.0	0.0	0.2	1.1	0.2	0.7	0.5	3.2	0.8	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.5	0.6	2.7	0.1	0.1	1.0	0.3	0.0	5.8	0.0	0.0	0.0	0.4	0.0	0.0	338.6	33.0	0.0	0.0	0.1	0.0	0.1	390.3	0.0	0.0	0.0	0.0	0.0	0.4	0.1	1.1	0.0	0.1	0.0	8.5	0.0	0.0	112.4	4.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.5	0.0	0.0	0.0	0.0	2.4	1.7	0.0	0.3	0.0	0.0	0.0
TMEM266	"C15orf27, FLJ38190"	ENSG00000169758	"Transmembrane protein 266"	Q2M3C6	15	76059837-76229121	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 50.7"	"Cell type enhanced"	"Detected in some"	8	"Cone photoreceptor cells: 9.8;Cytotrophoblasts: 12.8;Late spermatids: 11.1;Rod photoreceptor cells: 7.6;Sertoli cells: 6.5"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.3"	"Region enriched"	"Detected in many"	12	"cerebellum: 50.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.0;HEK 293: 3.6;NTERA-2: 3.7;U-937: 3.3"	"Region enriched"	"Detected in all"	6	"cerebellum: 65.8"	"Region enriched"	"Detected in all"	6	"cerebellum: 66.4"	"HPA041921, HPA049425"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA041921: AB_10796789, HPA049425: AB_2732552"	"unprognostic (8.63e-3)"	"unprognostic (6.11e-3)"	"unprognostic (3.44e-3)"	"unprognostic (9.17e-5)"	"unprognostic (4.67e-1)"	"unprognostic (2.61e-2)"	"unprognostic (9.34e-3)"	"unprognostic (5.61e-2)"	"unprognostic (8.48e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.68e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.13e-2)"	"unprognostic (7.86e-2)"	0.1	1.9	1.1	0.2	1.9	0.2	0.4	50.7	4.2	0.2	0.2	0.6	0.0	0.3	0.2	0.1	0.3	0.3	0.1	0.1	0.9	1.3	0.9	0.1	1.1	0.3	0.7	0.3	0.1	2.4	0.2	5.1	2.4	1.9	0.4	0.2	1.1	0.2	0.1	10.6	1.5	0.1	0.1	0.4	0.6	0.3	1.4	0.0	0.0	0.2	0.7	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.9	0.1	0.8	0.8	0.0	2.0	3.6	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	3.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.9	50.7	4.2	0.9	1.3	0.7	0.3	1.9	0.0	0.0	0.0	0.0	0.9	0.0	2.6	0.0	0.0	2.7	0.0	1.8	9.8	12.8	1.7	0.0	5.9	0.0	0.0	0.0	0.2	1.7	0.7	0.8	0.0	0.0	4.2	1.6	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.7	0.5	7.6	6.5	0.0	0.5	2.1	0.0	4.9	0.0	0.0	0.4
TMPRSS3	"DFNB10, DFNB8"	ENSG00000160183	"Transmembrane serine protease 3"	P57727	21	42371837-42396846	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 24.7"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 1: 11.9;Cholangiocytes: 28.1;Ciliated cells: 17.4;Ductal cells: 14.4;Exocrine glandular cells: 12.6;Muller glia cells: 23.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 6.3"	"Lineage enriched"	"Detected in single"	7	"T-cells: 6.3"	"Group enriched"	"Detected in some"	5	"HEL: 18.8;U-266/84: 75.2"	"Region enriched"	"Detected in single"	7	"cerebellum: 0.9"	"Not detected"	"Not detected"									NA	NA						"unprognostic (8.47e-3)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (3.64e-4)"	"unprognostic (2.85e-1)"	"unprognostic (2.45e-3)"	"unprognostic (3.97e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.17e-2)"	"unprognostic (9.62e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (8.24e-4)"	"unprognostic (2.66e-2)"	"unprognostic (2.73e-1)"	"unprognostic (8.00e-2)"	"unprognostic (1.33e-1)"	1.8	0.7	8.6	0.3	7.7	0.3	9.4	0.3	7.1	6.8	0.4	0.0	0.0	1.7	0.9	0.4	0.4	24.7	8.6	0.2	1.8	1.6	3.5	3.5	3.7	0.6	3.7	2.0	2.8	7.4	0.2	5.8	5.7	3.3	0.8	0.4	2.4	12.3	0.6	0.3	0.6	1.3	0.2	0.2	0.6	15.9	0.2	0.8	0.0	9.8	0.2	0.6	1.9	0.0	0.0	0.1	0.7	0.8	0.0	6.3	1.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	9.2	0.0	18.8	7.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	4.1	0.0	0.4	1.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.8	0.4	0.0	0.0	9.8	0.4	0.0	0.0	0.9	0.1	0.0	0.0	0.5	0.0	0.0	0.2	75.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.2	6.3	0.0	3.5	3.6	0.1	0.0	0.7	1.8	0.7	0.0	0.8	0.0	1.6	1.0	8.6	7.7	0.3	7.1	1.8	1.6	3.7	2.0	3.3	0.8	11.9	3.0	0.0	1.9	0.2	0.1	0.6	28.1	17.4	3.4	7.0	0.0	0.0	5.0	14.4	1.3	0.0	1.3	0.0	12.6	0.1	0.1	1.9	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.4	0.3	0.1	0.0	0.0	0.7	23.8	7.9	0.6	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.1	0.0	1.3	0.4	3.9
TNNC1	TNNC	ENSG00000114854	"Troponin C1, slow skeletal and cardiac type"	P63316	3	52451102-52454070	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Muscle protein"	"Cardiomyopathy, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"heart muscle: 431.6;skeletal muscle: 765.7"	"Cell type enriched"	"Detected in many"	8	"Cardiomyocytes: 2506.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 4.0"	"Lineage enriched"	"Detected in single"	7	"T-cells: 4.0"	"Cell line enhanced"	"Detected in some"		"CACO-2: 24.3;CAPAN-2: 12.2;EFO-21: 24.4;HeLa: 16.0;Hep G2: 16.2;HSkMC: 25.3;U-2 OS: 37.5"	"Region enriched"	"Detected in many"	4	"cerebral cortex: 88.3"	"Not detected"	"Not detected"			"CAB002450, HPA044848, HPA056897"	Enhanced		Approved	"Nucleoplasm,Actin filaments,Mitochondria"		NA	NA		260000	"Nucleoplasm, Actin filaments, Mitochondria"		"CAB002450: AB_564152, HPA044848: AB_2679110, HPA056897: AB_2683269"	"unprognostic (2.18e-2)"	"unprognostic (1.70e-1)"	"unprognostic (8.66e-2)"	"unprognostic (3.43e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.92e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.15e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.15e-2)"	"unprognostic (4.86e-1)"	2.0	0.3	0.1	0.0	0.1	0.0	0.7	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.1	17.8	12.8	0.1	0.0	431.6	0.1	0.1	0.6	0.1	2.6	0.0	0.1	0.0	0.1	0.2	0.0	0.6	0.2	0.5	5.5	0.1	0.7	10.4	0.0	765.7	0.4	0.1	0.1	0.7	0.1	0.1	0.7	0.0	0.0	3.0	86.9	8.7	0.4	0.2	0.2	0.6	0.0	0.0	0.0	4.0	0.5	0.2	1.8	1.3	0.2	0.0	0.2	2.9	0.1	0.1	0.1	0.1	24.3	12.2	0.2	24.4	3.5	0.0	0.1	0.0	0.1	0.0	0.4	0.6	0.1	16.0	16.2	0.1	0.1	0.0	25.3	0.4	0.0	0.2	0.2	0.0	0.7	0.0	1.9	0.7	0.0	0.0	0.2	0.2	5.4	0.2	0.0	1.0	0.8	1.2	4.6	0.0	0.0	0.1	2.5	0.0	1.5	9.8	0.2	0.0	0.0	37.5	0.3	0.0	1.0	0.4	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.7	0.0	4.0	0.2	0.9	0.5	0.0	0.1	1.4	0.5	0.0	0.0	0.0	0.6	2.5	0.5	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.5	0.0	116.1	13.0	0.0	0.6	1.3	0.2	2506.5	0.0	0.0	7.9	3.5	2.0	44.2	23.2	6.6	0.6	0.0	0.7	0.0	11.8	4.0	14.0	0.6	0.0	0.6	4.1	0.0	318.5	0.6	0.0	3.6	20.8	1.0	5.0	0.0	0.3	1.5	4.4	0.0	166.9	0.5	0.0	0.0	15.5	1.2	0.4	0.6	26.0	0.8	1.5	4.1
TNNT1	"ANM, FLJ98147, MGC104241, NEM5, STNT, TNT, TNTS"	ENSG00000105048	"Troponin T1, slow skeletal type"	P13805	19	55132794-55149354	"Disease related genes, Predicted intracellular proteins"		"Muscle protein"	"Nemaline myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"skeletal muscle: 1047.7"	"Cell type enhanced"	"Detected in many"	11	"Basal keratinocytes: 54.4;Cardiomyocytes: 49.6;Spermatogonia: 26.7;Suprabasal keratinocytes: 26.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	5	"eosinophil: 53.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 53.3"	"Cell line enhanced"	"Detected in many"		"HMC-1: 121.8;RH-30: 91.7"	"Region enriched"	"Detected in many"	5	"thalamus: 136.6"	"Low region specificity"	"Detected in some"			"CAB015168, HPA058448"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Nucleoplasm, Golgi apparatus, Cytosol"		"CAB015168: AB_2206426, HPA058448: AB_2683720"	"unprognostic (1.88e-1)"	"unprognostic (7.23e-2)"	"prognostic unfavorable (4.66e-4)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (3.47e-3)"	"unprognostic (3.92e-3)"	"unprognostic (1.35e-3)"	"unprognostic (1.03e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (2.53e-4)"	"unprognostic (3.23e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (4.91e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.14e-2)"	3.2	0.0	1.6	0.0	1.0	0.1	0.1	0.1	1.0	0.0	0.1	0.0	0.0	0.1	0.0	24.4	22.3	0.4	0.1	6.1	0.9	0.4	0.1	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.2	0.0	7.2	0.0	0.0	11.5	0.0	1047.7	1.8	0.0	0.0	0.1	0.1	0.1	0.5	0.0	0.0	9.2	124.4	17.8	0.3	0.1	0.1	9.9	53.3	11.6	0.1	0.1	2.6	24.8	14.6	0.1	3.2	0.0	0.2	4.8	1.1	4.3	1.6	4.8	5.3	16.6	0.3	9.7	0.4	13.0	12.7	3.4	10.8	1.3	1.6	27.6	4.7	1.5	0.9	0.5	0.3	121.8	5.4	17.6	0.5	18.7	18.5	0.0	5.0	23.6	23.1	1.5	23.7	0.4	0.0	3.1	6.3	29.0	15.9	91.7	2.9	3.8	0.8	0.9	7.2	1.5	0.2	8.0	1.3	15.1	14.5	0.5	24.1	35.9	0.9	1.8	0.1	0.9	1.2	25.4	3.7	7.3	0.5	11.6	53.3	0.0	5.9	0.1	0.0	0.1	0.0	9.9	0.1	0.1	0.1	0.5	0.1	2.6	0.2	0.0	2.6	1.6	1.0	0.1	1.0	0.9	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.4	1.5	49.6	0.0	6.7	0.0	0.0	0.0	1.3	0.0	1.8	1.3	0.0	0.0	0.0	0.0	14.0	8.0	0.0	0.0	0.0	13.2	0.0	2.4	1.8	12.0	6.0	0.3	4.2	3.3	0.0	0.2	0.8	0.4	0.0	0.0	0.0	0.6	0.0	0.9	2.8	26.7	26.6	3.0	0.0	0.3	0.1
TRDN		ENSG00000186439	Triadin	Q13061	6	123216339-123637093	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 52.8;skeletal muscle: 215.5;tongue: 80.1"	"Group enriched"	"Detected in some"	21	"Cardiomyocytes: 855.7;Muller glia cells: 805.6"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 2.2"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	30	"basophil: 2.9"	"Lineage enriched"	"Detected in single"	30	"granulocytes: 2.9"	"Cell line enhanced"	"Detected in some"		"HAP1: 1.6;K-562: 1.8;MCF7: 6.1;SCLC-21H: 1.2;SK-BR-3: 2.0"	"Region enriched"	"Detected in single"	10	"olfactory region: 13.6"					"HPA038226, HPA058226"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA038226: AB_10795574, HPA058226: AB_2683643"	"unprognostic (1.05e-2)"			"unprognostic (1.99e-1)"	"unprognostic (9.20e-2)"	"unprognostic (3.06e-3)"		"unprognostic (2.40e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.42e-1)"	"unprognostic (8.42e-2)"	"unprognostic (8.71e-2)"	"unprognostic (9.93e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.55e-2)"		"unprognostic (3.97e-2)"	3.8	0.4	0.4	0.0	0.5	0.0	0.3	0.2	0.2	0.3	0.1	0.0	0.7	0.1	0.3	9.2	3.0	1.9	0.1	52.8	1.6	1.3	0.1	0.1	0.1	0.1	1.6	0.1	1.5	0.1	0.0	3.2	0.1	1.3	1.9	0.1	1.3	2.0	0.2	215.5	0.1	0.1	0.2	3.4	0.1	0.1	0.7	0.5	0.0	1.2	80.1	1.6	0.1	0.1	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.2	0.0	6.1	0.0	0.0	0.2	0.8	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	2.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.0	0.2	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.2	0.2	1.6	1.3	1.6	0.1	1.3	0.5	0.0	0.0	0.0	0.0	0.0	5.8	855.7	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	40.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	22.9	12.0	0.0	1.7	0.0	0.0	805.6	0.0	0.0	10.6	0.0	13.4	0.0	0.8	0.1	0.5	0.0	0.0	0.0	0.0	0.0
TRIM40	RNF35	ENSG00000204614	"Tripartite motif containing 40"	Q6P9F5	6	30136108-30148735	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 13.5;placenta: 39.4"	"Group enriched"	"Detected in some"	7	"Enterocytes: 3.6;Intestinal endocrine cells: 1.7;Paneth cells: 3.5;Spermatocytes: 1.8"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 0.7;stomach cancer: 0.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	52	"HEL: 5.1"	"Region enriched"	"Detected in single"	19	"thalamus: 3.4"	"Low region specificity"	"Detected in all"			HPA043818	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA043818: AB_10963090"		"unprognostic (2.88e-1)"	"unprognostic (5.20e-2)"			"unprognostic (4.11e-1)"	"unprognostic (1.13e-1)"				"unprognostic (1.77e-1)"			"unprognostic (4.84e-2)"				0.1	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	4.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	39.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.1	0.3	2.5	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.5	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.0	0.2	0.0	0.2	0.0
TRIM55	"MURF-2, RNF29"	ENSG00000147573	"Tripartite motif containing 55"	Q9BYV6	8	66126896-66175487	"Predicted intracellular proteins, Predicted membrane proteins"		"Muscle protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"heart muscle: 34.3;liver: 22.0;skeletal muscle: 37.0;tongue: 24.4"	"Cell type enhanced"	"Detected in some"	26	"Cardiomyocytes: 96.0;Ciliated cells: 17.4;Hepatocytes: 28.0"	"Group enriched"	"Detected in some"	10	"liver cancer: 12.3;renal cancer: 5.8"	"Region enriched"	"Detected in single"	4	"cerebellum: 3.3"	"Cell type enhanced"	"Detected in single"		"T-reg: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	4	"LHCN-M2: 97.8"	"Region enriched"	"Detected in single"	8	"olfactory region: 0.5"	"Not detected"	"Not detected"			"HPA038793, HPA053691"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	Cytosol	"HPA038793: AB_10673289, HPA053691: AB_2682231"	"unprognostic (5.44e-3)"	"unprognostic (1.25e-2)"		"unprognostic (5.93e-3)"	"unprognostic (4.07e-2)"	"unprognostic (6.83e-3)"	"unprognostic (3.77e-3)"	"unprognostic (8.31e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.10e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.77e-3)"	2.1	0.0	0.3	0.2	0.2	0.0	0.1	3.3	0.1	0.4	0.1	0.1	0.3	0.0	0.0	6.6	0.8	3.0	0.1	34.3	0.4	0.1	2.7	22.0	0.1	0.4	0.1	0.1	0.5	0.1	0.0	2.0	1.4	0.8	0.3	0.0	0.1	1.0	0.0	37.0	0.3	0.1	0.0	0.1	0.1	0.1	3.8	0.0	0.0	0.9	24.4	1.2	0.1	0.0	0.6	0.0	0.0	0.3	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	14.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	97.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.3	6.4	0.0	0.5	0.0	0.0	0.0	0.0	22.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.3	0.2	3.3	0.1	0.4	0.1	0.1	0.1	0.8	0.0	0.0	1.3	0.0	0.1	0.0	0.0	96.0	0.0	17.4	2.3	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.0	0.1	0.0	0.0	1.3	1.3	3.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	6.9	0.0	6.5	0.0	9.3	1.0	0.0	3.2	0.0	0.0	0.1
TSHZ1	"NY-CO-33, SDCCAG33, TSH1"	ENSG00000179981	"Teashirt zinc finger homeobox 1"	Q6ZSZ6	18	75210755-75289950	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Peritubular cells: 176.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 27.9"	"Region enriched"	"Detected in many"	5	"olfactory region: 81.2"	"Low region specificity"	"Detected in all"			HPA006982	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA006982: AB_1079886"	"unprognostic (2.02e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.03e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.12e-2)"	"unprognostic (9.05e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.43e-3)"	"unprognostic (1.26e-1)"	"unprognostic (8.00e-2)"	"prognostic unfavorable (1.71e-5)"	"unprognostic (3.42e-3)"	16.2	9.4	13.8	10.3	16.8	3.6	25.6	25.9	23.2	20.9	22.4	8.5	9.3	15.3	13.1	11.3	11.7	19.0	11.9	13.6	11.9	9.2	13.9	9.3	9.3	10.0	9.9	7.7	41.6	8.9	12.6	18.5	32.1	12.7	10.8	10.8	13.7	13.3	13.6	9.4	12.0	17.5	13.5	19.0	10.2	11.5	8.7	7.9	14.3	9.7	5.2	6.2	14.7	19.9	1.2	1.7	1.2	1.2	3.2	5.1	1.4	3.3	4.0	1.4	8.2	12.4	6.0	1.4	15.3	14.5	2.5	4.9	2.0	8.2	6.7	2.0	13.9	2.9	3.0	1.8	4.4	0.9	27.9	15.1	5.2	9.3	2.6	3.2	12.2	6.1	6.0	4.7	2.1	4.2	4.0	6.5	7.9	2.9	12.1	4.2	3.2	8.7	6.9	0.5	3.9	5.0	8.0	4.2	8.0	4.9	2.4	10.4	7.9	4.3	5.6	4.2	0.6	1.3	6.4	4.9	5.7	3.9	3.9	2.4	4.0	9.5	5.5	5.5	10.4	5.1	0.0	1.2	1.2	4.8	0.5	3.4	1.0	2.4	4.2	1.7	1.2	3.7	5.1	0.8	3.2	0.5	1.7	1.0	1.4	13.8	16.8	25.9	23.2	11.9	9.2	9.9	7.7	12.7	7.9	11.9	12.3	6.2	4.8	15.0	42.4	21.6	22.9	12.0	10.3	3.5	2.0	3.7	3.3	4.4	1.0	26.9	17.4	0.0	8.8	1.7	35.1	6.4	6.9	18.1	5.4	11.1	16.3	18.4	12.9	2.4	59.8	10.0	8.5	1.8	17.0	16.6	3.3	10.5	176.0	16.7	10.9	25.8	11.8	0.7	4.9	11.5	3.0	15.8	16.4	5.2
TSPAN10	OCSP	ENSG00000182612	"Tetraspanin 10"		17	81637171-81648749	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	29	"retina: 117.4"	"Cell type enhanced"	"Detected in many"	5	"Collecting duct cells: 12.2;Horizontal cells: 12.7"	"Cancer enriched"	"Detected in many"	15	"melanoma: 32.7"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 6.2;SK-MEL-30: 17.9;U-138 MG: 6.5;U-87 MG: 8.2"	"Region enriched"	"Detected in single"	12	"olfactory region: 1.6"	"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.81e-2)"	"unprognostic (3.67e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.08e-3)"	"unprognostic (3.74e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.59e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.43e-2)"	"unprognostic (7.31e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.58e-1)"	1.0	0.1	0.1	1.3	0.1	0.0	0.4	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.9	1.1	0.5	0.3	0.7	0.1	0.1		0.1	0.2	0.5	2.2	0.1	0.1	0.2	0.9	0.0	0.1	1.4	0.2	1.1	0.0	117.4	0.3	1.0	0.1	4.0	0.1	0.1	0.1	0.2	0.2	0.5	0.1	0.4	0.1	0.5	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.8	1.9	0.2	0.2	0.6	0.7	0.2	1.9	6.0	2.9	1.7	0.6	3.2	0.8	0.7	1.8	1.6	0.1	0.1	0.4	0.3	0.6	3.6	0.0	0.4	0.4	0.4	0.0	1.1	0.7	0.8	3.4	0.1	6.2	0.0	0.7	0.0	0.2	2.8	0.2	0.1	0.4	0.2	0.0	2.9	1.3	0.0	0.0	0.2	0.5	0.0	1.3	3.3	0.4	17.9	1.7	3.6	0.4	0.1	6.5	2.0	0.5	1.7	0.0	0.0	0.0	8.2	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											3.0	8.2	0.5	2.3	0.0	1.7	1.4	5.1	6.7	4.5	12.2	3.9	1.6	8.3	2.4	0.6	1.0	1.3	0.0	2.0	4.6	1.4	1.9	7.0	1.0	7.5	12.7	0.0	3.7	1.3	1.8	1.4	0.9	0.0	0.0	0.8	5.2	1.0	0.0	1.1	2.2	4.9	0.0	0.5	2.6	6.4	0.0	1.1	0.0	0.9	0.9
TSPAN4	"NAG-2, TETRASPAN, TM4SF7, TSPAN-4"	ENSG00000214063	"Tetraspanin 4"	O14817	11	842808-867116	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hofbauer cells: 204.2;Leydig cells: 159.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 38.8;intermediate monocyte: 36.6"	"Group enriched"	"Detected in many"	9	"dendritic cells: 25.8;monocytes: 38.8;NK-cells: 22.0"	"Low cell line specificity"	"Detected in many"			"Region enriched"	"Detected in all"	4	"cerebellum: 179.6"	"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.49e-1)"	"unprognostic (2.85e-1)"	"unprognostic (6.39e-2)"	"unprognostic (2.53e-1)"	"prognostic unfavorable (2.91e-4)"	"unprognostic (1.88e-1)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (1.24e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.18e-1)"	42.2	14.0	4.5	19.3	4.6	3.8	42.5	8.0	6.6	29.3	19.9	5.2	11.1	5.3	26.2	30.2	18.7	22.6	30.9	23.1	4.3	5.6	23.0	16.4	48.1	44.4	5.4	5.0	31.9	13.0	7.2	7.6	33.4	6.7	26.5	4.1	35.0	23.8	15.0	15.7	16.6	11.9	32.7	5.0	44.3	11.4	16.7	3.2	7.5	36.3	20.2	10.7	24.1	22.8	1.5	25.8	0.8	38.8	22.0	3.1	13.7	6.2	49.0	8.6	15.5	13.3	26.6	5.8	31.8	38.6	25.3	17.5	10.1	7.8	0.4	12.9	45.8	14.5	2.3	3.0	30.4	4.8	4.1	3.6	6.6	15.6	14.3	44.0	2.0	8.2	46.1	5.5	9.1	27.7	24.9	16.5	2.6	2.7	39.0	24.3	12.9	1.4	2.6	11.1	8.0	35.9	4.9	6.1	11.1	29.2	0.4	10.2	6.1	15.7	17.7	33.3	3.9	25.0	1.5	23.9	28.9	11.5	5.7	10.7	2.1	0.3	0.8	29.8	2.2	25.5	0.0	38.8	0.0	2.0	36.6	1.2	1.5	0.9	1.8	25.8	1.5	1.7	3.1	0.8	22.0	9.4	1.7	0.8	13.7	4.5	4.6	8.0	6.6	4.3	5.6	5.4	5.0	6.7	3.2	98.3	62.2	5.2	21.9	42.2	7.4	7.7	58.6	6.7	26.1	29.6	3.9	37.2	6.6	54.1	1.7	85.0	1.3	0.0	14.3	23.6	121.4	11.3	34.8	21.2	204.2	12.7	0.0	96.3	82.9	3.6	159.9	57.3	140.0	15.4	2.9	41.7	42.9	0.0	89.5	27.8	6.1	58.2	40.6	3.2	27.9	28.7	14.1	9.6	0.9	5.2
TSTD1	KAT	ENSG00000215845	"Thiosulfate sulfurtransferase like domain containing 1"	Q8NFU3	1	161037631-161038990	"Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 37.5;OE19: 39.8;SK-BR-3: 52.8;T-47d: 51.1;U-266/70: 59.7;U-266/84: 41.9"	"Region enriched"	"Detected in some"	4	"olfactory region: 8.2"	"Low region specificity"	"Detected in many"			"HPA006518, HPA006655"	Approved		Approved	"Cytosol,Cytoplasmic bodies"		NA	NA			"Cytosol, Cytoplasmic bodies"		"HPA006518: AB_2667608, HPA006655: AB_10600919"	"unprognostic (6.10e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.43e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.63e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.51e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.83e-2)"	"unprognostic (8.57e-3)"	"unprognostic (8.88e-3)"	9.1	19.9	14.8	15.4	29.8	13.1	24.2	3.6	13.9	10.1	18.1	4.4	45.4	12.2	4.2	34.7	23.3	21.8	16.0	14.4	12.2	8.1	28.4	26.0	19.2	14.6	4.1	13.2	15.0	62.2	27.7	32.9	10.1	6.3	26.0	12.8	11.9	79.8	46.0	9.2	18.7	16.5	5.6	1.9	10.4	14.1	15.0	5.5	20.4	61.3	19.5	27.1	12.3	11.0	77.0	30.9	55.0	14.8	42.1	58.7	31.9	21.4	0.2	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.0	21.2	4.6	13.0	0.0	0.0	19.9	0.0	8.5	0.0	17.8	16.0	2.4	8.1	0.0	2.3	8.0	0.1	0.1	5.3	0.0	0.9	0.0	2.9	19.1	0.0	25.2	2.5	37.5	21.7	0.1	0.1	39.8	0.1	7.1	0.0	33.0	18.5	6.0	13.1	7.0	0.0	52.8	0.1	11.1	51.1	0.1	0.1	0.0	8.0	0.1	0.9	59.7	41.9	4.6	0.0	0.0	0.0	55.0	3.6	51.2	36.3	10.5	34.8	75.8	47.8	40.2	10.9	77.0	54.7	45.9	51.6	42.1	14.8	30.9	58.7	31.9	14.8	29.8	3.6	13.9	12.2	8.1	4.1	13.2	6.3	5.5	235.2	172.5	87.8	263.5	76.6	11.5	49.7	221.7	445.7	177.5	349.0	25.5	237.9	580.3	133.0	14.1	14.6	335.6	0.0	132.4	100.5	27.4	450.5	120.3	124.5	63.7	3.2	210.0	12.3	18.3	14.6	7.8	47.2	143.4	288.6	340.6	29.3	129.9	191.5	9.2	413.9	23.8	19.4	22.1	31.3	40.7	118.7	126.3	120.4	248.2	338.2
TUBB6	"HsT1601, MGC4083"	ENSG00000176014	"Tubulin beta 6 class V"	Q9BUF5	18	12307669-12344320	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Extravillous trophoblasts: 423.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 46.7"	"Group enriched"	"Detected in many"	5	"B-cells: 14.8;dendritic cells: 46.7"	"Cell line enhanced"	"Detected in many"		"TIME: 94.1"	"Region enriched"	"Detected in single"	10	"olfactory region: 24.5"	"Low region specificity"	"Detected in all"			"HPA043640, HPA046280"	Approved		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		NA	Yes		150000000	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (4.40e-2)"	"unprognostic (8.28e-3)"	"unprognostic (1.22e-2)"	"unprognostic (5.20e-3)"	"unprognostic (8.42e-2)"	"unprognostic (3.37e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.74e-2)"	"unprognostic (4.95e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.25e-2)"	"prognostic unfavorable (1.22e-7)"	"unprognostic (5.83e-3)"	"unprognostic (1.99e-1)"	"unprognostic (4.94e-2)"	"prognostic unfavorable (9.69e-4)"	63.0	7.2	4.2	24.0	7.6	7.9	46.6	3.2	3.9	47.4	38.7	5.6	14.7	8.9	62.8	36.3	83.3	28.6	35.9	39.5	5.1	5.5	13.6	8.2	23.6	28.4	6.1	2.5	42.3	18.0	0.9	7.3	27.3	11.9	34.7	8.3	15.6	14.9	27.1	17.4	21.6	16.2	84.4	7.1	15.3	22.0	15.0	4.7	4.2	14.5	47.4	32.8	62.1	26.1	14.8	46.7	0.5	5.8	0.3	0.1	3.5	23.2	16.0	17.1	8.8	17.6	24.5	12.2	72.5	48.3	56.0	52.3	12.0	7.6	0.1	33.7	48.2	17.2	11.3	9.2	71.6	43.0	0.2	5.0	3.7	18.4	8.0	17.8	0.3	6.9	25.5	16.6	47.9	25.9	17.5	40.6	1.4	17.4	0.3	47.6	23.6	0.1	17.6	9.1	0.4	7.7	0.1	29.7	0.2	10.9	0.6	2.3	3.1	42.1	4.1	12.4	18.1	8.9	23.3	94.1	71.8	59.0	66.2	67.2	1.3	0.4	0.4	55.2	5.2	25.5	0.5	5.8	0.0	0.1	2.2	0.1	11.7	0.0	0.0	7.6	14.8	0.0	0.1	0.1	0.3	2.0	46.7	0.0	3.5	4.2	7.6	3.2	3.9	5.1	5.5	6.1	2.5	11.9	4.7	77.4	9.3	11.5	34.7	61.8	1.0	45.2	10.2	13.4	23.9	7.0	0.0	49.8	1.7	133.5	171.4	65.5	0.0	0.0	92.9	423.0	106.7	14.4	43.9	0.4	67.7	0.0	0.0	79.2	11.7	98.9	65.0	55.0	32.1	111.0	0.1	0.0	147.5	0.0	85.9	0.6	1.6	25.8	106.6	5.0	4.3	58.5	18.5	2.5	0.2	49.6
UBASH3A	"CLIP4, STS-2, TULA"	ENSG00000160185	"Ubiquitin associated and SH3 domain containing A"	P57075	21	42403447-42447681	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"blood: 17.6;lymphoid tissue: 62.3"	"Cell type enriched"	"Detected in some"	14	"T-cells: 16.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	11	"gdT-cell: 6.9;MAIT T-cell: 12.1;memory CD4 T-cell: 15.1;memory CD8 T-cell: 13.1;naive CD4 T-cell: 17.6;naive CD8 T-cell: 12.8;T-reg: 13.6"	"Lineage enriched"	"Detected in many"	15	"T-cells: 17.6"	"Group enriched"	"Detected in some"	6	"HEL: 13.4;JURKAT: 23.5;MOLT-4: 27.5"	"Region enriched"	"Detected in single"	13	"hippocampal formation: 0.5"	"Low region specificity"	"Detected in all"			HPA035367			Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA035367: AB_2732466"	"unprognostic (5.14e-4)"	"unprognostic (3.91e-4)"	"unprognostic (1.57e-2)"	"unprognostic (4.10e-5)"	"unprognostic (4.33e-2)"	"unprognostic (1.85e-6)"	"unprognostic (5.54e-4)"	"unprognostic (1.46e-3)"	"unprognostic (6.17e-4)"	"unprognostic (2.47e-3)"	"unprognostic (1.94e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.37e-6)"	"unprognostic (1.65e-1)"	"unprognostic (7.96e-2)"	"unprognostic (3.24e-2)"	"unprognostic (4.17e-2)"	1.1	0.7	0.3	19.7	0.3	2.6	0.8	0.3	0.3	0.9	2.8	0.1	0.0	1.9	0.8	0.8	1.2	1.3	3.2	1.1	0.3	0.4	1.4	1.1	6.0	23.1	0.4	0.0	0.7	0.6	0.0	0.6	0.4	0.3	1.2	1.0	1.1	5.0	0.2	0.3	0.5	5.9	0.6	0.7	10.8	2.2	0.4	0.0	62.3	1.4	1.1	14.1	2.6	1.1	0.0	0.0	0.3	0.0	1.1	17.6	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	13.4	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	23.5	2.5	0.0	0.0	0.0	27.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	12.1	0.0	15.1	13.1	0.0	0.0	17.6	12.8	0.3	1.1	0.0	0.0	13.6	5.1	0.3	0.3	0.3	0.3	0.3	0.4	0.4	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.6	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.1	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	16.2	0.0	0.0
UNC13D	Munc13-4	ENSG00000092929	"Unc-13 homolog D"	Q70J99	17	75827225-75844717	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	Exocytosis		"Familial hemophagocytic lymphohistiocytosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 67.1"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 70.2;granulocytes: 43.9;Hofbauer cells: 46.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 56.1;HMC-1: 58.2;SK-BR-3: 39.8"	"Region enriched"	"Detected in single"	6	"cerebellum: 5.6"	"Not detected"	"Not detected"			"HPA067117, HPA073525"	Enhanced		Supported	Vesicles,Cytosol		NA	NA		14000000	Cytosol	Vesicles	"HPA067117: AB_2685784, HPA073525: AB_2686615"	"unprognostic (6.79e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (3.62e-4)"	"unprognostic (2.98e-2)"	"unprognostic (1.42e-3)"	"unprognostic (3.93e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (6.01e-4)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (5.28e-12)"	"unprognostic (3.27e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.59e-2)"	4.5	3.3	2.9	17.1	5.2	31.3	4.5	4.1	3.1	5.2	5.2	2.8	1.4	4.5	3.8	1.8	11.5	5.2	8.7	13.0	1.8	1.6	2.6	4.9	30.1	24.9	4.5	1.6	8.7	5.5	0.3	5.3	67.1	3.2	3.1	2.6	2.6	8.0	3.9	3.2	3.0	7.6	2.8	3.7	33.8	7.2	2.2	3.3	23.6	2.4	9.3	24.7	7.0	8.2	4.0	6.9	24.8	13.6	8.2	11.5	7.9	8.4	3.2	0.1	0.0	0.1	0.2	10.7	0.0	0.0	0.0	0.0	8.2	19.1	0.7	10.2	0.0	1.4	2.9	0.0	0.5	0.0	0.1	0.1	56.1	24.9	5.2	0.9	21.4	58.2	0.1	0.4	0.1	0.5	0.5	3.8	9.8	19.4	0.2	0.0	14.4	22.6	10.7	0.2	15.0	0.4	7.2	0.2	0.3	0.3	3.4	0.0	15.6	3.6	39.8	0.2	0.1	10.7	12.1	10.6	0.1	15.1	0.1	0.0	0.3	1.3	0.9	0.1	6.8	0.0	24.8	8.0	16.4	11.5	9.4	10.4	4.0	6.7	8.1	6.9	2.2	5.3	6.9	22.4	8.2	13.6	4.0	6.0	7.9	2.9	5.2	4.1	3.1	1.8	1.6	4.5	1.6	3.2	3.3	41.7	11.7	22.2	1.7	1.0	11.3	70.2	10.2	0.0	5.7	3.5	19.6	2.8	0.0	6.2	3.9	5.7	20.0	0.0	5.3	8.4	2.3	1.1	43.9	0.8	46.9	4.8	5.8	4.3	22.7	0.0	2.6	18.4	1.7	13.6	2.3	5.8	27.8	10.5	1.4	0.6	15.5	0.0	1.4	1.4	0.9	1.3	21.6	30.5	2.2	2.0
UNCX	Uncx4.1	ENSG00000164853	"UNC homeobox"	A6NJT0	7	1232907-1237318	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"brain: 44.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	20	"cerebellum: 44.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	20	"NB-4: 47.2"	"Region enriched"	"Detected in single"	5	"cerebellum: 3.6"	"Region enriched"	"Detected in many"	8	"cerebellum: 19.3"	HPA063294			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA063294: AB_2684977"					"unprognostic (1.15e-1)"										"unprognostic (9.71e-2)"			0.1	0.1	0.0	0.2	0.0	0.1	0.1	44.8	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	1.1	3.5	0.1	0.1	0.1	0.9	0.0	0.1	0.1	0.1	0.3	0.1	2.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.5	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.8	0.0	0.0	1.1	0.9	0.0	2.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USH1G	"ANKS4A, FLJ33924, Sans"	ENSG00000182040	"USH1 protein network component sans"	Q495M9	17	74916084-74923256	"Disease related genes, Predicted intracellular proteins"	Hearing		"Deafness, Disease mutation, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 13.9;epididymis: 11.4;esophagus: 11.8"	"Cell type enhanced"	"Detected in some"	17	"Early spermatids: 7.8;Late spermatids: 12.2;Muller glia cells: 11.4"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 2.6"	"Region enriched"	"Detected in single"	20	"cerebellum: 13.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 4.5;hTCEpi: 4.2;K-562: 3.1;MCF7: 4.8;OE19: 4.6;U-2 OS: 2.6"	"Region enriched"	"Detected in single"	12	"olfactory region: 12.1"	"Low region specificity"	"Detected in some"			HPA024360	Uncertain					NA	NA					"HPA024360: AB_1858660"	"unprognostic (2.95e-1)"	"unprognostic (6.17e-2)"	"unprognostic (6.34e-4)"	"unprognostic (2.92e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.59e-4)"	"unprognostic (1.60e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.10e-4)"	"unprognostic (1.57e-1)"	"unprognostic (8.48e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.35e-2)"	0.0	1.4	0.0	0.0	0.4	0.3	0.0	13.9	0.2	1.4	0.0	0.0	1.1	0.3	1.9	11.4	11.8	0.2	0.0	0.1	0.7	0.0	0.3	0.0	0.1	0.0	0.0	0.0	3.6	0.4	0.0	0.0	0.0	0.5	0.1	0.0	1.3	0.9	0.1	0.0	4.2	0.7	1.5	0.0	0.0	0.0	2.6	0.0	0.5	0.0	1.2	0.8	0.5	1.7	0.0	0.0	0.3	0.1	0.0	0.3	0.1	0.1	0.1	0.2	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.4	0.1	0.0	0.0	0.0	4.5	0.9	0.2	0.0	0.7	0.2	0.0	0.0	0.1	0.0	0.0	0.5	0.1	4.2	0.0	0.0	0.0	0.1	0.0	3.1	0.3	0.0	4.8	0.0	0.1	0.1	4.6	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.4	0.1	0.5	0.0	0.2	0.7	0.1	0.1	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.4	13.9	0.2	0.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	12.2	0.3	0.0	0.0	0.0	0.0	11.4	0.0	2.9	0.4	0.1	0.2	0.0	0.0	0.2	0.4	0.3	0.2	0.0	0.0	0.0
USP50		ENSG00000170236	"Ubiquitin specific peptidase 50"	Q70EL3	15	50500562-50546708	"Enzymes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	15	"testis: 20.2"	"Group enriched"	"Detected in some"	87	"Early spermatids: 76.1;Late spermatids: 42.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"GAMG: 1.2;HaCaT: 1.2;HEL: 1.1;OE19: 1.3;RH-30: 1.0;SK-BR-3: 1.6;SK-MEL-30: 2.8;U-698: 1.0"	"Region enriched"	"Detected in single"	9	"hippocampal formation: 0.4"	"Not detected"	"Not detected"			HPA039470	Uncertain					NA	NA					"HPA039470: AB_10672964"	"unprognostic (7.05e-3)"	"unprognostic (2.38e-1)"		"unprognostic (2.01e-2)"	"unprognostic (4.04e-3)"	"unprognostic (3.37e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.81e-2)"	"unprognostic (4.65e-2)"	"unprognostic (2.47e-1)"	"unprognostic (7.49e-4)"	"unprognostic (3.03e-1)"	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	20.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.2	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.2	1.6	2.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.6	1.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	76.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	42.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.1	0.0	0.0	0.0
WISP1	"CCN4, WISP-1, WISP1-OT1, WISP1-UT1"	ENSG00000104415	"WNT1 inducible signaling pathway protein 1"	O95388	8	133191039-133231690	"Cancer-related genes, Predicted secreted proteins"	"Cell adhesion, Wnt signaling pathway"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	20	"Early spermatids: 1.6;Fibroblasts: 2.1;Sertoli cells: 6.5;Smooth muscle cells: 2.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HHSteC: 8.1;HSkMC: 45.6;hTEC/SVTERT24-B: 26.0;U-2197: 24.9"	"Region enriched"	"Detected in single"	6	"olfactory region: 11.9"	"Low region specificity"	"Detected in single"			"HPA007121, CAB012205"	Uncertain		Approved	Cytosol	"Secreted to extracellular matrix"	NA	NA			Cytosol		"CAB012205: , HPA007121: AB_1858844"	"unprognostic (7.77e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.30e-2)"	"unprognostic (3.20e-1)"	"unprognostic (7.72e-2)"	"unprognostic (6.63e-2)"	"unprognostic (8.61e-3)"	"unprognostic (3.26e-2)"	"unprognostic (2.07e-3)"	"unprognostic (1.41e-3)"	"unprognostic (3.01e-2)"	"unprognostic (2.67e-1)"	"prognostic unfavorable (1.91e-5)"	"unprognostic (7.52e-3)"	"unprognostic (2.55e-3)"	"unprognostic (6.03e-2)"	"unprognostic (5.67e-3)"	4.2	11.0	0.6	7.7	1.6	0.0	2.3	0.6	2.9	14.7	3.9	1.0	0.0	1.2	18.5	6.4	2.2	6.5	8.5	4.0	0.7	0.3	18.0	2.9	8.9	13.4	0.8	0.4	13.0	1.0	0.2	2.7	3.5	1.2	3.4	0.9	4.5	1.3	4.2	2.0	1.6	3.9	14.4	6.2	14.6	3.8	3.7	0.4	0.3	1.3	2.7	4.2	14.4	4.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.1	1.7	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	45.6	0.0	26.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.0	6.0	0.3	24.9	0.0	0.0	0.0	0.0	5.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.6	1.6	0.6	2.9	0.7	0.3	0.8	0.4	1.2	0.4	0.0	0.3	0.0	0.7	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	2.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	2.0	0.0	0.0	0.1	0.1	0.0	0.0	0.4
WNT9B	"WNT14B, WNT15"	ENSG00000158955	"Wnt family member 9B"	O14905	17	46833201-46886730	"Predicted intracellular proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 31.6;epididymis: 13.0;seminal vesicle: 19.1"	"Group enriched"	"Detected in some"	5	"Alveolar cells type 2: 1.1;Collecting duct cells: 1.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	6	"AF22: 1.9;SuSa: 5.7"	"Region enriched"	"Detected in single"	7	"thalamus: 6.4"	"Low region specificity"	"Detected in all"			"HPA058361, HPA059572"	Approved				"Secreted to extracellular matrix"	NA	NA					"HPA058361: AB_2683691, HPA059572: AB_2684067"	"unprognostic (1.18e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.18e-2)"	"unprognostic (7.48e-3)"	"unprognostic (3.37e-3)"	"unprognostic (1.78e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.66e-2)"	"unprognostic (6.19e-4)"	"unprognostic (1.13e-1)"	"unprognostic (3.69e-2)"	"unprognostic (7.52e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.37e-1)"	1.0	0.4	0.3	0.2	0.4	0.3	0.8	1.4	1.6	0.4	0.5	0.1	31.6	1.5	0.8	13.0	0.2	0.6	0.2	2.1	1.1	1.0	7.4	2.4	2.4	0.5	1.0	0.0	0.3	0.3	4.2	0.1	0.5	2.0	0.5	0.2	6.7	0.2	19.1	0.6	2.5	4.5	0.4	0.7	1.8	0.2	0.9	0.0	0.0	0.3	0.0	0.1	0.8	0.3	0.6	0.5	2.0	0.5	0.3	0.4	0.0	0.0	0.3	1.9	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.4	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.1	0.0	0.1	5.7	0.3	0.0	0.0	0.2	0.0	0.4	0.1	0.4	0.0	0.6	0.1	0.1	0.0	2.0	0.3	0.3	0.3	0.1	0.2	0.3	0.2	0.2	0.1	0.6	0.4	0.4	1.8	0.3	0.5	0.5	0.2	0.0	0.3	0.4	1.4	1.6	1.1	1.0	1.0	0.0	2.0	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
YIPF7	"FinGER9, FLJ39576"	ENSG00000177752	"Yip1 domain family member 7"	Q8N8F6	4	44622065-44678556	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	9	"skeletal muscle: 45.3;tongue: 14.8"	"Cell type enhanced"	"Detected in single"	32	"Cardiomyocytes: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 3.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.5;fHDF/TERT166: 1.3;GAMG: 1.8;PC-3: 1.3;SCLC-21H: 2.8;WM-115: 1.6"	"Region enriched"	"Detected in single"	6	"cerebellum: 0.7"	"Region enriched"	"Detected in single"	29	"cerebellum: 14.8"	HPA030642	Uncertain					NA	NA					"HPA030642: AB_10601027"	"unprognostic (9.41e-4)"	"unprognostic (2.27e-1)"		"unprognostic (2.90e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.63e-2)"		"unprognostic (1.34e-1)"	"unprognostic (9.46e-2)"	"unprognostic (9.81e-2)"	"unprognostic (2.32e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.98e-2)"	1.5	0.0	0.3	0.0	0.5	0.0	0.1	0.8	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.9	0.0	0.0	0.5	0.3	0.5	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.6	0.1	45.3	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	14.8	0.7	0.0	0.0	2.3	3.3	0.3	1.0	0.3	0.9	0.3	0.2	0.0	0.1	0.0	0.0	0.0	1.5	0.8	0.0	0.0	0.8	0.0	0.0	0.0	0.8	1.3	1.8	0.0	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	2.8	0.0	1.0	0.0	0.3	0.3	0.0	0.7	0.0	0.6	0.3	0.0	0.3	0.5	1.1	0.0	0.0	0.0	1.6	0.0	1.0	0.0	0.5	0.7	0.4	2.3	0.9	0.7	0.6	0.6	0.3	0.4	0.3	0.3	0.2	3.3	0.1	0.3	0.3	0.5	0.8	0.3	0.3	0.5	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
ZNF385C		ENSG00000187595	"Zinc finger protein 385C"		17	42025576-42098479	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in many"	6	"brain: 19.0;testis: 21.9"	"Cell type enriched"	"Detected in some"	9	"Early spermatids: 27.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	9	"cerebellum: 19.0"	"Cell type enriched"	"Detected in single"	7	"plasmacytoid DC: 3.2"	"Lineage enriched"	"Detected in single"	7	"dendritic cells: 3.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 3.9;JURKAT: 3.7;MOLT-4: 6.7;SCLC-21H: 5.5"	"Region enriched"	"Detected in single"	12	"cerebellum: 31.8"	"Region enriched"	"Detected in all"	7	"cerebellum: 44.2"							NA	NA						"unprognostic (1.58e-3)"	"unprognostic (3.38e-2)"	"unprognostic (2.02e-3)"	"unprognostic (3.95e-2)"	"unprognostic (3.95e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.48e-1)"	"unprognostic (8.67e-3)"	"unprognostic (1.10e-1)"	"unprognostic (8.90e-2)"	"unprognostic (2.59e-1)"	"unprognostic (8.71e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.22e-2)"	"unprognostic (6.05e-2)"	0.4	0.0	0.7	1.6	0.7	0.5	1.6	19.0	0.8	0.5	0.4	0.4	0.4	0.1	1.0	0.5	0.4	2.0	0.4	0.4	0.5	0.4	0.6	0.4	0.8	0.4	2.0	0.4	3.4	3.1	0.6	2.1	0.4	1.4	1.4	0.2	0.4	2.3	0.5	2.9	0.7	0.4	0.4	0.9	0.6	0.5	21.9	0.4	0.9	0.4	0.9	1.5	0.4	0.5	0.4	3.2	0.0	0.0	0.0	0.2	0.0	0.3	0.3	0.5	0.0	0.0	0.0	0.4	0.1	0.1	0.1	0.1	0.5	2.4	0.0	1.2	0.0	0.1	0.8	0.3	0.0	0.0	3.9	2.4	0.0	0.0	0.8	0.1	0.0	1.0	0.0	2.9	0.0	1.4	0.1	0.0	3.7	0.2	0.0	0.0	0.5	6.7	0.1	0.5	1.2	0.0	0.5	0.0	1.1	0.1	0.4	5.5	0.6	0.2	0.5	0.3	0.7	3.1	1.2	0.0	0.0	0.4	0.0	0.0	2.6	0.5	0.4	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3.2	0.0	0.0	0.7	0.7	19.0	0.8	0.5	0.4	2.0	0.4	1.4	0.4	0.0	0.3	0.0	1.6	0.3	2.0	0.4	0.0	0.0	0.0	1.8	0.0	0.1	1.7	0.4	27.8	0.0	0.4	0.0	0.4	0.1	0.6	2.3	0.0	0.0	0.6	1.6	0.0	0.0	0.0	3.1	1.4	0.0	0.0	0.0	0.5	2.9	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.9	1.9	0.5	0.0	0.0	0.4	0.8
ZP1		ENSG00000149506	"Zona pellucida glycoprotein 1"	P60852	11	60867562-60875693	"Disease related genes, Predicted membrane proteins, Predicted secreted proteins"	Fertilization			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 6.5;epididymis: 2.2;pituitary gland: 3.3"	"Group enriched"	"Detected in some"	7	"Early spermatids: 25.5;Late spermatids: 62.7"	"Low cancer specificity"	"Detected in single"							"Cell type enriched"	"Detected in single"	66	"plasmacytoid DC: 6.5"	"Lineage enriched"	"Detected in single"	66	"dendritic cells: 6.5"	"Group enriched"	"Detected in some"	36	"RPMI-8226: 16.2;SK-BR-3: 4.6"	"Region enriched"	"Detected in single"	7	"basal ganglia: 0.7"										"Secreted in female reproductive system"	NA	NA						"unprognostic (6.40e-3)"	"unprognostic (2.18e-4)"	"unprognostic (1.63e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.02e-2)"	"unprognostic (8.27e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.94e-2)"	"unprognostic (8.15e-3)"	"unprognostic (2.52e-1)"	"unprognostic (9.25e-4)"	"unprognostic (5.31e-13)"	"unprognostic (4.13e-2)"	"unprognostic (2.38e-1)"	"unprognostic (6.27e-2)"	"unprognostic (5.61e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.7	0.0	0.0			0.0	0.0	2.2	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.8	3.3	0.0		1.3	0.0		0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1			0.0		0.0	0.2	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.1											0.0	2.2	0.0	0.0	0.1	1.4	0.4	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	25.5	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	62.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	6.5	2.0	0.5	0.0	0.1	0.2	0.0	0.0	0.0
ZPLD1		ENSG00000170044	"Zona pellucida like domain containing 1"	Q8TCW7	3	102099244-102479841	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 3.0;gallbladder: 6.7;kidney: 2.6"	"Cell type enhanced"	"Detected in some"	18	"Cholangiocytes: 7.6;Ductal cells: 2.6;Late spermatids: 3.6;Muller glia cells: 11.4;Pancreatic endocrine cells: 3.1"	"Low cancer specificity"	"Detected in some"							"Cell type enriched"	"Detected in single"	8	"non-classical monocyte: 3.0"	"Lineage enriched"	"Detected in single"	11	"monocytes: 3.0"	"Cell line enriched"	"Detected in some"	8	"RPTEC TERT1: 12.4"	"Region enriched"	"Detected in single"	7	"olfactory region: 3.4"	"Low region specificity"	"Detected in all"			HPA077519			Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA077519: AB_2732349"	"unprognostic (2.49e-1)"	"unprognostic (2.83e-3)"		"unprognostic (6.38e-3)"	"unprognostic (1.88e-1)"	"unprognostic (5.02e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.63e-1)"	"unprognostic (2.89e-4)"	"unprognostic (4.59e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.97e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.23e-2)"	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.5			2.5	1.0	0.0	0.0	0.2	6.7	0.3	0.0	0.6	2.6	0.3	0.0	0.0	0.3		0.7	0.2	0.0	0.0	0.0		0.0	0.0		0.3	0.0	0.3	0.1	0.5	0.0	0.0	0.0	0.1	1.9			0.0		0.0	0.0	0.0	0.2	0.0	0.0	3.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.1	1.3	0.0	0.0	0.1	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	12.4	0.1	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	3.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.4	7.6	0.0	0.0	0.0	0.0	0.0	0.0	2.6	2.4	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	11.4	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0